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Daniel S. Treitler 
 
Chapter 1. Introduction 
Natural product total synthesis has long fulfilled many roles in synthetic 
organic chemistry, one of the foremost being inspiration of the development of novel 
methods and strategies to access particular structures.  The halogenated natural 
products represent one class of secondary metabolites that can serve to inspire new 
chemical methods.  Although nature’s enzymatic machinery is capable of installing 
halogen atoms onto organic frameworks efficiently, synthetic chemists often lack 
these same tools.  In particular, the development of halonium-induced polyene 
cyclization, asymmetric halogenation, and medium-ring haloether formation would 
facilitate access to hundreds of halogenated natural products, but these reactions have 
traditionally proven challenging. 
 
Chapter 2. The Discovery of BDSB and Initial Investigations into Halonium-
Induced Polyene Cyclizations 
Currently available electrophilic bromination reagents are often not suitable 
initiators for halonium-induced polyene cyclizations, likely due to competing inter- 
and intramolecular processes.  As such, we explored bromosulfonium salts for this 
purpose and in doing so developed a novel bromonium reagent (BDSB, 





handled reagent proved capable of cyclizing an array of polyene precursors rapidly, in 
good yield, and with high diastereocontrol.  The chlorinated analogue (CDSC) proved 
somewhat successful for initiating the analogous chloronium-induced polyene 
cyclizations. 
 
Chapter 3. The Total Syntheses of 4-Isocymobarbatol, Peyssonol A, and 
Peyssonoic Acid A, and Evaluation of Peyssonol A Analogues for Anti-HIV 
Activity 
Our novel reagent, BDSB, was applied to the successful total syntheses of 
three brominated natural products (4-isocymobarbatol, peyssonol A, and peyssonoic 
acid A).  These syntheses were predicated upon bromonium-induced polyene 
cyclizations of substrates of increasing complexity.  The total synthesis of peyssonol 
A uncovered a structural mischaracterization, one that would require the synthesis of 
four diastereomeric final products to rectify.  Given that the anti-HIV properties of 
peyssonol A have been documented, we undertook an exploration of the structure-
activity relationship of peyssonol A utilizing the many synthetic precursors and 
analogues at our disposal.  These studies indicated that both the aromatic and 
aliphatic portions of peyssonol A contributed to its observed bioactivity. 
 
Chapter 4.  Enantioselective Halogenation 
Chiral variants of BDSB, CDSC, and IDSI (the iodinated analogue) were 
synthesized from chiral sulfides and applied to halonium-induced polyene 





enantioselectivity was observed for cyclization reactions, moderate e.e. values (up to 
63%) were observed for both asymmetric dichlorination and asymmetric 
iodohydroxylation of alkenes.  Additionally, we developed an effective two-step 
surrogate for asymmetric halonium-induced polyene cyclizations that proved capable 
of affording the desired cyclic products in good yield and with moderate enantiomeric 
excess (up to 81%). 
 
Chapter 5. Bromonium-Induced Ring Expansion for Accessing 8-Membered 
Bromoethers and Application of this Reaction to the Formal Total Synthesis of 
(E)- and (Z)-Pinnatifidenyne 
A fortuitous rearrangement led to the development of a novel method for 
bromonium-induced ring expansion, one that transforms tetrahydrofurans into 
brominated oxocanes (8-membered ring ethers).  This BDSB-mediated process is 
high yielding and both regio- and diastereoselective, making it ideal for application to 
the synthesis of lauroxocanes: a large family of natural products built around an 8-
membered ring bromoether core.  This synthetic utility was demonstrated during the 
application of this strategy to the formal total synthesis of (E)– and (Z)–
pinnatifidenyne; the completed route represents the most expedient total synthesis (of 
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1.1  Total Synthesis: An Essential Endeavor 
Over nearly two centuries, natural product total synthesis has established itself 
as a vitally important enterprise in the field of organic chemistry.  From Friedrich 
Wöhler’s synthesis of urea in 18281 to present-day syntheses of enormously complex 
structures,2 total synthesis has captivated untold numbers of chemists.  Often 
described as an art as well as a science, natural product total synthesis is not only 
fascinating from an academic standpoint, but also fulfills many important roles in the 
fields of chemistry and chemical biology.  
In the past, accessing natural products by total synthesis was often one of the 
central tools used for structure elucidation.3  Although not as common in the current 
era of advanced two-dimensional NMR studies and X-ray crystallography,4 natural 
product total synthesis still plays a vitally important role; hundreds of natural product 
structures have been reassigned following an attempted total synthesis.  In fact, 
between 2005 and 2010, within the realm of marine natural products alone, more than 
40 structural reassignments resulted from synthetic efforts (far more than from any 
other method).5  Thus, although typically no longer integral for structure 
determination, in the twenty-first century total synthesis remains a critical tool for 
verifying natural product structures.  
Moreover, one of the most oft-cited benefits of total synthesis is that it can 
provide access to substantial amounts of compounds with potential medicinal uses.6  
All too often, the scarcity of a natural substance or the difficulty associated with its 





to provide sufficient quantities of these compounds, albeit only if the route employed 
is suitably scalable and efficient. 
An additional benefit along this vein is the production of analogues.  It is very 
uncommon, although not unheard of, for natural products to become marketed drugs.7  
This is often due to the fact that potent natural products rarely have desirable 
pharmacokinetic or toxicity profiles.6  Thus, investigating structure-activity 
relationships via the production of analogues in order to overcome this deficiency is a 
common process.  The difficulty in manipulating complex, often highly 
functionalized natural products isolated from nature has inspired chemists to turn to 
total synthesis for the production of viable analogs.  Indeed, a whole field (“diversity 
oriented synthesis”) has resulted from these endeavors; this development is slowly 
shifting the paradigm of how drugs are discovered in a commercial setting.8 
Finally, one of the foremost driving forces advancing the field of natural 
product total synthesis has been the development of new chemical methods. While it 
is true that syntheses have become increasingly ambitious, expedient, and efficient 
thanks to novel chemical reactions,2,3 so too has total synthesis supplemented 
methodology.  There are a plethora of examples in which the absence of available 
methods to access a particular natural product structure or substructure has inspired 
the development of a new reaction.  For example, interest in synthesizing steroidal 
natural products, which burgeoned in the mid-20th century, resulted in the discovery 
of polyene cyclizations,9 the Oppenauer oxidation,10 and reductive alkylation,11 as 





Obviously, these discoveries continued paying dividends long after interest in 
steroidal natural products waned.   
This idea – that the pursuit of natural products can inspire new methodologies 
that may benefit the field of organic chemistry as a whole – is by no means novel, but 
it lies at the heart of the Snyder group’s efforts, including the research outlined in this 
dissertation. As will be described, my efforts have been focused on developing tools 
and strategies for the synthesis of complex halogenated structures, with an eye 
towards utilizing the developed chemistry for natural product total synthesis. 
 
1.2  Halogenated Natural Products 
Over the last century, natural product total synthesis has advanced at a 
remarkable pace, with numerous challenging synthetic achievements across nearly all 
classes of compounds.2,3  Total syntheses of highly complex alkaloids, terpenes, 
peptides, and polyketides have abounded, such that perhaps some would argue the 
number of challenges left to overcome are dwindling.  However, while many classes 
of natural products have been conquered by total synthesis, one of the clearest outliers 
to this trend are the halogenated natural products. 
Originally considered to be obscure curiosities, naturally occurring 
organohalide compounds are surprisingly abundant, especially among marine 
organisms.14  In fact, around 5000 of these compounds have been isolated and 
characterized to date.14  These natural structures include terpenes, acetogenins, 
alkaloids, peptides, and aromatics; a small subset of these (1 – 7) are shown in Figure 





natural products, including those with halogenated aromatic rings (i.e. russuphelol, 3), 
primary halides (i.e. convolutamydine B, 5), or halogen atoms adjacent to carbonyls 
(i.e. cavernicolin 1, 7).  However, there are many halogenated natural products for 
which synthetic chemists currently have no reliable avenues of approach.  The 
remaining four compounds in Figure 1 (peyssonol A (1), haterumaimide L (2), 
halomon (4), and laurencin (6)) may not seem highly complex, but these in fact 
represent examples of compounds which synthetic chemists have traditionally 
struggled to synthesize efficiently and/or biomimetically.   
 























































Figure 1. Selected halogenated natural products.
 
 
For example, peyssonol A (1) and haterumaimide L (2) are the products of 





broadly effective synthetic counterpart.  The deceptively simple natural product 
halomon (4) has been functionalized via enzymatic enantioselective alkene 
dihalogenation, a process which has attracted the recent attention of several organic 
chemistry groups as it remains largely unsolved.  Finally, laurencin (6) is one of 
nearly 100 naturally occuring medium-ring bromoethers, putatively assembled by 
bromoetherification of a linear precursor.  Once again, this is a process which nature 
accomplishes quite efficiently with enzymes, but it has no counterpart in the realm of 
organic synthesis.  The following sections will discuss in detail each of these 
perceived deficiencies based on literature precedents detailing methodology currently 
available to address them.   
 
1.3  Halonium-Induced Polyene Cyclizations 
Cyclizations initiated by halonium ions abound in the synthetic literature as 
well as in nature.16,17  These cyclizations are initiated when an alkene is activated by a 
halogen electrophile; subsequent intramolecular attack by a nucleophile completes the 
cyclization event.  Depending on the identity of the intramolecular nucleophile, a 
number of products can form.  Halogenated lactams, lactones, tetrahydrofurans, 
tetrahydropyrans, pyrrolidines and piperidines are commonly the products when the 
intramolecular nucleophile is a heteroatom.  These types of cyclizations are well-
documented synthetically, with the exception of medium-ring formation (to be 
addressed in the next section).16  When the intramolecular nucleophile involved in a 
cyclization event is another alkene, the resultant reaction is a halonium-induced 





utility in that it forges new carbon-carbon bonds to afford one or more carbocyclic 
rings, often highly diastereoselectively. 
In nature, marine organisms belonging to many families achieve success in 
halonium-induced polyene cyclizations through the use of oxidative enzymes known 
as haloperoxidases.17  These enzymes typically contain a highly oxidized iron or 
vanadium cofactor, which serves to oxidize the bromide and/or chloride ions found in 
seawater to their corresponding halonium ions.17  As illustrated in the upper portion 
of Scheme 1, these halonium ions can interact with oligoisoprene substrates to initiate 
a cyclization event in which one or more rings are formed.  Eventually, the 
cyclization terminates when a resultant carbocation (i.e. 9) is quenched by addition of 
a nucleophile (i.e. 10) or elimination of a proton (i.e. 11).  The hydrophobic pocket of 
the enzyme involved is thought to be crucial for the cyclization event.  In aqueous 
media the reaction would not be expected to succeed, since the initial halonium ion is 
quenched by water faster than the rate at which cyclization occurs.18  As depicted in 
the lower portion of Scheme 1, there are around 200 natural products that 
retrosynthetically derive from a halonium-induced polyene cyclization; most of them 
contain bromine atoms (14) while the remainder possess chlorine (13).  Based on 
structures isolated to date, nature appears not to employ fluoronium- or iodonium-































~40 Natural Products ~150 Natural Products 0 Natural Products
Scheme 1. General mechanism for halonium-induced polyene cyclization, as well as
the prevalence of such products in nature, categorized by the identity of the halogen.
 
In the realm of chemical synthesis, polyene cyclizations are very well-
documented when the initiating electrophile is a carbocation or activated epoxide.19  
However, the corresponding halonium-induced cyclizations have met with far less 
success.16  Much of the previous research done in this area has focused on the 
bromonium-induced variant, likely due to the relative abundance of cyclic bromides 
(see Scheme 1) in nature.  Unfortunately, most previously attempted bromonium-
induced polyene cyclizations have met with little success, as illustrated by the 




















































































































The major downfall associated with these previous attempts appears to be the 
competitive rates of intramolecular and intermolecular processes.  As shown in 
Scheme 2, the most commonly employed sources of electrophilic bromine, elemental 
bromine and N-bromosuccinimide, are indeed sources of “Br+”, but both contain an 
associated anion (bromide or succinimide).  These anions are typically too 
nucleophilic and/or basic to allow the desired cyclization to proceed; that is, the initial 
bromonium ion (34) is quenched intermolecularly prior to undergoing intramolecular 
cyclization.  This outcome may seem counterintuitive since intramolecular processes 
are typically faster than the corresponding intermolecular processes.  However, it can 
be explained by relative nucleophilicity; among the distal alkene of 34, the bromide 
ion, and the succinimide ion, the latter two are several orders of magnitude more 
nucleophilic.  This explanation is reinforced by the fact that compounds containing 
even moderately electron-poor alkenes, such as those with allylic esters (16, 27, Table 
1), nitriles (30, Table 1), or even acetate groups (21, Table 1), have traditionally 
behaved poorly as substrates for halonium-induced polyene cyclizations. 
In an attempt to circumvent the difficulty of inducing such cyclizations with 
typical electrophilic brominating sources, more recent synthetic efforts have utilized 
more exotic reagents, such as 2,4,4,6-tetrabromocyclohexa-2,5-dienone (TBCO, 
shown in the upper right of Scheme 2) or bis-pyridine/bis-collidine bromonium salts.  
Unfortunately, these reagents have proved at best only modestly successful (Entries 7 
– 10, Table 1), again likely due to the presence of nucleophilic and/or basic 





induced polyene cyclizations have typically suffered due to the choice of bromonium 












































Scheme 2. Traditional reagents employed for bromonium-induced polyene cyclization,
along with the postulated reason for their typical lack of success.
 
 
Polyene cyclizations initiated by other members of the halogen family are 
much scarcer in the literature.  To the best of our knowledge, there are no previous 
examples of synthetic fluoronium- or chloronium-induced polyene cyclizations.  A 
small number of iodonium-induced polyene cyclizations have been reported; the 
major developments are illustrated in Scheme 3.  Again, the reagents employed are 
not typical iodinating agents (I2 or NIS).  Barluenga’s solution relied on a 





Meanwhile, Ishihara et al. utilized a chiral iodophosphoramidite (produced in situ 
from NIS and phosphoramidite 42) to initiate their cyclizations.20c  Ishihara’s solution 
was particularly exciting because the products were produced with high enantiomeric 
excess.  Nonetheless, both Ishihara’s and Barluenga’s reagent combinations require 
very long reaction times at cryogenic temperatures, and substrate scope is narrow 
(only 3 polyene substrates were shown in each publication).20c,21  Notably, 
compounds with electron-deficient alkenes were not reported, and it was later 
determined that these substrates do not undergo cyclization when exposed to the 






































-80 °C, 15 h
-40 °C, 24 h
39 40
41 43
Scheme 3. The two published methods for iodonium-induced polyene cyclization.
1) Barluenga et al.
2) Ishihara et al.
 
In conclusion, although the synthetic community has exhibited a clear interest 
in undertaking halonium-induced polyene cyclizations, there currently exist no 
broadly applicable solutions.  While some reagents can effect bromonium- and 
iodonium-induced cyclizations, yields are generally low and substrate scope is 
typically modest.  Additionally, no solution has yet been uncovered for synthetic 





targets such as peyssonol A (1) or haterumaimide L (2) would likely be impossible 
using current methodology, even in a racemic sense. 
 
1.4  Enantioselective Halogenation 
The enzyme-mediated halonium-induced polyene cyclizations described 
above (as well as the halonium-induced cycloetherifications described in the 
following section) all proceed enantioselectively; halocyclic products are produced in 
nature as single enantiomers.  In fact, most halogen atoms installed onto aliphatic 
frameworks in nature are done so enantioselectively, including those halogens 
incorporated by simpler reactions like dihalogenation and halohydrin formation.17  
The compounds illustrated in Figure 2 represent a subset of the many natural products 
purported to arise from such reactions, including terpenes such as telfairine (44) and 
halomon (4), polychlorinated sulfolipids such as danicalipin A (46), and halogenated 



























Figure 2. Selected natural products that are likely the product of asymmetric

















Once again, however, nature’s success has not been mirrored by synthetic 
procedures.  Although the first synthetic halogenation of an alkene was performed 
more than 160 years ago,24 development of the asymmetric variant of this reaction has 
proven incredibly challenging.  The past several decades have seen many synthetic 
efforts aimed at asymmetric alkene halogenation reactions; however, unlike similar 
alkene oxidations such as epoxidation25 or dihydroxylation,26 enantioselectivity has 
been far more difficult to come by.   
To date, the only asymmetric halogenation reactions for which there are a 
number of effective, highly enantioselective solutions are α-halogenations.  Installing 
fluorine, chlorine, or bromine atoms adjacent to aldehydes, ketones, or carboxylic 
acid derivatives has proven challenging, but several effective solutions have come to 
light, mostly within the last decade.27  Meanwhile, successful protocols for 
asymmetric alkene halogenation, as well as asymmetric halohydrin, haloether, or 
haloester formation, have proven far more elusive. 
One major perceived challenge relating to asymmetric alkene halogenation is 
halonium-ion transfer.28  This process, depicted in Scheme 4, occurs when three-
membered halonium ions transfer their halogen atom to unreacted olefins.  This 
process has been well-studied and is extremely rapid,28e such that even if the 
appropriate chiral complex could add a halonium ion to a single face of an alkene (i.e. 
47 → 48), transfer events may have eliminated this initial enantioselectivity by the 
time a nucleophile attacks, resulting in a racemic product (50/51).  Traditionally, this 





which would require a high concentration of starting material with respect to reactive 
















II. Halonium transfer equally likely to either face of unreacted starting material:
























48 49 50 51
Scheme 4. How halonium transfer potentially erodes the




Recent studies, however, seem to indicate that halonium transfer reactions 
may not be faster than intramolecular cyclizations, even those in which the internal 
nucleophile is relatively weak (such as an electron-rich aromatic ring).29  Additional 
studies have shown that, depending on the conditions, even intermolecular 
nucleophilic additions can compete with halonium transfer processes.30  With recent 





does one then explain the dearth of successful catalytic enantioselective halogenation 
reactions? 
Perhaps the best argument is that it is very difficult to put halogen atoms into 
a chiral environment, since they typically only form one bond.  Just as 
enantioselective catalysis with Au(I) has traditionally been difficult,31 the 
monodentate coordination afforded by a halogen atom may afford too much free 
rotation (and hence a lack of conformational rigidity).  Additionally, bonds to 
halogens, especially bromine and iodine, are quite long; not only is a potential chiral 
“ligand” bound to a halogen atom 180° away from the approaching alkene, but the 
physical distance between the two could often preclude through-space interactions.  
As such, the real challenge in asymmetric alkene halogenation may be to somehow 
induce the chiral centers of the halonium ion “ligand” to be near enough to the 
substrate such that steric or electronic biases can become a factor in 
enantiodifferentiation. 
Nonetheless, a few effective enantioselective halogenation reactions have 
appeared in the recent literature.  One class of solutions avoids electrophilic halonium 
ions completely by utilizing chiral transition metal complexes to catalyze 
halogenation of alkenes (see Scheme 5).  For example, the Henry group recently 
discovered that a chiral palladium catalyst and a stoichiometric oxidant in the 
presence of very high concentrations of Br- or Cl- can perform catalytic 
enantioselective dibrominations and chlorohydroxylations of alkenes.32  While 
typically providing the products with high enantioselectivity, this method is currently 





utility.  A second metal-mediated process was employed by the Kang group, in which 
chiral complexes of several first row transition metals were able to catalyze 
asymmetric intramolecular iodoetherifications and iodolactonizations in the presence 














M = Cr : 89% yield, 84% e.e.
M = Mn: 89% yield, 52% e.e.
































Scheme 5. Asymmetric halogenation reactions catalyzed by chiral metal complexes.
1) Henry et al.
2) Kang et al.
 
 
Very recently (since 2009), several procedures have appeared in the literature 
for significantly enantioselective (>80% e.e.) alkene halogenations that successfully 
make use of electrophilic halogenating reagents and presumably proceed through 
halonium-intermediates;34 all eight of these procedures are illustrated by the examples 





enantioselective halogenation reactions.  An examination of the starting materials 
reveals that every alkene substrate has one or more polar functional groups (alcohol, 
ketone, carboxylic acid, or amine) that can serve as potential sites for coordination to 
a catalyst, cocatalyst, or initiator.  Additionally, the catalysts themselves (with the 
exception of 58, which is in fact not a catalyst but present at superstoichiometric 
levels) contain multiple heteroatoms in addition to one or more aromatic ring in all 
cases.  These motifs potentially facilitate binding to both the halogen source and the 
substrate by electrostatic interactions, cation-pi interactions, and/or hydrogen bonding.  
In conjunction with the observation that stoichiometric chiral amines fail to effect 
asymmetric alkene halogenation (i.e. appending a chiral “ligand” on an electrophilic 
halogen source),36 it appears that the successful asymmetric halogenation achieved by 
these newer methods requires multiple interactions to bring together chiral initiator, 
halogenating agent, and substrate in a carefully controlled environment.  Such a 
complex is found in the proposed mechanisms put forth in many of these 
publications.35  Additionally, if it is true that halonium transfer must be suppressed to 
maintain high enantioselectivity during these processes, these methods may succeed 
because the substrate/halonium/catalyst complex formed is sterically discouraged 
from undergoing halonium transfer.  Another possibility is that halonium transfer 
events are possible, but the presence of the substrate-bound chiral catalyst influences 
these events to occur with enantioselectivity.  One final explanation is that both 
halonium ion enantiomers can form, but the chiral catalyst/initiator remains bound to 
these ions resulting in diastereomeric complexes that may be attacked by nucleophiles 


































































































































































































































































































































































































































































































































































































































































































































Although the last few years have seen a drastic increase in the number of 
successful procedures for enantioselective halogenation reactions, many problems 
remain to be solved.  The substrate scopes for all methods are quite narrow – in many 
cases even small changes to the substrate structure result in significantly lower 
enantioselectivities.35  Additionally, it remains to be seen whether alkene substrates 
without a coordinating functional group can be asymmetrically halogenated by 
electrophilic reagents.  
 
1.5  Laurencia Medium-Ring Bromoethers 
One of the largest single classes of halogenated natural products are the 
Laurencia C15 acetogenins.37  More than 100 such compounds have been isolated 
from red algae of the genus Laurencia; all share the same linear 15-carbon skeleton, 
which has been subsequently oxidized to include both oxygen and halogen atoms (see 
Figure 3).  The vast majority of the Laurencia C15 acetogenins contain cyclic 
bromoethers, which range in size from 3- to 12-membered; surprisingly, medium-
sized rings (7-, 8-, and 9-membered) make up more than half of the known 
compounds.37  Of these, the 8-membered bromoethers, the so-called “lauroxocanes” 
(6, 83 – 85, Scheme 6) are the most numerous, with more than 50 members described 






























21 8-endo Lauroxocanes (Lauthisan-type)
30 8-exo Lauroxocanes (Laurenan-type)81
82








The Murai group has undertaken numerous studies that support a putative 
biosynthesis for the lauroxocanes involving either an 8-endo or 8-exo bromonium-
induced cyclization of a linear precursor (i.e. 82, Scheme 6).38  In order to facilitate 
this event, the enzymes in the producing organisms must overcome the significant 
entropic and enthalpic barriers inherent to 8-membered ring formation.  As most 
synthetic chemists are well-aware, the synthesis of 8-membered rings can be a 
daunting challenge; indeed, some studies have suggested that this ring-size is 
kinetically the single most difficult to access.39 
It is perhaps the difficulty associated with medium-ring formation that has 
been responsible for the substantial synthetic interest in the lauroxocanes over the 
past few decades.  Since 1979, there have been no less than 30 published syntheses of 





syntheses, including a select few depicted in Scheme 7, highlight a synthetic method 
capable of inducing medium-ring formation, such as the Prins cyclization,40b 
oxidative ring-expansion,40c ring-closing metathesis,40h or intramolecular enolate 
alkylation.40p  What is both surprising and illuminating, however, is that none of the 
chemical (non-enzymatic) syntheses of these unique natural products have forged the 
8-membered haloether core in a biomimetic sense by direct bromoetherification of an 
acyclic precursor.  Perhaps this is one explanation for the lengthy routes previously 
utilized to access such natural products (the Kim group’s recent synthesis of Z-
dihydrorhodophytin is the most concise at 16 linear steps;40z most other routes are 20–


































































































Although haloetherification reactions have been utilized by synthetic chemists 
for more than 100 years,41 there has been little success in building medium-sized 
rings using this methodology.  The most comprehensive investigations in this arena 
were undertaken by Rousseau et al,, who published a number of papers illustrating 
that these reactions are possible, but typically succeed only by properly tuning both 
the substrate and halogenating reagent.42  As shown in Scheme 8, the reaction of 
simple linear substrates with bis(collidine)halonium salts typically affords 8-
membered haloether products in very low yields; the introduction of rigidifying 
elements (as in 99 and 101) allows for somewhat higher yields, presumably by 
lowering the entropic barrier for the cyclization.  Nonetheless, even in the best cases, 
these bromoetherifications proceed with moderate yields and typically without 







Thus, it is likely that a high-yielding, diastereoselective medium-ring 
bromoetherification reaction would facilitate concise, expedient access to an entire 
family of halogenated natural products.  Unfortunately, such a reaction is not 
currently available to synthetic chemists.   
 
1.6  Conclusion 
Some of the greatest contributions to the field of synthetic organic chemistry 
have arisen from investigations towards the total synthesis of natural products.  In 
many cases, chemists have used the demanding architectures found in natural 
products to inspire new strategies and methods that in turn have facilitated solutions 
to a broad array of synthetic challenges.  After decades of constant progress, it may 





significantly.  For some methods, such as enantioselective hydrogenation,43 a 
staggering number of successful synthetic protocols can facilitate access to an 
enormous range of desired products, with a nearly limitless substrate scope.  
However, there are still many arenas, including the halogenated natural products, in 
which nature’s enzymatic machinery is far superior to the tools available to the 
synthetic organic chemist.   
Our investigation of a wide range of halogenated natural products has 
identified three areas in which the lack of developed methods has likely hindered or 
precluded efficient total syntheses.  The following four chapters will document our 
investigations and successes in the fields of halonium-induced polyene cyclization, 
asymmetric halogenation, and medium-ring haloether formation.  In addition, in the 
cases where a new method was successfully developed, its application to one or more 
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The Discovery of BDSB and CDSC: Initial Investigations into Halonium-












2.1  Introduction 
As discussed extensively in Section 3 of Chapter 1, the development of 
efficient halonium-induced polyene cyclization reactions would permit access to 
hundreds of halogenated natural products generated via this pathway in nature.  The 
most desirable cyclization would be the bromonium-induced variant, as the majority 
of these natural isolates are cyclic bromides.  Unfortunately, previous methods 
employed for bromonium-induced polyene cyclizations were largely ineffective.  The 
major concern (see Chapter 1, Scheme 2) with such protocols is that the reagents they 
employ all contain a nucleophilic or basic component that disfavors intramolecular 
cyclization.  
To establish a baseline level of reactivity for these established electrophilic 
bromine sources, we tested their effectiveness for the bromonium-induced polyene 
cyclization of two simple model substrates: homogeranylbenzene (1) and geranyl 
acetate (3; see Table 1).  From homogeranylbenzene (1), desired tricycle 2 is the 
result of a bromonium-induced polyene cyclization in which the aromatic ring 
terminates the cyclization via Friedel–Crafts alkylation (1 → 2).1  Meanwhile, 
product 5 is formed from geranyl acetate (3) after hydrolysis of the intermediate 
bicyclic oxocarbenium ion 4, which forms when the carbonyl oxygen of the acetate 
group terminates the cyclization.2  These two model substrates were selected in order 
to vary the electron-density of the alkenes participating in the cyclization: 3 contains 
a moderately electron-deficient distal alkene (‘distal alkene’ refers to the alkene that 
does not engage the bromonium source), whereas 1 contains a more electron-rich 
distal alkene.  As evidenced by all entries in Table 1, traditional electrophilic bromine 
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sources worked poorly for the desired cyclizations, even under optimized conditions.  
In addition, these results reinforce the previously observed notion that compounds 
containing electron-poor alkenes (such as 3) are even more difficult to cyclize;3 only 
one of five conditions investigated for geranyl acetate cyclization resulted in the 

















MeNO2, 5 min, -25 or 0
oC
THF or CH2Cl2, 15 h, 0 to 25
oC
CH2Cl2, 6 or 30 h, -78 to -40
oC
MeCN, 15 or 60 min, -25 or 0 oC




































Table 1. Bromonium-induced polyene cyclizations of homogeranylbenzene
(1) and geranyl acetate (3) using traditional electrophilic brominating reagents.




As such, upon first approaching this problem in 2008, it was believed that the 
best course of action would be to develop a novel electrophilic brominating reagent, 
one free from nucleophilic or basic components.  The simplest way to imagine such a 
reagent would involve sequestration of the bromide ion of elemental bromine, leaving 
behind the bromonium ion counterpart.  Previously, there has been some success 
using bromine in the presence of silver tetrafluoroborate in order to precipitate the 
bromide ion, thus preventing it from behaving as a nucleophile.4  However, this 
approach has afforded cyclic products in only very low yields, if at all (see Entry 2, 
Table 1); additionally, the use of stoichiometric silver is undesirable.  Other 
halophilic Lewis acids such as BX3, AlX3, or SbX5 were envisioned as possible 
bromide sequestration agents, but it was recognized that the resultant mixture would 
likely be far too reactive to be useful, as we had observed that trisubstituted alkenes 
react extremely rapidly with elemental bromine in the absence of Lewis acid 
activation, even at cryogenic temperatures.   
Since bromide anion sequestration to leave behind a more ‘naked’ Br+ seemed 
unfeasible, our next consideration was to temper the reactivity of the resultant 
bromonium species by complexation with a Lewis base.  This idea has been exploited 
previously, most notably in the cases of the bis-pyridine and bis-collidine bromonium 
salts.5  Unfortunately, in our hands these reagents proved unsatisfactory for 
bromonium-induced polyene cyclization (Entry 6, Table 1).  The majority of the 
material obtained from this attempted cyclization was not fully cyclized.  This result 
is presumably due to the basic nature of collidine, which is released into solution as 
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the reaction proceeds, thus enabling intermolecular elimination reactions of the 
bromonium intermediate rather than the desired intramolecular cyclization.  
Since nitrogen adducts of bromonium ions were poor initiators for 
bromonium-induced polyene cyclization, we next sought to investigate a less basic 
heteroatom as the Lewis basic component to stabilize a bromonium ion.  Although 
ethers would be far less basic than the corresponding amines, we decided to bypass 
them because the interaction between the ‘hard’ oxygen atom and the ‘soft’ bromine 
atom was unlikely to be strong.  In fact, a theoretical study of Lewis base/bromonium 
ion adducts revealed a binding strength of phosphines > sulfides > amines > ethers.6  
Given that phosphines typically exhibit higher basicity and nucleophilicity than 
sulfides,7 it was assumed that halosulfonium complexes would make more desirable 
reagents than the corresponding halophosphonium complexes.  A subsequent 
literature search for bromodialkylsulfonium cations turned up a series of dimethyl 
sulfide adducts of bromine with varying counterions (see Table 2).8  Intriguingly, 
although synthesized by multiple research groups over several decades, to the best of 
our knowledge none of these compounds were employed for halonium-induced 
cyclization (the majority of the reports detail synthetic protocols, spectroscopic 





An examination of the compounds in Table 2 reveals that the most common 
counterion associated with complexes of this type is hexahaloantimonate.  This 
outcome likely reflects the inert nature of the SbX6- counterion.9  In addition, the 
halophilicity of neutral SbX5 facilitates rapid sequestration of bromide ion from an 
initially-formed Me2S.Br2 adduct.8c  Thus, for our intended purposes of initiating 
polyene cyclization reactions, dialkylbromosulfonium hexahaloantimonate complexes 
of this type were envisioned as ideal for the following reasons: 
1.  The bromodialkylsulfonium cation should react readily with alkenes. 
2.  The SbX6- counterion is both non-nucleophilic and a very poor base. 
3.  The sulfide component is fairly non-nucleophilic and non-basic. 
4.  The complexes described to date were mostly stable crystalline solids. 
5.  Facile electronic and steric tuning of the sulfide component could fashion 
a number of analogues, including chiral variants. 
6.  The corresponding chlorosulfonium complexes are also known.10 
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The following sections will detail our efforts to explore the reactivity of such 
species.  The majority of the work herein has been published.11 
 
2.2  The Discovery of BDSB (Et2SBr•SbBrCl5, BromoDiethylSulfonium 
Bromopentachloroantimonate) 
Based on the reasoning outlined in the preceding section, our initial 
explorations were dedicated to the synthesis bromodialkylsulfonium 
hexahaloantimonate complexes and subsequent investigation of their reactivity in 
bromonium-induced polyene cyclizations.  We began by synthesizing known 
bromodimethylsulfonium bromopentachloroantimonate (12, see Table 2),8c which 
was afforded by combining Br2, Me2S, and SbCl5 in CH2Cl2, followed by filtration 
and recrystallization of the resultant orange solid.  To our delight, this compound 
proved capable of promoting the bromonium-induced polyene cyclization of geranyl 
acetate (3 → 5), albeit in rather low yield (Table 3, Entry 1).  However, a brief 
optimization of both solvent and temperature (Entries 2, 3, 4) led to a marked increase 
in yield.  Nitromethane was utilized as the solvent since its cation-solvating effects 
are known to help facilitate polyene cyclizations.12  It is postulated that this cation 
solvation leads to longer lived cations, which in turn are more likely to cyclize; 
additionally, the lower-energy nitromethane-solvated carbocations should be less 
likely to undergo undesired side reactions such as rearrangement or elimination.  
Experimentally, it was determined that for the cyclization of 3 to 5, the nitromethane 
must be dry, but not rigorously so, as consistently good results were obtained by 




The interesting temperature profile of the reaction of 3 to 5 in nitromethane 
warrants discussion.  At –25 °C, the predominant products were acyclic, consisting 
mostly of reaction only at the ‘proximal’ alkene (further from the acetate).  This 
implies that a certain temperature threshold must be reached in order for the distal, 
more electron-deficient, alkene to attack the initially-formed bromonium ion.  
Meanwhile, the drop-off in yield at ambient temperature was attributed to instability 
of the acetate-stabilized bicyclic oxocarbenium (4),2 which does not survive long 
enough at 25 °C to be hydrolyzed by the aqueous quench (the major products of the 
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reaction at ambient temperature are due to elimination, affording a mixture of alkenes 
where the hydroxyl group is in compound 5).   
With this promising result (Entry 3, Table 3) in hand, optimization of the 
reagent itself was undertaken prior to further optimization of the reaction conditions 
and investigation of the substrate scope.  The major concern with bromosulfonium 12 
was its poor solubility.  Unsurprisingly, this ionic, polar compound proved insoluble 
in most organic solvents, with the exception of the most polar (DMSO, DMF, MeCN, 
and MeNO2).  Since the bromocyclization reaction worked best in MeNO2, this 
insolubility problem manifested itself mostly during the synthesis of 12, which calls 
for purification by recrystallization from warm 1,2-dichloroethane.8c  On scale, 
several liters of this solvent would be required to synthesize multi-gram batches of 
12.  With this in mind, attempts were made to synthesize less polar variants of 12 by 
increasing the size of its alkyl groups.  As shown in Table 4, the corresponding 
diethylsulfonium and diisopropylsulfonium complexes (17 and 18, respectively) were 
readily synthesized.  Attempts to prepare the di-tert-butylsulfonium complex (19) 
were unsuccessful.  We surmise that this outcome reflects the facile heterolysis of the 
carbon-sulfur bonds in 19, which would afford the relatively stable tert-butyl cation 


















































Fortunately, both 17 and 18 displayed significantly higher solubility in 
organic solvents, as exemplified by their solubility in 1,2-dichloroethane at ambient 
temperature (see Table 4).  In terms of their capability to initiate polyene cyclizations, 
both compounds worked as well as the dimethyl variant for the cyclization of geranyl 
acetate (see Table 3, Entries 5 and 6).  Based on both the cost of the respective 
sulfides as well as the assumption that diethyl variant 17 would likely prove more 
stable than diisopropyl variant 18 (since the isopropyl variant should be more prone 
to undergo decomposition by the same pathway presumed to be responsible for the 
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instability of tert-butyl complex 19), the diethyl variant was selected as the most 
promising reagent at this junction.  Hereafter, compound 17 (bromodiethylsulfonium 
bromopentachloroantimonate) will be referred to by its acronym, BDSB. 
With our reagent of choice in hand, we initiated a more rigorous investigation 
of BDSB; a summary of physical data along with a crystal structure can be found in 
Figure 1.  The crystal structure (solved by Wesley Sattler, Parkin group) reveals that 
the counterion is not exclusively SbCl5Br-, but that halide exchange among the 
counterions occurs; a small but significant percentage of these counterions are SbCl6-, 
indicating that others of the formula SbClxBr6-x- are likely also present.  Since the 
counterion is merely a bystander during the polyene cyclization reactions, it is 
assumed that this variation has little to no impact on reactivity.  Additionally, the 
cationic and anionic portions of BDSB are directionally oriented; there appears to be 
a weak interaction between the electrophilic Br atom on the bromosulfonium and the 
Br atom of the counterion.  However, the distance between these bromine atoms (3.17 
Å; compare to 2.28 Å for Br2)14 clearly indicates effective scission of the Br-Br bond 







Appearance: Orange Crystalline Solid (thermochromic)






MP: 104 oC (dec)
Solubility: Very Soluble in MeNO2, EtNO2, MeCN, DMSO, DMF, EtOAc
Somewhat Soluble in CH2Cl2, ClCH2CH2Cl, CHCl3, toluene
Insoluble in TFE, HFIP, benzene, hexanes, pentane
Incompatible (reacts with) water, alcohols, ethers
Figure 1. BDSB (Bromodiethylsulfonium bromopentachloroantimonate) data.
 
 
Overall, BDSB is a stable compound (if stored cold) that is fairly easy to work 
with.  Although rapid hydrolysis occurs in the presence of water, BDSB is not 
hygroscopic and can be weighed and otherwise manipulated in air; if left exposed on 
the bench, it will slowly hydrolyze to the corresponding sulfoxide over minutes to 
hours, depending on the size of the crystals and the humidity of the air.  Interestingly, 
BDSB exhibits slight thermochromism (a change in color that accompanies a change 
in temperature):15 at –20 °C, the crystals appear yellow, while at ambient temperature 
they are orange; at elevated temperatures, they become even darker (reddish orange).  
These color changes are reversible so long as BDSB is not heated enough to cause 




The optimized synthesis of BDSB is remarkably straightforward, even on very 
large scale (see Scheme 1).  The synthesis proceeds in high yield from commercially 
available starting materials and without distinct workup or purification steps; the 
desired product crystallizes directly from the reaction solution.  To date, more than 
500 grams of BDSB have been produced using this procedure, in batches as large as 
150 grams.11b  Sigma-Aldrich recently became the first commercial supplier of BDSB 
(catalogue #751987). 
 
2.3  Optimal Conditions for Polyene Cyclizations using BDSB   
As described previously (see Table 3), preliminary optimization of solvent 
and temperature were undertaken based on the cyclization of geranyl acetate (3) using 
the dimethyl sulfide analogue of BDSB (12).  With an optimized reagent in hand, we 
next sought to more thoroughly investigate the optimal conditions for bromonium-
induced polyene cyclizations using BDSB. 
One of the most important conditions to control during polyene cyclization 
reactions is concentration.  There are numerous literature examples where reactions 
must be run at high dilution in order to facilitate the desired cyclization.16  Naturally, 
since the desired pathway is intramolecular, increased dilution is favorable.  
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Unsurprisingly, increasing the dilution of our BDSB model cyclization resulted in 
higher yields of cyclic product.  As shown in Table 5, the requisite level of dilution 
was defined by the scale of the reaction; on very small scale (0.1 mmol), 
concentrations of 0.1 M provided acceptable product yields; meanwhile on large scale 
(5 mmol), concentrations of 0.01 M were required to achieve the same level of 
efficiency.  We hypothesize that this scale-dependency is due to the exotherm that 
accompanies BDSB addition – on large scale this may be significant enough to 
disrupt the cyclization process if there is not a large amount of solvent acting as a 
thermal sink.  This result would imply that the need for large amounts of solvent 
could be obviated by the slow addition of BDSB to the reaction solution, but this is 
even more deleterious with respect to product yield (vide infra).  In order to reduce 
the amount of MeNO2 required for such large scale processes, solvent mixtures were 
investigated.  It was determined that a 1:1 MeNO2:CH2Cl2 mixture was equally 
effective; additionally, for nonpolar substrates such as homogeranylbenzene (1), a 
biphasic mixture of 9:1 hexanes:MeNO2 could also be used as solvent with only a 




Early optimization studies described to this point have utilized the geranyl 
acetate model system.  However, it was eventually determined that the high 
sensitivity of the reaction outcome to time and temperature (best results were 
obtained after only 1-2 minutes at 0 °C) made this model cyclization less than 
optimal.  As such, subsequent studies employed homogeranylbenzene (1) as the 
substrate; this material proved much less sensitive to small changes in reaction time 
or temperature.  In particular, the next variable investigated was the amount of BDSB.  
For this screen, NMR yields were utilized to eliminate uncertainty introduced during 
purification.  As shown in Table 6, a slight excess of BDSB proved beneficial to the 
product yield; meanwhile, a significant excess, although not detrimental to the 
reaction, failed to result in higher yield.  Importantly, electrophilic aromatic 
bromination was not observed even in the presence of excess BDSB.  Given the 
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results summarized in Table 6, it was determined that the optimal BDSB loading was 


















5 min, -25 oC
1 2
a: NMR yields, not isolated yields.
BDSB
MeNO2
Table 6. Optimization of BDSB loading for the
cyclization of homogeranylbenzene (1).
 
 
For the cyclization of homogeranylbenzene (1), we were unable to isolate and 
characterize the impurities produced during the reaction due to the highly nonpolar 
nature of the product mixture, which was not suitable for purification by silica gel 
chromatography (fortunately, analytically pure product could be obtained by 
recrystallization).  However, examination of the crude 1H NMR spectra allowed us to 
determine that in most cases, the major side product (in some cases up to 20% yield) 
was proton-cyclized analogue (23).  As depicted in Scheme 2, the desired 
bromonium-induced cyclization produces an equivalent of acid as the byproduct from 
the closure of the final ring by Friedel–Crafts cyclization (20 → 2); since Et2S is 
more basic than the SbX6- anion,17 we believe that this acid takes the form of 
protonated diethylsufide (22).  Unfortunately, it appears that this acid (22) is strong 
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enough to initiate a proton-induced polyene cyclization of any remaining starting 




























Scheme 2. Accounting for the observed proton-cyclized material (23)
produced during the BDSB-induced cyclization of homogeranylbenzene (1).
 
 
In order to suppress this undesired proton-cyclization pathway, a number of 
basic additives were investigated.  As illustrated by Table 7, amine bases were not 
tolerated, reacting immediately with BDSB (presumably via Pummerer-type 
chemistry)18 and shutting down the desired cyclization (Entries 2 and 3).  Inorganic 
bases (insoluble in the reaction medium) either had little effect on the desired 
cyclization (Entries 4 and 5) or, in the case of Ba(OH)2.8H2O (Entry 6), suppressed 
proton cyclization but also resulted in a reduced yield of product (perhaps due to the 
presence of water).   Ultimately, it was determined that basic additives were 
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unnecessary, so long as the reaction was initiated by very fast addition of a cold 
solution of BDSB to the substrate solution (Entry 8).  Presumably, fast addition 
precludes proton cyclization by not allowing the acid byproduct to build up in the 
presence of the unreacted starting material.  This pre-cooling/fast addition technique 
was used for all subsequent reactions; as with high dilution, it was determined to be 














































a: NMR Yield (not isolated).
b: addition of BDSB (as a solution in MeNO2 at 25
oC) over 30 s.
c: addition of BDSB (as a solution in MeNO2 at 25
oC) over 5 s.
d: addition of BDSB (as a solution in MeNO2 at -25
oC) over 5 s.
1 2 23
MeNO2
Table 7. Attempts to Suppress proton cyclization during the BDSB-
induced cyclization of homogeranylbenzene (1).
 
 
Reaction times required little optimization, since the cyclization reaction 
proved incredibly rapid.  As such, a 5 minute reaction time was established for most 
 52 
substrates as convenience more than necessity (in some cases, starting material was 
completely consumed in as little as 20 seconds).  The optimal quench for the reaction 
was determined to be a mixture of aqueous NaHCO3 and Na2SO3.  Upon quenching, 
the formation of an insoluble white precipitate is observed; this presumably contains 
insoluble antimony salts.  It was later determined that the addition of aqueous 
sodium/potassium tartrate and prolonged stirring will result in dissolution of these 
salts.  Extractions were traditionally performed with CH2Cl2, however the use of 
hexanes as the extraction solvent following the cyclization of very nonpolar 
substrates (i.e. 1 → 2) allows for the recovery of the MeNO2 solvent (MeNO2, water, 
and hexanes are mutually immiscible, thus forming three layers in the separatory 
funnel).  This recovered MeNO2 could be re-dried and reused in subsequent 
cyclizations if so desired.11b 
 
2.4  BDSB Substrate Scope: Terminating Group Variation 
Our initial studies and optimization efforts with BDSB utilized only two 
substrates: geranyl acetate (3) as an electron-deficient model and 
homogeranylbenzene (1) as an electron-rich model.  Naturally, the next step was to 
explore the substrate scope more thoroughly, in order to evaluate whether BDSB was 
capable of cyclizing a large range of polyenes.   
We began by exploring the identity of the terminating group.  Generally, the 
presence of a terminating group is integral to a useful polyene cyclization; without an 
internal nucleophilic trap, the latent carbocation formed after the final ring closes 
typically undergoes elimination of any of three adjacent protons, leading to a mixture 
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of products (see Scheme 1 of Chapter 1).  By virtue of their structural similarity, these 
alkene products can be difficult if not impossible to separate.  Classically, internal 
nucleophilic traps consist of heteroatoms or carbon nucleophiles such as enol ethers 
or electron-rich aromatic rings.19  For the two substrates demonstrated to this point (1 
and 3), the acetate and benzene moieties functioned as the terminating groups.  
Scheme 3 illustrates the successful cyclizations of a number of geraniol 
derivatives with varying terminating groups.  As exemplified by 24 and 28, 
attempting to utilize terminating groups that are poor nucleophiles due to their 
geometry (i.e. 24) or electron-deficiency (i.e. 28) affords the expected mixture of 
alkenes, biased towards the trisubstituted isomer.  Successful oxygen-based 
terminating groups for BDSB cyclizations include esters (3 → 5/32 and 38 → 37), 
carboxylic acids (36 → 37), and carbonates (33 → 34/35), all three of which are 
capable of delivering bicyclic products.  Carbon-based terminating groups in the form 
of aromatic rings provide tricyclic products in good yields (1 → 2 and 39 → 40).  
Pleasingly, substrate 39 was brominated exclusively at the alkene in preference to the 
electron-rich aromatic ring.  It should also be noted that for all substrates in Scheme 
3, cyclizations were attempted using previously published methods (Br2/AgBF4, 
TBCO, or NBS/PPh3).20  In all cases these procedures failed to provide the product in 
more than 30% yield by 1H NMR (all reactions were taken to completion), with the 



































































5 min, -25 oC
76% yield





































Scheme 3. Terminating group variation in BDSB-induced cyclization reactions.
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The successful cyclizations depicted in Scheme 3 (and disclosed in our initial 
communication) do not encompass all terminating groups we attempted to use for 
these cyclizations.11a  There were three other substrates that afforded the desired 
bromocyclic products in poor yield or along with significant byproducts; although not 
useful synthetically, these examples are nonetheless worthy of brief discussion.  As 
illustrated in Scheme 4, the first unsuccessful substrate, geranylacetone (41), 
contained a ketone terminating group.  The desired pathway was elimination from the 
resultant oxocarbenium ion to afford bicyclic enol ether 42.21  Unfortunately, 42 was 
isolated in very low yield, along with a plethora of undesired side products.  In this 
case, it is presumed that the resultant enol-ether product is much more reactive with 
BDSB than the alkenes of the starting material, such that the product undergoes 
further undesired reactions.  A second ketone substrate (43), one without α-protons 
(such that enol-ether formation is impossible), proved more successful, but still 
provided the desired 44 in fairly low yield and alongside a significant side product 
identified as monocyclic product 45.  An analogous monocyclic product (49) was also 
produced by the cyclization of homogeranylbenzene analogue 46, which contains a 
more electron-rich aromatic ring than either 1 or 39 (see Scheme 3).  With substrate 
46, it still appears that BDSB selectively brominates the alkene prior to the aromatic 







10 min, 0 oC
~20% yield
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47 (X=H): ~50% yield
48 (X=Br): ~10% yield
+
+
Scheme 4. Substrates for which BDSB cyclization was less successful.
 
 
The appearance of partially cyclized products such as 45 and 49 was 
unexpected, but a careful analysis of the purported reaction pathway may be able to 
explain their appearance.  Clearly these products arise from cyclizations in which the 
reactive bromonium ion is formed from the distal (internal) alkene rather than 
proximal (dimethyl) alkene.  In cases where a clear electronic differentiation between 
the alkenes exists (such as geranyl acetate), it seems natural that the more electron-
rich alkene (further from the inductively withdrawing acetate moiety) should react 
with the halonium source, in this case providing the desired cyclic product.  However, 
for substrates in which this situation no longer applies (i.e. homogeranylbenzene, 1) 
another explanation must be provided for why the halonium ion appears to ‘choose’ 
the proximal alkene.  Arguments that the internal alkene is sterically less accessible 
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than the distal alkene are tenuous, since this effect is marginal at best.  For example, 
mCPBA-mediated epoxidation of the electronically unbiased polyene squalene gives 
a nearly statistical mixture of epoxide regioisomers.22  Some studies have indicated 
that in aqueous solvents, bromohydrin formation can be selectively induced at the 
terminus of squalene.  This result was first observed by van Tamelen in 1962, who 
described it thusly: 
…in a more polar medium (such as that offered by a hydroxylic 
solvent) it appears possible that squalene would assume a more highly 
coiled, compact conformation, such that the triterpenoid would be 
‘internally solvated’, and the system of hydrogen bonds in the medium 
would be disrupted as little as possible. Should this be the case, the 
internal double bonds in this coiled conformation might be sterically 
shielded and thus chemically less reactive, whereas the terminal 
olefinic links should remain exposed.23 
 
Although this argument is persuasive in an aqueous medium, it is less likely to 
apply to our system, in which successful cyclizations are observed in both MeNO2 
and CH2Cl2 (to a lesser extent).  We cannot completely discount the occurrence of 
this phenomenon in these less polar solvents, but perhaps a second argument for the 
observed regioselectivity could be that bromonium transfer processes are playing a 
role (see Section 4 of Chapter 1 for a more in-depth explanation of this concept).24  
As depicted in Scheme 5, from generic substrate 50, it is expected that the 
bromonium ion can initially form from attack by either alkene, affording a mixture 51 
and 52.  If the terminating nucleophile is not very nucleophilic (i.e. Case 1), its attack 
on bromonium 52 would be relatively slow, so little or no 54 should be observed (this 
would also be conceivable if the nucleophilic addition was readily reversible under 
the reaction conditions).  Since 52 cannot undergo polyene cyclization from the other 
alkene (this would form a highly strained 4-membered ring) the most-likely pathway 
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is bromonium transfer to afford 51.  Thus, in Case 1 all the material likely funnels 
through bromonium 51 to the desired bicyclic product (53).  Meanwhile, the 
observation of partial cyclization invokes a terminating nucleophile that is potent 
enough (i.e. Case 2) such that the rate of nucleophilic trapping of 52, irreversibly in 
this case, exceeds the rate of bromonium transfer to form 51.  In this instance, the 
initial location of the bromonium ion should dictate the product ratio.  In the extreme 
case, if both irreversible nucleophilic capture and bromonium transfer were faster 
than polyene cyclization, all material would be expected to funnel through 52 to 

































Scheme 5.Mechanistic hypothesis for the formation of partially cyclized material.
 
 
Although we have no direct evidence for the mechanistic hypothesis depicted 
in Scheme 5, it is strongly supported by our experimental results.  The two cases in 
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which we observe these products involve electronically ambiguous polyene substrates 
with terminating nucleophiles that are more nucleophilic than those of their 
counterparts in which only the desired fully cyclized products are observed.  As such, 
for those substrates that are not electronically biased to engage BDSB only at the 
proximal alkene, bromonium transfer, traditionally viewed as an undesirable 
pathway,24 may be facilitating isolation of the desired products in high yield.  
 
2.5  BDSB Substrate Scope: Alkene Geometry and Substitution Patterns 
The identity of the terminating groups may have inadvertently provided 
information about the mechanism by which bromonium-induced polyene cyclization 
proceeds.  However, additional mechanistic insight could potentially be gleaned from 
investigating alternate alkene geometries and substitution patterns, since the alkenes 
are the functional groups actively participating in the cationic pi-cyclizations.   
In the best-case scenario, polyene cyclizations proceed through a transition 
state in which all rings are formed simultaneously, and each one forms in a fixed 
(usually chair) conformation.  This ideal case was formally described nearly 
simultaneously by Stork and Eschenmoser more than 50 years ago.25  The result is a 
diastereoselective cyclization, wherein the stereochemical configuration of the 
product is determined solely by the alkene geometry of the starting material.   
The substrates examined thus far were promising in this regard.  The 
cyclohexane products formed by cyclization of geraniol-derived dienes described 
previously all have the same relative stereochemistry (cis) between the newly 
installed bromine atom and the alkyl group two carbons away (previously the 
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substituent on the distal alkene); this observed relationship is indicative of cyclization 
via a chair-like transition state.25a  Minor diastereomers, when they have been 
observed (such as during the cyclization of 3 and 33, cf. Scheme 3), have been 
epimeric at the methyl position, which is dictated by the terminating group and not 
expected to be stereoselective based on the Stork–Eschenmoser postulate.  With these 
promising results in hand, attempting cyclization of a substrate with a Z-olefin 
geometry was perceived to be a valuable endeavor.   
Traditionally, examples of cis alkenes as substrates for polyene cyclizations 
have been relatively scarce,26 likely due to a number of factors.  First, the requisite Z-
alkene substrates are harder to obtain; for example, the (2E,6E) isomer of farnesol is 
commercially available, while the (2E,6Z), (2Z,6E), and (2Z,6Z) isomers require 
multi-step syntheses.27  Additionally, most terpenoid natural products arising from 
polyene cyclizations are derived from all-trans polyene substrates and thus have trans 
ring junctions.  As a result, cyclizations of E-alkenes are often more enticing to the 
synthetic community.  Finally, the resultant cyclic products of a polyene containing 
one or more Z-alkenes must contain cis(6,6) ring junctions, which are almost always 
less stable than the analogous trans junctions.28  Additionally, there are often superior 
synthetic protocols for accessing cis decalin compounds, including, but not limited to, 
the Diels–Alder reaction.29  
Nonetheless, we were delighted to find that BDSB cyclization of neryl acetate 
(56) afforded a 71% yield of 58 (see Scheme 6).  In this case, the stereochemistry of 
the methyl group is well-controlled, likely due to the axial orientation of the CH2OAc 
group in the transition state (57).  While the stereochemistry of geraniol-derived 
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products 5 and 32 were established spectroscopically (they are known compounds),2 
the relative configuration of nerol-derived product 58 was established conclusively by 
X-ray crystallography (performed by Aaron Sattler, Parkin group).  With this result, 
the substrate scope for BDSB-induced cyclization could be extended to Z-polyenes as 
well, allowing access to diastereomeric cyclic products.  This outcome proved 
significant for subsequent natural product total synthesis endeavors, as will be 






































5 min, 0 oC
BDSB
56 57 58
Scheme 6. Stereoselectivity in the BDSB-induced cyclizations of geranyl acetate (3)
and neryl acetate (56).
 
  
We next investigated the substitution pattern of the alkenes involved in the 
polyene cyclization events.  Classically, polyene cyclizations are undertaken with 
isoprene-derived substrates; as such, each alkene is trisubstituted.11  However, in 
order to truly understand the reactivity of BDSB, we desired to investigate other 
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substitution patterns.  As shown in Scheme 7, we were able to synthesize a number of 
geranyl acetate analogues from known geraniol-derived aldehyde 59,30 including the 
monosubstituted (60), disubstituted (62), and tetrasubstituted (64) alkene variants (the 
Wittig reaction to form the final tetrasubstituted product was very inefficient,31 but 
this step was not optimized as it provided enough material to attempt the BDSB 






































Reagents and Conditions: (a) MePPh3 (1.2 eq), KOt-Bu (1.1 eq), THF, 1 h, 25
oC, then 59,
15 min, 0 oC, 84%. (b) MeMgBr (2 eq), THF, 1.5 h, -78 to -15 oC, 60%. (c) DMP (1.5 eq),
NaHCO3 (10 eq), CH2Cl2, 45 min, 0 to 10
oC, 80%. (d) MePPh3 (1.3 eq), KOt-Bu (1.2 eq),
THF, 1 h, 25 oC, then SM, 30 min, 0 oC, 95%. (e) i-PrPPh3 (6 eq), KOt-Bu (4 eq), THF, 1
h, 25 oC, then SM, 20 h, 25 oC, 6%. KOt-Bu = Potassium tert-butoxide, DMP = Dess
Martin Periodinane, BDSB = bromodiethylsulfonium bromopentachloroantimonate.
Scheme 7. Synthesis and subsequent cyclization attempts of non-isoprene substrates







BDSB cyclization of each geranyl acetate analogue under optimized 
conditions resulted in the products illustrated in Scheme 7.  The terminal 
monosubstituted alkene of 60 was not nucleophilic enough to react with BDSB, 
which preferred to react with the trisubstituted internal alkene, notwithstanding the 
electron-withdrawing allylic acetate.  Meanwhile, terminal disubstituted alkene 62 
appeared to provide the expected 5-exo cyclization products, albeit as a complex 
mixture of alkene regioisomers as well as a number of uncharacterized side products.  
Interestingly, this particular cyclization was cleaner in CH2Cl2 than MeNO2; our 
rationale for this is that the bromonium ion formed from the 1,1-disubstituted alkene 
has a higher propensity to exist in the ‘open’ (α-bromo carbocation) conformation9c in 
the more polar MeNO2, leading to undesired side reactions.  By running the reaction 
in CH2Cl2, the classical ‘closed’ 3-membered ring bromonium should be more 
favored, leading to the desired cyclization products.32  Unfortunately, the nonpolar 
product mixture could never be fully purified; as such, we are unable to conclusively 
establish the structure of the compounds represented by 63.   
Lastly, tetrasubstituted alkene 64 provided a moderate yield 6-endo product 
65 along with a significant amount of what is believed to be proton-cyclized material 
(66).  That the predominant product is the 6-membered ring rather than the 
corresponding 5-exo product may be the result of a thermodynamic distribution, 
perhaps indicating that the cyclization event is reversible (a kinetically controlled 
reaction would be expected to produce mostly the 5-membered ring product).33  The 
appearance of large amounts of proton cyclized material implies that perhaps the 
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enhanced nucleophilicity of the tetrasubstituted alkene facilitates this undesired side 
reaction.  As a whole, these results indicate that BDSB cyclizations are most effective 
with isoprene-derived, trisubstituted alkene substrates.  Fortunately, from the 
standpoint of natural product total synthesis, the vast majority of natural products 
derived from bromonium-induced polyene cyclizations retrosynthetically derive from 
such substrates.   
 
2.6  BDSB Substrate Scope: Longer Polyenes 
Thus far, all polyene substrates discussed have in fact been dienes, such that 
the cyclization event produces a single cyclohexane ring (although with many of the 
substrates discussed above, bicyclic and tricyclic products result depending on the 
identity of the terminating group).  However, many bromocyclic natural products 
derive from cyclization of longer polyenes; in fact, a great many contain brominated 
decalin systems,34 requiring three alkenes to participate in the polyene cyclization 
event.  
In order to investigate the cyclizations of longer polyenes, we synthesized 
homofarnesylbenzene (67).35  As evidenced by Entry 1 of Table 8, initial results with 
this substrate were promising in that the polyene cyclization involving all three 
alkenes proceeded efficiently to the desired decalin system.  Unfortunately, 
termination by Friedel-Crafts alkylation was not so facile; as a result, a mixture of 68 
and 69/70 was isolated.  Replacing the benzene ring of 67 with a p-OMePh ring (the 
farnesyl analogue of 39, see Scheme 3) yielded identical results, although, in 
hindsight, the methoxy group is meta to the newly formed bond, such that its 
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installation probably would not be expected to accelerate Friedel-Crafts alkylation at 




As mentioned previously (see Scheme 2), each successful cyclization event 
terminated by Fredel-Crafts alkylation (desired pathway) or elimination (undesired 
pathway) produces an equivalent of strong acid.  At low temperatures, this acid was 
insufficiently powerful to catalyze the final Friedel-Crafts alkylation (Table 8, Entry 
2); however, allowing the reaction mixture to warm up (Entries 3 and 4) facilitated 
the conversion of bicyclic 69/70 to the desired tetracycle (68).  Closure of this final 
ring was not completely diastereoselective under these conditions, producing the 
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product with ~4:1 dr about the quaternary carbon adjacent to the aromatic ring.  
Additionally, at the higher temperatures required for this reaction to proceed, there 
was significant decomposition, which accounts for the observed decrease in yield.  As 
such, the optimal procedure required the addition of an excess of strong acid at low 
temperature (Table 8, Entry 5), which allowed for isolation of desired tetracycle 68 in 
approximately 58% yield (this material was contaminated by a very small amount of 
the undesired diastereomer). 
In conclusion, BDSB proved capable of forming multiple rings via cyclization 
of farnesyl derived polyenes.  Although significant modification of the reaction 
conditions was required for the successful production of tetracycle 68, this outcome 
was due to the sluggishness of the nucleophilic termination step rather than the 
bromonium-induced polyene cyclization itself, which proceeded both efficiently and 
diastereoselectively.  Although only two model substrates of this type were cyclized 
at this stage, several more successful polycyclizations will be discussed in Chapter 3.  
 
2.7  Chloronium-Induced Cyclizations: CDSC 
Up to this point, only bromonium-induced polyene cyclizations have been 
discussed.  However, as mentioned in Section 3 of Chapter 1, nature employs both the 
bromonium- and chloronium-induced variants of this reaction.  As there are dozens of 
chlorinated natural products that retrosynthetically derive from a chloronium-induced 
polyene cyclization, a synthetic procedure to afford cyclic chlorides would be quite 
valuable.  To the best of our knowledge, previously published results in the field of 
chloronium-induced polyene cyclization reactions do not exist. 
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Naturally, since BDSB had excelled at bromonium-induced cyclizations, the 
first compound we synthesized was simply its chloronium analogue.  As depicted in 
the upper portion of Scheme 8, the same procedure of adding Et2S and SbCl5 
sequentially to a cold solution of Cl2, followed by recrystallization afforded the off-
white crystalline solid chlorodiethylsulfonium hexachloroantimonate (71) in high 
yield on large scale.  For simplicity’s sake, we termed this compound CDSC 
(although the acronym CDSH would be more accurate, this has already been applied 
to the dimethyl variant).36  Physically, CDSC is similar to BDSB in that it is an 
odorless, air-stable solid that can be stored in a –20 °C freezer for long periods of 
time without decomposition (see lower portion of Scheme 8).  Its solubility profile is 
also similar to that of BDSB, with the only exception being its noticeably higher 



















Scheme 8. Optimized synthesis of CDSC (71, chlorodiethylsulfonium







Appearance: Off-white Crystalline Solid







Solubility: Same as BDSB, but more noticeably more




Although CDSC and BDSB were physically similar, their reactivities proved 
quite disparate.  As shown in the upper portion of Scheme 9, treatment of 
homogeranylbenzene with CDSC in MeNO2 at –25 °C for 5 minutes (the optimized 
protocol for BDSB) afforded only a modest yield of the desired product as a mixture 
of diastereomers (72 and 73), alongside numerous unidentified byproducts, most of 
which appeared to be uncyclized by 1H NMR.  Attempts to optimize this result by 
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modifying the temperature, reaction time, solvent, order/rate of addition, and 





















Scheme 9. Chloronium induced cyclization of homogeranylbenzene (1) with
CDSC and rationale for observed lack of diastereoselectivity.
 
 
Compared to the BDSB reaction, the lower yield and erosion of 
diastereoselectivity in the corresponding chlorocyclization can be rationalized by the 
differing reactivities of the two halonium ions.  It has been shown previously in both 
experimental and theoretical studies that the smaller size and higher electronegativity 
of chlorine (with respect to bromine) de-stabilizes traditional 3-membered cyclic 
‘closed’ halonium ions.37  As shown in the bottom portion of Scheme 9, the 
 71 
chloronium ion derived from 1 probably exists predominantly in the ‘open’ form (75), 
rather than the traditional ‘closed’ form (74).37a  Carbocation 72 can be attacked from 
either face by the internal alkene, generating the observed diastereomeric mixture of 
products 72 and 73.  Meanwhile closed chloronium 74 would be expected to be 
attacked from the face opposite the chlorine atom, generating only 72 assuming a 
chair-like transition state.  Additionally, the higher energy chloronium ion is 
presumably more susceptible to undesired side reactions including elimination and 
exogenous nucleophile capture, resulting in the low mass recovery of chlorocyclic 
products 72 and 73.  
Although we rationalized the relatively poor outcome of the chloronium-
induced polyene cyclization as a failure inherent to the reaction intermediates rather 
than the chlorinating reagent, we still felt compelled to explore other chloronium 
sources.  A number of analogues were targeted (76 – 83, Figure 2); several of these 
did not provide crystalline reagents, and as such were synthesized in-situ prior to use.  
For those synthetic efforts that afforded crystalline solids (76, 77, 81, 83), these 




Since CDSC appeared to be too reactive, it was initially thought that a more 
electron-rich sulfur Lewis base might be able to better stabilize the positive charge 
and temper its reactivity.  Diisopropyl sulfide was investigated as a slightly more 
electron-rich sulfide, while tetramethylthiourea was perceived to be a significantly 
more electron rich sulfide analogue.  Compound 76 was synthesized readily as an 
isolable crystalline solid, but this material behaved identically to CDSC for the 
cyclization of homogeranylbenzene (1).  Meanwhile, a crystalline compound was 
isolated upon reaction of tetramethylthiourea with Cl2 and SbCl5 (we could not verify 
the identity of this compound as chlorosulfonium 77), but this material proved 
incapable of chlorocyclization of homogeranylbenzene in any yield.   
A different approach to potentially improved chlorosulfonium reagents 
involved the use of multiple sulfur donors to help stabilize charge; tethered bis, tris, 
and tetra-sulfide compounds (78 – 80) were targeted, but these reagents were not 
crystalline.  Attempts were made to synthesize these compounds in-situ and 
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subsequently add homogeranylbenzene (1) were also unsuccessful – at best only trace 
amounts of desired product 72 were obtained.  We also investigated sulfides with a 
second nucleophilic moiety, hoping that a reagent such as 81 could stabilize the 
‘open’ configuration of the chloronium ion of the substrate by transiently binding to 
the carbocation.  In this case, a solid reagent was isolated but its reactivity proved 
inferior to CDSC. 
Since no improvements were seen by changing the sulfur component of the 
reagent, we also attempted to alter the counterion.  It was thought that a less 
halophilic Lewis acids such as BCl3 might result in a less reactive halonium source 
(i.e. 82).  Unfortunately, use of this non-antimony Lewis acid did not lead to a 
crystalline reagent, and its in situ reactivity proved inferior to CDSC.  One final effort 
investigated chlorophosphonium 83; since phosphorous should be a more Lewis basic 
donor than sulfur, it was envisioned that perhaps a chlorophosphonium species would 
be less electriphilic.6,7  Unfortunately, the reagent produced from the mixture of n-
Bu3P, Cl2, and SbCl5 was incapable of initiating the desired cyclization of 1.  
Ultimately, none of the modifications resulted in a compound that worked 
better than CDSC for the cyclization of homogeranylbenzene.  At this point, we 
accepted that the challenge lay in the cyclization itself rather than the choice of 
reagent.  It still bears noting that although both the yield and diastereoselectivity for 
the model cyclization (1 → 72/73) were modest, this result represents, to the best of 
our knowledge, the first successful chloronium-induced polyene cyclization reported 
in the literature.38   
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2.8  Conclusion 
Prior to our investigations, methods for bromonium-induced polyene 
cyclization were typically inefficient and often unsuccessful for all but a few, select 
substrates.  However, our examination of bromosulfonium salts as uniquely reactive 
bromonium sources led to the discovery of BDSB.  This easily synthesized, stable 
crystalline solid proved capable of cyclizing a variety of polyene substrates with 
generally good yields and excellent diastereoselectivities.  Extensive experimentation 
revealed that BDSB can successfully cyclize polyenes of varying length and with a 
number of oxygen- and carbon-based terminating groups.  BDSB efficiently cyclizes 
substrates with both E- and Z- alkenes, affording the corresponding products 
diastereoselectively.  Unfortunately, the corresponding chlorine analogue (CDSC) 
was less efficacious, although the desired chloronium-induced polyene cyclization is 
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2.10  Experimental Section 
 
General Procedures.  All reactions were carried out under an argon 
atmosphere with dry solvents under anhydrous conditions, unless otherwise noted.  
Dry methylene chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and 
tetrahydrofuran (THF) were obtained by passing commercially available pre-dried, 
oxygen-free formulations through activated alumina columns; acetonitrile (MeCN) 
and nitromethane (MeNO2) were stored over 3 Å molecular sieves, pyridine was 
distilled from CaH2 and stored over 3 Å molecular sieves; diisopropylamine (i-
Pr2NH) was distilled from KOH and stored over 3 Å molecular sieves; triethylamine 
(Et3N) was distilled from KOH; 1,2-dichloroethane, acetone, and methanol (MeOH) 
were purchased in anhydrous form from Sigma-Aldrich and used as received.  Yields 
refer to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated.  
Reactions were magnetically stirred and monitored by thin-layer chromatography 
(TLC) carried out on 0.25 mm E. Merck silica gel plates (60F-254) using UV light 
and/or I2 on silica as visualizing agents and an aqueous solution of phosphomolybdic 
acid and cerium sulfate or a solution of KMnO4 in aqueous sodium bicarbonate with 
heat as developing agents.  Preparative thin-layer chromatography was carried out on 
0.50 mm E. Merck silica gel plates (60F-254).  SiliCycle silica gel (60, academic 
grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
NMR spectra were recorded on Bruker DRX-300, DRX-400, and 500 ASCEND 
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instruments and calibrated using residual undeuterated solvent as an internal 
reference.  The following abbreviations were used to explain the multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent.  
IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR spectrometer. 
High-resolution mass spectra (HRMS) were recorded in the Columbia University 
Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (Fast 
Atom Bombardment) and EI (Electron Ionization) techniques.  The majority of the 
halosulfonium salts were not characterized due to their sensitivity to moisture.  
Characterization data are not provided for known compounds. 
 
Abbreviations.  Ac2O = acetic anhydride, BDSB = bromodiethylsulfonium 
bromopentachloroantimonate, Boc2O = di-tert-butyldicarbonate, DCE = 1,2-
dichloroethane, DMAP = 4-dimethylaminopyridine, DMF = N,N-dimethylformamide, 
KOt-Bu = potassium tert-butoxide, mCPBA = meta-chloroperoxybenzoic acid, 
MeSO3H = methanesulfonic acid, n-BuLi = n-butyllithium, TFAA = trifluoroacetic 
anhydride. 
 
Homogeranylbenzene (1).  (Procedure adapted from: Araki, S.; Sato, T.; 
Butsugan, Y. J. Org. Chem. 1982, 47, 285).  Diethyl chlorophosphate (6.20 mL, 42.8 
mmol, 1.50 equiv) was added dropwise to a solution of geraniol (5.00 mL, 28.5 
mmol, 1.00 equiv) and pyridine (6.90 mL, 85.5 mmol, 3.00 equiv) in Et2O (15 mL) at 
–15 °C.  The reaction mixture was allowed to warm slowly to 25 °C over the course 
of 3 h, then quenched by the addition of aqueous 1 M HCl (75 mL) and extracted with 
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EtOAc (3 × 50 mL).  The combined organic layers were washed with saturated 
aqueous sodium bicarbonate (2 × 30 mL) and brine (30 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:3) to afford geranyl diethyl phosphate (7.28 g, 88% yield) 
as a light yellow oil.  Next, a solution of benzyl chloride (0.23 mL, 2.0 mmol, 2.0 
equiv) in THF (5 mL) was added dropwise to Mg turnings (activated with an acidic 
rinse and thoroughly flame dried, 0.097 g, 4.0 mmol, 4.0 equiv) at 0 °C.  After 1 h at 
0 °C, the resultant benzylmagnesium chloride solution was cooled to –40 °C and 
added quickly via syringe to a solution of geranyl diethyl phosphate (0.29 g, 1.0 
mmol, 1.0 equiv) in THF (1 mL) at –40 °C.  The resultant reaction mixture was then 
allowed to warm slowly to 25 °C over 12 h, then quenched by the addition of 10% 
aqueous ammonium chloride (15 mL) and extracted with hexanes:EtOAc (2:1, 3 × 20 
mL).  The combined organic layers were washed with brine (20 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 9:1) to afford 1 (0.21 g, 92% yield) as a colorless oil.   
 
Bromocyclized Homogeranylbenzene (2).  Optimized Reaction: A pre-
cooled solution of BDSB (17, 3.02 g, 5.50 mmol, 1.10 equiv) in MeNO2 (15 mL) was 
added quickly via syringe to a solution of 1 (1.14 g, 5.00 mmol, 1.00 equiv) in 
MeNO2 (485 mL) at –25 °C.  After 5 min at –25 °C, the reaction mixture was 
quenched by the addition of saturated aqueous sodium bicarbonate and 5% aqueous 
sodium sulfite (1:1, 400 mL).  The resultant mixture was stirred vigorously for 20 min 
at 25 °C, then poured into brine (200 mL) and extracted with hexanes
 
(4 × 200 mL).  
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The combined organic layers were dried (MgSO4), filtered, concentrated, and purified 
by recrystallization from boiling methanol (crop 1: 80 mL, crop 2: 20 mL) to afford 
pure 2 (1.17 g, 76% yield) as white needles.  2: m.p. 100.0 – 101.5 °C; Rf = 0.49 
(silica gel, hexanes:CH2Cl2, 4:1); IR (film) νmax 3058, 2968, 2947, 2838, 1488, 1476, 
1448, 1377, 764, 723 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.24 – 7.04 (m, 4 H), 4.06 
(dd, J = 12.8, 4.4 Hz, 1 H), 3.02 – 2.85 (m, 2 H), 2.44 – 2.23 (m, 3 H), 1.99 (m, 1 H), 
1.82 (m, 1 H), 1.61 (dt, J = 13.6, 3.6 Hz, 1 H), 1.48 (dd, J = 12.0, 2.4 Hz, 1 H), 1.26 
(s, 3 H), 1.17 (s, 3 H), 1.08 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 148.8, 134.9, 
129.2, 126.0, 125.7, 124.6, 69.0, 51.4, 40.2, 40.0, 38.0, 31.7, 30.9, 30.7, 25.0, 20.7, 
18.4; HRMS (FAB) calcd for C17H23Br+ [M]+ 306.0983, found 306.0981. 
 
Geranyl Acetate (3).  Ac2O (3.22 mL, 34.1 mmol, 1.20 equiv) was syringed 
slowly into a solution of geraniol (5.00 mL, 28.4 mmol, 1.00 equiv), DMAP (0.069 g, 
0.568 mmol, 0.02 equiv), and triethylamine (5.91 mL, 42.6 mmol, 1.50 equiv) in 
CH2Cl2 (60 mL) at 0 °C.  After 20 min at 0 °C, the reaction mixture was poured into 
water (50 mL) and extracted with CH2Cl2 (3 × 75 mL).  The combined organic layers 
were washed with aqueous 1 M HCl (50 mL), saturated aqueous sodium bicarbonate 
(50 mL), and brine (50 mL), dried (MgSO4), filtered through a silica plug with 
hexanes:EtOAc (2:1, ~ 300 mL), and concentrated to afford 3 (5.42 g, 97% yield) as a 
colorless oil. 
 
Bromocyclized Geranyl Acetate (5).  Optimized Reaction:  A pre-cooled 
solution of BDSB (17, 3.02 g, 5.50 mmol, 1.10 equiv) in MeNO2 (15 mL) was added 
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quickly via syringe to a solution of 3 (0.982 g, 5.00 mmol, 1.00 equiv) in MeNO2 
(485 mL) at 0 °C.  After 2 min at 0 °C, the reaction mixture was quenched by the 
addition of saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite 
(1:1, 400 mL).  The resultant mixture was stirred vigorously for 20 min at 25 °C, then 
poured into brine (200 mL) and extracted with EtOAc
 
(3 × 500 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 1:0 → 1:1) to afford 5 (0.926 g, 
63% yield) in addition to its separable diastereomer, 32 (0.176 g, 12% yield).  5: Rf = 
0.38 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3456 (br), 2973, 2948, 2875, 
1736, 1367, 1243, 1155, 1030 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.43 (dd, J = 11.6, 
4.8 Hz, 1 H), 4.32 (dd, J = 12.0, 5.2 Hz, 1 H), 3.97 (dd, J = 12.4, 4.4 Hz, 1 H), 2.50 
(s, 1 H), 2.18 (dq, J = 14.0, 4.0 Hz, 1 H), 2.06 (s, 3 H), 2.02 (dq, J = 13.2, 3.6 Hz, 1 
H), 1.81 (dt, J = 13.6, 3.6 Hz, 1 H), 1.72 (t, J = 4.8 Hz, 1 H), 1.59 (dt, J = 13.6, 4.0 
Hz, 1 H), 1.24 (s, 3 H), 1.17 (s, 3 H), 1.00 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 
171.2, 71.8, 66.0, 63.5, 55.7, 43.1, 39.9, 32.1, 30.4, 23.9, 21.3, 17.8; HRMS (FAB) 
calcd for C12H22BrO3+ [M+H]+ 293.0752, found 293.0742. 
 
Bromodimethylsulfonium Bromopentachloroantimonate (12).  (Procedure 
adapted from: Meerwein, H.; Zenner, K.-F.; Gipp, R. Liebigs Ann. Chem. 1965, 688, 
67).  Dimethyl sulfide (0.27 mL, 3.7 mmol, 1.4 equiv) and a solution of SbCl5 (4.0 
mL, 1.0 M in CH2Cl2, 4.0 mmol, 1.5 equiv) were added slowly and sequentially to a 
solution of bromine (0.15 mL, 2.6 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at –78 °C.  
The resultant orange heterogeneous mixture was allowed to warm to ~0 °C over 15 
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min, then filtered under argon.  The resultant solid was rinsed with cold CH2Cl2 (5 
mL), then recrystallized from hot DCE (20 mL) to afford 12 (0.40 g, 30% yield) as 
dark orange plates.  As with most of the halosulfonium salts produced, spectral data 
were not obtained for this compound.  
 
Bromodiethylsulfonium Bromopentachloroantimonate (BDSB, 17).  
Diethyl sulfide (9.88 mL, 8.27 g, 91.7 mmol, 1.1 equiv) was added slowly to a 
solution of bromine (4.27 mL, 13.3 g, 83.3 mmol, 1.0 equiv) in DCE (200 mL) at –35 
°C.  Next, a solution of SbCl5 (100 mL, 1 M in CH2Cl2, 100 mmol, 1.2 equiv) was 
cannulated slowly into the yellow reaction solution.  The resultant orange, 
heterogeneous solution was stirred at –30 °C for an additional 30 min, then allowed to 
warm to 25 °C and heated gently until the solution became homogeneous (~30–35 
°C).  The reaction flask was then sealed and cooled to 4 °C for 8 h, then cooled 
further to –20 °C for 14 h.  The filtrate was decanted and the crystalline product was 
washed with cold CH2Cl2 (2 × 10 mL) and dried to afford BDSB (17, 39.7g, 87% 
yield) as light orange plates.  17: m.p. = 102 – 105 °C (with decomposition); IR (KBr) 
νmax 2985, 2939, 1455, 1403, 1384, 1261, 932, 877 cm–1; 1H NMR (400 MHz, 
CD3NO2, solvent referenced at 4.33 ppm) δ: 1.67 (t, J = 7.3 Hz, 6 H), 3.92 (dq, J = 
1.4, 7.3 Hz, 4 H); 13C NMR (100 MHz, CD3NO2, solvent referenced at 63.8 ppm) δ: 
11.3, 46.3.  NMR spectra show trace amounts of diethyl sulfoxide (1H NMR δ: 1.55 
(t, J = 7.3 Hz, 6 H), 3.54 (q, J = 7.3 Hz, 4 H); 13C NMR δ: 8.1, 44.3), presumably due 
to trace water present in the deuterated solvent. 
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Bromodiisopropylsulfonium Bromopentachloroantimonate (18).  
Isopropyl sulfide (0.80 mL, 5.5 mmol, 1.1 equiv) and a solution of SbCl5 (6.0 mL, 1 
M in CH2Cl2, 6.0 mmol, 1.2 equiv) were added slowly and sequentially to a solution 
of bromine (0.26 mL, 5.0 mmol, 1.0 equiv) in CH2Cl2 (15 mL) at –78 °C.  The 
resultant orange heterogeneous mixture was allowed to warm to 25 °C over 30 min, 
then re-cooled to –78 °C and filtered under argon.  The resultant solid was rinsed with 
cold CH2Cl2 (5 mL), then recrystallized from hot DCE (15 mL) to afford 18 (0.55 g, 
19% yield) as yellow needles. As with most of the halosulfonium salts produced, 
spectral data were not obtained for this compound. 
 
Proton Cyclized Homogeranylbenzene (23).  Produced as an undesired 
byproduct during the cyclization of 1 to 2.  23: Not isolated as a pure compound. 1H 
NMR (400 MHz, CDCl3, diagnostic signals only) δ 0.95 (s, 3 H), 0.94 (s, 3 H). 
 
Geranyl Cyanide (24).  (Procedure adapted from: Mori, K.; Funaki, Y. 
Tetrahedron 1985, 41, 2369).  PBr3 (0.92 mL, 9.7 mmol, 0.50 equiv) was added 
dropwise over the course of 10 min to a solution of geraniol (3.0 g, 19.4 mmol, 1.0 
equiv) in Et2O (60 mL) at –20 °C.  The resultant mixture was allowed to warm slowly 
to 0 °C over the course of 1 h, then poured into ice-cold water (125 mL) and extracted 
with hexanes (3 × 75 mL).  The combined organic layers were washed with saturated 
aqueous sodium bicarbonate (100 mL) and brine (100 mL), dried (MgSO4), filtered, 
and concentrated to afford geranyl bromide (4.08 g, 97% yield) which was used 
directly without further purification [Note: geranyl bromide can be stored at –20 °C 
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for several weeks, but will slowly decompose].  Next, a portion of the newly-
synthesized geranyl bromide (2.00 g, 9.21 mmol, 1.00 equiv) was added dropwise to 
a suspension of NaCN (0.495 g, 10.1 mmol, 1.10 equiv) in DMF (8 mL) at 0 °C.  The 
resultant heterogeneous mixture was warmed slowly to 25 °C and maintained at that 
temperature for 40 h.  Upon completion, the reaction contents were poured into water 
(50 mL) and extracted with Et2O (3 × 50 mL).  The combined organic layers were 
then washed with water (50 mL) and brine (50 mL), dried (MgSO4), filtered, and 
concentrated.  The resultant yellow oil was purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 9:1) to afford 24 (1.18 g, 79% yield) as a colorless oil. 
 
Bromocyclized Geranyl Cyanide (25, 26, 27).  A solution of BDSB (17, 
0.055 g, 0.100 mmol, 1.00 equiv) in MeNO2 (0.5 mL) was added quickly via syringe 
to a solution of 24 (16.3 mg, 0.100 mmol, 1.00 equiv) in MeNO2 (1.5 mL) at 25 °C.  
After 5 min at 25 °C, the reaction mixture was quenched by the addition of saturated 
aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  The 
resultant heterogeneous mixture was stirred vigorously for 15 min at 25 °C, then 
poured into water (5 mL), and extracted with CH2Cl2 (3 × 10 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 9:1) to afford 25, 26, and 27 
(17.6 mg, 73% yield) as an inseparable mixture in a 6.5:2.5:1 ratio.  25, 26, 27: Rf = 
0.42 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2972, 2939, 2246, 1469, 1445, 
1422, 1392, 1372, 1186, 1161, 873, 849 cm–1; 1H NMR (400 MHz, CDCl3) Major 
Isomer (25): δ 5.43 (br s, 1 H), 4.12 (dd, J = 8.4, 7.6 Hz, 1 H), 2.72 (dd, J = 17.6, 5.2 
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Hz, 1 H), 2.46 (dd, J = 17.6, 6.0 Hz, 1 H), 1.81 (s, 3 H), 1.18 (s, 3 H), 1.05 (s, 3 H); 
selected 1H NMR signals for 26: δ 4.21 (dd, J = 10.4, 3.2 Hz, 1 H), 3.05 (AB, J = 
40.0, 17.2 Hz, 2 H), 1.74 (s, 3 H), 1.26 (s, 3 H), 1.19 (s, 3 H); selected 1H NMR 
signals for 27: δ 5.07 (s, 1 H), 4.80 (s, 1H), 1.21 (s, 3 H), 0.89 (s, 3 H); 13C NMR (75 
MHz, CDCl3) Major Isomer (25): δ 132.7, 123.4, 120.0, 62.1, 46.8, 38.6, 34.8, 28.6, 
21.8, 17.3, 16.9; HRMS (FAB) calcd for C11H16BrN+ [M]+ 241.0466, found 
241.0469.  
 
Geranyl Trifluoroacetate (28).  TFAA (2.34 mL, 16.9 mmol, 1.30 equiv) 
was added dropwise to a solution of geraniol (2.00 g, 13.0 mmol, 1.00 equiv) and 
Et3N (3.6 mL, 25.9 mmol, 2.00 equiv) in CH2Cl2 (25 mL) at 0 °C.  After 30 min at 0 
°C, the reaction mixture was quenched with cold water (50 mL) and extracted with 
CH2Cl2 (3 × 25 mL).  The combined organic layers were washed with brine (50 mL), 
dried (MgSO4), filtered, concentrated, and purified by vacuum distillation (→ 100 °C 
@ 2 mm Hg) to afford 28 (3.06 g, 94%) as a colorless oil [Note: compound 28 turns 
bright pink over time, even when stored at –20 °C in the dark; by NMR analysis, 
however, this compound is still pure even when colored].  28: Rf = 0.52 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2971, 2921, 2860, 1784, 1222, 1145, 910 cm–1; 
1H NMR (400 MHz, CDCl3) δ 5.39 (t, J = 7.6 Hz, 1 H), 5.06 (m, 1 H), 4.85 (d, J = 
7.2 Hz, 2 H), 2.15 – 2.05 (m, 4 H), 1.75 (s, 3 H), 1.68 (s, 3 H), 1.60 (s, 3 H); 13C 
NMR (75 MHz, CDCl3) δ 157.5 (q, J = 42 Hz), 145.9, 132.3, 123.5, 116.1, 114.7 (q, 




Bromocyclized Geranyl Trifluoroacetate (29, 30, 31).  A solution of BDSB 
(17, 0.055 g, 0.100 mmol, 1.00 equiv) in MeNO2 (0.5 mL) was added quickly via 
syringe to a solution of 28 (25.0 mg, 0.100 mmol, 1.00 equiv) in MeNO2 (1.5 mL) at 
25 °C.  After 5 min at 25 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  
The resultant heterogeneous mixture was stirred vigorously for 15 min at 25 °C, then 
poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 19:1) to afford 29, 30, and 31 
(18.4 mg, 56% yield) as an inseparable mixture in an 8:1:1 ratio.  29, 30, 31: Rf = 
0.44 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2974, 2935, 1785, 1353, 1223, 
1152, 776, 731 cm–1; 1H NMR (400 MHz, CDCl3) Major Isomer (29): δ 5.41 (br s, 1 
H), 4.69 (dd, J = 11.6, 4.0 Hz, 1 H), 4.48 (dd, J = 11.6, 5.2 Hz, 1 H), 4.16 (dd, J = 
8.8, 6.4 Hz, 1 H), 2.59 (m, 2 H), 2.29 (br s, 1 H), 1.71 (s, 3 H), 1.22 (s, 3 H), 1.00 (s, 
3 H); 13C NMR (75 MHz, CDCl3) Major Isomer (29): δ 157.4 (q, J = 43.0 Hz), 132.4, 
123.0, 118.4 (q, J = 284 Hz), 67.5, 62.5, 48.9, 37.9, 34.9, 28.6, 21.7, 17.6; HRMS 
(FAB) calcd for C12H16BrF3O2+ [M]+ 328.0286, found 328.0294. 
 
Bromocyclized Geranyl Acetate Minor Diastereomer (32).  Produced 
during the synthesis of 5 [Note: could not be completely purified by flash column 
chromatography].  32: Rf = 0.55 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3500 
(br), 2967, 2933, 1724, 1455, 1371, 1241, 1184, 1031 cm–1; 1H NMR (400 MHz, 
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CDCl3) δ 4.46 (dd, J = 12.4, 4.8 Hz, 1 H), 4.34 (dd, J = 12.0, 2.8 Hz, 1 H), 3.99 (dd, J 
= 12.8, 3.6 Hz, 1 H), 2.42 (dq, J = 4.0, 13.6 Hz, 1 H), 2.08 – 2.00 (m, 4 H), 1.69 (dt, J 
= 13.6, 3.2 Hz, 1 H), 1.58 (m, 1 H), 1.49 (s, 1 H), 1.41 (dd, J = 4.8, 2.8 Hz, 1 H), 1.23 
(s, 3 H), 1.17 (s, 3 H), 1.13 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 170.8, 71.8, 67.5, 
63.4, 53.1, 42.2, 39.9, 30.7, 30.5, 30.0, 21.3, 17.9; HRMS (FAB) calcd for 
C12H22BrO3+ [M+H]+ 293.0752, found 293.0748. 
 
Geranyl tert-Butylcarbonate (33).  A solution of n-BuLi (0.667 mL, 1.5 M 
in hexanes, 1.00 mmol, 1.00 equiv) was added dropwise to a solution of geraniol 
(0.154 g, 1.00 mmol, 1.00 equiv) in THF (4 mL) at –78 °C.  After 10 min at –78 °C, a 
solution of Boc2O (0.218 g, 1.00 mmol, 1.00 equiv) in THF (1 mL) was added via 
syringe, and the reaction flask was then removed from the cold bath and maintained 
at 25 °C for 30 min.  The reaction contents were then quenched by the slow addition 
of water (5 mL), poured into aqueous 1 M HCl (5 mL), and extracted with EtOAc (3 
× 10 mL).  The combined organic layers were washed with saturated aqueous sodium 
bicarbonate (2 × 10 mL) and brine (10 mL), dried (MgSO4), filtered, and 
concentrated.  Purification by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1) afforded 33 (0.215 g, 85% yield) as a colorless viscous oil.  33: 
Rf = 0.50 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2979, 2930, 1740, 1455, 
1369, 1276, 1254, 1167, 862 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.36 (dt, J = 1.2, 
7.2 Hz, 1 H), 5.07 (app t, J = 6.4 Hz, 1 H), 4.58 (d, J = 7.2 Hz, 2 H), 2.14 – 2.01 (m, 4 
H), 1.70 (s, 3 H), 1.67 (s, 3 H), 1.59 (s, 3 H), 1.48 (s, 9 H); 13C NMR (75 MHz, 
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CDCl3) δ 153.8, 142.6, 131.9, 123.9, 118.2, 81.9, 63.9, 39.6, 27.9 (3 C), 26.4, 25.8, 
17.8, 16.6; HRMS: no molecular ion peak observed. 
 
Bromocyclized Geranyl tert-Butylcarbonate (34, 35).  A solution of BDSB 
(17, 0.055 g, 0.100 mmol, 1.00 equiv) in MeNO2 (0.5 mL) was added quickly via 
syringe to a solution of 33 (25.4 mg, 0.100 mmol, 1.00 equiv) in MeNO2 (1.5 mL) at 
–25 °C.  After 5 min at –25 °C, the reaction solution was allowed to warm to 25 °C 
and stirred at that temperature for an additional 25 min.  Upon completion, the 
reaction mixture quenched by the addition of saturated aqueous sodium bicarbonate 
and 5% aqueous sodium sulfite (1:1, 5 mL).  The resultant heterogeneous mixture 
was stirred vigorously for 15 min at 25 °C, then poured into water (5 mL) and 
extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:1) to afford 34 (14.9 mg) and 35 (3.1 mg; 65% combined 
yield) as separable white crystalline solids.  34: Rf = 0.55 (silica gel, hexanes:EtOAc, 
3:7); IR (film) νmax 2977, 2951, 2876, 1747, 1222, 1153, 1131, 1088 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 4.50 (dd, J = 10.8, 6.0 Hz, 1 H), 4.42 (dd, J = 12.4, 10.8 Hz, 1 
H), 3.96 (dd, J = 12.8, 4.4 Hz, 1 H), 2.31 (dq, J = 14.0, 3.6 Hz, 1 H), 2.12 – 1.96 (m, 
3 H), 1.77 (dt, J = 4.0, 14.0 Hz, 1 H), 1.52 (s, 3 H), 1.16 (s, 3 H), 1.00 (s, 3 H); 13C 
NMR (75 MHz, CDCl3) δ 148.4, 80.8, 67.7, 62.8, 47.2, 39.5, 38.1, 31.1, 29.3, 20.9, 
17.3; HRMS (FAB) calcd for C11H18BrO3+ [M+H]+ 277.0439, found 277.0458.  35: 
Rf = 0.34 (silica gel, hexanes:EtOAc, 3:7); IR (film) νmax 2978, 2938, 1746, 1216, 
1160, 1136, 1110 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.74 (dd, J = 12.4, 6.0 Hz, 1 
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H), 4.56 (d, J = 12.4 Hz, 1 H), 3.97 (dd, J = 13.2, 3.6 Hz, 1 H), 2.38 (dq, J = 3.6, 13.2 
Hz, 1 H), 2.13 – 2.05 (m, 2 H), 1.72 – 1.60 (m, 2 H), 1.48 (s, 3 H), 1.18 (s, 3 H), 1.15 
(s, 3 H); 13C NMR (75 MHz, CDCl3) δ 149.2, 80.4, 67.9, 63.6, 44.5, 39.3, 39.1, 30.3, 
29.6, 28.2, 17.4; HRMS (FAB) calcd for C11H18BrO3+ [M+H]+ 277.0439, found 
277.0448.   
 
Homogeranic Acid (36).  Prepared from geranyl cyanide (24) according to 
the following reference: Couladouros, E. A.; Vidali, V. P. Chem. Eur. J. 2004, 10, 
3822. 
 
Bromocyclized Homogeranic Acid (37).  A solution of BDSB (17, 0.055 g, 
0.100 mmol, 1.00 equiv) in MeNO2 (0.5 mL) was added quickly via syringe to a 
solution of 36 (18.2 mg, 0.100 mmol, 1.00 equiv) or 38 (23.8 mg, 0.100 mmol, 1.00 
equiv) in MeNO2 (1.5 mL) at –25 °C (36) or 0 °C (38).  After 5 min at the appropriate 
temperature, the reaction mixture was quenched by the addition of saturated aqueous 
sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL). The resultant 
heterogeneous mixture was stirred vigorously for 15 min at 25 °C, then poured into 
water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 4:1) to afford 37 (19.0 mg, 73% yield 
from 36; 20.7 mg, 79% yield from 38) as a white crystalline solid.  37: Rf = 0.39 
(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2955, 2873, 1775, 1457, 1225, 1193, 
1150, 1032, 921 cm–1; 1H NMR (400 MHz, CDCl3) δ 3.92 (dd, J = 12.4, 4.4 Hz, 1 H), 
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2.52 (dd, J = 14.4, 16.0 Hz, 1 H), 2.42 – 2.33 (m, 2 H), 2.17 – 1.98 (m, 3 H), 1.80 (dt, 
J = 4.4, 12.4 Hz, 1 H), 1.40 (s, 3 H), 1.08 (s, 3 H), 1.02 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 175.5, 84.7, 62.9, 54.6, 38.7, 38.5, 32.4, 30.3, 30.1, 20.6, 17.1; HRMS 
(FAB) calcd for C11H18BrO2+ [M+H]+ 261.0490, found 261.0479.  
 
tert-Butyl Homogeranate (38).  (Procedure adapted from: Couladouros, E. 
A.; Vidali, V. P. Chem. Eur. J. 2004, 10, 3822).  A solution of homogeranic acid (36, 
0.235 g, 1.29 mmol, 1.00 equiv) in t-BuOH (2 mL) was cooled to 0 °C with the 
simultaneous and dropwise addition of TFAA (0.896 mL, 6.45 mmol, 5.00 equiv) at a 
rate appropriate to prevent freezing of the solution.  After 10 min of stirring at 0 °C, 
the reaction contents were warmed to 25 °C and maintained at that temperature for an 
additional 10 min.  Upon completion, the reaction contents were poured into cold 
saturated aqueous sodium bicarbonate (30 mL) and extracted with Et2O (3 × 25 mL).  
The combined organic layers were then washed with saturated aqueous sodium 
bicarbonate (25 mL) and brine (25 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 9:1 
containing 0.5% Et3N by total volume) to afford 38 (0.210 g, 68% yield) as a light 
yellow oil. 
 
p-Methoxyhomogeranylbenzene (39).  (Procedure adapted from: Araki, S.; 
Sato, T.; Butsugan, Y. J. Org. Chem. 1982, 47, 285).  A solution of 4-methoxybenzyl 
chloride (0.470 mL, 3.00 mmol, 2.00 equiv) in THF (8 mL) was added dropwise to 
Mg turnings (activated with an acidic rinse and thoroughly flame dried, 0.146 g, 6.00 
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mmol, 4.00 equiv) at 0 °C.  After 1 h at 0 °C, the resultant 4-
methoxybenzylmagnesium chloride solution was cooled to –40 °C and added quickly 
via syringe to a solution of geranyl diethyl phosphate [see synthesis of 1] (0.435 g, 
1.50 mmol, 1.00 equiv) in THF (2 mL) at –40 °C.  The resultant reaction mixture was 
allowed to warm slowly to 25 °C over the course of 12 h, then quenched by the 
addition of 10% aqueous ammonium chloride (15 mL) and extracted with 
hexanes:EtOAc (2:1, 3 × 20 mL).  The combined organic layers were then washed 
with brine (20 mL), dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 2:1), then dried for 1 h at 
60 °C under vacuum to remove residual 4-methoxytoluene in order to afford pure 39 
(0.352 g, 91% yield) as a colorless oil.  39: Rf = 0.46 (silica gel, hexanes:EtOAc, 9:1); 
IR (film) νmax 2921, 2855, 1613, 1513, 1442, 1246, 1176, 1040, 823 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 7.11 (d, J = 8.4 Hz, 2 H), 6.82 (d, J = 8.4 Hz, 2 H), 5.18 (app t, 
J = 6., 1 H), 5.10 (dt, J = 6.0, 1.2 Hz, 1 H), 3.79 (s, 3 H), 2.59 (t, J = 7.2 Hz, 2 H), 
2.27 (q, J = 7.2 Hz, 2 H), 2.11 – 1.95 (m, 4 H), 1.69 (s, 3 H), 1.61 (s, 3 H), 1.56 (s, 3 
H); 13C NMR (75 MHz, CDCl3) δ 157.8, 135.8, 134.7, 131.5, 129.5 (2 C), 124.5, 
123.8, 113.8 (2 C), 55.4, 39.9, 35.4, 30.3, 26.9, 25.8, 17.8, 16.1; HRMS (FAB) calcd 
for C18H26O+ [M]+ 258.1984, found 258.1977. 
 
Bromocyclized p-Methoxyhomogeranylbenzene (40).  A solution of BDSB 
(17, 0.055 g, 0.100 mmol, 1.00 equiv) in MeNO2 (0.5 mL) was added quickly via 
syringe to a solution of 39 (25.8 mg, 0.100 mmol, 1.00 equiv) in MeNO2 (1.5 mL) at 
–25 °C.  After 5 min at –25 °C, the reaction mixture was quenched by the addition of 
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saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  
The resultant heterogeneous mixture was stirred vigorously for 15 min at 25 °C, then 
poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by preparative 
TLC (silica gel, hexanes:CH2Cl2, 1:1) to afford 40 (25.6 mg, 76% yield) as a white 
crystalline solid.  40: Rf = 0.44 (silica gel, hexanes:CH2Cl2, 1:1); IR (film) νmax 2968, 
2948, 2834, 1610, 1503, 1266, 1044, 872 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.97 
(d, J = 8.4 Hz, 1 H), 6.74 (d, J = 2.8 Hz, 1 H), 6.68 (dd, J = 8.4, 2.8 Hz, 1 H), 4.04 
(dd, J = 12.4, 4.0 Hz, 1 H), 3.77 (s, 3 H), 2.94 – 2.75 (m, 2 H), 2.42 – 2.22 (m, 3 H), 
1.97 (m, 1 H), 1.80 (m, 1 H), 1.61 (m, 1 H), 1.45 (dd, J = 12.0, 2.0 Hz, 1 H), 1.25 (s, 
3 H), 1.16 (s, 3 H), 1.06 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 157.9, 150.1, 130.0, 
127.1, 111.3, 110.3, 69.0, 55.4, 51.4, 40.2, 40.0, 38.2, 31.7, 30.7, 30.1, 24.9, 20.9, 
18.4; HRMS (FAB) calcd for C18H25BrO+ [M]+ 336.1089, found 336.1097.  
   
Bromocyclized Geranylacetone (42).  A solution of BDSB (17, 30 mg, 0.056 
mmol, 1.1 equiv) in MeNO2 (0.5 mL) was added quickly via syringe to a solution of 
41 (10 mg, 0.051 mmol, 1.0 equiv) in MeNO2 (1.5 mL) at 0 °C.  After 10 min at 0 °C, 
the reaction mixture was quenched by the addition of saturated aqueous sodium 
bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  The resultant heterogeneous 
mixture was stirred vigorously for 15 min at 25 °C, then poured into water (5 mL) 
and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by preparative TLC (silica gel, 
hexanes:EtOAc, 7:1) to afford 42 (3.0 mg, contaminated with minor amounts of 
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unknown byproducts, ~20% yield) as a colorless viscous oil.  42: Rf = 0.6 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3, selected peaks only) δ 4.48 (d, J = 
7.6 Hz, 1 H), 4.01 (dd, J = 12.4, 4.0 Hz, 1 H), 1.68 (s, 3 H), 1.19 (s, 3 H), 1.08 (s, 3 
H), 0.95 (s, 3 H).  
 
Geranyl Isobutyrophenone (43).  A solution of n-BuLi (2.75 mL, 1.6 M in 
hexanes, 4.40 mmol, 2.20 equiv) was added dropwise to a solution of i-Pr2NH (0.703 
mL, 5.00 mmol, 2.50 equiv) in THF (10 mL) at –78 °C.  The resultant light yellow 
solution was allowed to warm to 25 °C over 20 min, then re-cooled to –78 °C.  
Isobutyrophenone (0.605 mL, 4.00 mmol, 2.00 equiv) was added dropwise to the 
resultant LDA solution.  After 30 min at –78 °C, the resultant orange enolate solution 
was cannulated into a solution of geranyl bromide (0.434 g, 2.00 mmol, 1.00 equiv) 
in THF (3 mL) at –40 °C.  The reaction mixture was allowed to warm slowly to 25 °C 
over 15 h, then quenched by the addition of 10% aqueous ammonium chloride (30 
mL).  The crude product was extracted with hexanes:EtOAc (2:1, 3 × 30 mL) and the 
combined organic layers were washed with brine (30 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0 → 2:1).  The resultant material was dried at 2 torr and 100 °C 
for 2 h to remove residual isobutyrophenone, affording 43 (0.405 g, 71% yield) as a 
colorless viscous oil.  43: Rf = 0.30 (silica gel, hexanes:CH2Cl2, 1:1); IR (film) νmax 
2966, 2915, 2855, 1687, 1448, 690 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.63 (m, 2 
H), 7.47 – 7.35 (m, 3 H), 5.11 – 5.01 (m, 2 H), 2.43 (d, J = 7.2 Hz, 2 H), 2.08 – 1.94 
(m, 4 H), 1.66 (s, 3 H), 1.58 (s, 3 H), 1.54 (s, 3 H), 1.30 (s, 6 H); 13C NMR (75 MHz, 
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CDCl3) δ 209.6, 139.6, 138.0, 131.5, 130.7, 128.1 (2 C), 127.6 (2 C), 124.3, 119.9, 
48.5, 40.1, 38.9, 26.7, 25.8 (3 C), 17.8, 16.3; HRMS (FAB) calcd for C20H28O+ [M]+ 
284.2140, found 284.2142. 
 
Bromocyclized Geranyl Isobutyrophenone (44, 45).  A solution of BDSB 
(17, 9.7 mg, 0.018 mmol, 1.0 equiv) in MeNO2 (0.25 mL) was added quickly via 
syringe to a solution of 43 (5.0 mg, 0.018 mmol, 1.0 equiv) in MeNO2 (0.75 mL) at –
25 °C.  After 5 min at –25 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL)  
The resultant heterogeneous mixture was stirred vigorously for 15 min at 25 °C, then 
poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by preparative 
TLC (silica gel, hexanes:EtOAc, 19:1) to afford 44 (3 mg, ~40% yield) and 45 (4 mg, 
contaminated with minor unidentified byproducts, ~40% yield), both as colorless 
viscous oils.  44: Rf = 0.2 (silica gel, hexanes:EtOAc, 19:1); 1H NMR (400 MHz, 
CDCl3) δ 7.51 (dd, J = 8.4, 1.6 Hz, 2 H), 7.34 – 7.24 (m, 3 H), 4.05 (dd, J = 12.4, 4.8 
Hz, 1 H), 2.30 – 2.10 (m, 3 H), 2.06 (t, J = 12.8 Hz, 1 H), 1.82 – 1.68 (m, 3 H), 1.51 
(s, 3 H), 1.32 (dd, J = 12.8, 1.6 Hz, 1 H), 1.08 (s, 3 H), 1.05 (s, 3 H), 0.96 (s, 3 H), 
0.65 (s, 3 H).  45: Rf = 0.3 (silica gel, hexanes:EtOAc, 19:1); 1H NMR (400 MHz, 
CDCl3) δ 7.57 – 7.50 (m, 2 H), 7.36 – 7.28 (m, 3 H), 5.26 (t, J = 7.2 Hz, 1 H), 4.41 
(dd, J = 10.8, 6.0 Hz, 1 H), 2.63 (s, 1 H), 2.38 – 2.16 (m, 3 H), 2.01 – 1.83 (m, 3 H), 
1.80 (s, 3 H), 1.71 (s, 3 H), 1.60 (s, 3 H), 1.20 (s, 3 H), 0.66 (s, 3 H).  
 
 96 
3,5-Dimethoxyhomogeranylbenzene (46).  (Procedure adapted from: Araki, 
S.; Sato, T.; Butsugan, Y. J. Org. Chem. 1982, 47, 285).  A solution of 3,5-
dimethoxybenzyl chloride (0.37 mL, 2.0 mmol, 2.0 equiv) in THF (5 mL) was added 
dropwise to Mg turnings (activated with an acidic rinse and thoroughly flame dried, 
0.097 g, 4.0 mmol, 4.0 equiv) at 0 °C.  After 1 h at 0 °C, the resultant 3,5-
dimethoxybenzylmagnesium chloride solution was cooled to –40 °C and added 
quickly via syringe to a solution of geranyl diethyl phosphate [see synthesis of 1] 
(0.29 g, 1.0 mmol, 1.0 equiv) in THF (1 mL) at –40 °C.  The resultant reaction 
mixture was allowed to warm slowly to 25 °C over the course of 16 h, then quenched 
by the addition of 10% aqueous ammonium chloride (15 mL) and extracted with 
hexanes:EtOAc (2:1, 3 × 20 mL).  The combined organic layers were washed with 
brine (20 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 2:1).  The resultant product was 
dried for 1 h at 100 °C under vacuum to remove residual 3,5-dimethoxytoluene in 
order to afford pure 46 (0.27 g, 95% yield) as a colorless oil.  46: Rf = 0.41 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2928, 2855, 2837, 1596, 1462, 1428, 1205, 1155, 
1068, 829 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.37 (d, J = 2.0 Hz, 2 H), 6.30 (t, J = 
2.0 Hz, 1 H), 5.19 (dt, J = 1.2, 7.2 Hz, 1 H), 5.10 (tt, J = 6.8, 1.2 Hz, 1 H), 3.78 (s, 6 
H), 2.59 (t, J = 8.0 Hz, 2 H), 2.30 (q, J = 7.6 Hz, 2 H), 2.12 – 1.96 (m, 4 H), 1.69 (s, 3 
H), 1.61 (s, 3 H), 1.59 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 160.8 (2 C), 145.0, 
135.9, 131.5, 124.5, 123.7, 106.7 (2 C), 97.8, 55.4 (2 C), 39.9, 36.6, 29.9, 26.9, 25.8, 
17.8, 16.2; HRMS (FAB) calcd for C19H28O2+ [M]+  288.2089, found 288.2086. 
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Bromocyclized 3,5-Dimethoxyhomogeranylbenzene (47, 48, 49).  A 
solution of BDSB (17, 21 mg, 0.037 mmol, 0.9 equiv) in MeNO2 (0.5 mL) was added 
quickly via syringe to a solution of 46 (12 mg, 0.042 mmol, 1.0 equiv) in MeNO2 (2.0 
mL) at –25 °C.  After 5 min at –25 °C, the reaction mixture was quenched by the 
addition of saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite 
(1:1, 5 mL).  The resultant heterogeneous mixture was stirred vigorously for 15 min 
at 25 °C, then poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
preparative TLC (silica gel, hexanes:EtOAc, 6:1) to afford 47 (9 mg, contaminated 
with minor byproducts, ~50% yield) along with 48 (2 mg, contaminated with minor 
byproducts, ~10% yield), both as colorless amorphous solids.  Because of their very 
similar Rf values, compound 49 (~2 mg, ~10% yield) could not be completely 
separated from compound 47.  47: Rf = 0.5 (silica gel, hexanes:EtOAc, 6:1); 1H NMR 
(400 MHz, CDCl3) δ 6.28 (d, J = 2.4 Hz, 1 H), 6.19 (d, J = 2.4 Hz, 1 H), 4.07 (dd, J = 
12.8, 4.4 Hz, 1 H), 3.75 (s, 6 H), 3.10 (dt, J = 14.0, 3.6 Hz, 1 H), 2.90 – 2.82 (m, 2 
H), 2.37 – 2.25 (m, 2 H), 2.14 (dq, J = 14.0, 4.0 Hz, 1 H), 1.87 (m, 1 H), 1.65 (m, 1 
H), 1.37 (d, J = 12.0 Hz, 1 H), 1.30 (s, 3 H), 1.16 (s, 3 H), 1.05 (s, 3 H).  48: Rf = 0.4 
(silica gel, hexanes:EtOAc, 6:1); 1H NMR (400 MHz, CDCl3) δ 6.38 (s, 1 H), 4.04 
(dd, J = 12.8, 4.4 Hz, 1 H), 3.87 (s, 3 H), 3.81 (s, 3 H), 3.09 (dt, J = 3.6, 14.0 Hz, 1 
H), 2.96 (dd, J = 17.6, 3.6 Hz, 1 H), 2.67 (ddd, J = 19.2, 12.4, 6.8 Hz, 1 H), 2.30 (dq, 
J = 3.6, 13.2 Hz, 1 H), 2.13 (dq, J = 13.6, 4.0 Hz, 1 H), 1.96 (dd, J = 13.2, 6.8 Hz, 1 
H), 1.62 (dq, J = 5.6, 12.4 Hz, 1 H), 1.32 (s, 3 H), 1.28 (m, 2 H), 1.16 (s, 3 H), 1.05 
(s, 3 H).  49: Rf = 0.4 (silica gel, hexanes:EtOAc, 6:1); 1H NMR (300 MHz, CDCl3, 
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selected peaks only) δ 6.30 (m, 1 H), 6.17 (m, 1 H), 5.07 (t, J = 7.2 Hz, 1 H), 4.64 (t, 
J = 7.2 Hz, 1 H), 3.77 (s, 3 H), 3.76 (s, 3 H), 1.64 (s, 3 H), 1.48 (s, 3 H), 1.44 (s, 3 H). 
 
Neryl Acetate (56).  Synthesized according to the procedure described above 
for 3, substituting nerol for geraniol, to afford 56 (1.10 g, 98% yield) as a colorless 
oil.   
 
Bromocyclized Neryl Acetate (58).  A solution of BDSB (17, 0.15 g, 0.28 
mmol, 1.1 equiv) in MeNO2 (1 mL) was added quickly via syringe to a solution neryl 
acetate (56, 0.049 g, 0.25 mmol, 1.0 equiv) in MeNO2 (24 mL) at 0 °C.  After 5 min 0 
°C, the reaction mixture was quenched by the addition of 5% aqueous sodium sulfite 
and saturated aqueous sodium bicarbonate (1:1, 10 mL).  The resultant heterogeneous 
mixture was stirred vigorously for 15 min at 25 °C, then poured into brine (10 mL) 
and extracted with EtOAc
 
(3 × 15 mL).  The combined organic layers were washed 
with brine (30 mL), dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 1:0 → 1:1) to afford 58 as a 
white crystalline solid (0.052 g, 71% yield).  58: m.p. = 71.5 – 72.5 °C; Rf = 0.56 
(silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3508 (br), 2965, 1722, 1369, 1234, 
1211, 1030 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.46 (dd, J = 12.0, 3.2 Hz, 1 H), 4.31 
(br s, 1 H), 4.30 (dd, J = 11.6, 3.2 Hz, 1 H), 2.44 (app tt, 1 H), 2.14 (dt, J = 4.0, 13.6 
Hz, 1 H), 2.06 (s, 3 H), 1.89 – 1.80 (m, 2 H), 1.60 (s, 1 H), 1.54 (dt, J = 14.0, 2.8 Hz, 
1 H), 1.31 (s, 3 H), 1.23 (s, 3 H), 1.14 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 170.8, 
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72.0, 70.0, 62.5, 46.9, 38.8, 36.1, 32.3, 31.0, 27.8, 23.2, 21.4; HRMS (FAB) calcd for 
C12H22BrO3+ [M+H]+ 293.0752, found 293.0744. 
 
(4E)-4-Methyl-6-Acetoxy-4-Hexenal (59).  (Procedure adapted from Uyanik, 
M.; Ishihara, K.; Yamamoto, H. Org. Lett. 2006, 8, 5649).  A solution of mCPBA 
(77%, 13.4 g, 59.8 mmol, 1.05 equiv) in CH2Cl2 (125 mL) was added dropwise via 
addition funnel to a solution of geranyl acetate (3, 11.1 g, 57.0 mmol, 1.00 equiv) in 
CH2Cl2 (100 mL) at –20 °C.  The reaction mixture was allowed to warm slowly to –5 
°C over 1 h, then quenched by the addition of cold aqueous 3 M sodium hydroxide 
(75 mL) and extracted with CH2Cl2 (2 × 100 mL).  The combined organic layers were 
washed with aqueous 1 M sodium hydroxide (2 × 100 mL) and brine (100 mL), then 
dried (MgSO4), filtered, and concentrated to afford the crude epoxide, which was 
carried forward without additional purification.  Solid periodic acid dihydrate (12.7 g, 
1.05 eq) was added slowly to a solution of the crude epoxide in THF:Et2O (7:1, 400 
mL) at 0 °C.  After 1 h at 0 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate (100 mL) and filtered through celite.  The 
resultant mixture was extracted with Et2O (3 × 100 mL) and the combined organic 
layers were washed with water (100 mL) and brine (100 mL), then dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:Et2O, 1:0 → 1:1) to afford 59 (5.96 g, 61% yield) as a light yellow oil.  
 
Monosubstituted Alkene 60.  A solution of KOt-Bu (12.9 mL, 1.0 M in 
THF, 12.9 mmol, 1.14 equiv) was added dropwise to a suspension of 
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methyltriphenylphosphonium bromide (4.86 g, 13.6 mmol, 1.20 equiv) in THF (17 
mL) at 25 °C.  The resultant yellow ylid mixture was stirred for 1 h at 25 °C, then 
cannulated into a solution of 59 (1.93 g, 11.3 mmol, 1.00 equiv) in THF (30 mL) at 0 
°C.  After an additional 15 min at 0 °C, the reaction mixture was quenched by the 
addition of 10% aqueous ammonium chloride (100 mL) and extracted with Et2O (2 × 
50 mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, 
and purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 4:1) 
to afford 60 (1.61 g, 84% yield) as a light yellow oil.  60: Rf = 0.5 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 5.79 (m, 1 H), 5.35 (app t, 1 H), 
5.07 – 4.92 (m, 2 H), 4.59 (d, J = 7.2 Hz, 2 H), 2.24 – 2.08 (m, 4 H), 2.05 (s, 3 H), 
1.70 (s, 3 H). 
 
Bromohydrin 61.  A solution of BDSB (17, 0.060 g, 0.11 mmol, 1.1 equiv) in 
MeNO2 (0.5 mL) was added quickly via syringe to a solution of 60 (0.017 g, 0.10 
mmol, 1.0 equiv) in MeNO2 (4.5 mL) at –25 °C.  After 15 min at –25 °C, the reaction 
mixture was quenched by the addition of saturated aqueous sodium bicarbonate and 
5% aqueous sodium sulfite (1:1, 10 mL).  The resultant heterogeneous mixture was 
and stirred vigorously for 15 min at 25 °C, then extracted with CH2Cl2 (3 × 5 mL).  
The combined organic layers were dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 1:1) to afford 61 
(13 mg, contaminated with small amounts of unknown products, ~50% yield) as a 
colorless viscous oil.  61: Rf = 0.3 (silica gel, hexanes:EtOAc, 2:1); 1H NMR (400 
MHz, CDCl3) δ 5.84 (m, 1 H), 5.08 (dd, J = 17.2, 1.6 Hz, 1 H), 5.00 (dd, J = 10.0, 1.6 
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Hz, 1 H), 4.59 (dd, J = 12.0, 4.0 Hz, 1 H), 4.37 (dd, J = 12.0, 8.4 Hz, 1 H), 4.19 (dd, J 
= 8.4, 4.0 Hz, 1 H), 2.27 – 2.13 (m, 2 H), 2.11 (s, 3 H), 2.00 (s, 1 H), 1.87 (m, 1 H), 
1.67 (m, 1 H), 1.55 (s, 3 H), 1.36 (s, 3 H).  
 
Disubstituted Alkene 62.  A solution of methylmagnesium bromide (2.67 
mL, 3.0 M in Et2O, 8.0 mmol, 2.0 equiv) was added dropwise to a solution of 59 
(0.681 g, 4.00 mmol, 1.00 equiv) in THF (20 mL) at –78 °C.  The resultant cloudy 
solution was allowed to warm slowly to –15 °C over 90 min, then quenched by the 
addition of 10% aqueous ammonium chloride (50 mL) and extracted with Et2O (3 × 
50 mL).  The combined organic layers were washed with brine (50 mL), dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 → 1:1) to afford the desired methylated alcohol (0.450 g, 
60% yield) as a colorless oil.  Next, Dess-Martin periodinane (1.53 g, 3.63 mmol, 
1.50 equiv) was added in one portion to a solution of this alcohol (0.450 g, 2.42 
mmol, 1.00 equiv) in CH2Cl2 (15 mL) buffered with sodium bicarbonate (2.03 g, 24.2 
mmol, 10.0 equiv) at 0 °C.  The resultant reaction mixture was allowed to warm to 10 
°C over 45 min, then quenched by the addition of 5% aqueous sodium sulfite (30 mL) 
and extracted with CH2Cl2 (3 × 15 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 → 2:1) to afford the desired ketone (0.354 g, 80% yield) as a 
light yellow oil.  Lastly, a solution of KOt-Bu (0.723 mL, 1.0 M in THF, 0.73 mmol, 
1.2 equiv) was added dropwise to a suspension of methyltriphenylphosphonium 
bromide (0.280 g, 0.783 mmol, 1.30 equiv) in THF (1.3 mL) at 25 °C.  The resultant 
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yellow ylid mixture was stirred for 1 h at 25 °C, then cannulated into a solution of the 
ketone produced above (0.111 g, 0.603 mmol, 1.00 equiv) in THF (3 mL) at 0 °C.  
After an additional 15 min at 0 °C, the reaction mixture was quenched by the addition 
of 10% aqueous ammonium chloride (10 mL) and extracted with Et2O (3 × 15 mL).  
The combined organic layers were dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:Et2O, 1:0 → 4:1) to afford 62 
(0.104 g, 95% yield) as a light yellow oil.  62: Rf = 0.6 (silica gel, hexanes:EtOAc, 
2:1); 1H NMR (300 MHz, CDCl3) δ 5.34 (td, J = 7.2 Hz, 1.2 Hz, 1 H), 4.69 (app d, 2 
H), 4.58 (d, J = 6.9 Hz, 2 H), 2.21 – 2.09 (m, 4 H), 2.05 (s, 3 H), 1.72 (s, 3 H), 1.71 
(s, 3 H).  
 
Bromocyclized Disubstituted Alkene (63).  Solid BDSB (17, 0.033 g, 0.060 
mmol, 1.1 equiv) was added in a single portion to a solution of 62 (0.010 g, 0.055 
mmol, 1.0 equiv) in CH2Cl2 (3.0 mL) at –30 °C.  After 30 min at –30 °C, the reaction 
mixture was quenched by the addition of saturated aqueous sodium bicarbonate and 
5% aqueous sodium sulfite (1:1, 10 mL).  The resultant heterogeneous mixture was 
stirred vigorously for 15 min at 25 °C, then poured into water (5 mL) and extracted 
with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:1) to afford a complex mixture presumed to contain 
substantial amounts of 63 (10 mg, ~60% yield) as a colorless viscous oil.  The 
products could not be separated for full characterization, but the presence of 63 was 
inferred by the 1H NMR spectrum, which contains several alkene peaks (including a 
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clear signal for an exocyclic alkene) and three vinyl methyl peaks in addition to 
characteristic quartet peaks between 3 and 4 corresponding to an exocyclic CH2Br 
group (see attached spectrum).   63: Rf = 0.7 (silica gel, hexanes:EtOAc, 2:1).  
 
Tetrasubstituted Alkene 64.  A solution of KOt-Bu (1.3 mL, 1.0 M in THF, 
1.3 mmol, 4.0 equiv) was added dropwise to a suspension of 
isopropyltriphenylphosphonium iodide (0.85 g, 2.0 mmol, 6.0 equiv) in THF (1.2 
mL) at 25 °C.  The resultant yellow ylid mixture was stirred for 30 min at 25 °C, then 
cannulated into a solution of the same ketone utilized in the synthesis of 62 (0.060 g, 
0.33 mmol, 1.0 equiv) in THF (1 mL) at 25 °C.  After 20 h at 25 °C, the reaction 
mixture was quenched by the addition of 10% aqueous ammonium chloride (10 mL) 
and extracted with Et2O (3 × 15 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by preparatory TLC (silica gel, 
hexanes:EtOAc, 9:1) to afford 64 (4.0 mg, 6% yield) as a light yellow oil.  64: Rf = 
0.6 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 5.34 (td, J = 7.2, 
1.8 Hz, 1 H), 4.58 (d, J = 7.2 Hz, 2 H), 2.17 – 2.00 (m, 4 H), 2.06 (s, 3 H), 1.72 (s, 3 
H), 1.63 (s, 9 H).  
 
Bromocyclized Tetrasubstituted Alkene (65, 66).  A solution of BDSB (17, 
12 mg, 0.021 mmol, 1.1 equiv) in MeNO2 (0.5 mL) was added quickly via syringe to 
a solution of 64 (17 mg, 0.10 mmol, 1.0 equiv) in MeNO2 (1.5 mL) at 0 °C.  After 5 
min at 0 °C, the reaction mixture was quenched by the addition of saturated aqueous 
sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  The resultant 
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heterogeneous mixture was stirred vigorously for 15 min at 25 °C, then poured into 
water (5 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by preparatory TLC (silica 
gel, hexanes:EtOAc, 1:1) to afford what are presumed to be two diastereomers of 65 
(~3 mg, each contaminated with small amounts of an unknown byproduct, ~40% 
yield) as colorless amorphous solids as well as what is presumed to be 66 (~2 mg, 
contaminated with 2 minor impuritites, ~15% yield).  65: Less polar diastereomer: Rf 
= 0.7 (silica gel, hexanes:EtOAc, 1:2); 1H NMR (400 MHz, CDCl3, selected peaks 
only) δ 4.44 (dd, J = 12.4, 5.2 Hz, 1 H), 4.33 (dd, J = 12.4, 2.8 Hz, 1 H), 2.89 (td, J = 
13.6, 4.0 Hz, 1 H), 2.06 (s, 3 H), 1.88 (s, 3 H), 1.31 (s, 3 H), 1.23 (s, 3 H), 1.16 (s, 3 
H). 65: More polar diastereomer: Rf = 0.5 (silica gel, hexanes:EtOAc, 1:2); 1H NMR 
(400 MHz, CDCl3, selected peaks only) δ 4.42 – 4.31 (m, 2 H), 2.14 (dt, J = 14.0, 4.0 
Hz, 1 H), 2.07 (s, 3 H), 1.93 (s, 3 H), 1.27 (s, 3 H), 1.18 (s, 3 H), 1.16 (s, 3 H). 66: Rf 
= 0.6 (silica gel, hexanes:EtOAc, 1:2); 1H NMR (400 MHz, CDCl3, selected peaks 
only) δ 4.42 (d, J = 5.6 Hz, 2 H), 2.08 (s, 3 H), 1.26 (s, 3 H), 1.22 (s, 3 H), 1.16 (s, 3 
H), 0.98 (s, 3 H); LRMS: 208 [M–OH]; no Br doublet observed.      
 
Homofarnesylbenzene (67).  (Procedure adapted from: Araki, S.; Sato, T.; 
Butsugan, Y. J. Org. Chem. 1982, 47, 285).  Diethyl chlorophosphate (1.76 mL, 12.1 
mmol, 2.00 equiv) was added dropwise to a solution of trans,trans-farnesol (1.35 g, 
6.07 mmol, 1.00 equiv) and pyridine (2.45 mL, 30.4 mmol, 5.00 equiv) in Et2O (5 
mL) at –50 °C.  The reaction mixture was allowed to warm slowly to 25 °C over the 
course of 3 h, then quenched by the addition of aqueous 1 M HCl (75 mL) and 
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extracted with EtOAc (3 × 25 mL).  The combined organic layers were washed with 
saturated aqueous sodium bicarbonate (2 × 20 mL) and brine (20 mL), dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 → 2:3) to afford farnesyl diethyl phosphate (1.85 g, 85% 
yield) as a light yellow oil.  Next, a solution of benzyl chloride (0.23 mL, 2.0 mmol, 
2.0 equiv) in THF (5 mL) was added dropwise to Mg turnings (activated with an 
acidic rinse and thoroughly flame dried, 0.097 g, 4.0 mmol, 4.0 equiv) at 0 °C.  After 
1 h at 0 °C, the resultant benzylmagnesium chloride solution was cooled to –40 °C 
and added quickly via syringe to a solution of farnesyl diethyl phosphate (0.36 g, 1.0 
mmol, 1.0 equiv) in THF (1 mL) at –40 °C.  The resultant reaction mixture was 
allowed to warm slowly to 25 °C over the course of 12 h, then quenched by the 
addition of 10% aqueous ammonium chloride (15 mL) and extracted with 
hexanes:EtOAc (2:1, 3 × 20 mL).  The combined organic layers were washed with 
brine (20 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 7:1) to afford 67 (0.287 g, 
contaminated with a small amount of bibenzyl, ~92% yield) as a colorless oil.  67: Rf 
= 0.56 (silica gel, hexanes:CH2Cl2, 4:1); IR (film) νmax 3063, 3027, 2966, 2922, 2855, 
1496, 1453, 1382, 749, 698 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.33 – 7.18 (m, 5 
H), 5.22 (app t, 1 H), 5.12 (m, 2 H), 2.66 (t, J = 8.0 Hz, 2 H), 2.33 (q, J = 7.6 Hz, 2 
H), 2.14 – 2.05 (m, 4 H), 2.04 – 1.98 (m, 4 H), 1.71 (s, 3 H), 1.63 (s, 6 H), 1.58 (s, 3 
H); 13C NMR (75 MHz, CDCl3) δ 142.6, 135.9, 135.1, 131.4, 128.6 (2 C), 128.3 (2 
C), 125.8, 124.6, 124.4, 123.8, 39.9 (2 C), 36.3, 30.1, 26.9, 26.8, 25.9, 17.8, 16.1 (2 
C); HRMS (FAB) calcd for C22H32+ [M]+ 296.2504, found 296.2511. 
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Bromocyclized Homofarnesylbenzene (68, 69, 70).  Optimized conditions: 
A solution of BDSB (17, 0.055 g, 0.100 mmol, 1.00 equiv) in MeNO2 (0.5 mL) was 
added quickly via syringe to a solution of 67 (29.7 mg, 0.100 mmol, 1.00 equiv) in 
MeNO2 (1.5 mL) at –25 °C.  After 5 min at –25 °C, MeSO3H (0.100 mL, 1.5 mmol, 
15 equiv) was added to the reaction mixture, and the resultant solution was stirred for 
an additional 1 h at –25 °C.  Upon completion, the reaction mixture was quenched by 
the addition of saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite 
(1:1, 5 mL) and stirred vigorously for 15 min at 25 °C.  The resultant heterogeneous 
mixture was poured into water (5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
preparative TLC (silica gel, hexanes:CH2Cl2, 1:1) to afford 68 (23.0 mg, 
contaminated with small amounts of a side product – presumably a diastereomer, 
~58% yield) as a white crystalline solid.  Without the added acid, significant amounts 
of 69 and 70 could be isolated as an inseparable mixture.  68: Rf = 0.49 (silica gel, 
hexanes:CH2Cl2, 4:1); IR (film) νmax 2945, 2873, 2852, 1488, 1450, 1160, 759 cm–1; 
1H NMR (400 MHz, CDCl3) δ 7.25–6.98 (m, 4 H), 4.01 (dd, J = 12.8, 4.4 Hz, 1 H), 
2.97 – 2.78 (m, 2 H), 2.41 (dt, J = 12.4, 3.2 Hz, 1 H), 2.26 (dq, J = 13.2, 3.6 Hz, 1 H), 
2.12 (dq, J = 14.0, 4.0 Hz, 1 H), 1.89 – 1.49 (m, 6 H), 1.29 – 0.98 (m, 3 H), 1.21 (s, 3 
H), 1.08 (s, 3 H), 1.00 (s, 3 H), 0.99 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 149.9, 
135.0, 129.0, 125.9, 125.4, 124.7, 69.9, 56.7, 55.2, 41.5, 40.7, 39.9, 38.0, 37.8, 31.1, 
30.8, 30.6, 26.1, 20.7, 18.2 (2 C), 16.4; HRMS (FAB) calcd for C22H30Br+ [M–H]+ 
373.1531, found 373.1542.  69: Rf = 0.55 (silica gel, hexanes:CH2Cl2, 4:1); 1H NMR 
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(400 MHz, CDCl3, selected peaks only) δ 5.25 (br s, 1 H), 4.03 (dd, J = 12.4, 4.0 Hz, 
1 H), 1.63 (s, 3 H).  70: Rf = 0.55 (silica gel, hexanes:CH2Cl2, 4:1); 1H NMR (400 
MHz, CDCl3, selected peaks only) δ 4.79 (t, J = 2.4 Hz, 1 H), 4.60 (t, J = 2.0 Hz, 1 
H), 3.95 (dd, J = 12.4, 4.0 Hz, 1 H).   
 
Chlorodimethylsulfonium Hexachloroantimonate (CDSC, 71).  (Procedure 
adapted from: Meerwein, H.; Zenner, K.-F.; Gipp, R. Liebigs Ann. Chem. 1965, 688, 
67).  Diethyl sulfide (6.7 mL, 62 mmol, 1.1 equiv) and a solution of SbCl5 (68 mL, 1 
M in CH2Cl2, 68 mmol, 1.2 equiv) were added slowly and sequentially to a solution 
of chlorine (4.0 g, 56 mmol, 1.0 equiv) in CH2Cl2 (56 mL) at –78 °C.  The resultant 
yellow heterogeneous mixture was removed from the cold bath allowed to warm until 
all solids had redissolved (~10 °C), then the reaction flask was sealed and moved to 4 
°C for 12 h, then cooled further at –20 °C for 24 h.  The resultant crystals were 
isolated, rinsed with cold hexanes:CH2Cl2 (1:1, 10 mL), and dried to afford 71 (23.1 
g, 90% yield) as large off-white blocks.  As with most of the halosulfonium salts 
produced, spectral data were not obtained for this compound. 
 
Chlorocyclized Homogeranylbenzene (72, 73).  A solution of CDSC (71, 
9.5 mg, 0.022 mmol, 1.0 equiv) in MeNO2 (0.5 mL) was added quickly via syringe to 
a solution of 1 (5.0 mg, 0.022 mmol, 1.0 equiv) in MeNO2 (2.5 mL) at –25 °C.  After 
5 min at –25 °C, the reaction mixture was quenched by the addition of saturated 
aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  This 
biphasic mixture was stirred vigorously for 15 min at 25 °C, then poured into water (5 
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mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were 
dried (MgSO4), filtered, concentrated, and purified by preparative TLC (silica gel, 
hexanes:CH2Cl2, 1:1) to afford an inseparable mixture 72 and 73 (1:1, 2.5 mg, 
contaminated with small amounts of unknown byproducts ~40% yield) as a colorless 
amorphous solid.  72/73: Rf = 0.56 (silica gel, hexanes: CH2Cl2, 9:1); IR (film) νmax 
2945, 1452, 1262, 1027, 766, 726 cm–1; 1H NMR (400 MHz, CDCl3) 72 (selected 
peaks only): δ 3.81 (dd, J = 12.0, 4.8 Hz, 1 H), 1.24 (s, 3 H), 1.15 (s, 3 H), 1.03 (s, 3 
H); 73 (selected peaks only): δ 4.13 (t, J = 2.8 Hz, 1 H), 1.22 (s, 3 H), 1.11 (s, 3 H), 
1.09 (s, 3 H) 13C NMR (75 MHz, CDCl3) 72: δ 148.9, 134.9, 129.1, 126.0, 125.7, 
124.5, 72.8, 51.4, 40.1, 38.9, 37.8, 30.8, 30.3, 29.3, 25.0, 20.0, 16.8; 73: δ 149.5, 
135.1, 129.1, 125.9, 125.5, 124.3, 71.9, 43.1, 38.6, 37.6, 32.0, 31.0, 30.1, 27.8, 25.4, 
23.0, 18.5;  HRMS (EI) calcd for C17H23Cl [M]+ 262.1488, found 262.1490.  (NMR 
peaks were able to be differentiated because we had prepared 72 as a single 
diastereomer using a mercury-induced cyclization followed by chlorination – see 
Section 3 of Chapter 4). 
 
Chlorodiisopropylsulfonium Hexachloroantimonate (76).  Isopropyl 
sulfide (0.46 mL, 3.2 mmol, 1.0 equiv) and a solution of SbCl5 (3.5 mL, 1 M in 
CH2Cl2, 3.5 mmol, 1.1 equiv) were added slowly and sequentially to a solution of 
chlorine (0.23 g, 3.2 mmol, 1.0 equiv) in CH2Cl2 (3 mL) at –78 °C.  The resultant 
yellow heterogeneous mixture was removed from the cold bath allowed to warm until 
all solids had redissolved (~20 °C), then the reaction flask was sealed and moved to –
20 °C for 2 h.  The resultant crystals were isolated, rinsed with cold CH2Cl2 (2 mL), 
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then dried to afford 76 (1.29 g, 84% yield) as large off-white blocks.  As with most of 
the halosulfonium salts produced, spectral data were not obtained for this compound. 
 
Chlorosulfonium Derived from Tetramethylthiourea (77).  A solution of 
chlorine (0.28 g, 4.0 mmol, 1.0 equiv) in CH2Cl2 (4 mL) and SbCl5 (4.0 mL, 1.0 M in 
CH2Cl2, 4.0 mmol, 1.0 equiv) were added slowly and sequentially to a solution of 
tetramethylthiourea (0.53 g, 4.0 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at –78 °C.  
After 5 min at –78 °C, the reaction contents were allowed to warm to 25 °C and 
concentrated by rotary evaporation.  The resultant solid was recrystallized from DCE 
(~6 mL) to afford crystals of what may have been 77 as light green blocks.  As with 
most of the halosulfonium salts produced, spectral data were not obtained for this 
compound.  However, a test reaction with 1 (10 mg, 0.044 mmol) afforded no 72 or 
73.   
 
Chlorosulfonium Derived from Bis-Sulfide (78).  A solution of chlorine 
(0.071 g, 1.0 mmol, 1.0 equiv) in CH2Cl2 (1 mL) and SbCl5 (1.0 mL, 1.0 M in 
CH2Cl2, 1.0 mmol, 1.0 equiv) were added slowly and sequentially to a solution of 
1,3-bis(methylthio)propane (0.14 mL, 1.0 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at –78 
°C.  Attempts to purify the resultant precipitate by recrystallization from CH2Cl2 or 
DCE were unsuccessful.  As such, the synthesis was repeated (1/5th scale) and 
homogeranylbenzene (0.046 mg, 1.0 equiv) was added to the crude reaction mixture 
at  –78 °C.  After 1 h at  –78 °C, the reaction mixture was quenched by the addition of 
5% aqueous sodium sulfite and saturated aqueous sodium bicarbonate (5 mL ea.) and 
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extracted with CH2Cl2 (3 × 5 mL).  The resultant material contained no 72 or 73 by 
1H NMR. 
 
Chlorosulfonium Derived from Tris-Sulfide (79).  Synthesis was 
undertaken exactly as in 78, starting from 1,4,7-trithiacyclononane.  Once again, the 
desired compound was recalcitrant to purification by recrystallization; as such, a test 
reaction with homogeranylbenzene (1) was undertaken utilizing reagent synthesized 
in situ.  The resultant material contained on trace amounts of 72 and 73 by 1H NMR.  
 
Chlorosulfonium Derived from Tetra-Sulfide (80).  Synthesis was 
undertaken exactly as in 78, starting from 1,4,7,10-tetrathiacyclododecane.  Once 
again, the desired compound was recalcitrant to purification by recrystallization; as 
such, a test reaction with homogeranylbenzene (1) was undertaken utilizing reagent 
synthesized in situ.  The resultant material contained on trace amounts of 72 and 73 
by 1H NMR. 
 
β-Keto Chlorosulfonium 81.  The requisite sulfide was prepared by 
thiomethylation (using MeSCl, prepared in situ by reacting dimethyldisulfide with 
chlorine) of the enolate derived from isobutyrophenone:  A solution of n-BuLi (5.0 
mL, 1.3 M in hexanes, 6.5 mmol, 1.3 equiv) was added dropwise to a solution of i-
Pr2NH (0.984 mL, 7.0 mmol, 1.4 equiv) in THF (25 mL) at –78 °C.  The resultant 
light yellow solution was allowed to warm to 25 °C over 20 min, then re-cooled to –
78 °C.  Isobutyrophenone (0.907 mL, 6.0 mmol, 1.2 equiv) was added dropwise to 
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the resultant LDA solution, which was subsequently stirred for 30 min at –78 °C.  
Meanwhile, a solution of methanesulfenyl chloride was prepared by the dropwise 
addition of dimethyldisulfide (0.50 mL, 5.5 mmol, 1.1 equiv) to a solution of chlorine 
(0.35 g, 5.0 mmol, 1.0 equiv) in CH2Cl2 (5 mL) at –78 °C.  The resultant orange 
solution was cannulated into the isobutyrophenone enolate solution, which was 
subsequently allowed to warm slowly to 5 °C over 1 h.  Upon completion, the 
reaction mixture was quenched by the addition of 10% aqueous ammonium chloride 
(30 mL) and extracted with hexanes:EtOAc (2:1, 3 × 30 mL).  The combined organic 
layers were washed with brine (30 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 19:1) to afford 
the desired sulfide (0.88 g, contaminated with some inseparable isobutyrophenone, 
~70% yield) as a light yellow oil.  The chlorosulfonium salt was prepared as in 78; 
recrystallization efforts afforded only white powder, which was utilized in a test 
reaction with homogeranylbenzene (10 mg, 0.044 mmol) to afford only small 
amounts of 72 and 73 alongside numerous other unidentified products. 
 
Diisopropylchlorosulfonium Tetrachloroborate (82).  Prepared as in the 
synthesis of 76, using boron trichloride rather than antimony pentachloride.  The 
resultant product was not solid when concentrated, and several recrystallization 
efforts proved fruitless.  Preparation of the reagent in situ and reaction with 
homogeranylbenzene (1) afforded small amounds of 72 and 73 alongside numerous 
other unidentified products. 
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Tributlychlorophosphonium Hexachloroantimonate (83). 
Tributylphosphine (0.35 mL, 1.4 mmol, 1.0 equiv) and a solution of SbCl5 (1.4 mL, 1 
M in CH2Cl2, 1.4 mmol, 1.0 equiv) were added slowly and sequentially to a solution 
of chlorine (0.10 g, 1.4 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at –78 °C.  The resultant 
colorless solution was allowed to warm to 25 °C and concentrated by rotary 
evaporation to afford a light brown powder.  Recrystallization from hexanes:CH2Cl2 
(1:4, ~20 mL) afforded only powder.  This powder proved incapable of affording the 
desired chlorocyclized products (72 and 73) upon reaction with homogeranylbenzene.  




























































































































The Total Syntheses of 4-Isocymobarbatol, Peyssonol A, and Peyssonoic Acid A, 












3.1  Introduction 
As discussed in Section 3 of Chapter 1, the original inspiration for the 
development of broadly effective halonium-induced polyene cyclization reactions 
was the existence of hundreds of natural products that retrosynthetically derive from 
such an event.  With a viable reagent in hand to accomplish such transformations (see 
Chapter 2), our next investigations were in the field of natural product total synthesis.  
In particular, because BDSB had proved much more effective than CDSC, we 
targeted bromocyclic natural products.  
The total syntheses of several brominated natural products have been 
previously accomplished via bromonium-induced polyene cyclization.  These 
syntheses have relied on traditional electrophilic bromine sources such as elemental 
bromine, N-bromosuccinimide, or 2,4,4,6-tetrabromocyclohexa-2,5-dienone (TBCO) 
to initiate the cyclization events.  As discussed previously (see Chapter 1, Section 3 
and Chapter 2, Section 1), these reagents perform poorly for bromonium-induced 
polyene cyclizations.  Thus, these prior total syntheses have typically been facilitated 
by a key step that proceeded in low to moderate yield.  Scheme 1 illustrates four 
relevant examples; in all cases, the bromonium-induced polyene cyclization is the 
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3) Shieh & Prestwich (1982):
1) Wolinsky & Faulkner (1976):
2) Gonzalez et al. (1976):








In the following sections, we will describe how BDSB was used to facilitate 
the total synthesis of three brominated natural products of increasing complexity.  
Additionally, a collaborative study allowed for the evaluation of two of these natural 
products, along with a number of analogues, as potential reverse transcriptase 
inhibitors.  The majority of the work herein has been published.2 
 
3.2  The Total Synthesis of 4-Isocymobarbatol 
In 1989, an antimutagenic bioassay-guided purification of the crude extract 
from the green algae Cymopolia barbarata resulted in the isolation and 
characterization of 4-isocymobarbatol (13).3  The structure of this brominated 
monoterpene hydroquinone was established conclusively by X-ray crystallography; a 
three-dimensional model is shown in Figure 1.  The antimutagenic properties of 4-
isocymobarbatol were impressive: in a bacterial cell assay, this compound negated the 
destructive impact of two known mutagens (2-aminoanthracene and ethyl 
methanesulfonate) at levels well below its toxicity threshold.  The mechanism of 
action for this observed inhibition was not probed by the isolation chemists, nor was 








Figure 1. 4-Isocymobarbatol (with X-ray crystal structure by Wall et al.)3a
 
 
The seminal total synthesis of 4-isocymobarbatol was published in 1995 by 
Tanaka and coworkers.4  Interestingly, their synthesis was based on a fortuitous result 
observed five years prior during an attempted synthesis of a related green algae 
metabolite, cyclocymopol (14).5  As indicated in Scheme 2, the attempted 
monocyclization/elimination of polyene 15 using TBCO (2,4,4,6 
tetrabromocyclohexa-2,5-dienone) afforded only trace amounts of desired 16, instead 
affording tricycle 17 as the predominant product in 35% yield.  Presumably, the 
MOM-protected phenolic oxygen participated in the cyclization event to form 
intermediate 18; product 17 then formed by subsequent loss of the methoxymethyl 
group, either as a cation or via nucleophilic displacement.  Of these pathways, 
nucleophilic displacement seems more likely, considering that 2,4,6-
tribromophenoxide is liberated during the reaction.  Although 17 was not the desired 
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product, at some point Tanaka’s group recognized that this compound was in fact 
protected 4-isocymobarbatol; their subsequent disclosure in 1995 essentially 
describes removal of the final MOM group in refluxing aqueous acetic acid in order 




























Scheme 2. Tanaka's synthetic ef forts towards cyclocymopol (14) af ford
protected 4-isocymobarbatol (17) instead.
 
 
As with many other syntheses of bromocyclic terpenoids (see Scheme 1),1 the 
biomimetic bromonium-induced polyene cyclization employed by Takana’s group to 
form the core of the molecule proceeded in modest yield.  However, the synthesis of 
the cyclization precursor was concise and straightforward, and only a single step 
(deprotection) subsequent to cyclization was required to arrive at the natural product.  
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As such, we viewed this synthesis as an ideal proving ground to further evaluate the 
synthetic potential of BDSB by using it to effect the key bromocycliation step (15 → 
17).   
Our final, optimized route to 4-isocymobarbatol (13) is depicted in Scheme 
3.2a  For the sake of direct comparison, Scheme 3 also describes the previous 
synthetic route used by Tanaka and coworkers.  Although the synthetic intermediates 
accessed by our synthesis are identical to those used in Tanaka’s synthesis, a number 
of improvements were made.  First, we discovered that bis-methoxymethyl protection 
of starting bis-phenol 19 could be accomplished in nearly quantitative yield and with 
significantly less waste by utilizing NaH and MOMCl.  Additionally, the coupling 
reaction between the resultant aryl bromide (20) and geranyl bromide was more 
efficient and the resultant product more easily purified if CuBr was omitted (the 
cuprate addition in our hands gave significant amounts of SN2’ product, which was 
nearly impossible to separate by chromatography).  Most notably, however, the yield 
of the cyclization step (15 → 17) was more than doubled by employing BDSB rather 




















Tanaka et al. (1995): (a) P2O5 (27 eq), dimethoxymethane (18 eq), CHCl3, ?
h, 25 oC, 83%. (b) 20 (2.0 eq) n-BuLi (2.0 eq), CuBr.Me2S (2.0 eq), THF, ? h,
? oC, then geranyl bromide (1.0 eq), THF, 2 h, -78 to 0 oC, 68%. (c) TBCO
(1.0 eq), MeNO2, 45 min, 25
oC, 35%. (d) 80% aqueous AcOH, 1.5 h, 100
oC, 99%. TBCO = 2,4,4,6-tetrabromocyclohexa-2,5-dienone, AcOH = acetic
acid.
Snyder & Treitler (2009): (a) NaH (2.5 eq), MOMCl (3.0 eq), THF, 2 h, 0 oC,
98%. (b) 20 (2.0 eq), n-BuLi (1.7 eq), THF, 30 min, -78 oC, then geranyl
bromide (1.0 eq), 2 h, -40 to 0 oC, 75%. (c) BDSB (1.1 eq), MeNO2, 5 min, -
25 oC, 74%. (d) 12 M HCl (excess), THF, 5 h, 25 oC, 97%. MOMCl =








Scheme 3. Comparison of Tanaka's synthesis of 4-isocymobarbatol with our own.
 
 
Overall, our improvements resulted in a synthesis of (±)-4-isocymobarbatol in 
53% overall yield, with the key bromocyclization step proceeding in 74% yield.  This 
synthesis reflects a marked improvement over the previously published route (20% 
overall yield),4 with most of this enhancement due to the improved efficiency of the 
polyene cyclization step.  In fact, to the best of our knowledge, the 74% yield 
observed for our BDSB cyclization in this synthesis is the highest reported yield for a 
halonium-induced polyene cyclization in any natural product total synthesis to date.  
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3.3  The Total Synthesis of the Proposed Structure of Peyssonol A 
Peyssonol A (21, see the upper portion of Scheme 4) was isolated in 1994 
from an undisclosed species of red algae belonging to the genus Peyssonnelia.6  This 
brominated sesqueterpenoid hydroqinone was discovered by bioassay-guided 
fractionation, as it exhibited significant inhibition of the reverse transcriptase (RT) 
enzyme of HIV.  A follow-up study indicated that peyssonol A acted to inhibit the 
RNA-dependent DNA synthesis function of RT at single-micromolar concentrations.7  
Structural characterization of the natural product was carried out spectroscopically, 

















Scheme 4. The proposed structure for peyssonol A, and the




We were initially attracted to peyssonol A (21) as a synthetic target for a 
number of reasons.  The structure was certainly more complex than our previous 
target (4-isocymobarbatol, 13), incorporating a bicyclic decalin core with 4 
stereogenic centers.  Additionally, the decalin core was cis-fused, the only example of 
such stereochemistry among brominated terpenes of this type.8  As we had previously 
shown that BDSB was capable of cyclizing Z-alkenes to afford products of this type 
(see Section 5 of Chapter 2), we were confident that the observed stereoselectivity of 
the cyclization could facilitate a BDSB-induced key step during the synthesis of 
peyssonol A.  The potency of the compound as a reverse transcriptase inhibitor (RTI) 
was also enticing, especially given that a total synthesis could permit access to 
analogues as well as synthetic precursors for biochemical investigations.  Finally, our 
synthetic interest was piqued by the fact that no previous total syntheses of peyssonol 
A had been reported, despite its unique structure and appealing bioactivity profile.  
As depicted in the bottom portion of Scheme 4, evaluation of the cis-decalin 
portion of peyssonol A (i.e 22) revealed that the requisite starting material for a 
bromonium-induced polyene cyclization should be (2E,6Z)-farnesol derivative 23.  
The regions corresponding to the olefins in starting material 23 are highlighted in 
bold on bicycle 22 in Scheme 4 to better illustrate the required olefin geometry.  We 
recognized initially that direct formation of the exocyclic alkene at C7 during the 
cyclization event was unlikely; our previous studies with systems lacking terminating 
groups had indicated that elimination predominantly affords a mixture of endocyclic 
alkenes (see Chapter 2, Scheme 3).  Given this knowledge, we desired to design our 
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cyclization such that a terminating group would initially functionalize C7, hoping that 
subsequent regioselective elimination could afford the requisite exocyclic olefin.   
Two conceptually different approaches were initially designed, differing 
fundamentially in the stage of the synthesis at which the aromatic portion of 
peyssonol A would be incorporated.  As shown in Scheme 5, incorporation of the 
aromatic moiety prior to cyclization could allow the protected phenol of 25 to 
participate in the cyclization event (as in the transformation of 15 → 17; see Scheme 
2).  The expected product would be tetracycle 26, which could then hopefully be 
elaborated to the natural product in relatively short order.  Alternatively, cyclization 
of a farnesol derivative with an ordinary terminating group (27) could result in 
functionalized bicycle 28 that could subsequently be elaborated further to incorporate 























Scheme 5. Two routes that could potentially access peyssonol A, differing in the timing

















Unfortunately, the starting material required for both pathways, (2E,6Z)-
farnesol (24), is not commercially available; farnesol can only be purchased as either 
the E,E-isomer or an intractable mixture of all four isomers.  Thankfully, however, 
published procedures exist for the controlled synthesis of any of the four geometric 
isomers of farnesol.9  Our endeavor thus began with the five-step sequence depicted 
in Scheme 6, which is a modified combination of two of these literature precedents.9bd  
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Neryl bromide, synthesized by treatment of commercially available nerol (29) with 
PBr3, was used to alkylate ethyl acetoacetate.  Subsequent ester hydrolysis and 
decarboxylation resulted in nerylacetone (30).  Olefination using a Horner-
Wadsworth-Emmons reaction was followed by reduction of the resultant ester with 
LiAlH4 to afford (2E,6Z)-farnesol (24) in 36% yield over 5 steps.  This sequence was 






Reagents and Conditions: (a) PBr3 (0.5 eq), Et2O, 1 h, -20 to
0 oC. (b) Ethyl acetoacetate (2.5 eq), K2CO3 (1.3 eq),
acetone, 6 h, 65 oC. (c) KOH (3.0 eq), MeOH/H2O, 2 h, 80
oC, 61% over 3 steps. (d) Triethylphosphonoacetate (1.1
eq), NaH (1.15 eq), THF, 16 h, -20 to 25 oC, 72%. (e) LiAlH4




Scheme 6. Scalable synthesis of (2E,6Z)-farnesol (24).
 
 
For our first attempted synthesis of peyssonol A, we reasoned that 
incorporating the aromatic ring prior to cyclization would probably lead to the most 
efficient synthesis of the natural product (see Scheme 5).  As such, our initial 
sequence commenced with the synthesis of the requisite arylated polyene, compound 
33 (Scheme 7).  Formylation and acetal formation of 2,5-dibromohydroquinone 
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derivative 20 (see Scheme 3) afforded aryl bromide 31.  Subsequent lithium-halogen 
exchange using n-butyllithium was followed by addition of (2E,6Z)-farnesyl bromide 


















Reagents and Conditions: (a) n-BuLi (1.0 eq), THF, 20 min, -78 oC, then
DMF (10 eq), 20 min, -78 to 0 oC. (b) Ethylene glycol (10 eq), PPTS (0.1
eq), benzene, 2.5 h, 95 oC, 75% over 2 steps. (c) PBr3 (0.5 eq), Et2O, 1
h, -25 to 5 oC, ~75%. (d) 31 (1.3 eq), n-BuLi (1.2 eq), THF, 30 min, -78
oC, then 32 (1.0 eq), 3 h, -40 to 5 oC, 80%. DMF = N,N-






Scheme 7. Peyssonol A route 1: assembling the requisite polyene precursor.
 
 
As shown in Scheme 8, upon treatment with BDSB, polyene 33 did in fact 
afford desired tetracycle 34 in moderate yield, but as a mixture of diastereomers.  It 
was not rigorously determined which stereocenter was being set with poor selectivity, 
but it was believed to be the site of attachment to the phenoxy group.  Previous 
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studies (see Chapter 2) had established that BDSB-induced cationic pi-cyclizations 
proceed diastereoselectively, but that terminating groups can often attack from either 
of two faces.2a  Fortuitously, the BDSB reaction conditions were acidic enough to 
facilitate total removal of the acetal protecting group.  However, under typical 
reaction conditions (–25 °C, 5 min), only partial deprotection of the adjacent MOM 
ether occurred, affording a mixture of monoprotected and fully deprotected products.  
However, simply adding water to the acidic reaction mixture and stirring at ambient 
temperature for 15 min prior to quenching with NaHCO3 facilitated complete 
deprotection of the remaining MOM ether.  Overall, tetracycle 34 is likely the most 














Reagents and Conditions: (a) BDSB (1.1 eq), MeNO2, 2




Scheme 8. Peyssonol A route 1: key step (bromonium-induced





At this junction, we were encouraged that we had accessed advanced 
intermediate 34 in only 3 steps from (2E,6Z)-farnesol (24).  All that remained at this 
point was to regioselectively eliminate the phenoxide group of 34 to afford the natural 
product (21).  Unfortunately, as illustrated in Table 1, none of the reactions attempted 
could effect this transformation.  Efforts to facilitate elimination of the phenoxide by 
treating 34 with base (Entries 1-4) typically resulted in the recovery of starting 
material; under more forcing conditions (i.e. Entry 5), the aliphatic bromide was the 
first group eliminated, leading to alkene 35.  These disappointing results suggested 
that the phenoxide within 34 was not a good enough leaving group.  As a result, 
subsequent endeavors focused on enhancing the phenoxide’s leaving group potential 
by appending an electron-withdrawing ester or sulfonate group onto the free phenol 
of 34 (Entries 6-9); unfortunately, these attempts were also unsuccessful.  As shown 
in Entries 10-13, Brønsted acids were also unable to cleave the aryl ether.  However, 
Lewis acid additives did provide some encouraging results.  BCl3 (Entry 18) 
facilitated the desired ether cleavage/elimination, but resulted in incorrect alkene 
regioisomer 36 (ablating a necessary stereocenter in the process).  Meanwhile, 
treatment of 34 with BBr3 led to moderate yields of an unstable compound tentatively 
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Table 1. Peyssonol A route 1: attempted aryl ether cleavage of 34 with





Although we were initially optimistic that regioselective elimination of the 
tertiary bromide from 37 could lead to peyssonol A (21), treatment of 37 with 
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hindered amine or alkoxide bases resulted only in the production of 36.  As illustrated 
in Scheme 9, this outcome can be rationalized by the idea that the added base first 
deprotonated the free phenol of 37 to afford phenoxide 38.  This phenoxide anion was 
presumably the base that facilitates dehydrobromination in an intramolecular fashion.  
In this intramolecular proton transfer, removal of proton A (a six-membered transition 
state) to afford 36 is likely much faster kinetically than removal of proton B (an eight-
membered transition state), even though proton B is less sterically hindered.  Efforts 
to avoid this undesired elimination by a three step phenol protection-elimination-

































36 21: peyssonol A38
- HA - HB
-
Scheme 9. Peyssonol A route 1: mechanistic explanation for the undesired regiochemical




Since we had little success cleaving the aryl ether within 34 under acidic or 
basic conditions, our next attempts focused on oxidation to cleave the C-O bond by 
quinone formation.  Subsequent reduction could then afford peyssonol A (21) in two 
steps from 34.  Oxidation of hydroquinone monoethers of this type to the resultant 
quinones are well-precedented.10  Unfortunately, with this particular substrate, no 
encouraging results were observed after investigating a range of oxidative conditions 
(see Table 2).  The only result of note was that attempted oxidation with 
PhI(OCOCF3)2 (PIFA), afforded a rearranged product tentatively assigned to be 42.  
Mechanistically, PIFA may have preferentially oxidized the bromine atom over the 
hydroquinone.  The resulting bromane (a hypernucleofuge, i.e. fantastic leaving 
group)11 could readily ionize with an accompanying methyl migration and elimination 
























































Table 2. Peyssonol A route 1: attempted oxidative cleavage of the aryl ether of 34.
 
 
After dozens of unsuccessful attempts to cleave the ether linkage in tetracycle 
34, we next decided to pursue a cyclization strategy in which the aromatic ring would 
be present, but does not participate as a terminating group.  We imagined that the 
simplest way to explore this was to replace the MOM ethers with methyl ethers, 
functional groups which are not known to participate in polyene cyclizations;5 we 
therefore assembled polyene 43.  As depicted in Scheme 10, BDSB cyclization of 43 
afforded the expected mixture of alkene isomers, with the tricyclic and tetracyclic 
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alkenes predominating (as anticipated).  In previous instances, ethylene carbonate has 
been shown to act as an intermolecular nucleophilic trap during polyene cyclizations, 
affording tertiary alcohols upon workup.13  However, in the presence of this additive 
(up to 500 equivalents), the cyclization of 43 still resulted in predominantly alkene 
mixture 44.  Attempted deprotection of the methyl ethers within 44 using BBr3 at low 
temperatures cleanly removed the methyl group adjacent to the carbonyl (presumably 
directed by coordination of boron to the aldehyde oxygen).14  Efforts to remove the 
final methyl ether using BBr3 at higher temperatures resulted in decomposition prior 




The cyclization of 43 to 44 highlighted that nonselective elimination of the 
tertiary carbocation formed after the formation of the second ring was a significant 
hurdle to be overcome.  As such, we next attempted to build a substrate in which 
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elimination would be coerced to occur from the exocyclic position.  As illustrated in 
the upper portion of Scheme 11, we imagined that cyclization of an allyl silane (45) 
would result in cationic intermediate 46, which could undergo β-elimination to afford 
the requisite exocyclic alkene of 22 regioselectively.  This proposed β-silicon 
elimination is a well-precedented process in polyene cyclizations.15  Pleasingly, 
synthesis of the desired substrate was fairly straightforward, again starting from nerol 
(29).  We employed a one-pot alkylation/phosphorylation of the dianion of ethyl 
acetoacetate to build up the carbon framework (47) and a Negishi coupling to install 
the requisite –CH2TMS moiety;15d reduction of the resultant ester provided alcohol 
48.  A PBr3 mediated substitution then afforded the corresponding bromide, although 
this reaction was markedly less efficient than it had been for prior substrates lacking 
the allylic TMS group (the major side product in this case was the SN2’ derivative, 
presumably formed because of the enhanced stabilization of positive charge at the 
tertiary carbon due to the adjacent carbon-silicon bond).16  Nonetheless, arylation 
employing the aryllithium nucleophile derived from 20 resulted in formation of 






















Reagents and Conditions: (a) PBr3 (0.5 eq), Et2O, 1.5 h, -20 to 0
oC. (b) Ethyl
acetoacetate (1.2 eq), NaH (1.3 eq), n-BuLi (1.2 eq), THF, 20 min, 0 oC, then neryl
bromide (1.0 eq), 10 min, 0 oC, then (OEt)2POCl (2.0 eq), 1.5 h, 0
oC, ~70% over 2 steps.
(c) TMSCH2MgCl (1.5 eq), Ni(acac)2 (0.1 eq), Et2O, 10 min, 0
oC. (d) LiAlH4 (0.6 eq),
Et2O, 3 h, 0 to 35
oC, ~60% over 2 steps. (e) PBr3 (0.5 eq), Et2O, 1 h, -78 to 0
oC. (f) 20
(1.7 eq), n-BuLi (1.5 eq), THF, 10 min, -78 oC, then bromide (1.0 eq), 1.5 h, -40 to 5 oC,
52% over 2 steps. (g) BDSB (1.1 eq), MeNO2, 2 min, -25
oC, ~30% of 50, ~10% of 51.















29: nerol 47 48
49
Scheme 11. Peyssonol A route 3: Attempting to use an allylsilane to facilitate exocyclic
alkene formation upon BDSB cyclization.
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Bromonium-induced cyclization of 49 initiated by BDSB unfortunately did 
not provide the desired exocyclic alkene isomer.  The major isolated products were 
indeed bicyclic alkenes (50 and 51), but the predominant alkene isomer was 
tetrasubstituted.  Subsequent deprotection with aqueous acid did not produce any 
detectable peyssonol A by 1H NMR.  The mechanism for the formation of the 
tetracyclic alkene is unclear, but it may be that the BDSB reaction medium is acidic 
enough to promote alkene isomerization from the initially formed exocyclic alkene to 
the more stable tetrasubstituted variant.  Attempts to avoid this outcome by buffering 
the reaction mixture with inorganic bases were not successful.  
With the failure of substrate 49 to afford the desired exocyclic alkene, we 
finally abandoned our plan to incorporate the aromatic ring of peyssonol A prior to 
the bromocyclization step.  Our subsequent efforts focused on building the decalin 
core first, then incorporating the exocyclic olefin, and finally introducing the aromatic 
moiety (see the bottom portion of Scheme 5).17  Specifically, we wished to 
incorporate a terminating group onto (2E,6Z)-farnesol that could result in an alcohol 
at the tertiary carbon that will eventually become part of the exocyclic alkene 
(mindful that a number of synthetic methods exist for regioselective elimination of 
alcohols to afford the least-substituted alkenes).18  Our previous model studies had 
indicated that allylic acetates (i.e. geranyl acetate or neryl acetate; see Chapter 2, 
Scheme 6) effectively act as terminating groups to form dioxocarbenium ions that 
afford tertiary alcohols upon workup.  
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As shown in Scheme 12, we readily accessed acetate 52 by acetylation of  
(2E,6Z)-farnesol (24).  Cyclization with BDSB afforded a moderate yield of desired 
bicycle 53; for this cyclization, the product was contaminated with a small amount of 
an inseparable diastereomer.  Although the identity of this diastereomer was initially 
unknown, later efforts (see Section 4) would indicate that it was in fact the trans-
decalin with the opposite stereochemistry at the –CH2OAc group (68); this material 
would derive from a transition state in which the initial ring forms as a boat.  Efforts 
to improve the moderate yield observed during the cyclization by increasing the 
nucleophilicity of the ester group (i.e. pivalate, benzoate, p-methoxybenzoate) were 
met with little success.  Nonetheless, the tertiary alcohol of 53 could indeed be 
eliminated regioselectively to afford the least substituted alkene by utilizing SOCl2 
and Et3N at cryogenic temperatures (–78 °C).19  Addition of NaOMe in MeOH and 
warming to ambient temperature led to acetate methanolysis in the same pot, 





With the bicyclic core constructed and the exocyclic olefin in place, all that 
remained to access peyssonol A was to incorporate the aromatic ring.  Initial attempts 
focused on transformation of the primary alcohol into a leaving group (Br or OMs) 
and treatment with the aryllithium nucleophile derived from 20, hoping that an SN2-
like displacement would result.  Unfortunately, these procedures were unsuccessful, 
with elimination, rather than substitution, proving to be the observed pathway.  
Instead, a three-step protocol was undertaken.  As depicted in Scheme 13, oxidation 
of primary alcohol 54 with Dess–Martin periodinane20 afforded aldehyde 55.  As 
expected, facile addition of the aryllithium nucleophile derived from 20 to this 
aldehyde afforded benzylic alcohol 56 as a mixture of diastereomers.  This lack of 
stereoselectivity was inconsequential, since the alcohols were subsequently reduced 
off under ionic conditions with trifluoroacetic acid and Et3SiH.21  Unfortunately, this 
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deoxygenation (56 → 57) proceeded in modest yield, and attempts to optimize this 
step by utilizing different acids or hydride sources did not improve the outcome.  
Radical reduction methods were also attempted (i.e. Barton-McCombie 
deoxygenation, Li/NH3),22 but these conditions effected undesired reduction of the 




Nevertheless, with 57 in hand, all that remained to complete the total synthesis 
were formylation and deprotection; these steps are illustrated in Scheme 14.  Lithium-
halogen exchange was used to generate the aryllithium derivative of 57; subsequent 
quenching with DMF afforded the desired formylated product (58) in around 50% 
yield.23  This moderate yield was attributed to the small scale of the reaction (0.035 
mmol) and consequently large impact of trace amounts of water (as evidenced by the 
major side product, des-bromo 57).  Finally, deprotection of 58 using p-TsOH in 
warm t-BuOH24 afforded the desired hydroquinone, compound 21.  Disappointingly, 
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NMR analysis conclusively determined that this product was not peyssonol A (see 
page 268 for a comparison of 1H and 13C NMR shift values).2b 
 
Reagents and Conditions: (a) n-BuLi (1.2 eq), DMF (5 eq), THF, -78 oC, 10
min, ~50%. (b) p-TsOH (40 eq), t-BuOH, 2 h, 65 oC, ~90%. DMF = N,N-






















3.4  The Total Synthesis of the Revised Structure of Peyssonol A 
Once it was discovered that compound 21 was spectroscopically distinct from 
peyssonol A, there were two obvious possibilities to investigate.  It could be that 
product 21 did not have the structure which we had assigned to it; alternatively, the 
natural product might not in fact have structure 21.25  Rather than doubt the isolation 
chemists, we decided to first thoroughly investigate the structure of our synthetic 21.  
From a comparison of the 1H and 1C NMR spectra of the natural isolate and our 
synthetic material, it was clear that our material was an isomer of the natural product; 
the slight differences observed for all peaks suggested that it was most likely a 
diastereomer.  As such, our focus was on conclusively determining the relative 
configuration of the four stereocenters of our product. 
 196 
Unfortunately, 21 was an amorphous solid, and no crystals could be obtained 
for X-ray diffraction analysis.  An attempt was made to append p-bromobenzoate 
groups onto the phenols, but the resultant material was similarly recalcitrant to 
crystallization.  At this junction, we examined all the other intermediates in the route, 
but found that none were crystalline.  However, we surmised that if the bromonium-
induced cyclization was undertaken with a carbonate rather than an ester as the 
terminating group, then the resultant tricyclic carbonate would have a good chance of 
being crystalline.  As shown in Scheme 15, this hypothesis proved correct; cyclization 
of the tert-butyl carbonate derivative of (2E,6Z)-farnesol (59) afforded a 28% yield 
(unoptimized) of crystalline 60.  X-ray crystallography (performed by Wesley Sattler, 
Parkin group) established that the structure did indeed have the requisite 
stereochemistry for the purported structure of peyssonol A (21).  For completeness, 
we also showed that 60 could be transformed into aldehyde 55 by carbonate 




Reagents and Conditions: (a) n-BuLi (1.1 eq), Boc2O (1.1 eq), THF, 30 min, -78 to
25 oC, 81%. (b) BDSB (1.1 eq), MeNO2, 30 min, -25 to 25
oC, 28%. Boc2O = di-










Scheme 15. Identifying the stereochemistry of the cyclization product by X-ray




Since the BDSB cyclization step sets every stereocenter present in 21, in the 
absence of any epimerization steps, the stereochemistry of 21 must be as drawn.  
Therefore, we next examined the other steps in our route to determine if 
epimerization was possible.  The only likely candidate for epimerization was 
aldehyde 55 (see Scheme 13).  Considering the basic reaction conditions used in the 
transformation of 55 to 56, it was possible that the stereocenter adjacent to the 
aldehyde had been inverted.  It was also possible that the Dess-Martin oxidation step 
to afford 55 was facilitating epimerization via the acidic byproducts of this oxidation 
procedure, although this outcome seemed less likely based on literature precedent.26   
We decided to test for epimerization of 55 by the classical approach of 
intentionally synthesizing its epimer, as depicted in Scheme 16.  Thankfully, we 
could rely on the diastereoselectivity of the bromonium-induced polyene cyclization 
reaction: simply by starting with a (2Z,6Z)-farnesol derivative, we hoped to access the 
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cyclized material with the opposite stereochemistry at the desired carbon.  
Fortunately, at this stage we already had access to ethyl (2Z,6Z)-farnesate (62), since 
the HWE reaction used to prepare ethyl (2E,6Z)-farnesate (61) proceeded with only 
~4:1 E:Z selectivity,9d and the two olefin isomers were separable by chromatography.  
Reduction of this minor isomer followed by acetylation afforded desired (2E,6Z)-
farnesyl acetate (63).  Subsequently, the same steps of bromocyclization, 
elimination/acetate methanolysis, and oxidation provided aldehyde 64.  
Spectroscopically, 64 was distinct from 55, confirming we had synthesized a 
diastereomer, and that epimerization under the oxidation conditions was not a factor.  
In the following step, addition of the aryllithium reagent derived from 20 afforded 
two diastereomeric benzylic alcohols (65), both of which were spectroscopically 
distinct from those derived from 55, ruling out epimerization under the basic 




Reagents and Conditions: * = See Schemes 6, 12, and 13. (a) Triethylphosphonoacetate (1.1 eq),
NaH (1.15 eq), THF, 17 h, -20 to 25 oC, 72% of 61, 18% of 62. (b) LiAlH4 (0.6 eq), Et2O, 2 h, -78 to
25 oC, 81%. (c) Ac2O (1.5 eq), Et3N (2.0 eq), DMAP (0.02 eq), CH2Cl2, 20 min, 0
oC, 95%. (d)
BDSB (1.1 eq), MeNO2, 30 s, 0
oC, 20%. (e) SOCl2 (3.0 eq), Et3N (10 eq), CH2Cl2, 20 min, -78
oC,
then NaOMe (20 eq), MeOH, 1.5 h, 25 oC, ~50%. (f) DMP (1.5 eq), NaHCO3 (5.0 eq), CH2Cl2, 1 h,
0 oC, ~50%. (g) 20 (1.3 eq), n-BuLi (1.2 eq), THF, 15 min, -78 oC, then 64 (1.0 eq), 15 min, -78 oC,
61%. (h) TFA (5-10 eq), Et3SiH (10 eq), CH2Cl2, 60-90 min, 0
oC, 44%. (i) n-BuLi (1.2 eq), DMF (5
eq), THF, 10 min, -78 oC, then 12M aq HCl (50 eq), 1.5 h, 40 oC, 58%. Ac2O = acetic anhydride,
DMAP = 4-N,N-dimethylaminopyridine, BDSB = bromodiethylsulfonium

















































Scheme 16. Investigating the stereochemical integrity of aldehyde 55 by intentionally
synthesizing epimer 64, then advancing 64 to the end of the sequence, af fording a second




At this point, we believed we had diligently established the structure of our 
synthetic 21 to be that originally assigned to peyssonol A.  Since the NMR spectra did 
not match the isolation data, however, the only remaining possibility was that the 
natural product had been misassigned.  Since we had no access to the natural material, 
we decided that the best course of action would be to synthesize the other possible 
diastereomers of the final product, since the NMR data suggested that the natural 
product was diastereomeric with respect to the structure we had produced (21).   
Our first task was to simply take compound 65 through to the end of the 
synthesis, which was completed without incident (see Scheme 16).  Unfortunately, 
the resultant hydroquinone (66) was not peyssonol A; the NMR data suggested we 
had prepared a second diastereomer (see table on page 268).  At this point, we had 
cyclized both (2E,6Z)- and (2Z,6Z)-farnesol derivatives in order to access two cis-
fused diastereomers of peyssonol A.  We began to suspect that perhaps peyssonol A 
was not the only cis-fused bromocyclic terpenoid, but in fact had a trans ring fusion, 
as did the other members of this family.8  In retrospect, the evidence the isolation 
chemists offered in support of a cis-decalin core was not substantial; they relied 
exclusively on the 13C NMR shift values of the angular methyl at the ring junction 
and the attached quaternary carbon.6   
If the natural product did in fact have a trans-fused decalin core, we could 
access two diastereomers of this material by starting the seqeuence anew with 
(2E,6E)- and (2Z,6E)-farnesol.  We chose to first investigate the cyclization of the 
trans,trans-isomer (67), since it is commercially available.  As illustrated in Scheme 
17, following the same 8-step route as before (acetylation, bromocyclization, 
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elimination/acetate cleavage, oxidation, aryllithium addition, deoxygenation, 
formylation, and deprotection) resulted in 70, the third potential peyssonol A 
structure.  However, once again this material proved spectroscopically distinct from 
the natural product; by 1H NMR it appeared that we had in fact prepared a third 
diastereomer (see table on page 268).   
 
Reagents and Conditions: (a) Ac2O (1.5 eq), Et3N (2.0 eq), DMAP (0.02 eq),
CH2Cl2, 30 min, 0
oC, 94%. (b) BDSB (1.1 eq), MeNO2, 30 s, 0
oC, 43%. (c)
SOCl2 (2.0 eq), Et3N (6.0 eq), CH2Cl2, 30 min, -78
oC, then K2CO3 (10 eq),
MeOH, 1 h, 50 oC, 82%. (d) DMP (1.5 eq), NaHCO3 (5.0 eq), CH2Cl2, 1 h, 0
oC,
86%. (e) 20 (1.3 eq), n-BuLi (1.2 eq), THF, 15 min, -78 oC, then aldehyde (1.0
eq), 30 min, -78 oC, 92%. (f) TFA (5.0 eq), Et3SiH (10 eq), CH2Cl2, 2.5 h, 0
oC,
54%. (g) n-BuLi (1.3 eq), DMF (10 eq), THF, 30 min, -78 oC, 70%. (h) p-TsOH
(10 eq), t-BuOH, 2 h, 70 oC, 88%. Ac2O = acetic anhydride, DMAP = 4-N,N-
dimethylaminopyridine, BDSB = bromodiethylsulfonium
bromopentachloroantimonate, DMP = Dess Martin periodinane, TFA =
trifluoroacetic acid, DMF = N,N-dimethylformamide, p-TsOH = para-




























The fourth and final option for a bromonium-induced polyene cyclization 
approach to peyssonol A was to begin with (2Z,6E)-farnesol (73).  As shown in the 
upper portion of Scheme 18, this material could be readily synthesized in four steps 
from geranyl bromide (71).9  Alkylation with the dianion of ethyl acetoacetate, 
followed by quenching of the potassium enolate prepared from this material with 
diethyl chlorophosphate in DMF afforded mostly the E-isomer of enol-phosphate 72 
(compare to the phosphorylation of the lithium/sodium enolate in THF to afford 47 
[Scheme 11] as predominantly the Z-isomer).27  Copper-catalyzed methylation 
(presumably better described as a coupling reaction rather than a 1,4-
addition/elimination because no erosion in olefin geometry is observed) followed by 
reduction afforded (2Z,6E)-farnesol (73).  Again, this material was taken through the 
same 8-step route as the previous three farnesol isomers.  Fortunately, comparison of 
NMR data indicated that the resultant final product (76) was in fact peyssonol A (see 
table on page 268).  In addition, 76 was a crystalline solid, and X-ray crystallographic 
analysis (performed by Aaron Sattler, Parkin group) clearly established the 
stereochemistry of the natural product to be that drawn.  
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Reagents and Conditions: (a) Ethyl acetoacetate (1.2 eq), NaH (1.25 eq), n-BuLi (1.25 eq),
THF, 40 min, 0 oC, then 71 (1.0 eq), 15 min, 0 oC, 84%. (b) KOt-Bu (1.1 eq), (OEt)2POCl
(1.3 eq), DMF, 15 min, 0 oC, 70%. (c) CuI (2.5 eq), MeLi (2.5 eq), THF, 15 min, 0 oC, then
MeMgCl (4.0 eq), 30 min, -50 oC, then 72 (1.0 eq), 5 h, -50 to -30 oC, 80%. (d) LiAlH4 (0.6
eq), Et2O, 2 h, -78 to 0
oC, 88%. (e) Ac2O (1.3 eq), Et3N (1.5 eq), DMAP (0.02 eq),
CH2Cl2, 30 min, 0
oC, 91%. (f) BDSB (1.1 eq), MeNO2, 30 s, 0
oC, 40%. (g) SOCl2 (2.0
eq), Et3N (6.0 eq), CH2Cl2, 30 min, -78
oC, then K2CO3 (10 eq), MeOH, 1 h, 50
oC, 32%.
(h) DMP (1.5 eq), NaHCO3 (5.0 eq), CH2Cl2, 45 min, 0
oC, 82%. (i) 20 (1.2 eq), n-BuLi (1.1
eq), THF, 15 min, -78 oC, then 75 (1.0 eq), 5 min, -40 oC, 80%. (j) TFA (5.0 eq), Et3SiH (10
eq), CH2Cl2, 2.5 h, 0
oC, ~40%. (k) n-BuLi (1.3 eq), DMF (10 eq), THF, 30 min, -78 oC,
56%. (l) p-TsOH (10 eq), t-BuOH, 2 h, 70 oC, ~90%. DMF = N,N-dimethylformamide,
Ac2O = acetic anhydride, DMAP = 4-N,N-dimethylaminopyridine, BDSB =
bromodiethylsulfonium bromopentachloroantimonate, DMP = Dess Martin periodinane,



























Scheme 18. Synthesis of (2Z,6E)-farnesol (73), and subsequent elaboration to the correct




At this stage, we were pleased to have completed the total synthesis of 
peyssonol A, but simultaneously acknowledged that our route was quite inefficient.  
From (2E,6Z)-farnesyl acetate (52), the subsequent 7 steps had a combined yield of 
only 1.7%, including a yield of only 40% for the key BDSB-promoted 
bromocyclization cascade.  Driven by a desire for a more efficient synthesis, a series 
of optimizations led to the second generation route shown in Scheme 19.  One key 
realization was that the tert-butyl carbonate terminating group afforded a significantly 
higher yield for the BDSB cyclization (56%).  Although still modest, we felt this 
yield was acceptable since this step forms the entire core of the molecule and sets five 
stereocenters with high fidelity in a single operation.   
 
Reagents and Conditions: (a) n-BuLi (1.1 eq), Boc2O (1.1 eq), THF, 30 min, -78 to 25
oC,
96%. (b) BDSB (1.1 eq), MeNO2, 1 h, -25 to 25
oC, 56%. (c) K2CO3 (3.0 eq), MeOH, 3 h,
40 oC. (d) (COCl)2 (1.5 eq), DMSO (3.0 eq), CH2Cl2, 5 min, -78
oC, then SM, 5 min, -78 oC,
then Et3N (6.0 eq), 1 h, -78 to -40
oC, 91% over 2 steps. (e) SOCl2 (1.5 eq), Et3N (5.0 eq),
CH2Cl2, 1 h, -196 to -97
oC, 83%. (f) 20 (1.2 eq), n-BuLi (1.1 eq), THF, 15 min, -78 oC, then
75 (1.0 eq), 5 min, -40 oC, 80%. (g) TFA (5.0 eq), Et3SiH (10 eq), CH2Cl2, 30 min, 0
oC,
and 90 min, 0 oC, 58%. (h) n-BuLi (1.1 eq), DMF (5 eq), THF, 1 h, -78 oC, then 12 M aq
HCl (5 eq), 1 h, 50 oC, 77%. Boc2O = di-tert-butyldicarbonate, BDSB =
bromodiethylsulfonium bromopentachloroantimonate, DMSO = dimethylsulfoxide, TFA =
























Subsequent elaboration to intercept aldehyde 75 was optimized by the 
recognition that Swern oxidation28 provided a consistently higher yield than Dess–
Martin periodinane oxidation.  Additionally, the regioselectivity of the elimination of 
the tertiary alcohol could be boosted by running this reaction at extremely low 
temperatures (the yield of the desired exocyclic olefin was only ~65% even at –78 
°C).  Operationally, we achieved an increase in yield of nearly 20% by freezing a 
solution of the starting material and Et3N in liquid nitrogen, dripping in SOCl2, and 
then allowing thawing of the reaction mixture to occur very slowly in a CH2Cl2 slurry 
at –97 °C.   
Another low yielding step, the reductive deoxygenation, was optimized by the 
realization that one diastereomer of the benzylic alcohols reacts significantly faster 
than the other.  Since unnecessarily prolonged reaction times led to decomposition, 
separating the diastereomers chromatographically and deoxygenating them separately 
(with two different reaction times) allowed for a significant boost in yield, although it 
still remained unspectacular at 58%.  Lastly, we discovered that the 
formylation/deprotection sequence could be undertaken in one pot simply by adding 
aqueous acid at the conclusion of the formylation step.  Attempts were made to 
incorporate the formyl group earlier by adding the aryllithium reagent derived from 
31 (see Scheme 7) to aldehyde 75.  However, subsequent deoxygenation of the 
resultant benzylic alcohol under a number of conditions was never successful in the 
presence of either the benzylic acetal or aldehyde.  Nonetheless, our total synthesis of 
peyssonol A (76) was improved significantly by optimization; the second generation 
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route included 12 linear steps from commercially available geranyl bromide and 
proceeded in 6.0% overall yield (14% yield from (2Z,6E)-farnesol).2b 
In retrospect, the diastereoselectivity of bromonium-induced polyene 
cyclizations initiated by BDSB was integral to the total synthesis and structural 
reassignment of peyssonol A (76).  Four diastereomeric decalin cores were prepared 
from the four geometric isomers of farnesol in order to thoroughly investigate the 
actual stereochemistry of the misassigned natural product.  Although three of the four 
syntheses resulted in peyssonol A diastereomers (21, 66, and 70) rather than the 
natural product (76), these routes provided us with a number of synthetic analogues 
and precursors that would later be evaluated for biochemical activity (see Section 6).  
 
3.5  The Total Synthesis of Peyssonoic Acid A 
Three months after we began work towards the total synthesis of peyssonol A, 
a publication appeared detailing the isolation and characterization of a remarkably 
similar natural product, peyssonoic acid A (78).8e  As shown in Figure 2, this natural 
product differs from the revised structure of peyssonol A in only the location of the 
alkene and the replacement of the aromatic aldehyde with an acetic acid moiety.  The 
trans-decalin core of peyssonoic acid A served to reinforce our belief (as we had not 





Once we had accessed peyssonol A, we recognized that our synthesis could 
readily be adapted to result in a comparably efficient synthesis of peyssonoic acid A.  
However, we were reluctant to do this, as it seemed like a rather trivial exercise 
(especially since there was less biological impetus for the chemical synthesis of 
peyssonoic acid A, which exhibits none of the anti-HIV properties of peyssonol A).  
We recognized, however, that with the problem of the exocyclic alkene obviated, we 
might have more success with our original peyssonol A strategy of incorporating the 
aromatic ring as a terminating group during the bromonium-induced cyclization step 
(see Schemes 5 through 8).  Specifically, we recalled that the action of BCl3 on 
tetracycle 34 (see Table 1, Entry 18) led to predominantly tetrasubstituted alkene 36.  
However, given that the revised stereochemistry of peyssonol A has implications for 
the axial/equatorial nature of the hydrogen atom abstracted to form this alkene, we 
were hopeful that perhaps we could induce formation of the requisite trisubstituted 
alkene by instead starting from the correct (trans-syn-cis) diastereomer of the 
tetracycle.  
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Reagents and Conditions: (a) PBr3 (0.5 eq), Et2O, 1 h, -20 to 0
oC. (b)
20 (1.8 eq), n-BuLi (1.5 eq), THF, 20 min, -78 oC, then (2Z,6E)-farnesyl
bromide (1.0 eq), 2 h, -40 to 5 oC, 45% yield over 2 steps. (c) BDSB
(1.1 eq), MeNO2, 5 min, -25














Scheme 20. Peyssonoic acid A route 1: accessing dibromo-tetracycle
80 via BDSB cyclization.
 
 
With this in mind, we prepared arylated (2Z,6E)-farnesyl derivative 79, as 
shown in Scheme 20.  Cyclization with BDSB afforded desired tetracycle 80 in 42% 
yield; presumably, the reaction yield was somewhat higher than this, but pure 
material could only be obtained by recrystallization, which resulted in some material 
loss during purification.  With 80 in hand, we attempted a number of reactions in 
order to install the acetic acid moiety; these efforts are showcased in Scheme 21.  
Direct installation of an ethyl acetate unit (80 → 81) proved unsuccessful; using 
either copper-mediated or palladium-catalyzed couplings reported to work for such 
systems resulted in only trace amounts of 81.29  Installation of the requisite two-
carbon piece by reaction of the aryllithium derived from 80 with ethylene oxide to 
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afford 82 was also unsuccessful; although, in retrospect, this reaction would probably 
not be expected to succeed without the addition of a Lewis acid to activate the 
epoxide.  Attempted installation of an oxidized version of the requisite two carbon 
piece by lithium-halogen exchange and reaction with ethyl chlorooxoacetate was 
successful, furnishing desired α-keto ester 83.30  However, subsequent attempts to 
reduce the benzylic ketone to a methylene resulted only in reduction to the benzylic 
alcohol.  Alternatively, homologation by trapping the aryllithium species derived 
























































Scheme 21. Peyssonoic acid A route 1: synthetic ef forts towards the incorporation
of the requisite 2 carbons to complete the carbon framework of peyssonoic acid A
from 80.
 
From compound 84, an Arndt-Eistert homologation32 was employed to furnish 
the desired acetic acid moiety.  As shown in Scheme 22, treatment of 84 with SOCl2 
followed by TMSCHN2 afforded the expected diazoketone;33 subsequent treatment 
with Ag(OCOCF3) in aqueous THF initiated the Wolff rearrangement to provide the 
desired homologated carboxylic acid (85).34  Unfortunately, the yield for this 
sequence was quite low, and was considerably worse on larger scale.  Nonetheless, 
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we had access to desired tetracycle 85 and attempted the final
 
reaction, hoping to 
cleave the MOM ether in addition to forming the requisite trisubstituted alkene.  We 
were delighted to see that this proceeded as planned; treatment with excess BCl3 in 
dichloromethane resulted in predominantly the desired alkene isomer.  Unfortunately, 
the material we obtained (78) was spectroscopically distinct from the natural product. 
  
 
In this case, the solution to the problem turned out to be much simpler than 
synthesizing three additional diastereomers.  In fact, a comparison of the 1H NMR 
spectra (see Figure 3) of our synthetic 78 and peyssonoic acid A isolated from natural 
sources revealed that most peaks aligned quite nicely.  The only peaks with 
significantly different chemical shift values were those protons adjacent to the 
carboxylic acid and those on the aromatic ring (labeled 1, 2, and 3 in Figure 3).  Since 
these protons were shifted significantly upfield in the natural isolate, we hypothesized 
that perhaps inadvertent deprotonation of the carboxylic acid had resulted in a 
significantly more electron rich carboxylate anion.  This hypothesis proved correct: 
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stirring our synthetic material over powdered sodium bicarbonate in deuterated 
DMSO resulted in a perfect spectroscopic match with the isolated material.  
Thankfully, peyssonoic acid A was not misassigned, but appears to have been 















Figure 3. Comparison of 1H NMR spectra of synthetic and natural peyssonoic acid A





At this stage, we had completed the total synthesis of peyssonoic acid A, but 
once again wished to optimize our route.  In particular, we were disappointed with the 
very low yields associated with the Arndt-Eistert homologation.  We therefore looked 
for an alternative method to install the requisite carboxylic acid of 78.  Our second 
generation route (shown in Scheme 23) relied upon allylated cyclization precursor 87.  
BDSB cyclization afforded desired tetracycle 88 in rather low yield.  The remaining 
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material appeared to be mostly partially cyclized or perhaps diastereomeric to 88.  
None of the side products appeared to have undergone bromination of the allyl group 
or the electron-rich aromatic ring.  Nonetheless, we took the pure material forward, 
subjecting the allyl group of 88 to oxidative cleavageby one-pot 
dihydroxylation/periodate cleavage,35 followed by Pinnick oxidation36 of the resultant 
aldehyde.  This sequence provided access to much larger amounts of carboxylic acid 
85 in significantly higher yield.  On scale, the final deprotection/ether cleavage 
proceeded in 72% yield to afford peyssonoic acid A (78).  Once again, treatment with 
base afforded material that was spectroscopically identical to the natural isolate (89).  
Overall, the optimized route to peyssonoic acid A included 10 linear steps from 
commercially available geranyl bromide and proceeded in 4.9% overall yield. 
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Reagents and Conditions: (a) 86 (1.7 eq), n-BuLi (1.7 eq), THF, 15 min, -78 oC, then
(2Z,6E)-farnesyl bromide (1.0 eq), 2 h, -40 to 5 oC, 84%. (b) BDSB (1.1 eq), MeNO2, 5
min, -25 oC, 31%. (c) OsO4 (0.2 eq), NaIO4 (5.0 eq), pyridine (3.0 eq), t-BuOH/H2O/THF,
2 h, 0 to 25 oC, 89%. (d) NaClO2 (4.0 eq), NaH2PO4
.H2O (10 eq), 2-Me-2-butene (10 eq),
t-BuOH/H2O/THF, 20 min, 0
oC, 81%. (e) BCl3 (6.0 eq), CH2Cl2, 1 h, -78
oC, 72%. (f)
NaHCO3 (10 eq), (CD3)2SO, 12 h, 25
oC, ~80%. BDSB = bromodiethylsulfonium





















78: peyssonoic acid A












3.6  Anti-HIV Properties of Peyssonol A, Peyssonoic Acid A, and Analogues 
As mentioned previously, the isolation of peyssonol A was guided by the fact 
that the natural product exhibits reverse transcriptase inhibition.6,7  In fact, peyssonol 
A belongs to a privileged class of secondary metabolites, the sequeterpenoid 
 215 
(hydro)quinones, of which several members are known to exhibit anti-HIV activity 
(see Figure 4).37  Perhaps the most well-known of these is avarol (90), which, along 
with its oxidized variant, avarone (91), was shown to inhibit HIV in vitro at 
concentrations as low as 300 nM.38  Efforts to produce a non-nucleoside reverse 
transcriptase inhibitor (nnRTI) drug from avarol were unsuccessful, presumably due 
to its high cytotoxicity.39 
 
 
In an effort to improve upon the potency and cytotoxicity of the 
sesquiterpenoid (hydro)quinones, a number of synthetic analogues of avarol have 
been prepared from chemical modification of the parent structure.40  To date, these 
modifications have focused on the hydroquinone or quinone ring of the natural 
products, and the resultant compounds were generally less potent and/or equally 
toxic.  To the best of our knowledge, no SAR (structure-activity relationship) studies 
have been undertaken to examine the effects of modifying the aliphatic decalin 
portion of these types of compounds, presumably due to the difficulty of 
functionalizing this relatively inert alkane framework.   
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However, we felt uniquely suited to undertake such an investigation, largely 
because we had access to a large number of decalin frameworks both with and 
without the appended hydroquinone ring (due to the four separate syntheses of 
peyssonol A diastereomers).  In this way, we hoped to gain insight into which motifs 
and/or three-dimensional conformations of peyssonol A were potentially responsible 
for its observed reverse transcriptase inhibition.  
The synthetic efforts described in the previous three sections had left us with 
nearly 50 synthetic intermediates en route to peyssonol A and peyssonoic acid A.  
Our collaborators in the virology group at Bristol-Myers Squibb (Mark Krystal and 
Nicholas Meanwell) graciously offered to screen a subset of these compounds.  As 
shown in Figure 5, the first batch compounds we sent included most of the 
intermediates in the synthesis of the naturally occurring diastereomer of peyssonol A, 
from bromocyclic acetate 74 and carbonate 77 up to and including the natural product 
(76).  In addition, we included tetracyclic aldehyde 97 (the diastereomer of compound 
34, which we were never able to successfully transform into the reported structure for 
peyssonol A; see Table 1 and Table 2), as well as geometric isomers of peyssonol A 
(98 and 99) that derived from ether cleavage of tetracycle 97 with BCl3.  As shown in 
Figure 6, we also included tricyclic carbonate and bicyclic acetate intermediates from 
the syntheses of the incorrect peyssonol A diastereomers, as well as the final products 







































EC50 = 12 M
CC50 = 93 M
77
EC50 = 4 M
CC50 = 91 M
94
EC50 = 2 M
CC50 = 88 M
76: peyssonol A
EC50 = 1.1 M
CC50 = 4 M
98
EC50 = 0.9 M
CC50 = 4 M
99
EC50 = 0.8 M
CC50 = 4 M
97
EC50 = 1.1 M
















EC50 = 20 M
CC50 = 26 M
95
EC50 = 14 M
CC50 = 20 M
96
EC50 = 63 M
CC50 = >100 M
Figure 5. Evaluation of HIV inhibition for analogues and synthetic precursors of the




















































EC50 = 9 M
CC50 = >100 M
100
EC50 = 22 M
CC50 = 69 M
68
EC50 = 14 M
CC50 = 39 M
53
EC50 = 41 M
CC50 = >100 M
101
EC50 = 7 M
CC50 = 68 M
102
EC50 = 10 M
CC50 = >100 M
21
EC50 = 0.7 M
CC50 = 5 M
66
EC50 = 0.5 M
CC50 = 4 M
70
EC50 = 0.5 M
CC50 = 2 M
78: peyssonoic acid A
EC50 = 51 M
CC50 = >100 M
Figure 6. Evaluation of HIV inhibition for analogues and synthetic precursors of the




Bioactivity screening of the compounds in Figures 5 and 6 consisted of a cell-
based assay measuring inhibition of a recombinant HIV (Rep-Rluc Sac II) in MT-2 
human lymphocytes (see Section 9 for details); the initial results of this assay are 
depicted in Figures 5 and 6.41  The EC50 value is a measure of efficacy (concentration 
at which HIV replication rate is 50% relative to control) while the CC50 value is a 
measure of toxicity (concentration at which half the cells are no longer viable).  With 
an EC50 value of approximately 1 uM, peyssonol A (76) was indeed a fairly potent in 
vitro inhibitor of the recombinant HIV.  Surprisingly, however, the three 
diastereomers (21, 66, and 70) and two regioisomers (98 and 99) of peyssonol A 
exhibited bioactivity profiles nearly identical to the natural product (if anything, a few 
of these variants were actually slightly more potent than peyssonol A).  The 
consistent level of potency observed across these isomers argues that the three-
dimensional shape of the aliphatic subunit is of little consequence for the 
antiretroviral activity of peyssonol A.  Moreover, the remarkably similar bioactivities 
observed for compounds 76, 98, 99 and 97 suggests that the true biologically active 
molecule might in fact be 97, which could potentially be formed from the three others 
in the cellular environment (in a laboratory flask, treatment of 76, 98, or 99 with acid 
leads to 97).   
Interestingly enough, however, the aliphatic subunit of these compounds does 
not strictly require the aromatic subunit to retain potency.  The low EC50 values 
observed for all four diastereomeric tricyclic carbonates (77, 60, 101, and 102) argue 
that, at least with a polar cyclic carbonate group appended, the aliphatic subunit of 
peyssonol A is active enough to produce a measurable inhibition of HIV.  Overall, the 
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corresponding acetylated bicycles (74, 53, 100, 68) appeared somewhat less active 
than the tricyclic carbonates.  The collated results of all eight bicyclic acetates and 
tricyclic carbonates serve to reinforce the notion that the stereochemical configuration 
of the decalin system is relatively unimportant with respect to potency.  The large 
drop in potency associated with aldehyde 75 (with respect to diol 94 or carbonate 77) 
suggests that polar groups appended to the decalin framework are important for 
bioactivity.  Similarly, the low potencies observed for intermediates 95 and 96 argue 
that the aromatic moiety of peyssonol A is only beneficial to potency if it is 
functionalized with phenol and/or aldehyde groups.  The high EC50 value measured 
for peyssonoic acid A (78) also lends credence to this hypothesis; more specifically, it 
points to the importance of the aldehyde moiety (or, alternatively, highlights the 
detrimental effect of the carboxylic acid).  
At this junction, our collaborators offered to screen an additional five to ten 
compounds of our choosing, based on what we had observed in the initial results.  We 
decided to investigate the importance of the aliphatic halogen atom as well as the 
potency derived from the aromatic subunit of peyssonol A.  As shown in Scheme 24, 
the chloride analogue (104) of tricyclic carbonate 77 was produced via mercury-
induced cyclization of (2Z,6E)-farnesol derivative 103,42 followed by stereoselective 
replacement of mercury with electrophilic chlorine.43  Iodinated analogue 105 was 
synthesized by iodonium-induced cyclization initiated by IDSI, the iodine analogue 
of BDSB.2b  Finally, dehalogenated carbonate analogue 106 was produced by radical 












Reagents and Conditions: (a) Hg(OTf)2 (1.1 eq), MeCN/CH2Cl2, 15 min, -20
oC.
(b) Cl2, CH2Cl2/pyr, 30 min, -40
oC, 19% over 2 steps. (c) IDSI (1.1 eq), MeNO2,
20 min, 0 to 25 oC, 31%. (d) AIBN (0.2 eq), n-Bu3SnH (5.0 eq), toluene, 1 h, 85


















Scheme 24. Synthesis of chloride (104), iodide (105), and debrominated (106)
analogues of tricyclic carbonate 77.
 
 
While a number of analogues and precursors in Figures 5 and 6 lacked the 
aromatic portion of peyssonol A, the final two compounds synthesized for testing 
were intended to investigate the effects of partial or complete removal of the aliphatic 
portion of the natural product.  As illustrated in Scheme 25, protected 
dibromodihydroquinone 20 could be methylated using lithium-halogen exchange 
followed by iodomethane addition to provide 107.  A second lithium-halogen 
exchange facilitated formylation with DMF; same-pot acidic deprotection afforded 
108 in good yield.  Compound 110 was synthesized in a similar fashion, with its 
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methylenecyclohexyl substituent seemingly intermediate in size between the methyl 
group of 108 and the decalin system of peyssonol A (76) and its isomers. 
 
Reagents and Conditions: (a) n-BuLi (1.0 eq), MeI (2.0 eq), THF, 1 h, -78 to 25 oC,
74%. (b) n-BuLi (1.1 eq), DMF (3.0 eq), THF, 1 h, -78 oC, then 12M aq HCl (10 eq), 1
h, 60 oC, 64%. (c) n-BuLi (1.0 eq), CyCHO (1.5 eq), THF, 20 min, -78 to 25 oC, 75%.
(d) TFA (3.0 eq), Et3SiH (6.0 eq), CH2Cl2, 8 h, 0
oC. (e) n-BuLi (1.1 eq), DMF (3.0 eq),
THF, 1 h, -78 oC, then 12M aq HCl (10 eq), 1 h, 60 oC, 39% over 2 steps. DMF = N,N-


























Scheme 25. Synthesis of analogues mimicking the aromatic portion of peyssonol A.
 
The bioassay data from these five new compounds are shown in Figure 7.  
Compounds 104, 105, and especially 106 indicate that the aliphatic bromine atom is 
almost certainly not playing a role in HIV inhibition.  Meanwhile, the results from 
compounds 108 and 110 make the case that the aromatic subunit of peyssonol A is a 
significant contributor to its observed potency.  Compound 108, which is essentially 
just the aromatic ring of peyssonol A, is only a single order of magnitude less potent 
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than the natural product.  Meanwhile, compound 110 exhibits even better HIV 

















EC50 = 5 mM
CC50 = 29 mM
104
EC50 = 11 mM
CC50 = 40 mM
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EC50 = 11 mM
CC50 = 32 mM
Figure 7. Evaluation of HIV inhibition of additional analogues.
 
 
In conclusion, although peyssonol A (78) and its various regio- and 
stereoisomers (97, 98, 99, 21, 66, and 70) were the most potent of all compounds 
tested, their CC50 values reveal that they were also the most cytotoxic (as is to be 
expected from their sesquiterpenoid hydroquinone structures).39  Not one of the seven 
peyssonol A isomers exhibited a therapeutic index (EC50/CC50) greater than 10.  
Meanwhile, although not quite as potent, several of the aliphatic tricyclic carbonates 
(77, 60, 102, and 106) were significantly less cytotoxic, such that therapeutic indices 
greater than ten were observed.  From this perspective, the most promising candidates 
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for further elaboration are carbonate 77, diol 94 and hydroquinone 110, all three of 
which displayed single-digit micromolar EC50 values and therapeutic indices of >20.  
 
3.7  Conclusion 
Our initial studies with BDSB using model substrates for polyene cyclization 
provided valuable data, but it was the use of BDSB for natural product total synthesis 
that truly validated its utility.  Whether used to improve the yield of an existing 
synthesis (as in 4-isocymobarbatol) or facilitate the inaugural total syntheses of 
complex brominated terpenoids (as in peyssonol A and peyssonoic acid A), BDSB 
excelled in rapidly assembling brominated core ring systems.   
As a result of these undertakings, we furthered our understanding of the 
diastereoselectivity of the cyclization process and pushed the limits of the number of 
rings that could be formed.  We also were able to effect a structural reassignment of 
the anti-HIV compound peyssonol A; these efforts resulted in access to a large 
number of peyssonol A diastereomers, regioisomers, and truncated analogues.  
Testing more than two dozen of these compounds against a recombinant HIV strain 
revealed that both the aliphatic and aromatic portions of peyssonol A are important 
for its observed bioactivity, but that significantly less toxic analogues could be 
synthesized by omission or truncation of one of these two motifs.  
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3.9  Experimental Section 
 
General Procedures.  All reactions were carried out under an argon 
atmosphere with dry solvents under anhydrous conditions, unless otherwise noted.  
Dry methylene chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and 
tetrahydrofuran (THF) were obtained by passing commercially available pre-dried, 
oxygen-free formulations through activated alumina columns; acetonitrile (MeCN) 
and nitromethane (MeNO2) were stored over 3 Å molecular sieves, pyridine was 
distilled from CaH2 and stored over 3 Å molecular sieves; diisopropylamine (iPr2NH) 
was distilled from KOH and stored over 3 Å molecular sieves; triethylamine (Et3N) 
was distilled from KOH; 1,2-dichloroethane, acetone, and methanol (MeOH) were 
purchased in anhydrous form from Sigma-Aldrich and used as received.  Yields refer 
to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated.  
Reactions were magnetically stirred and monitored by thin-layer chromatography 
(TLC) carried out on 0.25 mm E. Merck silica gel plates (60F-254) using UV light 
and/or I2 on silica as visualizing agents and an aqueous solution of phosphomolybdic 
acid and cerium sulfate or a solution of KMnO4 in aqueous sodium bicarbonate with 
heat as developing agents.  Preparative thin-layer chromatography was carried out on 
0.50 mm E. Merck silica gel plates (60F-254).  SiliCycle silica gel (60, academic 
grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
NMR spectra were recorded on Bruker DRX-300, DRX-400, and 500 ASCEND 
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instruments and calibrated using residual undeuterated solvent as an internal 
reference.  The following abbreviations were used to explain the multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent.  
IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR spectrometer. 
High-resolution mass spectra (HRMS) were recorded in the Columbia University 
Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (Fast 
Atom Bombardment) and EI (Electron Ionization) techniques.  Characterization data 
are not provided for known compounds. 
 
Abbreviations.  Ac2O = acetic anhydride, AcOH = acetic acid, AgOTf = 
silver(I) trifluoromethanesulfonate, Boc2O = di-tert-butyldicarbonate, BDSB = 
bromodiethylsulfonium bromopentachloroantimonate, DMAP = 4-
dimethylaminopyridine, DMF = N,N-dimethylformamide, DBU = 1,8-
diazobicycloundec-7-ene, IDSI = bis(diethyliodosulfonium) chloride 
hexachloroantimonate, KOt-Bu = potassium tert-butoxide, MeLi = methyllithium, 
MOMCl = chloromethyl methyl ether, n-BuLi = n-butyllithium, Ni(acac)2 = nickel(II) 
acetylacetonate, PIFA  = bis(trifluoroacetoxy)iodobenzene, PPTS = pyridinium para-
toluenesulfonate, t-BuOH = tert-butyl alcohol, TFA = trifluoroacetic acid, TMSCHN2 
= trimethylsilyldiazomethane. 
 
4-Isocymobarbatol (13).  Aqueous 12 M HCl (0.107 mL, 1.28 mmol, 40.0 
equiv) was added dropwise to a solution of 17 (14.3 mg, 0.0320 mmol, 1.00 equiv) in 
THF (1 mL) at 25 °C.  After 5 h at 25 °C, the reaction mixture was quenched with 
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water (5 mL) and extracted with EtOAc (3 × 10 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0 → 4:1) to afford 13 (12.5 mg, 97% 
yield) as a white crystalline solid.  13: m.p. = 140.0 – 144.0 °C; Rf = 0.51 (silica gel, 
hexanes:EtOAc, 7:3); IR (film) νmax 3518, 2999, 2975, 2868, 1487, 1476, 1219, 1148, 
912, 868 cm–1; 1H NMR (400 MHz, CDCl3) δ 6.88 (s, 1 H), 6.74 (s, 1 H), 5.03 (s, 1 
H), 4.03 (dd, J = 12.8, 4.0 Hz, 1 H), 2.77 – 2.60 (m, 2 H), 2.27 (dq, J = 14.0, 4.0 Hz, 
1 H), 2.11 (dq, J = 3.6, 14.0 Hz, 1 H), 1.96 (dt, J = 3.6, 13.2 Hz, 1 H), 1.81 – 1.69 (m, 
2 H), 1.20 (s, 3 H), 1.16 (s, 3 H), 1.02 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 147.1, 
145.8, 123.1, 119.8, 115.8, 108.1, 76.0, 65.8, 48.1, 40.7, 39.3, 31.6, 29.7, 24.7, 19.8, 
17.0; HRMS (FAB) calcd for C16H20Br2O2+ [M]+ 401.9830, found 401.9840.  All 
spectral data for this natural product matches those found in the original isolation 
paper: Wall, M. E.; Wani, M. C.; Manikumar, G.; Taylor, H.; Hughes, T. J.; Gaetano, 
K.; Gerwick, W. H.; McPhail, A. T.; McPhail, D. R. J. Nat. Prod. 1989, 52, 1092. 
 
4-Isocymobarbatol Polyene Precursor (15).  (Procedure adapted from: 
Tanaka, A.; Sato, M.; Yamashita, K. Agric. Biol. Chem. 1990, 54, 121).  A solution of 
n-BuLi (0.74 mL, 1.3 M in hexanes, 0.96 mmol, 1.7 equiv) was added dropwise to a 
solution of 20 (0.40 g, 1.12 mmol, 2.0 equiv) in THF (15 mL) at –78 °C.  The 
resultant solution was stirred for 30 min at –78 °C, then quickly added via syringe to 
a solution of geranyl bromide (0.12 g, 0.56 mmol, 1.0 equiv) in THF (2 mL) at –40 
°C.  The resultant mixture was allowed to warm slowly to 0 °C over the course of 2 h, 
at which time the reaction contents were quenched by the addition of 10% aqueous 
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ammonium chloride (15 mL) and extracted with hexanes:EtOAc (2:1, 3 × 15 mL).  
The combined organic layers were washed with brine (15 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0 → 1:4) to afford 15 (0.17 g, 75% yield) as a light yellow viscous 
oil.  15: Rf = 0.55 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2960, 2913, 2853, 
2827, 1488, 1377, 1151, 1081, 999, 933 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 
1 H), 6.96 (s, 1 H), 5.27 (dt, J = 7.2, 1.2 Hz, 1 H), 5.15 (s, 2 H), 5.12 (s, 2 H), 5.10 (tt, 
J = 6.8, 1.2 Hz, 1 H), 3.53 (s, 3 H), 3.48 (s, 3 H), 3.28 (d, J = 7.2 Hz, 2 H), 2.13 – 
2.00 (m, 4 H), 1.70 (s, 3 H), 1.67 (s, 3 H), 1.60 (s, 3 H); 13C NMR (75 MHz, CDCl3) 
δ 150.6, 148.8, 137.0, 131.7, 131.6, 124.3, 121.8, 119.4, 118.5, 110.3, 96.2, 95.3, 
56.5, 56.2, 39.9, 28.6, 26.9, 25.8, 17.8, 16.3; HRMS (FAB) calcd for C20H29BrO4+ 
[M]+ 412.1249, found 412.1249. 
 
Protected 4-Isocymobarbatol (17).  A cold solution of BDSB (0.073 g, 0.13 
mmol, 1.1 equiv) in MeNO2 (1 mL) was added quickly via syringe to a solution of 15 
(0.050 g, 0.12 mmol, 1.0 equiv) in MeNO2 (11 mL) at –25 °C.  After 5 min at –25 °C, 
the reaction mixture was quenched by the addition of 5% aqueous sodium bicarbonate 
and 5% aqueous sodium sulfite (1:1, 10 mL), stirred vigorously at 25 °C for 15 min, 
then extracted with CH2Cl2 (3 × 20 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 → 4:1) to afford 17 (0.040 g, 74% yield) as a white 
crystalline solid.  17: Rf = 0.3 (silica gel, hexanes:EtOAc, 9:1); 1H NMR (300 MHz, 
CDCl3) δ 6.96 (s, 1 H), 6.87 (s, 1 H), 5.13 (s, 2 H), 4.03 (dd, J = 11.7, 4.2 Hz, 1 H), 
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3.53 (s, 3 H), 2.79 – 2.61 (m, 2 H), 2.28 (dq, J = 14.1, 3.9 Hz, 1 H), 2.11 (qd, J = 
14.1, 3.6 Hz, 1 H), 1.98 (dt, J = 13.8, 3.6 Hz, 1 H), 1.81 – 1.72 (m, 2 H), 1.21 (s, 3 
H), 1.16 (s, 3 H), 1.01 (s, 3 H). 
 
MOM-Protected 2,5-Dibromohydroquinone (20).  A solution of 2,5-
dibromohydroquinone (2.00 g, 7.47 mmol, 1.00 equiv) in THF (15 mL) was added 
dropwise to a suspension of NaH (rinsed with 3 × 5 ml hexanes to remove mineral 
oil, 0.449 g, 18.7 mmol, 2.50 equiv) in THF (10 mL) at 0 °C under a constant flow of 
argon.  After 5 min, MOMCl (1.70 mL, 22.4 mmol, 3.00 equiv) was added slowly.  
After an additional 2 h at 0 °C, the reaction contents were quenched by the careful 
addition of water (30 mL), and extracted with EtOAc (3 × 30 mL).  The combined 
organic layers were washed with 1 M NaOH (2 × 30 mL) and brine (30 mL), dried 
(MgSO4), filtered, and concentrated to afford 20 (2.61 g, 98% yield) as a white 
crystalline solid.  
 
Purported Peyssonol A (21).  Solid p-TsOH•H2O (0.038 g, 0.20 mmol, 40 
equiv) was added in a single portion to a solution of 58 (2.5 mg, 0.0049 mmol 
assumed, 1.0 equiv) in t-BuOH (1 mL) at 65 °C.  After 2 h, the reaction contents were 
poured into water (5 mL) and extracted with EtOAc (3 × 5 mL).  The combined 
organic layers were washed with brine (5 mL), dried (MgSO4), filtered, and 
concentrated.  Purification of the resultant residue by flash column chromatography 
(silica gel, hexanes:EtOAc, 4:1) afforded the originally proposed structure for 
peyssonol A (21, 1.9 mg, ~90% yield) as a light yellow amorphous solid.  For a 
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comparison of NMR shifts of this compound with the natural product, see table on pg 
268.  21: Rf = 0.38 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 3392 (br), 2927, 
2855, 1648, 1440, 1348, 1172, 799 cm–1; 1H NMR (400 MHz, C6D6) δ 11.11 (s, 1 H), 
9.20 (s, 1 H), 6.84 (s, 1 H), 5.74 (s, 1 H), 4.74 (s, 1 H), 4.62 (s, 1 H), 3.90 (br s, 1 H), 
3.86 (dd, J = 12.8, 4.8 Hz, 1 H), 2.68 (dd, J = 16.4, 10.8 Hz, 1 H), 2.49 (app d, J = 
16.0 Hz, 1 H), 2.10 – 1.80 (m, 4 H), 1.52 – 1.02 (m, 4 H), 1.24 (s, 3 H), 1.01 – 0.73 
(m, 2 H), 0.98 (s, 3 H), 0.91 (s, 3 H); 13C NMR (100 MHz, C6D6) δ 194.9, 156.6, 
147.6, 146.8, 141.0, 128.6, 118.2, 117.0, 107.8, 64.5, 54.8, 53.0, 41.6, 40.1, 37.6, 
32.3, 32.0, 28.6 (2 C), 28.2, 26.8, 25.6; HRMS (FAB) calcd for C22H30BrO3 [M+H]+ 
421.1378, found 421.1362. 
 
(2E,6Z)-Farnesol (24).  (Procedure adapted from: Yu, J. S.; Kleckley, T. S.; 
Wiemer, D. F. Org. Lett. 2005, 7, 4803).  Triethylphosphonoacetate (7.32 mL, 36.9 
mmol, 1.10 equiv) was syringed dropwise (with a constant flow of argon) into a 
vigorously stirring suspension of NaH (60% dispersion in mineral oil, 1.54 g, 38.6 
mmol, 1.15 equiv) in THF (70 mL) at –20 °C.  After 30 min at –20 °C, a solution of 
30 (6.52 g, 33.6 mmol, 1.00 equiv) in THF (10 mL) was added slowly to the reaction 
mixture.  The resultant contents were allowed to warm slowly to 25 °C over the 
course of 16 h, then quenched by the addition of 10% aqueous ammonium chloride 
(200 mL) and extracted with Et2O (3 × 150 mL).  The combined organic layers were 
washed with brine (200 mL), dried (MgSO4), filtered, and concentrated.  By 1H 
NMR, the crude product was discovered to be a 4.2:1 mixture of E:Z isomers about 
the newly formed alkene.  Careful purification by flash column chromatography 
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(silica gel, hexanes:CH2Cl2, 4:1 → 1:2) afforded ethyl (2E,6Z)-farnesate (5.65 g, 64% 
yield) as a colorless oil.  Next, a portion of this ethyl (2E,6Z)-farnesate (4.33 g, 16.4 
mmol, 1.00 equiv) was syringed dropwise into a suspension of LiAlH4 (0.373 g, 9.83 
mmol, 0.60 equiv) in THF (66 mL) at –78 °C.  The reaction mixture was allowed to 
warm slowly to 25 °C over the course of 2 h, and then maintained at 25 °C for 2 
additional h.  At this time, residual hydride was quenched by careful dropwise 
addition of saturated aqueous ammonium chloride (2 mL).  An aqueous 1 M solution 
of sodium/potassium tartrate (150 mL) was added and the resultant biphasic mixture 
was stirred vigorously for 2 h at 25 °C, then extracted with Et2O (4 × 100 mL).  The 
combined organic layers were washed with brine (200 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, hexanes:Et2O, 
4:1) to afford (2E,6Z)-farnesol (24, 2.98 g, 82% yield) as a colorless viscous oil. 
 
Nerylacetone (30).  (Procedure adapted from: Kato, T.; Suzuki, M.; 
Kobayashi, T.; Moore, B. P. J. Org. Chem. 1980, 45, 1126).  Phosphorous tribromide 
(2.58 mL, 27.3 mmol, 0.500 equiv) was added dropwise to a solution of nerol (29, 
8.42 g, 54.6 mmol, 1.00 equiv) in Et2O (160 mL) at –20 °C.  The resultant solution 
was allowed to warm slowly to 0 °C over the course of 1 h, then quenched by the 
addition of ice-cold water (300 mL) and extracted with hexanes (4 × 100 mL).  The 
combined organic layers were washed with saturated aqueous sodium bicarbonate 
(200 mL), then brine (200 mL), dried (MgSO4), filtered, and concentrated.  The 
resultant crude neryl bromide (11.7 g, 53.7 mmol, 1.00 equiv), K2CO3 (9.65 g, 69.8 
mmol, 1.30 equiv), and ethyl acetoacetate (17.5 g, 134 mmol, 2.50 equiv) were 
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combined in acetone (70 mL) and refluxed at 65 °C for 6 h.  The reaction mixture was 
then cooled to 25 °C, quenched by the addition of 10% aqueous ammonium chloride 
(200 mL) and extracted with Et2O (3 × 150 mL).  The combined organic layers were 
washed with brine (200 mL), dried (MgSO4), filtered, and concentrated.  Excess ethyl 
acetoacetate was then removed by distillation (70 °C @ 2 torr).  The crude alkylation 
product was dissolved in MeOH (64 mL), and aqueous 5 M KOH (32.0 mL, 160 
mmol, 3.00 equiv assumed) was added slowly.  The mixture was refluxed at 80 °C for 
2 h with vigorous stirring, then cooled to 0 °C and quenched by the slow addition of 
aqueous 1 M HCl (250 mL) and extracted with Et2O (3 × 200 mL).  The combined 
organic layers were washed with saturated aqueous sodium bicarbonate (200 mL) and 
brine (200 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 19:1) to afford 30 (6.52 g, 61% yield 
over 3 steps) as a light yellow oil. 
 
Dioxolane-Appended Aryl Bromide 31.  A solution of n-BuLi (3.56 mL, 
2.10 M in hexanes, 7.47 mmol, 1.00 equiv) was added dropwise to a solution of 20 
(2.66 g, 7.47 mmol, 1.00 equiv) in THF (100 mL) at –78 °C.  After 20 min at –78 °C, 
anhydrous DMF (5.75 mL, 74.7 mmol, 10.0 equiv) was added and the reaction flask 
was removed from the cold bath.  After 20 min (reaction contents ~ 0°C), the reaction 
mixture was quenched by the addition of 10% aqueous ammonium chloride (100 mL) 
and extracted with EtOAc (3 × 150 mL).  The combined organic layers were washed 
with brine (100 mL), dried (MgSO4), filtered, and concentrated to afford the crude 
formylated product as a bright yellow solid.  Next, PPTS (0.188 g, 0.747 mmol, 0.100 
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equiv assumed) and ethylene glycol (4.18 mL, 74.7 mmol, 10.0 equiv assumed) were 
added to a solution of the formylated product (7.47 mmol assumed, 1.00 equiv) in 
benzene (75 mL).  The resultant mixture was stirred vigorously at reflux (95 °C) for 
2.5 h, then cooled to 25 °C, poured into cold aqueous 1 M NaOH (200 mL), and 
extracted with EtOAc (3 × 100 mL).  The combined organic layers were washed with 
water (100 mL) and brine (100 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc + 1% Et3N by 
volume, 1:0 → 1:1) to afford 31 (1.95 g, 75% yield over 2 steps) as a white 
crystalline solid.  31: Rf = 0.4 (silica gel, hexanes:EtOAc, 1:1); 1H NMR (400 MHz, 
CDCl3) δ 7.37 (s, 1 H), 7.32 (s, 1 H), 6.07 (s, 1 H), 5.19 (s, 2 H), 5.16 (s, 2 H), 4.18 – 
3.95 (m, 4 H), 3.52 (s, 3 H), 3.49 (s, 3 H). 
 
(2E,6Z)-Farnesyl Bromide (32).  Phosphorous tribromide (0.141 mL, 1.50 
mmol, 0.500 equiv) was added dropwise to a solution of (2E,6Z)-farnesol (24, 0.667 
g, 3.00 mmol, 1.00 equiv) in Et2O (10 mL) at –25 °C.  The resultant mixture was 
allowed to warm slowly to 5 °C over the course of 1 h, then quenched by the addition 
of ice-cold water (20 mL) and extracted with hexanes (3 × 20 mL).  The combined 
organic layers were washed with saturated aqueous sodium bicarbonate (20 mL), then 
brine (20 mL), dried (MgSO4), filtered, and concentrated to afford farnesyl bromide 
(0.685 g, contaminated with minor impurities, ~75% yield) as a colorless oil that was 
unstable to silica gel chromatography. 
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MOM-Protected Arylated Polyene 33.  A solution of n-BuLi (2.02 mL, 1.44 
M in hexanes, 2.91 mmol, 1.20 equiv) was added dropwise to a solution of 31 (1.10 g, 
3.15 mmol, 1.30 equiv) in THF (60 mL) at –78 °C.  The resultant mixture was stirred 
for 30 min at –78 °C, then quickly cannulated into a solution of 32 (0.692 g, 2.43 
mmol, 1.0 equiv) in THF (15 mL) at –40 °C.  The reaction mixture was allowed to 
warm slowly to 5 °C over the course of 3 h, then quenched by the addition of 10% 
aqueous ammonium chloride (100 mL) and extracted with hexanes:EtOAc (1:1, 3 × 
100 mL).  The combined organic layers were washed with brine (100 mL), dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 → 2:1) to afford 33 (0.922 g, 80% yield) as a colorless 
viscous oil.  33: Rf = 0.4 (silica gel, hexanes:EtOAc, 3:2); 1H NMR (400 MHz, 
CDCl3) δ 7.21 (s, 1 H), 6.49 (s, 1 H), 6.11 (s, 1 H), 5.29 (t, J = 6.8 Hz, 1 H), 5.15 (s, 2 
H), 5.14 (s, 2 H), 5.15 – 5.08 (m, 2 H), 4.17 – 3.98 (m, 4 H), 3,48 (s, 3 H), 3.47 (s, 3 
H), 3.33 (d, J = 7.2 Hz, 2 H), 2.15 – 1.97 (m, 8 H), 1.70 (s, 3 H), 1.68 (s, 6 H), 1.60 
(s, 3 H). 
 
Tetracycle 34.  Optimized Procedure: A cold solution of BDSB (0.127 g, 
0.232 mmol, 1.10 equiv) in MeNO2 (1 mL) was added quickly via syringe to a 
solution of 33 (0.100 g, 0.211 mmol, 1.00 equiv) in MeNO2 (20 mL) at –25 °C.  After 
2 min at –25 °C, water (0.076 mL, 4.2 mmol, 20 equiv) was added and the resultant 
mixture was removed from the cold bath and stirred vigorously for 15 min at 25 °C.  
The resultant solution was concentrated to dryness by rotary evaporation and purified 
directly by flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 2:1) to 
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afford both diastereomers of 34 (0.051 g, contaminated with small amounts of 
undesired byproducts, ~50% yield) as a light brown amorphous solid.  The individual 
diastereomers of 34 could be isolated by crystallization as follows: Recrystallization 
from hexanes:CH2Cl2 (4:1) with slow evaporation afforded the major diastereomer as 
yellow needles.  Meanwhile, recrystallization from boiling hexanes afforded a 
mixture of yellow and orange needles; isolation of only the orange crystals afforded 
the minor diastereomer.  34: Major Diastereomer: Rf = 0.4 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 10.47 (s, 1 H), 9.75 (s, 1 H), 
6.91 (s, 1 H), 6.70 (s, 1 H), 4.21 (dd, J = 12.4, 4.4 Hz, 1 H), 2.84 (dd, J = 17.2, 4.4 
Hz, 1 H), 2.60 (dd, J = 17.2, 13.6 Hz, 1 H), 2.24 (qd, J = 13.2, 4.0 Hz, 1 H), 2.13 (dq, 
J = 14.0, 4.0 Hz, 1 H), 2.03 – 1.93 (m, 2 H), 1.76 (dd, J = 13.6, 4.4 Hz, 1 H), 1.70 – 
1.27 (m, 5 H), 1.35 (s, 3 H), 1.29 (s, 3 H), 1.22 (s, 3 H), 1.15 (s, 3 H).  Minor 
Diastereomer: Rf = 0.4 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) 
δ 10.35 (s, 1 H), 9.67 (s, 1 H), 6.83 (s, 1 H), 6.62 (s, 1 H), 4.24 (br s, 1 H), 2.71 (dd, J 
= 17.2, 4.8 Hz, 1 H), 2.57 (dd, J = 17.6, 5.2 Hz, 1 H), 2.19 (dd, J = 12.8, 5.2 Hz, 1 
H), 2.01 – 1.66 (m, 8 H), 1.55 (dd, J = 5.6 Hz, 2.4 Hz, 1 H), 1.24 (s, 3 H), 1.18 (s, 3 
H), 1.11 (s, 3 H), 0.99 (s, 3 H).   
 
Eliminated Tetracycle 35.  Formed by treatment of 34 with base under any 
of the following conditions: (a) NaOAc (100 equiv), AcOH , 3 h, 120 °C.  (b) KOt-
Bu (10 equiv), THF, 16 h, 65 °C.  (c) Collidine (solvent), 12 h, 160 °C.  (d) DBU 
(solvent), 20 h, 160 °C.  This material was difficult to purify by chromatography, 
since under the forcing conditions required for its synthesis decomposition was often 
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observed.  35: Rf = 0.4 (silica gel, hexanes:EtOAc, 3:2); 1H NMR (400 MHz, CDCl3, 
selected peaks only) δ 10.44 (s, 1 H), 9.76 (s, 1 H), 6.93 (s, 1 H), 6.71 (s, 1 H), 4.80 
(d, J = 2.0 Hz, 1 H), 4.73 (d, J = 2.4 Hz, 1 H).   
 
Tetracyclic Alkene 36.  A solution of boron trichloride (0.03 mL, 1.0 M in 
CH2Cl2, 0.03 mmol, 6 equiv) was added dropwise to a solution of 34 (2 mg, 0.005 
mmol, 1 equiv) in CH2Cl2 (1 mL) at 0 °C.  After 1.5 h at 0 °C, the yellow reaction 
contents were quenched by the addition of water (5 mL), poured into brine (5 mL), 
and extracted with EtOAc (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 7:3) to afford 36 (1 mg, contaminated with small amounts of 
unidentified byproducts, ~50% yield) as a yellow amorphous solid.  36: Rf = 0.3 
(silica gel, hexanes:EtOAc, 2:1); 1H NMR (400 MHz, CDCl3, selected peaks only) δ 
10.63 (s, 1 H), 9.77 (s, 3 H), 6.90 (s, 1 H), 6.74 (s, 1 H), 4.87 (s, 1 H), 4.23 (dd, J = 
6.4, 2.8 Hz, 1 H), 3.43 (AB q, J = 51.6, 13.6 Hz, 2 H), 1.59 (s, 3 H), 1.22 (s, 3 H), 
1.16 (s, 3 H), 1.08 (s, 3 H).   
 
Dibromide 37.  A solution of boron tribromide (0.17 mL, 1.0 M in CH2Cl2, 
0.17 mmol, 5.0 equiv) was added dropwise to a solution of 34 (14 mg, 0.034 mmol, 
1.0 equiv) in CH2Cl2 (1 mL) at –78 °C.  After 1 h at –78 °C, the reaction contents 
were quenched by the addition of water (5 mL), poured into brine (5 mL), and 
extracted with CH2Cl2 (2 × 10 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated to afford crude 37, which was unstable to silica 
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gel chromatography.  37: Rf = N/A; 1H NMR (400 MHz, CDCl3, selected peaks only) 
δ 10.52 (s, 1 H), 9.87 (d, J = 2.4 Hz, 1 H), 8,51 (s, 1 H), 6.93 (s, 1 H), 4.44 (dd, J = 
12.8, 4.8 Hz, 1 H), 3.13 (dd, J = 17.2, 5.6 Hz, 1 H), 2.95 (dd, J = 17.6, 3.2 Hz, 1 H), 
2.07 (quintet, J = 2.4 Hz, 3 H), 1.34 (s, 3 H), 1.25 (s, 3 H), 1.17 (s, 3 H).   
 
Rearranged Tetracycle 42.  PIFA (15 mg, 0.036 mmol, 5 equiv) was added 
in a single portion to a solution of 34 (3 mg, 0.007 mmol, 1 equiv) in 
hexafluoroisopropanol:water (10:1, 0.5 mL) at 25 °C.  After 48 h at 25 °C, the 
reaction contents were quenched by the addition of 5% aqueous sodium sulfite (5 
mL) and extracted with EtOAc (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography to 
afford 42 (1 mg, contaminated with minor impurities, ~40% yield) as a yellow 
amorphous solid.  42: Rf = 0.3 (silica gel, hexanes:EtOAc, 9:1); 1H NMR (400 MHz, 
CDCl3, selected peaks only) δ 10.43 (s, 1 H), 9.75 (s, 1 H), 6.93 (s, 1 H), 6.71 (s, 1 
H), 1.66 (s, 3 H), 1.59 (s, 3 H), 1.21 (s, 3 H), 0.99 (s, 3 H).   
 
Methoxy-Protected Arylated Polyene 43.  A solution of 33 (0.200 g, 0.421 
mmol, 1.00 equiv) and PPTS (0.847 g, 3.37 mmol, 8.00 equiv) in t-BuOH (3 mL) was 
heated to reflux at 85 °C for 5 h.  Upon completion, the reaction contents were cooled 
to 25 °C, quenched by the addition of 10% ammonium chloride (20 mL), and 
extracted with EtOAc (3 × 20 mL).  The combined organic layers were washed with 
water (40 mL) and brine (40 mL), dried (MgSO4), filtered, and concentrated to afford 
the corresponding diphenol.  Next, potassium carbonate (0.289 g, 2.09 mmol, 5.00 
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equiv) and iodomethane (0.260 mL, 4.18 mmol, 10.0 equiv) were added to a solution 
of this diphenol (0.421 mmol assumed) in DMF (3 mL) at 40 °C.  After 2 h at 40 ° C, 
the reaction contents were poured into water (20 mL) and extracted with 
hexanes:EtOAc (2:1, 3 × 20 mL).  The combined organic layers were washed with 
aqueous 1 M NaOH (30 mL) and brine (30 mL), then dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 6:1) to afford 43 (0.105 g, 67% yield over 2 steps) as a light 
yellow viscous oil.  43: Rf = 0.6 (silica gel, hexanes:EtOAc, 7:3); 1H NMR (300 
MHz, CDCl3) δ 10.39 (s, 1 H), 7.25 (s, 1 H), 6.81 (s, 1 H), 5.29 (t, J = 7.2 Hz, 1 H), 
5.16 – 5.03 (m, 2 H), 3.86 (s, 3 H), 3.82 (s, 3 H), 3.36 (d, J = 7.5 Hz, 2 H), 2.17 – 
1.94 (m, 8 H), 1.69 (s, 3 H), 1.67 (s, 3 H), 1.59 (s, 3 H) [Note: The attached spectrum 
is for the crude compound, since a spectrum of the purified compound could not be 
located].    
 
Eliminated Decalin 44.  A cold solution of BDSB (11 mg, 0.021 mmol, 1.1 
equiv) in MeNO2 (0.5 mL) was added quickly via syringe to a solution of 43 (7.0 mg, 
0.019 mmol, 1.0 equiv) in MeNO2 (1.5 mL) at –25 °C.  After 2 min at –25 °C, the 
reaction mixture was quenched by the addition of 5% aqueous sodium bicarbonate 
and 5% aqueous sodium sulfite (1:1, 10 mL), stirred vigorously at 25 °C for 5 min, 
then extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 4:1) to afford an inseparable mixture of the three alkene 
regioisomers of 44 (6 mg, contaminated with several minor byproducts, ~50% yield) 
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as a colorless amorphous solid.  This procedure was repeated in the presence of 2, 20, 
100, and 500 equivalents of ethylene carbonate with no change in the ratio of 
products formed.  44: Rf = 0.5 (silica gel, hexanes:EtOAc, 7:3); 1H NMR (300 MHz, 
CDCl3) Characteristic Peaks for Tetrasubstituted Alkene: δ 4.21 (dd, J = 7.5, 3.3 Hz, 
1 H), 3.42 (d, J = 3.0 Hz, 2 H); Characteristic Peak for Trisubstituted Alkene: δ 5.34 
(br s, 1 H); Characteristic Peaks for Exocyclic Alkene: δ 4.90 (s, 1 H), 4.60 (s, 1 H). 
 
Enol-Phosphate 47.  (Procedure adapted from: Brown, R. C. D.; Bataille, C. 
J.; Hughes, R. M.; Kenney, A.; Luker, T. J. J. Org. Chem. 2002, 67, 8079).  Ethyl 
acetoacetate (0.456 mL, 3.60 mmol, 1.20 equiv) was added dropwise to a suspension 
of NaH (0.156 g, 60% in mineral oil, 3.90 mmol, 1.30 equiv) in THF (10 mL) at 0 °C 
under a constant flow of argon.  After 10 min at 0 °C, a solution of n-BuLi (2.57 mL, 
1.4 M in hexanes, 3.6 mmol, 1.2 equiv) was added dropwise, and the resultant yellow 
dianion solution was stirred for an additional 10 min at 0 °C.  Neryl bromide (see the 
synthesis of 30; 0.561 mL, 3.00 mmol, 1.00 equiv) was added dropwise and the 
resultant reaction mixture was stirred for an additional 10 min at 0 °C.  At this time, 
diethyl chlorophosphate (0.870 mL, 6.00 mmol, 2.00 equiv) was added quickly to the 
reaction mixture, which was maintained at 0 °C for an additional 1.5 h.  Upon 
completion, the reaction contents were quenched by the careful addition of aqueous 
0.25 M HCl (20 mL) and extracted with EtOAc (3 × 20 mL).  The combined organic 
layers were washed with saturated aqueous sodium bicarbonate (30 mL) and brine (30 
mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography to afford 47 (0.980 g, contaminated with ~10% of an unknown 
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phosphate-derived byproduct, ~73% yield) as a yellow viscous oil.  32: Rf = N/A; 1H 
NMR (400 MHz, CDCl3) δ 5.13 – 5.05 (m, 2 H), 4.32 – 4.21 (m, 4 H), 4.15 (q, J = 
7.2 Hz, 2 H), 2.44 (t, J = 7.6 Hz, 2 H), 2.26 (q, J = 7.2 Hz, 2 H), 2.10 – 2.01 (m, 4 H), 
1.68 (s, 6 H), 1.61 (s, 3 H), 1.44 – 1.34 (m, 6 H), 1.27 (t, J = 7.2 Hz, 3 H). 
 
TMS-Appended (2E,6Z)-farnesol (48).  (Procedure adapted from: Beszant, 
S.; Giannini, E.; Zanoni, G.; Vidari, G. Tetrahedron: Asymmetry 2002, 13, 1245).  
1,2-Dibromoethane (~0.01 mL) was added to a suspension of finely divided 
magnesium turnings (activated with an acidic rinse and thoroughly flame dried; 0.061 
g, 2.5 mmol, 2.0 equiv) in Et2O (4 mL) at 25 °C.  After 10 min at 25 °C, 
chloromethyltrimethylsilane (0.260 mL, 1.86 mmol, 1.50 equiv) was added dropwise.  
The resultant grignard solution was stirred vigorously for 30 min at 35 °C, then 
syringed into a suspension of Ni(acac)2 (0.032 g, 0.12 mmol, 0.10 equiv) in Et2O (4 
mL) at 0 °C.  After 5 min at 0 °C, a solution of 47 (0.500 g, 1.24 mmol, 1.00 equiv) in 
Et2O (2 mL) was added and the resultant solution was stirred for 10 min at 0 °C.  
Upon completion, the reaction contents were quenched by the addition of aqueous 1 
M HCl (10 mL) and extracted with hexanes:EtOAc (2:1, 3 × 10 mL).  The combined 
organic layers were washed with saturated aqueous sodium bicarbonate (15 mL) and 
brine (15 mL), dried (MgSO4), filtered, and concentrated to afford the desired ester, 
which was taken forward without additional purification.  Next, a solution of the ester 
(1.24 mmol assumed) in Et2O (2 mL) was added dropwise into a suspension of 
LiAlH4 (0.028 g, 0.74 mmol, 0.60 equiv) in Et2O (2 mL) at 0 °C.  The resultant 
reaction mixture was heated to 35 °C for 3 h, then allowed to cool to 25 °C and 
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quenched by the careful addition of saturated aqueous ammonium chloride (1 mL).  
An aqueous 1 M solution of sodium/potassium tartrate (10 mL) was added and the 
biphasic mixture was stirred vigorously at 25 °C for 1 h, then extracted with Et2O (4 
× 15 mL).  The combined organic layers were washed with brine (30 mL), dried 
(MgSO4), filtered, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 4:1) to afford 48 (0.229 g, contaminated with a small amount 
of an undesired byproduct, ~60% yield over 2 steps) as a colorless viscous oil.  48: Rf 
= 0.3 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 5.29 (t, J = 7.2 
Hz, 1 H), 5.15 – 5.06 (m, 2 H), 4.08 (t, J = 6.0 Hz, 2 H), 2.18 – 1.92 (m, 8 H), 1.69 (s, 
6 H), 1.61 (s, 3 H), 1.09 (t, J = 5.6 Hz, 1 H), 0.02 (s, 9 H). 
 
Silylated Cyclization Precursor (49). Phosphorous tribromide (0.16 mL, 1.7 
mmol, 1.0 equiv) was added dropwise to a solution of 48 (0.10 g, 0.34 mmol, 1.0 
equiv) in Et2O (6 mL) at –78 °C.  The resultant solution was allowed to warm slowly 
to 0 °C over the course of 1 h.  Upon completion, the reaction mixture was quenched 
by the addition of ice-cold water (10 mL) and extracted with hexanes (3 × 10 mL).  
The combined organic layers were washed with saturated aqueous sodium 
bicarbonate (20 mL) and brine (20 mL), dried (MgSO4), filtered, and concentrated 
[Note: by 1H NMR, this crude material was mostly a 2:1 mixture of the desired 
primary bromide and the undesired teriary bromide (SN2’ product)].  Next, a solution 
of n-BuLi (0.22 mL, 2.2 M in hexanes, 0.48 mmol, 1.5 equiv) was added dropwise to 
a solution of 31 (0.18 g, 0.52 mmol, 1.7 equiv) in THF (6 mL) at –78 °C.  The 
resultant solution was stirred for 10 min at –78 °C, then quickly cannulated into a 
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solution of previously synthesized bromide (0.34 mmol assumed) in THF (3 mL) at –
40 °C.  The reaction mixture was then allowed to warm slowly to 5 °C over the 
course of 90 min, at which time the reaction contents were quenched by the addition 
of 10% aqueous ammonium chloride (10 mL) and extracted with hexanes:EtOAc 
(1:1, 3 × 10 mL).  The combined organic layers were washed with brine (15 mL), 
dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 1:0 → 4:1) to afford 49 (0.084 g, contaminated with a 
minor impurity, 52% yield over 2 steps) as a light yellow viscous oil.  48: Rf = 0.5 
(silica gel, hexanes:EtOAc, 2:1); 1H NMR (400 MHz, CDCl3) δ 7.21 (s, 1 H), 6.94 (s, 
1 H), 6.12 (s, 1 H), 5.18 – 5.04 (m, 7 H), 4.18 – 3.96 (m, 4 H), 3.48 (s, 3 H), 3.47 (s, 3 
H), 3.26 (d, J = 6.8 Hz, 2 H), 2.15 – 1.92 (m, 8 H), 1.67 (s, 6 H), 1.59 (s, 3 H), 0.05 
(s, 9 H) [Note: the attached 1H NMR spectrum is from a crude batch of 48, since a 
spectrum of the purified compound could not be located]. 
 
Eliminated Decalins 50/51.  A cold solution of BDSB (0.033 g, 0.060 mmol, 
1.1 equiv) in MeNO2 (1 mL) was added quickly via syringe to a solution of 49 (0.030 
g, 0.055 mmol, 1.0 equiv) in MeNO2 (5 mL) at –25 °C.  After 2 min at –25 °C, the 
reaction mixture was quenched by the addition of 5% aqueous sodium bicarbonate 
and 5% aqueous sodium sulfite (1:1, 10 mL).  The resultant biphasic mixture was 
stirred vigorously at 25 °C for 5 min, then extracted with CH2Cl2 (3 × 5 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
preparatory TLC (silica gel, CH2Cl2, run up 2×) to afford 50 (8 mg, ~30% yield) and 
51 (3 mg, ~10% yield), both in conjunction with other impurities and as colorless 
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amorphous solids.  50: Rf = 0.1 (silica gel, CH2Cl2); 1H NMR (400 MHz, CDCl3, 
selected peaks only) δ 10.42 (s, 1 H), 7.50 (s, 1 H), 7.06 (s, 1 H), 5.23 – 5.15 (m, 4 
H), 4.32 (dd, J = 9.6, 6.0 Hz, 1 H), 3.52 (s, 3 H), 3.48 (s, 3 H), 3.38 – 3.24 (m, 2 H), 
1.71 (s, 3 H).  51: Rf = 0.2 (silica gel, CH2Cl2); 1H NMR (400 MHz, CDCl3, selected 
peaks only) δ 10.73 (s, 1 H), 9.82 (s, 1 H), 7.27 (s, 1 H), 6.80 (s, 1 H), 4.31 (dd, J = 
9.6 Hz, 6.0 Hz, 1 H), 3.51 (s, 3 H), 3.31 (d, J = 7.6 Hz, 2 H), 1.71 (s, 3 H). 
 
(2E,6Z)-Farnesyl Acetate (52).  Ac2O (0.111 mL, 1.17 mmol, 1.30 equiv) 
was added dropwise to a solution of 24 (0.200 g, 0.899 mmol, 1.00 equiv), DMAP (2 
mg, 0.02 mmol, 0.02 equiv), and Et3N (0.187 mL, 1.35 mmol, 1.50 equiv) in CH2Cl2 
(3 mL) at 0 °C.  After 30 min at 0 °C, the reaction contents were quenched by the 
addition of water (10 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined 
organic layers were washed with 1 M HCl (10 mL; back-extracted with 3 mL 
CH2Cl2), saturated aqueous sodium bicarbonate (10 mL; back-extracted with 3 mL 
CH2Cl2), and brine (10 mL; back-extracted with 3 mL CH2Cl2).  The combined 
organic layers were then dried (MgSO4), filtered, concentrated, and pushed through a 
silica gel plug with hexanes:EtOAc (4:1, 50 mL) to afford 52 (0.233 g, 98% yield) as 
a light yellow viscous oil.  52: Rf = 0.53 (silica gel, hexanes:EtOAc, 4:1); IR (film) 
νmax 2965, 2926, 2856, 1742, 1447, 1378, 1365, 1232, 1023 cm–1; 1H NMR (400 
MHz, CDCl3) δ 5.34 (tt, J = 7.2, 1.2 Hz, 1 H), 5.14 – 5.07 (m, 2 H), 4.59 (d, J = 7.2 
Hz, 2 H), 2.15 – 1.98 (m, 8 H), 2.05 (s, 3 H), 1.70 (s, 3 H), 1.69 (s, 6 H), 1.61 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 171.2, 142.4, 135.7, 131.7, 124.6, 124.4, 118.4, 
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61.5, 39.9, 32.1, 26.7, 26.2, 25.8, 23.5, 21.2, 17.8, 16.6; HRMS (EI) calcd for 
C17H28O2 [M]+ 264.2089, found 264.2083. 
 
Bicyclic Acetate 53.  A cold solution of BDSB (0.228 g, 0.420 mmol, 1.10 
equiv) in nitromethane (1 mL) was syringed quickly into a solution of 52 (0.100 g, 
0.380 mmol, 1.00 equiv) in nitromethane (37 mL) at 0 °C.  After 30 s at 0 °C, the 
reaction mixture was quenched by the sequential addition of 5% aqueous sodium 
sulfite (20 mL) and saturated aqueous sodium bicarbonate (20 mL).  The resultant 
biphasic mixture was stirred vigorously for 1 h at 25 °C, poured into brine (40 mL), 
and extracted with EtOAc (3 × 50 mL).  The combined organic layers were washed 
with brine (50 mL), dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 9:1 → 3:2) to afford 53 (0.058 g, 
41% yield) as a colorless amorphous solid composed of a 4:1 mixture of inseparable 
diastereomers (the minor diastereomer was later determined to be 68).  Analytically 
pure 53 could be obtained by hydrolysis and monoacetylation of cyclic carbonate 60.  
53: Rf = 0.21 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 3431 (br), 2970, 2930, 
2873, 1734, 1367, 1244, 1028 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.35 (dd, J = 12.0, 
4.0 Hz, 1 H), 4.24 (dd, J = 12.4, 6.4 Hz, 1 H), 4.17 (dd, J = 12.8, 4.4 Hz, 1 H), 2.67 
(s, 1 H), 2.19 (dq, J = 13.2, 4.0 Hz, 1 H), 2.07 (m, 1 H), 2.06 (s, 3 H), 1.90 – 1.77 (m, 
2 H), 1.70 – 1.59 (m, 2 H), 1.45 – 1.33 (m, 2 H), 1.32 – 1.19 (m, 2 H), 1.30 (s, 3 H), 
1.29 (s, 3 H), 1.24 (s, 3 H), 1.11 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 171.0, 72.0, 
64.1, 63.5, 56.9, 56.0, 42.1, 40.1, 39.8, 32.6, 31.6, 29.8, 28.6, 28.0, 24.5, 22.9, 21.4; 
HRMS (FAB) calcd for C17H30BrO3 [M+H]+ 361.1378, found 361.1396.  
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Bicyclic Alkene 54.  A solution of thionyl chloride (0.054 mL, 0.75 mmol, 
2.0 equiv) in CH2Cl2 (0.7 mL) was added dropwise very slowly to a solution of 53 
(0.135 g, 0.374 mmol, 1.00 equiv) and Et3N (0.31 mL, 2.2 mmol, 6.0 equiv) in 
CH2Cl2 (3 mL) at –78 °C.  After 30 min at – 78 °C, the reaction mixture was removed 
from the cold bath and a solution of sodium methoxide (0.20 g, 3.7 mmol, 10 equiv) 
in MeOH (3.7 mL) was added.  After an additional 1.5 h at 25 °C, the reaction 
mixture was quenched by the addition of cold aqueous 1 M HCl (20 mL) and 
extracted with CH2Cl2 (3 × 15 mL).  The combined organic layers were washed with 
saturated aqueous sodium bicarbonate (15 mL), dried (MgSO4), filtered, and 
concentrated to afford crude bicycle 54 (0.115 g, still contaminated with small 
amounts of a minor isomer presumably derived from the minor isomer of 53 (68), 
~80% yield) as a colorless amorphous solid.  54: Rf = 0.3 (silica gel, hexanes:EtOAc, 
4:1); 1H NMR (400 MHz, CDCl3) δ 4.99 (s, 1 H), 4.66 (s, 1 H), 4.20 (dd, J = 12.8, 4.4 
Hz, 1 H), 3.88 (m, 1 H), 3.75 (m, 1 H), 2.36 (m, 1 H), 2.21 – 1.87 (m, 5 H), 1.62 – 
1.46 (m, 3 H), 1.36 (m, 1 H), 1.34 (s, 3 H), 1.32 (s, 3 H), 1.07 (s, 3 H).   
 
Bicyclic Aldehyde 55.  Dess-Martin periodinane (0.237 g, 0.561 mmol, 1.50 
equiv) was added in a single portion to a solution of 54 (0.115 g, 0.374 mmol 
assumed, 1.0 mmol) buffered with sodium bicarbonate (0.16 g, 1.9 mmol, 5.0 equiv) 
in CH2Cl2 (4 mL) at 0 °C.  After 45 min at 0 °C, the reaction mixture was quenched 
by the addition of 5% aqueous sodium sulfite (10 mL) and saturated aqueous sodium 
bicarbonate (10 mL).  The crude product was extracted into CH2Cl2 (3 × 15 mL) and 
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the combined organic layers were dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 19:1) to afford 55 
(0.078 g, still contaminated with a minor diastereomer, presumably derived from the 
same in 54, ~80% yield) as a light yellow amorphous solid [Note: analytically pure 
55 could be obtained from hydrolysis, oxidation, and elimination of carbonate 60].  
55: Rf = 0.47 (silica gel, hexanes:EtOAc, 9:1); IR (film) νmax 2966, 2934, 2869, 1720, 
1454, 1393, 895 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.87 (d, J = 4.8 Hz, 1 H), 4.94 
(s, 1 H), 4.46 (s, 1 H), 4.27 (dd, J = 12.4, 4.8 Hz, 1 H), 2.69 (m, 1 H), 2.38 – 2.10 (m, 
3 H), 2.06 – 1.90 (m, 3 H), 1.62 (m, 1 H), 1.55 – 1.45 (m, 2 H), 1.31 (s, 3 H), 1.27 (s, 
3 H), 1.08 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 204.7, 144.5, 109.1, 65.4, 63.3, 
54.3, 40.5, 40.4, 36.6, 31.9, 31.5, 29.3, 28.5, 28.0, 26.7; HRMS (EI) calcd for 
C15H23BrO [M]+ 298.0932, found 298.0930. 
 
Benzylic Alcohol 56.  A solution of n-BuLi (0.197 mL, 1.4 M in hexanes, 
0.28 mmol, 1.1 equiv) was added dropwise to a solution of 20 (0.107 g, 0.301 mmol, 
1.20 equiv) in THF (6 mL) at –78 °C.  After 15 min at –78 °C, the resultant 
aryllithium solution was syringed quickly into a solution of aldehyde 55 (0.075 g, 
0.25 mmol, 1.0 equiv) in THF (3 mL) at –78 °C.  After 10 min at –78 °C, the reaction 
mixture was quenched by the addition of 10% aqueous ammonium chloride (10 mL) 
and extracted with EtOAc (3 × 15 mL).  The combined organic layers were washed 
with brine (20 mL), dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 1:0 → 4:1) to afford 56 (0.092 g, 
63% yield) as a colorless amorphous solid composed of a 2.2:1 mixture of inseparable 
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alcohol diastereomers. 56: Rf = 0.3 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (400 
MHz, CDCl3) Major Diastereomer (selected peaks only): δ 4.53 (s, 1 H), 4.39 (s, 1 
H), 4.25 (dd, J = 12.0, 4.4 Hz, 1 H), 3.50 (s, 3 H), 3.49 (s, 3 H), 2.49 (d, J = 8.8 Hz, 1 
H), 1.39 (s, 3 H), 1.28 (s, 3 H), 1.07 (s, 3 H); Minor Diastereomer (selected peaks 
only): δ 5.49 (t, J = 3.6 Hz, 1 H), 4.93 (s, 1 H), 4.87 (s, 1 H), 4.28 (dd, J = 12.0, 4.4 
Hz, 1 H), 3.51 (s, 3 H), 3.47 (s, 3 H), 1.41 (s, 3 H), 1.34 (s, 3 H), 1.08 (s, 3 H). 
 
Benzylated Decalin 57.  TFA (0.057 mL, 0.75 mmol, 5.0 equiv) was added 
dropwise to a solution 56 (0.086 g, 0.15 mmol, 1.0 equiv) and Et3SiH (0.24 mL, 1.5 
mmol, 10 equiv) in CH2Cl2 (1.5 mL) at 0 °C.  After 2 h at 0 °C, the reaction mixture 
was quenched by the careful addition of saturated aqueous sodium bicarbonate (5 
mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:CH2Cl2, 1:0 → 1:1) to afford 57 (0.042 g, 50% yield) as a colorless 
amorphous solid.  57: Rf = 0.52 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2953, 
2932, 2855, 1488, 1151, 1081, 995 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.24 (s, 1 H), 
6.93 (s, 1 H), 5.13 (s, 2 H), 5.11 (d, J = 1.6 Hz, 2 H), 4.81 (s, 1 H), 4.62 (s, 1 H), 4.26 
(dd, J = 12.8, 4.8 Hz, 1 H), 3.51 (s, 3 H), 3.48 (s, 3 H), 2.79 (m, 1 H), 2.68 (m, 1 H), 
2.32 – 2.06 (m, 4 H), 1.98 (dq, J = 12.8, 4.0 Hz, 1 H), 1.85 (dt, J = 4.0, 12.8 Hz, 1 H), 
1.70 – 1.57 (m, 2 H), 1.41 (s, 3 H), 1.38 (m, 1 H), 1.36 (s, 3 H), 1.26 (m, 1 H), 1.09 
(s, 3 H); 13C NMR (100 MHz, CDCl3) δ 150.9, 148.5, 147.6, 131.8, 119.0, 118.9, 
110.1, 107.9, 96.4, 95.2, 64.9, 56.5, 56.3, 55.5, 53.5, 41.8, 40.4, 37.9, 32.3, 31.9, 28.8 
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(2 C), 28.6, 27.1, 25.1; HRMS (FAB) calcd for C25H36Br2O4 [M]+ 558.0980, found 
558.0983. 
 
Protected Purported Peyssonol A (58).  A solution of n-BuLi (0.043 mL, 1.4 
M in hexanes, 0.060 mmol, 1.1 equiv) was syringed dropwise into a solution of 57 
(0.028 g, 0.050 mmol, 1.0 equiv) in THF (1 mL) at –78 °C.  After 15 min at –78 °C, 
DMF (0.019 mL, 0.25 mmol, 5.0 equiv) was added dropwise.  After an additional 20 
min at –78 °C, the reaction mixture was quenched by the addition of 10% aqueous 
ammonium chloride (5 mL) and extracted with EtOAc (3 × 5 mL).  The combined 
organic layers were washed with brine, dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:0→2:1) to 
afford 58 (0.014 g, contaminated with small amounts of undesired byproducts, ~50% 
yield) as a light yellow amorphous solid.  58: Rf = 0.5 (silica gel, hexanes:EtOAc, 
2:1); 1H NMR (400 MHz, CDCl3, selected peaks only) δ 10.36 (s, 1 H), 7.45 (s, 1 H), 
7.01 (s, 1 H), 5.23 – 5.23 (m, 4 H), 4.82 (s, 1 H), 4.60 (s, 1 H), 4.26 (dd, J = 12.8, 4.4 
Hz, 1 H), 3.49 (s, 3 H), 3.48 (s, 3 H), 2.93 – 2.74 (m, 2 H), 1.43 (s, 3 H), 1.37 (s, 3 H), 
1.09 (s, 3 H).  
 
Boc-Protected (2E,6Z)-Farnesol (59).  A solution of n-BuLi (0.733 mL, 1.5 
M in hexanes, 1.1 mmol, 1.1 equiv) was added dropwise to a solution of (2E,6Z)-
farnesol (0.222 g, 1.00 mmol, 1.00 equiv) in THF (4 mL) at –78 °C.  After 10 min at 
–78 °C, a solution of Boc2O (0.240 g, 1.10 mmol, 1.10 equiv) in THF (1 mL) was 
added slowly.  Upon completion of this addition, the reaction flask was removed from 
 252 
the cold bath and the reaction contents were stirred for 30 min at 25 °C, then 
quenched by the careful addition of water (5 mL).  This heterogeneous mixture was 
poured into aqueous 1 M HCl (5 mL), and extracted with EtOAc (3 × 10 mL).  The 
combined organic layers were washed with saturated aqueous sodium bicarbonate (2 
× 10 mL) and brine (10 mL), dried (MgSO4), filtered, and concentrated.  Purification 
by flash column chromatography (silica gel, hexanes:EtOAc, 19:1) afforded 59 
(0.300 g, 93% yield) as a colorless viscous oil.  59: Rf  = 0.63 (silica gel, 
hexanes:EtOAc, 4:1); IR (film) νmax 2967, 2930, 2857, 1740, 1277, 1254, 1166 cm–1; 
1H NMR (400 MHz, CDCl3) δ 5.36 (tq, J = 7.2, 1.2 Hz, 1 H), 5.13 – 5.06 (m, 2 H), 
4.58 (d, J = 7.2 Hz, 2 H), 2.13 – 1.98 (m, 8 H), 1.70 (s, 3 H), 1.68 (s, 6 H), 1.60 (s, 3 
H), 1.48 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 153.8, 142.6, 135.7, 131.7, 124.6, 
124.4, 118.2, 81.9, 63.9, 40.0, 32.1, 27.9 (3 C), 26.7, 26.2, 25.8, 23.5, 17.8, 16.6; 
HRMS (FAB) calcd for C20H33O3 [M-H]+ 321.2430, found 321.2418. 
 
Tricyclic Carbonate 60.  A cold solution of BDSB (0.19 g, 0.34 mmol, 1.1 
equiv) in nitromethane (1 mL) was syringed rapidly into a solution of 59 (0.100 g, 
0.31 mmol, 1.0 equiv) in nitromethane (30 mL) at –25 °C.  Once the addition was 
complete, the reaction mixture was removed from the cold bath and stirred at 25 °C 
for 15 min, then quenched by the sequential addition of 5% aqueous sodium sulfite 
(20 mL) and saturated aqueous sodium bicarbonate (20 mL).  The resultant biphasic 
mixture was stirred vigorously for 1 h at 25 °C, then poured into brine (40 mL) and 
extracted with EtOAc (3 × 50 mL).  The combined organic layers were washed with 
brine (50 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
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chromatography (silica gel, hexanes:EtOAc, 9:1→1:1) to afford 60 (0.036 g, 
contaminated with a small amount of an unidentified impurity presumed to be a 
diastereomer, see 53).  Analytically pure 60 (0.028 g, 26% yield) was provided by 
recrystallization from boiling Et2O.  60: Rf = 0.50 (silica gel, hexanes:EtOAc, 2:3); IR 
(film) νmax 2973, 2938, 2873, 1747, 1223, 1120, 1079 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 4.53 (dd, J = 10.8, 5.6 Hz, 1 H), 4.32 (dd, J = 12.8, 10.8 Hz, 1 H), 4.13 (dd, 
J = 12.4, 4.8 Hz, 1 H), 2.25 – 1.95 (m, 5 H), 1.69 (dt, J = 4.4, 13.2 Hz, 1 H), 1.63 – 
1.47 (m, 2 H), 1.49 (s, 3 H), 1.38 (m, 1 H), 1.31 (s, 3 H), 1.29 (s, 3 H), 1.15 (m, 1 H), 
1.11 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 149.0, 81.2, 67.4, 62.6, 54.7, 49.0, 39.9, 
38.4, 38.1, 32.1, 31.2, 29.6, 28.3, 28.1, 22.5, 21.2; HRMS (FAB) calcd for 
C16H26BrO3 [M+H]+ 345.1065, found 345.1073. 
 
Ethyl (2Z,6Z)-Farnesate (62).  Obtained as a byproduct (1.20 g, 13% yield) 
from the HWE olefination of 30 during the synthesis of 24. 
 
(2Z,6Z)-Farnesyl Acetate (63).  A solution of 62 (0.470 g, 1.78 mmol, 1.00 
equiv) in Et2O (3 mL) was syringed slowly into a suspension of LiAlH4 (0.068 g, 1.8 
mmol, 1.0 equiv) in Et2O (7 mL) at –78 °C.  The reaction mixture was allowed to 
warm to 0 °C over the course of 90 min, then quenched by the careful addition of 
10% aqueous ammonium chloride (1 mL).  An aqueous solution of 1 M 
sodium/potassium tartrate (20 mL) was added to the reaction contents and the 
resultant biphasic mixture was stirred vigorously for 12 h at 25 °C, then extracted 
with Et2O (4 × 15 mL).  The combined organic layers were washed with brine (20 
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mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1) to afford (2Z,6Z)-farnesol (0.320 g, 
81% yield) as a light yellow oil.  Acetylation was effected following the same 
procedure used to access 52, affording 63 (0.112 g, 95% yield) as a light yellow 
viscous oil.  63: Rf = 0.57 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2966, 2930, 
2858, 1741, 1447, 1377, 1233, 1023 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.35 (t, J = 
7.2 Hz, 1 H), 5.13 – 5.06 (m, 2 H), 4.54 (d, J = 7.2 Hz, 2 H), 2.14 – 1.98 (m, 11 H), 
1.75 (s, 3 H), 1.67 (s, 6 H), 1.59 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 171.1, 142.6, 
136.0, 131.6, 124.4 (2 C), 119.3, 61.2, 32.5, 32.1, 26.7, 26.5, 25.8, 23.6, 23.4, 21.1, 
17.7; HRMS (FAB) calcd for C17H28O2 [M]+ 264.2089, found 264.2092. 
 
Bicyclic Aldehyde 64.  A cold solution of BDSB (0.22 g, 0.42 mmol, 1.1 
equiv) in nitromethane (1 mL) was syringed rapidly into a solution of 63 (0.100 g, 
0.38 mmol, 1.0 equiv) in nitromethane (37 mL) at 0 °C.  After 30 s at 0 °C, the 
reaction mixture was quenched by the sequential addition of 5% aqueous sodium 
sulfite (20 mL) and saturated aqueous sodium bicarbonate (20 mL).  The resultant 
biphasic mixture was stirred vigorously for 1 h at 25 °C, then poured into brine (40 
mL) and extracted with EtOAc (3 × 50 mL).  The combined organic layers were 
washed with brine (50 mL), dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 3:1) to afford 64 
(0.028 g, 20% yield) as a white crystalline solid.  Next, elimination/acetate 
methanolysis and DMP oxidation were carried out following the same procedure used 
to access 54 and 55, affording 64 (7.0 mg, contaminated with a small amount of a 
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minor byproduct, ~25% yield over 2 steps) as a colorless amorphous solid.  64: Rf = 
0.5 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 9.73 (d, J = 3.2 
Hz, 1 H), 4.96 (app t, 1 H), 4.79 (app t, 1 H), 4.26 (dd, J = 12.0, 4.8 Hz, 1 H), 2.72 (d, 
J = 3.2 Hz, 1 H), 2.32 – 1.93 (m, 7 H), 1.81 (td, J = 13.2, 4.0 Hz, 1 H), 1.48 (m, 1 H), 
1.27 (s, 3 H), 1.26 (s, 3 H), 1.10 (s, 3 H). 
 
Benzylic Alcohol 65.  Synthesized following the same procedure used to 
access 56.  In this case, the diastereomeric products (less polar diastereomer: 15 mg, 
33% yield; more polar diastereomer: 13 mg, 28% yield) were separable by flash 
column chromatography.  65: Less Polar Diastereomer: Rf = 0.3 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 7.23 (s, 1 H), 7.14 (s, 1 H), 5.55 
(t, J = 4.0 Hz, 1 H),  5.18 – 5.10 (m, 4 H), 4.54 (s, 1 H), 4.34 (dd, J = 12.8, 4.8 Hz, 1 
H), 3.93 (s, 1 H), 3.50 (s, 3 H), 3.47 (s, 3 H), 2.55 (td, J = 13.2, 5.6 Hz, 1 H), 2.31 
(qd, J = 13.2, 4.4 Hz, 1 H), 2.24 – 1.77 (m, 8 H), 1.43 (m, 1 H), 1.42 (s, 3 H), 1.30 (s, 
3 H), 1.08 (s, 3 H); More Polar Diastereomer: Rf = 0.25 (silica gel, hexanes:EtOAc, 
4:1); 1H NMR (400 MHz, CDCl3) δ 7.28 (s, 1 H), 7.05 (s, 1 H), 5.19 – 5.12 (m, 4 H), 
5.06 (t, J = 7.2 Hz, 1 H), 4.49 (s, 1 H), 4.44 (m, 1 H), 4.28 (dd, J = 12.8, 4.8 Hz, 1 H), 
3.51 (s, 3 H), 3.50 (s, 3 H), 2.42 (d, J = 7.2 Hz, 1 H), 2.38 – 2.21 (m, 2 H), 2.06 (m, 1 
H), 1.98 – 1.68 (m, 5 H), 1.47 (s, 3 H), 1.38 (m, 1 H), 1.32 (s, 3 H), 1.08 (s, 3 H). 
 
Peyssonol A Diastereomer 66.  The benzylic alcohols (65) were reduced 
separately as follows: TFA (0.010 mL, 0.13 mmol, 5.0 equiv) was added dropwise to 
a solution of the less polar diastereomer of 65 (0.015 g, 0.026 mmol, 1.0 equiv) and 
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Et3SiH (0.041 mL, 0.26 mmol, 10 equiv) in CH2Cl2 (0.5 mL) at 0 °C.  After 1 h at 0 
°C, the reaction mixture was quenched by the careful addition of saturated aqueous 
sodium bicarbonate (5 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined 
organic layers were dried (MgSO4), filtered, and concentrated.  Separately, TFA 
(0.018 mL, 0.23 mmol, 10 equiv) was added dropwise to a solution of the more polar 
diastereomer of 65 (0.013 g, 0.023 mmol, 1.0 equiv) and Et3SiH (0.37 mL, 0.23 
mmol, 10 equiv) in CH2Cl2 (0.5 mL) at 0 °C.  After 90 min at 0 °C, the reaction 
mixture was quenched by the careful addition of saturated aqueous sodium 
bicarbonate (5 mL) and extracted into CH2Cl2 (3 × 5 mL).  The combined organic 
layers were dried (MgSO4), filtered, and concentrated.  Combination of the two crude 
products and purification by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0→1:1) afforded the desired deoxygenated product (0.012 g, 44% 
yield) as a colorless amorphous solid.  Next, a solution of n-BuLi (0.016 mL, 1.6 M 
in hexanes, 0.026 mmol, 1.2 equiv) was added dropwise into a solution of the 
deoxygenated product (0.012 g, 0.021 mmol, 1.0 equiv) in THF (1 mL) at –78 °C.  
After 15 min at –78 °C, a solution of DMF (0.008 mL, 0.1 mmol, 5 equiv) in THF 
(0.1 mL) was added slowly.  After an additional 15 min at –78 °C, aqueous 12 M HCl 
(0.1 mL, final solution ~1 M in HCl) was added to the reaction mixture, and the 
reaction flask was heated to 40 °C.  After 90 min at 40 °C, the reaction mixture was 
quenched by the addition of water (5 mL) and extracted with EtOAc (3 × 5 mL).  The 
combined organic layers were washed with brine (5 mL), dried (MgSO4), filtered, 
concentrated, and purified by preparative TLC (silica gel, hexanes:EtOAc, 7:3) to 
afford 66 (5.2 mg, 58% yield) as a light yellow powder.  For a comparison of NMR 
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shifts of this compound with the natural product, see table on pg 268.  66: Rf = 0.34 
(silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 3381 (br), 2964, 2926, 2872, 1652, 
1633, 1381, 1228, 866 cm–1; 1H NMR (400 MHz, C6D6) δ 11.14 (s, 1 H), 9.24 (s, 1 
H), 6.70 (s, 1 H), 5.74 (s, 1 H), 4.51 (t, J = 2.0 Hz, 1 H), 4.24 (s, 1 H), 3.97 (dd, J = 
12.4, 4.8 Hz, 1 H), 3.76 (s, 1 H), 2.80 (dd, J = 13.2, 4.0 Hz, 1 H), 2.39 (dd, J = 13.2, 
11.6 Hz, 1 H), 2.16 (dq, J = 4.0, 13.2 Hz, 1 H), 2.05 – 1.85 (m, 3 H), 1.78 (m, 1 H), 
1.59 (dt, J = 4.0, 13.6 Hz, 1 H), 1.48 – 1.32 (m, 2 H), 1.21 (s, 3 H), 1.06 (s, 3 H), 0.97 
(s, 3 H), 0.91 (dd, J = 12.8, 5.2 Hz, 1 H), 0.64 (m, 1 H); 13C NMR (100 MHz, C6D6) δ 
195.0, 156.4, 147.2, 146.9, 140.3, 119.9, 118.9, 117.3, 110.0, 64.3, 57.7, 48.2, 39.7, 
38.8, 34.4, 32.3, 31.5, 30.3, 29.3, 28.3, 27.8, 25.8; HRMS (FAB) calcd for 
C22H29BrO3 [M]+ 420.1300, found 420.1315. 
 
Bicyclic Acetate 68.  Acetylation of commercially available (2E,6E)-farnesol 
was carried out following the same procedure used to access 52, affording (2E,6E)-
farnesyl acetate (0.111 g, 94% yield) as a colorless viscous oil.  BDSB-induced 
cyclization was carried out following the same procedure used to access 53, affording 
68 (0.058 g, 43% yield) as a white crystalline solid [Note: this reaction also afforded 
significant amounts of diastereomer 74 (0.036 g, 26% yield), which would arise if the 
second ring forms as a boat during the cyclization].  68: Rf = 0.27 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 3459 (br), 2971, 2946, 2875, 1735, 1391, 1369, 
1244, 1031 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.35 (dd, J = 12.0, 4.0 Hz, 1 H), 4.17 
(dd, J = 11.6, 5.6 Hz, 1 H), 3.98 (dd, J = 12.4, 4.4 Hz, 1 H), 2.36 (br s, 1 H), 2.18 (dq, 
J = 3.6, 12.8 Hz, 1 H), 2.09 (m, 1 H), 2.03 (s, 3 H), 1.88 (dt, J = 12.8, 3.2 Hz, 1 H), 
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1.74 (m, 1 H), 1.68 (dt, J = 13.6, 3.6 Hz, 1 H), 1.53 – 1.31 (m, 3 H), 1.25 (dt, J = 3.6, 
13.2 Hz, 1 H), 1.16 (s, 3 H), 1.08 (s, 3 H), 1.07 (m, 1 H), 0.93 (s, 3 H), 0.90 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 171.3, 72.2, 68.6, 62.2, 59.8, 56.1, 43.9, 41.0, 39.8, 
38.2, 30.8, 30.7, 24.6, 21.9, 21.4, 18.3, 15.9; HRMS (FAB) calcd for C17H30BrO3 
[M+H]+ 361.1378, found 361.1376. [Note: The stereochemistry at the alcohol 
position was originally ambiguous. However, NOE analysis of 68 showed cross peaks 
between the hydroxyl hydrogen and the α-H at C-9 as well as between the axial β-H 
at C-6 and the axial methyl groups appended to C-4, C-8, and C-10 (steroid 
numbering conventions).  This strongly suggested that the methyl group was in the 
axial β-position at C-8].  
 
Benzylic Alcohol 69.  Elimination/methanolysis and DMP oxidation of 68 
were carried out following the same procedure used to access 55, affording the 
requisite bicyclic aldehyde (0.030 g, 71% yield over 2 steps) as a colorless 
amorphous solid.  Arylation of this aldehyde was carried out following the same 
procedure used to access 56, affording two inseparable diastereomers (1.1:1 dr) of 69 
(0.053 g, 92% yield) as a colorless amorphous solid.  69: Rf = 0.3 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) Major Diastereomer (selected 
peaks only): δ 5.22 (dd, J = 8.4, 5.2 Hz, 1 H), 4.66 (s, 1 H), 4.19 (s, 1 H), 4.06 (dd, J 
= 12.8, 4.4 Hz, 1 H), 3.50 (s, 3 H), 3.49 (s, 3 H); Minor Diastereomer (selected peaks 
only): δ 5.38 (t, J = 4.0 Hz, 1 H), 5.09 (s, 1 H), 4.95 (s, 1 H), 3.99 (dd, J = 12.8 Hz, 
4.0 Hz, 1 H), 3.51 (s, 3 H), 3.48 (s, 3H). 
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Peyssonol A Diastereomer 70.  TFA (0.039 mL, 0.50 mmol, 5.0 equiv) was 
added dropwise to a solution of 69 (0.058 g, 0.10 mmol, 1.0 equiv) and Et3SiH (0.161 
mL, 1.01 mmol, 10 equiv) in CH2Cl2 (1 mL) under argon at 0 °C.  After 2.5 h at 0 °C, 
the reaction contents were quenched by the careful addition of saturated aqueous 
sodium bicarbonate (5 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 1:1) to afford the desired 
deoxygenated product (0.030 g, 54% yield) as a colorless amorphous solid.  
Subsequently, formylation and deprotection were carried out following the same 
procedures used for the synthesis of 58 and 21 to afford 70 (0.014 g, 62% yield over 2 
steps).  For a comparison of NMR shifts of this compound with the natural product, 
see table on pg 268.  70: Rf = 0.40 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 
3403 (br), 2971, 2945, 2849, 1643, 1348, 1173, 1156 cm–1; 1H NMR (400 MHz, 
C6D6) δ 11.13 (s, 1 H), 9.24 (s, 1 H), 6.85 (s, 1 H), 5.78 (s, 1 H), 4.76 (s, 1 H), 4.65 (s, 
1 H), 3.85 (s, 1 H), 3.83 (dd, J = 12.4, 4.8 Hz, 1 H), 2.73 (dd, J = 16.0, 10.8 Hz, 1 H), 
2.42 (dd, J = 16.0, 2.0 Hz, 1 H), 2.15 – 1.87 (m, 4 H), 1.67 (dt, J = 4.8, 12.8 Hz, 1 H), 
1.49 – 1.32 (m, 2 H), 1.15 (dq, J = 4.0, 12.8 Hz, 1 H), 1.01 (s, 3 H), 0.90 (s, 3 H), 
0.90 – 0.80 (m, 2 H), 0.62 (s, 3 H); 13C NMR (75 MHz, C6D6) δ 195.0, 156.6, 147.2, 
146.8, 140.7, 118.6, 118.5, 117.2, 108.6, 69.0, 55.6, 55.4, 40.2, 40.0, 39.9, 37.9, 31.9, 




Enol Phosphate 72.  (Procedure adapted from: Brown, R. C. D.; Bataille, C. 
J.; Hughes, R. M.; Kenney, A.; Luker, T. J. J. Org. Chem. 2002, 67, 8079).    Ethyl 
acetoacetate (15.2 mL, 120 mmol, 1.20 equiv) was added dropwise under constant 
flow of argon to a suspension of NaH (5.00 g, 60% in mineral oil, 125 mmol, 1.25 
equiv) in THF (260 mL) at 0 °C.  After 30 min at 0 °C, a solution of n-BuLi (83.0 
mL, 1.50 M in hexanes, 125 mmol, 1.25 equiv) was added slowly and the resultant 
light orange solution was stirred for an additional 10 min at 0 °C.  This dianion 
solution was then cannulated slowly into a solution of geranyl bromide (71, 21.7 g, 
100 mmol, 1.00 equiv) in THF (100 mL) at 0 °C.  After 15 min at 0 °C, the reaction 
mixture was quenched by the careful addition of 10% aqueous ammonium chloride 
(500 mL) and extracted with hexanes:EtOAc (1:1, 3 × 300 mL).  The combined 
organic layers were washed with brine (300 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1) to afford the desired β-ketoester (22.4 g, 84% yield) as a viscous 
yellow oil.  Next, solid KOt-Bu (10.4 g, 92.5 mmol, 1.10 equiv) was sealed under 
argon, cooled to 0 °C, and slowly dissolved in DMF (250 mL).  The newly 
synthesized β-ketoester (22.4 g, 84.1 mmol, 1.00 equiv) was then added dropwise.  
After an additional 5 min at 0 °C, diethyl chlorophosphate (15.8 mL, 109 mmol, 1.30 
equiv) was added into the reaction mixture, and the resultant heterogeneous solution 
was stirred for 15 min at 0 °C.  Upon completion, the reaction mixture was poured 
into aqueous 0.25 M HCl (500 mL) and extracted with EtOAc (3 × 200 mL).  The 
combined organic layers were washed with saturated aqueous sodium bicarbonate 
(200 mL) and brine (200 mL), dried (MgSO4), filtered, and concentrated.  The 
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resultant crude orange oil, consisting of a 3.2:1 mixture of E:Z isomers based on 1H 
NMR analysis, was purified by careful flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1 → 7:3) to afford the desired E-isomer (72, 23.5 g, 70% yield) as 
a light orange oil.  72: Rf = 0.4 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (400 MHz, 
CDCl3) δ 5.84 (d, J = 1.6 Hz, 1 H), 5.15 (t, J = 6.8 Hz, 1 H), 5.08 (t, J = 6.8 Hz, 1 H), 
4.27 – 4.11 (m, 6 H), 2.83 (t, J = 7.6 Hz, 2 H), 2.28 (q, J = 7.6 Hz, 2 H), 2.09 – 1.93 
(m, 4 H), 1.67 (s, 3 H), 1.62 (s, 3 H), 1.59 (s, 3 H), 1.37 (t, J = 7.2 Hz, 6 H), 1.26 (t, J 
= 7.2 Hz, 3 H). 
 
(2Z,6E)-Farnesol (73).  (Procedure adapted from: Sum, F.-W.; Weiler, L. 
Can. J. Chem. 1979, 57, 1431).  A solution of MeLi (1.6 M in Et2O, 62.5 mL, 100 
mmol, 2.50 equiv) was added slowly to a suspension of CuI (19.0 g, 100 mmol, 2.50 
equiv) in THF (375 mL) at 0 °C.  The resultant cloudy yellow solution was stirred for 
15 min at 0 °C, then cooled to –50 °C.  Next, a solution of MeMgCl (3.0 M in THF, 
53.3 mL, 160 mmol, 4.00 equiv) was added slowly, and the resultant cloudy pale 
yellow solution was stirred for an additional 30 min at –50 °C.  A solution of 72 (16.1 
g, 40.0 mmol, 1.00 equiv) in THF (25 mL) was then cannulated dropwise into the 
methyl cuprate solution, and the resultant mixture was stirred for 4 h at –50 °C and 
then allowed to warm slowly to –30 °C over the course of 1 h.  Upon completion, the 
reaction mixture was quenched by the careful addition of saturated aqueous 
ammonium chloride (400 mL) and the resultant slurry was stirred vigorously for 60 
min, then filtered to remove insoluble copper salts.  The filtrate was extracted with 
hexanes:EtOAc (1:1, 3 × 300 mL), and the combined organic layers were washed 
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with saturated aqueous ammonium chloride (2 × 200 mL) and brine (300 mL), dried 
(MgSO4), filtered, and concentrated to afford crude ethyl (2Z,6E)-farnesate as a along 
with a small amount of its geometric isomer (10:1).  The minor isomer was removed 
by careful flash column chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 1:1) to 
afford pure ethyl (2Z,6E)-farnesate (8.44 g, 80% yield) as a colorless viscous oil.  
Next, reduction of ethyl (2Z,6E)-farnesate was carried out according to the same 
procedure used for the synthesis of (2E,6Z)-farnesol (24), affording 73 (6.24 g, 88% 
yield) as a colorless viscous oil. 
 
Bicyclic Acetate 74.  Acetylation of 73 was carried out according to the same 
procedure used to access 52, affording (2Z,6E)-farnesyl acetate (0.107 g, 91% yield) 
as a colorless viscous oil.  Next, BDSB-induced cyclization was carried out according 
to the same procedure used to access 53, affording 74 (0.055 g, 40% yield) as a white 
crystalline solid.  74: Rf = 0.34 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 3469 
(br), 2964, 1734, 1385, 1366, 1245, 1029 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.61 
(dd, J = 12.0, 2.0 Hz, 1 H), 4.27 (dd, J = 12.0, 5.2 Hz, 1 H), 3.97 (dd, J = 12.0, 4.0 
Hz, 1 H), 2.27 (dq, J = 3.6, 13.2 Hz, 1 H) 2.17 – 2.08 (m, 2 H), 2.04 (s, 3 H), 1.75 – 
1.67 (m, 3 H), 1.46 (s, 3 H), 1.45 – 1.38 (m, 3 H), 1.35 – 1.27 (m, 2 H), 1.14 (s, 3 H), 
1.07 (s, 3 H), 0.94 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 171.5, 72.0, 68.8, 63.3, 
59.2, 48.5, 39.9, 38.6, 38.2, 37.9, 32.2, 31.1, 30.8, 24.6, 21.7, 21.4, 18.1; HRMS 
(FAB) calcd for C17H28BrO2 [M–OH]+ 343.1273, found 343.1256. 
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Bicyclic Aldehyde 75.  First Generation Synthesis: One-pot 
elimination/methanolysis and DMP oxidation of acetate 74 were carried out 
according to the procedures used to access 55, affording 75 (0.020 g, 26% yield over 
2 steps) as a colorless amorphous solid [Note: The elimination procedure for this 
diastereomer was far less selective, affording large amounts of both the 
tetrasubstituted and trisubstituted alkene isomers].  Second Generation Synthesis: 
Solid K2CO3 (0.742 g, 5.37 mmol, 3.00 equiv) was added portion-wise to a solution 
of carbonate 77 (0.618 g, 1.79 mmol, 1.00 equiv) in MeOH (50 mL) at 40 °C.  The 
resultant mixture was stirred for 3 h at 40 °C, then quenched by the addition of ice-
cold 10% aqueous ammonium chloride (40 mL) and extracted with EtOAc (4 × 50 
mL).  The combined organic layers were washed with brine (50 mL), dried (MgSO4), 
filtered, and concentrated under reduced pressure to afford the corresponding bicyclic 
diol (94) as a white crystalline solid, which was carried forward without any 
additional purification.  [Note: The diol was co-evaporated with anhydrous toluene to 
remove traces of water before being subjected to the subsequent oxidation procedure].  
Next, a solution of DMSO (0.381 mL, 5.36 mmol, 3.00 equiv) in CH2Cl2 (3 mL) was 
added dropwise to a solution of oxalyl chloride (0.233 mL, 2.68 mmol, 1.50 equiv) in 
CH2Cl2 (17 mL) at –78 °C.  After 5 min at –78 °C, a solution of the bicyclic diol 
(1.79 mmol assumed, 1.00 equiv) in a mixture of CH2Cl2 (20 mL) and DMSO (1 mL, 
to enhance solubility) was added slowly.  After an additional 5 min at –78 °C, Et3N 
(1.48 mL, 10.7 mmol, 6.00 equiv) was added slowly.  The reaction mixture was 
allowed to warm slowly from –78 °C to –40 °C over the course of 1 h, then quenched 
by the careful addition of saturated aqueous sodium bicarbonate (50 mL) and 
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extracted with CH2Cl2 (3 × 50 mL).  The combined organic layers were washed with 
water (100 mL; back-extracted with 10 mL CH2Cl2) and brine (100 mL; back-
extracted with 10 mL CH2Cl2), dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:EtOAc 7:3) to afford the desired β–
hydroxy aldehyde intermediate (0.516 g, 91% yield over 2 steps) as a white 
crystalline solid.  Next, a solution of this β–hydroxy aldehyde (0.516 g, 1.63 mmol, 
1.00 equiv) and Et3N (1.13 mL, 8.13 mmol, 5.00 equiv) in CH2Cl2 (32 mL) under N2 
gas (do not use argon!) was frozen at –196 °C in a liquid N2 bath.  A solution of 
thionyl chloride (0.177 mL, 2.44 mmol, 1.50 equiv) in CH2Cl2 (1 mL) was added 
dropwise to this frozen mixture over approximately 3 min.  The reaction flask was 
then moved to a –97 °C bath (liquid N2/CH2Cl2 slurry), where the reaction mixture 
was allowed to slowly melt/react over the course of 1 h.  The reaction flask was then 
removed from the cold bath and its contents were quenched by the addition of MeOH 
(1 mL).  Filtration through a silica gel plug (25 × 100 mm) using CH2Cl2 (150 mL) as 
eluent effected removal of ammonium salts.  Concentration of the filtrate yielded a 
solid residue that was purified directly by careful flash column chromatography 
(silica gel, hexanes:CH2Cl2, 1:0 → 2:1) to afford 75 (0.404 g, 83% yield) as a white 
crystalline solid.  75: Rf = 0.40 (silica gel, hexanes:CH2Cl2, 1:1); IR (film) νmax 2973, 
2948, 1715, 1459, 1385, 1370, 1157, 899 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.79 
(d, J = 3.2 Hz, 1 H), 4.97 (s, 1 H), 4.81 (s, 1 H), 4.02 (dd, J = 12.4, 4.0 Hz, 1 H), 2.64 
(d, J = 3.2 Hz, 1 H), 2.44 (m, 1 H), 2.31 – 2.09 (m, 3 H), 1.90 – 1.72 (m, 3 H), 1.53 
(m, 1 H), 1.41 (dt, J = 13.6, 3.6 Hz, 1 H), 1.12 (s, 3 H), 0.98 (s, 3 H), 0.96 (s, 3 H); 
13C NMR (75 MHz, CDCl3) δ 201.7, 141.3, 114.7, 70.6, 68.3, 48.5, 40.0, 39.1, 38.2, 
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33.2, 31.2, 30.8, 24.5, 21.5, 18.6; HRMS (EI) calcd for C15H23BrO [M]+ 298.0932, 
found 298.0923. 
 
Peyssonol A – Revised Structure (76).  First Generation Synthesis:  Aryl 
addition to 75 was carried out according to the procedure used to access 56, affording 
a mixture of two diastereomers of the resultant benzylic alcohol (0.037 g, 80% yield) 
as a colorless amorphous solid.  Next, TFA (0.025 mL, 0.32 mmol, 5.0 equiv) was 
added dropwise to a solution of both benzylic alcohol diastereomers (0.037 g, 0.064 
mmol, 1.0 equiv) and Et3SiH (0.10 mL, 0.64 mmol, 10 equiv) in CH2Cl2 (0.64 mL) at 
0 °C.  After 2.5 h at 0 °C, the reaction contents were quenched by the careful addition 
of saturated aqueous sodium bicarbonate (5 mL) and extracted with CH2Cl2 (3 × 5 
mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:CH2Cl2, 1:0→1:1) to 
afford the desired deoxygenated product (0.018 g, ~40% yield, contaminated with 
~30% of an unknown impurity) as a colorless amorphous solid.  Lastly, formylation 
and deprotection of this compound were carried out according to the procedures used 
to access 58 and 21, affording 76 (8 mg, ~50% yield over 2 steps) as a yellow 
crystalline solid.  Second Generation Synthesis:  Aryl addition to 75 was carried out 
following the procedure used to access 56, affording two diastereomers of the 
resultant benzylic alcohol that were separated by careful flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0 → 9:1) to afford both the less polar 
diastereomer (0.400 g, 51% yield) and the more polar diastereomer (95, 0.222 g, 29% 
yield) as colorless amorphous solids.  Next, TFA (0.267 mL, 3.47 mmol, 5.00 equiv) 
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was added dropwise to a solution of the less polar benzylic alcohol diastereomer 
(0.400 g, 0.694 mmol, 1.00 equiv) and Et3SiH (1.11 mL, 6.94 mmol, 10.0 equiv) in 
CH2Cl2 (7 mL) at 0 °C.  After 30 min at 0 °C, the reaction mixture was quenched by 
the careful addition of saturated aqueous sodium bicarbonate (20 mL) and extracted 
with CH2Cl2 (3 × 15 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated.  Separately, TFA (0.148 mL, 1.93 mmol, 5.00 equiv) was 
added dropwise to a solution of the more polar benzylic alcohol diastereomer (0.222 
g, 0.385 mmol, 1.00 equiv) and Et3SiH (0.613 mL, 3.85 mmol, 10.0 equiv) in CH2Cl2 
(4 mL) at 0 °C.  After 90 min at 0 °C, the reaction mixture was quenched by the 
careful addition of saturated aqueous sodium bicarbonate (20 mL) and extracted into 
CH2Cl2 (3 × 15 mL).  The combined organic layers were dried (MgSO4), filtered, and 
concentrated.  Combination of the two crude products and purification by flash 
column chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 1:1) afforded the desired 
deoxygenated aryl addition product (0.351 g, 58% yield) as a colorless amorphous 
solid.  Lastly, a solution of n-BuLi (0.41 mL, 1.6 M in hexanes, 0.65 mmol, 1.1 
equiv) was added dropwise to a solution of the deoxygenated aryl addition product 
(0.332 g, 0.592 mmol, 1.00 equiv) in THF (30 mL) at –78 °C.  After 15 min at –78 
°C, DMF (0.228 mL, 2.96 mmol, 5.00 equiv) was added slowly to the resultant 
solution.  After an additional 60 min at –78 °C, aqueous 12 M HCl (2.8 mL; reaction 
solution now ~1 M in HCl) was added dropwise and the reaction mixture was 
warmed slowly to 50 °C.  After 1 h at 50 °C, the resultant green solution was allowed 
to cool to 25 °C, poured into water (30 mL), and extracted with EtOAc (3 × 20 mL).  
The combined organic layers were washed with brine, dried (MgSO4), filtered, 
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concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 4:1) to afford revised peyssonol A (76, 0.192 g, 77% yield) as 
a light yellow crystalline solid.  For a comparison of NMR shifts of this compound 
with the natural product, see table on the following page.  76: Rf = 0.41 (silica gel, 
hexanes:EtOAc, 2:1); IR (film) νmax 3383 (br), 2972, 2947, 2859, 1651, 1369, 1197, 
1167 cm–1; 1H NMR (400 MHz, C6D6) δ 11.13 (s, 1 H), 9.25 (s, 1 H), 6.68 (s, 1 H), 
5.81 (s, 1 H), 4.50 (t, J = 2.0 Hz, 1 H), 4.23 (t, J = 2.0 Hz, 1 H), 3.82 (s, 1 H), 3.74 
(dd, J = 12.4, 4.0 Hz, 1 H), 2.69 (dd, J = 12.8, 4.0 Hz, 1 H), 2.33 (dd, J = 12.8 Hz, 
11.2 Hz, 1 H), 2.14 (dq, J = 3.2, 13.2 Hz, 1 H), 2.10 – 1.95 (m, 3 H), 1.88 (dd, J = 
11.2, 4.0 Hz, 1 H), 1.50 – 1.36 (m, 2 H), 1.21 – 1.12 (m, 2 H), 1.04 (s, 3 H), 0.93 (s, 3 
H), 0.92 (m, 1 H), 0.80 (s, 3 H); 13C NMR (100 MHz, C6D6) δ195.0, 156.4, 147.0, 
146.8, 140.4, 120.0, 119.0, 117.4, 111.2, 69.1, 57.6, 46.6, 39.8, 37.7, 31.7, 31.4, 30.9, 
28.9, 25.0, 22.3, 18.6; HRMS (FAB) calcd for C22H30BrO3 [M+H]+ 421.1378, found 
421.1350. 
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Comparison of 1H and 13C NMR data for peyssonol A and 4 synthetic diastereomers: 
1H 
Natural 
peyssonol A 76 21 66 70 
0.80 (s, 3H) 0.80 (s, 3H) 0.91 (s, 3H) 0.97 (s, 3H) 0.62 (s, 3H) 
0.90 (s, 3H) 0.93 (s, 3H) 0.98 (s, 3H) 1.06 (s, 3H) 0.90 (s, 3H) 
0.92 (m) 0.92 (m)    
1.05 (s, 3H) 1.04 (s, 3H) 1.24 (s, 3H) 1.21 (s, 3H) 1.01 (s, 3H) 
1.15 (m, 2H) 1.16 (m, 2H)    
1.39 (m) 1.41 (m)    
1.42 (m) 1.44 (m)    
1.85 (m) 
1.88 (dd, J = 
11.2, 4.0)    
1.89 (m) 1.95 (m)    
1.96 (m) 2.00 (m)    
2.05 (m) 2.03 (m)    
2.14 (qd, J = 
13, 3) 
2.14 (qd, J = 
13.2, 3.2)    
2.30 (t, J  = 
12) 
2.33 (dd, J = 
12.8, 11.2) 
2.49 (app d, J = 
16.0) 
2.39 (dd, J = 
13.2, 11.6) 
2.42 (dd, J = 
16.0, 2.0) 
2.70 (dd, J = 
12, 4) 
2.69 (dd, J = 
12.8, 4.0) 
2.68 (dd, J = 
16.4, 10.8) 
2.80 (dd, J = 
13.2, 4.0) 
2.73 (dd, J = 
16.0, 10.8) 
3.70 (dd, J = 
10, 3) 
3.74 (dd, J = 
12.4, 4.0) 
3.86 (dd, J = 
12.8, 4.8) 
3.97 (dd, J = 
12.4, 4.8) 
3.83 (dd, J = 
12.4, 4.8) 
4.20 (t, J = 2) 4.23 (t, J = 2.0) 4.62 (s) 4.24 (s) 4.65 (s) 
4.50 (t, J = 2) 4.50 (t, J = 2.0) 4.74 (s) 4.51 (s) 4.76 (s) 
5.80 (s) 5.81 (s) 5.74 (s) 5.74 (s) 5.78 (s) 
6.70 (s) 6.68 (s) 6.84 (s) 6.70 (s) 6.85 (s) 
9.40 (s) 9.30 (s) 9.20 (s) 9.24 (s) 9.24 (s) 
11.20 (s) 11.13 (s) 11.11 (s) 11.14 (s) 11.13 (s) 
13C 
peyssonol A 76 21 66 70 
19.2 18.6 25.6 25.8 14.5 
22.5 22.3 26.8 27.8 18.5 
25.6 25.0 28.2 28.3 24.5 
29.0 28.9 28.6 29.3 25.7 
31.3 30.9 28.6 30.3 30.8 
32.1 31.4 32.0 31.5 31.9 
32.2 31.7 32.3 32.3 37.9 
37.2 37.7 37.6 34.4 39.9 
39.0 38.4 40.1 38.8 40.0 
40.1 39.8 41.6 39.7 40.2 
46.0 46.6 53.0 48.2 55.4 
57.3 57.6 54.8 57.7 55.6 
69.5 69.1 64.5 64.3 69.0 
111.4 111.2 107.8 110.0 108.6 
117.6 117.4 117.0 117.3 117.2 
118.2 119.0 118.2 118.9 118.5 
120.2 120.0 128.6 119.9 118.6 
140.0 140.4 141.0 140.3 140.7 
146.0 146.8 146.8 146.9 146.8 
146.1 147.0 147.6 147.2 147.2 
156.0 156.4 156.6 156.4 156.6 
195.8 195.0 194.9 195.0 195.0 
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Tricyclic Carbonate 77.  Carbonate protection of 73 was carried out 
according to the same procedure used to access 59, affording Boc-protected (2Z,6E)-
farnesol (1.12 g, 96% yield) as a colorless viscous oil.  Next, a cold solution of BDSB 
(1.55 g, 2.83 mmol, 1.10 equiv) in nitromethane (8 mL) was added rapidly via 
syringe to a solution of Boc-protected (2Z,6E)-farnesol (0.831 g, 2.58 mmol, 1.00 
equiv) in nitromethane (250 mL) at –25 °C.  Following this addition, the reaction 
flask was removed from the cold bath and stirred for 60 min at 25 °C, then quenched 
by the sequential addition of 5% aqueous sodium sulfite (100 mL) and saturated 
aqueous sodium bicarbonate (100 mL).  The resultant biphasic mixture was stirred 
vigorously for 1 h at 25 °C, then poured into brine (200 mL) and extracted with 
EtOAc (3 × 200 mL).  The combined organic layers were washed with brine (300 
mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1 → 1:1) to afford 77 (0.502 g, 56% 
yield) as a white crystalline solid.  77: Rf = 0.46 (silica gel, hexanes:EtOAc, 2:3); IR 
(film) νmax 2971, 2878, 1751, 1247, 1118, 732 cm–1; 1H NMR (400 MHz, CDCl3) δ 
4.39 – 4.23 (m, 2 H), 3.87 (dd, J = 12.4, 4.4 Hz, 1 H), 2.26 (dq, J = 4.4, 12.8 Hz, 1 
H), 2.11 (dq, J = 13.6, 4.0 Hz, 1 H), 2.06 – 1.78 (m, 4 H), 1.62 (s, 3 H), 1.51 – 1.37 
(m, 3 H), 1.20 (s, 3 H), 1.17 (m, 1 H), 1.06 (s, 3 H), 0.92 (s, 3 H); 13C NMR (75 MHz, 
CDCl3) δ 149.5, 86.2, 66.9, 65.8, 50.6, 48.8, 39.8, 37.7, 37.3, 36.0, 30.6, 30.4 (2 C), 
23.9, 21.7, 18.5; HRMS (FAB) calcd for C16H26BrO3 [M+H]+ 345.1065, found 
345.1053. [Note: The stereochemistry at C8 was originally ambiguous, although 
inconsequential since this stereocenter is later ablated.  A chair-chair-chair 
conformation of the tricycle in which the C-3 hydrogen is axial (as apparent from J-
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values from the 1H NMR) has the group at C-9 in the α-position and axial, implying 
that the neighboring carbon-oxygen bond at C-8 must also be in the α-orientation. 
This hypothesis was verified by NOESY analysis, in which a clear cross-peak was 
observed between the methyl group at C-8 and the methyl group at C-10.  This 
indicates that the methyl group is in the axial β-position at C-8]. 
 
Peyssonoic Acid A (78).  A solution of boron trichloride (0.28 mL, 1.0 M in 
CH2Cl2, 0.28 mmol, 6.0 equiv) was added dropwise to a solution of 85 (0.023 g, 
0.046 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at –78 °C.  The resultant light orange 
reaction mixture was stirred for 1 h at –78 °C, then quenched by the addition of water 
(5 mL) and extracted with EtOAc (3 × 5 mL).  The combined organic layers were 
washed with acidic brine (5 mL), dried (MgSO4), filtered, concentrated, and purified 
by preparatory TLC (silica gel, hexanes:EtOAc:AcOH, 25:75:2) to afford peysonnoic 
acid A (78, 0.015 g, 72% yield) as a light yellow amorphous solid.  78: Rf =  0.46 
(silica gel, hexanes:EtOAc:AcOH, 25:75:2); IR (film) νmax 3258 (br), 2967, 2925, 
1712, 1433, 1201, 1023, 988 cm-1; 1H NMR (400 MHz, (CD3)2SO) δ 8.51 (br s, 2 H), 
6.52 (s, 1 H), 6.50 (s, 1 H), 5.25 (s, 1 H), 4.20 (dd, J = 12.4, 3.6 Hz, 1 H), 3.33 (s, 2 
H), 2.82 (dd, J = 14.4, 6.0 Hz, 1 H), 2.19 – 2.02 (m, 3 H), 1.96 – 1.82 (m, 3 H), 1.77 
(t, J = 5.6 Hz, 1 H), 1.63 (dd, J = 11.2, 6.0 Hz, 1 H), 1.48 (s, 3 H), 1.00 (s, 3 H), 0.99 
(m, 1 H), 0.97 (s, 3 H), 0.87 (s, 3 H); 13C NMR (100 MHz, (CD3)2SO) δ 172.9, 147.5, 
146.8, 136.4, 127.7, 119.6, 119.1, 117.2, 116.3, 70.7, 53.7, 41.8, 39.1, 36.4 (2 C), 
35.0, 30.8, 30.4, 29.9, 25.2, 23.7, 21.9, 17.5; HRMS (FAB) calcd for C23H31BrO4 
[M]+ 450.1406, found 450.1425 [Note: These NMR data do not match the data given 
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for this compound in the original isolation paper.  However, as discussed in the text, 
NMR spectra coalesced with those of the reported compound after stirring the product 
with excess sodium bicarbonate in DMSO to 89; see table below]. 
Comparison of 1H and 13C NMR data: peyssonoic Acid A vs. “Sodium Peyssonoate”: 
1H 
Natural Peyssonoic Acid A 78 78 (stirred over NaHCO3) 
0.86 (s, 3H) 0.87 (s, 3H)  
0.97 (s, 3H) 0.97 (s, 3H)  
0.99 (m) 0.99 (m)  
1.00 (s, 3H) 1.00 (s, 3H)  
1.49 (s, 3H) 1.48 (s, 3H)  
1.64 (m) 
1.63 (dd, J = 11.2, 
6.0)  
1.78 (t, J = 5.2) 1.77 (t, J = 5.6)  
1.88 (m) 1.82-1.96 (m, 3H)  
1.92 (m)   
1.93 (m)   
2.06 (m) 2.07 (m, 1H)  
2.13 (m, 2H) 2.19-2.10 (m, 2H)  
2.77 (dd, J = 14.6, 6.2) 
2.82 (dd, J = 14.4, 
6.0) 2.77 (dd, J = 14.8, 6.0) 
3.09 (s, 2H) 3.33 (s, 2H) 3.11 (s, 2H) 
4.20 (dd, J = 12.5, 3.0) 
4.20 (dd, J = 12.4, 
3.6)  
5.23 (s) 5.25 (s) 5.23 (s) 
6.31 (s) 6.50 (s) 6.32 (s) 
6.35 (s) 6.52 (s) 6.36 (s) 
8.38 (br s, OH) 8.51 (br s, 2 OH)  
13.39 (br s, OH)   
13C 
Natural Peyssonoic Acid A 78 78 (stirred over NaHCO3) 
17.5 17.5  
21.8 21.9  
23.6 23.7  
25.1 25.2  
29.9 29.9  
30.3 30.4  
30.8 30.8  
36.3 36.4  
36.4 36.4  
39.1 39.1  
41.8 41.8  
44.5 35.0 44.3 
53.7 53.7  
70.9 70.7  
116.6 116.3 116.7 
117.8 117.2 117.9 
119.2 119.1  
122.6 119.6 122.6 
126.6 127.7 126.8 
136.7 136.4 136.7 
146.1 146.8 146.3 
150.1 147.5 150.0 
175.3 172.9 175.7 
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Arylated Polyene 79.  Phosphorous tribromide (0.236 mL, 2.50 mmol, 0.500 
equiv) was added dropwise to a solution of (2Z,6E)-farnesol (73, 1.11 g, 5.00 mmol, 
1.00 equiv) in Et2O (15 mL) at –20 °C.  The reaction mixture was allowed to warm 
slowly to 0 °C over 1 h.  Upon completion, the reaction contents were quenched by 
the addition of ice-cold water (25 mL) and extracted with hexanes (4 × 15 mL).  The 
combined organic layers were washed with saturated aqueous sodium bicarbonate (30 
mL) and brine (30 mL), dried (MgSO4), filtered, and concentrated to afford crude 
(2Z,6E)-farnesyl bromide, which was carried forward without further purification.  
Next, a solution of n-BuLi (5.36 mL, 1.4 M in hexanes, 7.5 mmol, 1.5 equiv) was 
added dropwise to a solution of 20 (3.20 g, 9.00 mmol, 1.80 equiv) in THF (125 mL) 
at –78 °C.  The resultant solution was stirred for 20 min at –78 °C, then cannulated 
into a solution of (2Z,6E)-farnesyl bromide (5.00 mmol assumed, 1.00 equiv) in THF 
(25 mL) at –40 °C.  The reaction mixture was then allowed to warm slowly to 5 °C 
over the course of 2 h, at which time the reaction contents were quenched by the 
addition of 10% aqueous ammonium chloride (100 mL) and extracted with 
hexanes:EtOAc (1:1, 3 × 150 mL).  The combined organic layers were washed with 
brine (150 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 1:4) to afford 79 (0.99 g, 45% 
yield from 73) as a light yellow viscous oil.  79: Rf =  0.45 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2961, 2928, 2854, 1488, 1151, 1081, 998 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.26 (s, 1 H), 6.95 (s, 1 H), 5.25 (t, J = 7.2 Hz, 1 H), 
5.15 (s, 2 H), 5.12 (s, 2 H), 5.18 – 5.08 (m, 2 H), 3.52 (s, 3 H), 3.47 (s, 3 H), 3.28 (d, 
J = 7.2 Hz, 2 H), 2.19 – 1.92 (m, 8 H), 1.74 (s, 3 H), 1.68 (s, 3 H), 1.61 (s, 3 H), 1.60 
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(s, 3 H); 13C NMR (100 MHz, (CDCl3) δ 150.6, 148.7, 137.0, 135.5, 131.7, 131.5, 
124.5, 124.2, 122.5, 119.3, 118.5, 110.3, 96.1, 95.2, 56.5, 56.2, 39.9, 32.2, 28.5, 26.8, 
26.6, 25.8, 23.6, 17.8, 16.1; HRMS (FAB) calcd for C25H37BrO4 [M]+ 480.1875, 
found 480.1885. 
 
Tetracyclic Dibromide 80.  A cold solution of BDSB (0.251 g, 0.458 mmol, 
1.10 equiv) in MeNO2 (2 mL) was syringed quickly into a solution of 79 (0.200 g, 
0.416 mmol, 1.00 equiv) in MeNO2 (40 mL) at –25 °C.  After 5 min at –25 °C, the 
reaction mixture was quenched by the sequential addition of 5% aqueous sodium 
sulfite (20 mL) and saturated aqueous sodium bicarbonate (20 mL).  This 
heterogeneous mixture was stirred vigorously for 1 h at 25 °C, then poured into brine 
(40 mL) and extracted into hexanes:EtOAc (1:1, 3 × 60 mL).  The combined organic 
layers were washed with brine (100 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 19:1) to 
afford 80 (0.112 g) contaminated with a small amount of an inseparable, unidentified 
diastereomer.  This minor by-product could be completely removed by 
recrystallization from CH2Cl2:EtOH (1:1, 5 mL) with slow evaporation to afford pure 
80 (0.090 g, 42% yield) as a white crystalline solid.  80: Rf =  0.39 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2947, 1483, 1390, 1151, 1088, 1011, 971 cm-1; 
1H NMR (400 MHz, CDCl3) δ 6.96 (s, 1 H), 6.85 (s, 1 H), 5.12 (s, 2 H), 3.95 (dd, J = 
12.8, 4.4 Hz, 1 H), 3.53 (s, 3 H), 2.76 – 2.62 (m, 2 H), 2.31 (dq, J = 3.6, 13.2 Hz, 1 
H), 2.14 (dq, J = 13.6, 4.0 Hz, 1H), 1.82 – 1.45 (m, 6 H), 1.56 (s, 3 H), 1.38 (dd, J = 
12.0, 2.8 Hz, 1 H), 1.23 (m, 1 H), 1.22 (s, 3 H), 1.07 (s, 3 H), 0.97 (s, 3 H); 13C NMR 
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(100 MHz, (CDCl3) δ 148.7, 147.1, 121.8, 120.7, 117.3, 111.2, 96.3, 79.0, 68.7, 56.5, 
50.3, 47.1, 39.9, 38.3, 37.5, 34.5, 31.1, 30.8, 30.3, 25.4, 24.9, 22.4, 28.3; HRMS 
(FAB) calcd for C23H32Br2O3 [M]+ 514.0718, found 514.0720. 
Tetracyclic α-Ketoester 83.  A solution of n-BuLi (0.042 mL, 1.4 M in 
hexanes, 0.058 mmol, 1.0 equiv) was added dropwise to a solution of 81 (0.030 g, 
0.058 mmol, 1.0 equiv) in THF (1 mL) at –78 °C.  After 15 min at –78 °C, ethyl 
chlorooxoacetate (0.032 mL, 0.29 mmol, 5.0 equiv) was added dropwise.  After 30 
additional min at –78 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate (5 mL) and extracted with EtOAc (3 × 5 mL).  
The combined organic layers were washed with brine (10 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 3:1) to afford 83 (0.016 g, contaminated with small amounts 
of an unknown impurity, ~50% yield) as a light yellow amorphous solid.  
(Hydrogenation of 80 afforded mostly the corresponding benzylic alcohol, which 
could not be further reduced under hydrogenation conditions [with or without added 
acid] or by the action of TFA/Et3SiH).  83: Rf = 0.4 (silica gel, hexanes:EtOAc, 2:1); 
1H NMR (400 MHz, CDCl3) δ 7.26 (s, 1 H), 6.90 (s, 1 H), 5.07 (s, 2 H), 4.36 (q, J = 
7.2 Hz, 2 H), 3.94 (dd, J = 12.8 Hz, 4.4 Hz, 1 H), 3.47 (s, 3 H), 2.86 – 2.72 (m, 2 H), 
2.31 (qd, J = 13.6, 3.6 Hz, 1 H), 2.14 (dq, J = 14.0, 4.0 Hz, 1 H), 1.80 – 1.45 (m, 7 
H), 1.57 (s, 3 H), 1.37 (t, J = 7.2 Hz, 3 H), 1.26 (m, 1 H), 1.23 (s, 3 H), 1.07 (s, 3 H), 
0.97 (s, 3 H). 
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Tetracyclic Carboxylic Acid 84.  A solution of n-BuLi (0.093 mL, 1.4 M in 
hexanes, 0.13 mmol, 1.2 equiv) was added dropwise to a solution of 81 (not 
recrystallized, 0.056 g, 0.108 mmol, 1.0 equiv) in THF (2.2 mL) at –78 °C.  After 15 
min at –78 °C, dry carbon dioxide was bubbled through the reaction solution for 2 
min at –78 °C.  The reaction flask was removed from the cold bath and allowed to 
warm to 25 °C for 15 min, then the reaction mixture was quenched by the careful 
addition of aqueous 0.5 M HCl (5 mL) and extracted with EtOAc (3 × 10 mL).  The 
combined organic layers were washed with brine (10 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc + 0.5% AcOH by volume, 2:1) to afford 84 (0.045 g, containing an 
impurity likely carried through from 81, ~80% yield) as a white crystalline solid.  84: 
Rf = 0.2 (silica gel, hexanes:EtOAc, 1:4); 1H NMR (400 MHz, CDCl3) δ 7.52 (s, 1 H), 
6.97 (s, 1 H), 5.31 (s, 2 H), 3.94 (dd, J = 12.4, 4.4 Hz, 1 H), 3.55 (s, 3 H), 2.84 – 2.72 
(m, 2 H), 2.32 (qd, J = 12.8, 3.6 Hz, 1 H), 2.14 (dq, J = 14.0, 3.6 Hz, 1 H), 1.81 – 
1.46 (m, 6 H), 1.58 (s, 3 H), 1.36 (dd, J = 12.0, 3.2 Hz, 1 H), 1.24 (m, 1 H), 1.23 (s, 3 
H), 1.07 (s, 3 H), 0.97 (s, 3 H). 
 
Tetracyclic Homologated Carboxylic Acid 85.  First Generation Synthesis: 
Thionyl chloride (0.017 mL, 0.23 mmol, 5.0 equiv) was added dropwise to a solution 
of 84 (0.022 g, 0.046 mmol, 1.0 equiv) and DMF (3 µL, 0.03 mmol, 0.6 equiv) in 
CH2Cl2 (1 mL) at 0 °C.  After 15 min at 0 °C, the resultant solution was concentrated 
under reduced pressure, redissolved in THF/MeCN (1:1, 1 mL), and stirred at 0 °C.  
A solution of TMSCHN2 (0.23 mL, 2.0 M in Et2O, 0.46 mmol, 10 equiv) was added 
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dropwise.  After 1 h at 0 °C, the reaction solution was concentrated under reduced 
pressure and purified directly by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:1) to afford the desired diazoketone (9.0 mg, 39% yield) as 
a yellow crystalline solid.  Next, a solution of AgOTf (0.8 mg, 0.004 mmol, 0.2 
equiv) in Et3N (12 µL) was added to a solution of this diazoketone (9.0 mg, 0.018 
mmol, 1.0 equiv) in THF/H2O (9:1, 0.5 mL) in the dark at –20 °C.  The reaction 
solution was allowed to warm slowly to 5 °C over the course of 1 h, then quenched 
by the addition of aqueous 0.5 M HCl (5 mL) and extracted with EtOAc (3 × 5 mL).  
The combined organic layers were washed with brine (5 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc + 0.5% AcOH by volume, 1:1) to afford 85 (3.0 mg, contaminated by 
small amounts of an unknown byproduct, ~30% yield) as a yellow amorphous solid.  
This sequence was difficult to reproduce – a subsequent attempt on double the 
amount of material afforded only a trace amount of product.  Second Generation 
Synthesis:  A suspension of OsO4 (0.0037 g, 0.015 mmol, 0.20 equiv) in t-BuOH (0.2 
mL) and a solution of NaIO4 (0.078 g, 0.37 mmol, 5.0 equiv) in water (1 mL) were 
added sequentially to a solution of 88 (0.035 g, 0.073 mmol, 1.0 equiv) and pyridine 
(0.018 mL, 0.22 mmol, 3.0 equiv) in THF/t-BuOH/water (4:1:1, 3 mL) at 0 °C.  Once 
the addition was complete, the reaction mixture was removed from the cold bath and 
stirred at 25 °C for 2 h.  Upon completion, the reaction contents were quenched by 
the addition of 5% aqueous sodium sulfite (10 mL) and extracted with CH2Cl2 (3 × 10 
mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, and 
filtered through a silica gel plug (5 × 1 cm) with hexanes:EtOAc (1:1, 15 mL) to 
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afford the desired aldehyde (0.031 g, 89% yield) as a light yellow amorphous solid.  
Next, NaH2PO4•H2O (0.10 g, 0.65 mmol, 10 equiv) was added to a solution of this 
aldehyde (0.031 g, 0.065 mmol, 1.0 equiv) in THF/t-BuOH/water (5:2:2, 1.8 mL).  
The resultant suspension was stirred vigorously for 10 min until the buffer had 
completely dissolved, then cooled to 0 °C.  2-Methyl-2-butene (0.069 mL, 0.65 
mmol, 10 equiv) was then added, followed by a solution of NaClO2 (0.023 g, 0.26 
mmol, 4.0 equiv) in water (0.2 mL).  After 20 min at 0 °C, the reaction mixture was 
quenched by the addition of solid sodium sulfite (0.131 g, 1.04 mmol, 16 equiv) and 
water (3 mL); the resultant biphasic mixture was stirred vigorously for 5 min at 0 °C.  
This biphasic mixture was poured into aqueous 1 M HCl (3 mL) and extracted into 
EtOAc (3 × 10 mL).  The combined organic layers were washed with acidic brine, 
dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:EtOAc + 1% AcOH by volume, 6:4) to afford 85 (0.026 g, 81% 
yield) as a white crystalline solid.  85: Rf = 0.52 (silica gel, hexanes:EtOAc, 1:4); IR 
(film) νmax 2946, ~2900 (br), 2876, 1709, 1506, 1222, 1151, 1009 cm-1; 1H NMR (400 
MHz, CDCl3) δ 6.81 (s, 1 H), 6.61 (s, 1 H), 5.10 (s, 2 H), 3.96 (dd, J = 12.4, 4.4 Hz, 1 
H), 3.59 (d, J = 2.0 Hz, 2 H), 3.46 (s, 3 H), 2.72 (app d, J = 7.2 Hz, 2 H), 2.32 (dq, J = 
3.6, 13.2 Hz, 1 H), 2.14 (dq, J = 13.6, 4.0 Hz, 1 H), 1.82 – 1.45 (m, 6 H), 1.56 (s, 3 
H), 1.39 (dd, J = 12.0, 2.0 Hz, 1 H), 1.22 (s, 3 H), 1.21 (m, 1 H), 1.07 (s, 3 H), 0.97 
(s, 3 H); 13C NMR (100 MHz, CDCl3) δ 177.5, 148.7, 147.6, 122.4, 121.6, 118.6, 
114.9, 95.4, 78.5, 68.8, 56.1, 50.5, 47.1, 39.9, 38.3, 37.5, 35.8, 34.5, 31.2, 30.8, 30.4, 




Allylated Aryl Bromide 86.  A solution of n-BuLi (0.876 mL, 2.5 M in 
hexanes, 2.19 mmol, 1.00 equiv) was added dropwise to a solution of 20 (0.780 g, 
2.19 mmol, 1.00 equiv) in THF (22 mL) at –78 °C.  After 20 min at –78 °C, the 
resultant aryllithium solution was cannulated onto dry CuI (0.209 g, 1.10 mmol, 0.50 
equiv) and stirred for 10 min at 0 °C, during which time the solids dissolved to form a 
homogeneous yellow solution.  Allyl bromide (0.568 mL, 6.57 mmol, 3.0 equiv) was 
then added to the resultant aryl cuprate solution at 0 °C.  After 20 min at 0 °C, the 
reaction contents were quenched by the careful addition of 10% aqueous ammonium 
chloride (30 mL) and extracted with hexanes:EtOAc (1:1, 3 × 30 mL).  The combined 
organic layers were washed with brine (30 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 9:1) to afford 86 (0.525 g, 75% yield) as a colorless amorphous 
solid.  86: Rf = 0.56 (silica gel, hexanes:CH2Cl2, 1:2); IR (film) νmax 2955, 2903, 
2827, 1489, 1151, 1081, 994, 921 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.28 (s, 1 H), 
6.95 (s, 1 H), 5.92 (m, 1 H), 5.16 (s, 2 H), 5.12 (s, 2 H), 5.07 (s, 1 H), 5.03 (m, 1 H), 
3.53 (s, 3 H), 3.47 (s, 3 H), 3.34 (d, J = 6.4 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 
150.6, 148.8, 136.3, 130.0, 119.5, 118.7, 116.1, 110.8, 96.1, 95.3, 56.6, 56.2, 34.4; 
HRMS (FAB) calcd for C13H17BrO4 [M]+ 316.0310, found 316.0311. 
 
Allylated Polyene 87.  A solution of n-BuLi (0.536 mL, 2.5 M in hexanes, 
1.34 mmol, 1.70 equiv) was added dropwise to a solution of 86 (0.425 g, 1.34 mmol, 
1.70 equiv) in THF (14 mL) at –78 °C.  After 15 min at –78 °C, the resultant 
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aryllithium solution was added rapidly via syringe into a solution of (2Z,6E)-farnesyl 
bromide [see the synthesis of 79] (0.204 g, 0.788 mmol, 1.0 equiv) in THF (2 mL) at 
–40 °C.  The resultant solution was allowed to warm slowly to 5 °C over the course 
of 2 h, then quenched by the careful addition of 10% aqueous ammonium chloride 
(20 mL) and extracted with hexanes:EtOAc (1:1, 3 × 20 mL).  The combined organic 
layers were washed with brine (20 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:CH2Cl2, 4:1→2:3) to 
afford 87 (0.372 g, 84% yield) as a colorless viscous oil.  87: Rf = 0.64 (silica gel, 
hexanes:CH2Cl2, 1:2); IR (film) νmax 2927, 2855, 1503, 1149, 1080, 1011, 922 cm-1; 
1H NMR (400 MHz, CDCl3) δ 6.87 (s, 1 H), 6.86 (s, 1 H), 5.97 (m, 1 H), 5.29 (t, J = 
7.2 Hz, 1 H), 5.18 (t, J = 6.4 Hz, 1 H), 5.12 (s, 2 H), 5.10 (s, 2 H), 5.12–5.02 (m, 3 
H), 3.48 (s, 6 H), 3.36 (d, J = 6.8 Hz, 2 H), 3.32 (d, J = 7.6 Hz, 2 H), 2.19 – 1.97 (m, 
8 H), 1.73 (s, 3 H), 1.68 (s, 3 H), 1.62 (s, 3 H), 1.61 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 149.8 (2 C), 137.0, 136.1, 135.2, 131.3, 129.9, 127.8, 124.4, 124.2, 123.2, 
116.5 (2 C), 115.4, 95.4, 95.2, 56.0 (2 C), 39.7, 34.3, 32.0, 28.4, 26.7, 26.6, 25.7, 
23.5, 17.7, 16.0; HRMS (FAB) calcd for C28H42O4 [M]+ 442.3083, found 442.3073. 
 
Allylated Tetracycle 88.  A cold solution of BDSB (0.239 g, 0.435 mmol, 
1.10 equiv) in MeNO2 (2 mL) was syringed quickly into a solution of 87 (0.175 g, 
0.395 mmol, 1.00 equiv) in MeNO2 (38 mL) at –25 °C.  After 5 min at –25 °C, the 
reaction mixture was quenched by the sequential addition of 5% aqueous sodium 
sulfite (20 mL) and saturated aqueous sodium bicarbonate (20 mL).  This 
heterogeneous mixture was then stirred vigorously for 1 h at 25 °C, poured into brine 
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(40 mL), and extracted with hexanes:EtOAc (1:1, 3 × 60 mL).  The combined organic 
layers were washed with brine (100 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:CH2Cl2, 9:1→1:1) to 
afford tetracycle 88 (0.073 g, contaminated with a small amount of an inseparable, 
unidentified diastereomer) as an off-white solid.  The minor byproduct could be 
completely removed by recrystallization from CH2Cl2:MeOH (1:1, 3 mL) with slow 
evaporation to afford pure 88 (0.058 g, 31%) as a white crystalline solid.  88: Rf = 
0.60 (silica gel, hexanes:CH2Cl2, 1:2); IR (film) νmax 2946, 1500, 1222, 1150, 1066, 
1012, 920 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.77 (s, 1 H), 6.60 (s, 1 H), 5.95 (m, 1 
H), 5.09 (s, 2 H), 5.09 – 5.00 (m, 2 H), 3.96 (dd, J = 12.4, 4.4 Hz, 1 H), 3.49 (s, 3 H), 
3.32 (d, J = 6.0 Hz, 2 H), 2.72 (app d, J = 8.4 Hz, 2 H), 2.32 (dq, J = 3.6, 13.2 Hz, 1 
H), 2.14 (dq, J = 13.6, 4.0 Hz, 1 H), 1.85 – 1.49 (m, 6 H), 1.56 (s, 3 H), 1.41 (dd, J = 
12.0, 2.4 Hz, 1 H), 1.24 (m, 1 H), 1.23 (s, 3 H), 1.07 (s, 3 H), 0.97 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 148.5, 147.6, 137.1, 129.0, 119.8, 117.5, 115.6, 115.1, 95.6, 
78.3, 68.9, 56.1, 50.6, 47.1, 39.9, 38.4, 37.5, 34.5, 34.3, 31.2, 30.8, 30.5, 25.4, 24.9, 
22.4, 18.3; HRMS (FAB) calcd for C26H37BrO3 [M]+ 476.1926, found 476.1945. 
 
“Sodium Peyssonoate” (89).  Treating peyssonol A (78) with sodium 
bicarbonate in deuterated DMSO for 12 h at 25 °C afforded a crude sample of 89 
(~80% yield; contaminated with minor unidentified byproducts).  The spectral data 
for 89 matched those of the isolation paper describing peyssonoic acid A; see: Lane, 
A. L.; Mular, L.; Drenkard, E. J.; Shearer, T. L.; Engel, S.; Fredericq, S.; Fairchild, C. 
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R.; Prudhomme, J.; Le Roch, K.; Hay, M. E.; Aalbersberg, W.; Kubanek, J. 
Tetrahedron 2010, 66, 455. 
   
Bicyclic Diol 94.  Formed by methanolysis of 77 (see second generation 
synthesis of 75 for procedure).  94: Rf = 0.42 (silica gel, hexanes:EtOAc, 1:1); 1H 
NMR (400 MHz, CDCl3) δ 4.04 – 3.95 (m, 2 H), 3.92 (dd, J = 11.6, 6.0 Hz, 1 H), 
2.53 (br s, 2 H), 2.26 (qd, J = 13.2, 3.2 Hz, 1 H), 2.12 (dq, J = 13.6, 4.0 Hz, 1 H), 1.96 
(dt, J = 12.8, 3.2 Hz, 1 H), 1.80 – 1.71 (m, 3 H), 1.51 – 1.32 (m, 3 H), 1.46 (s, 3 H), 
1.32 (dd, J = 6.0, 2.4 Hz, 1 H), 1.11 (s, 3 H), 1.05 (s, 3 H), 0.94 (s, 3 H). 
 
Arylated Alcohol 95.  The more polar diastereomer (chirality at the alcohol 
position not determined) formed by arylation of aldehyde 75, as described in the 
synthesis of 76.  95: Rf = 0.3 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (400 MHz, 
CDCl3) δ 7.08 (s, 1 H), 6.98 (s, 1 H), 5.35 (d, J = 5.2 Hz, 1 H), 5.17 – 5.08 (m, 4 H), 
4.74 (s, 1 H), 4.42 (s, 1 H), 4.15 (br s, 1 H), 4.06 (dd, J = 12.4, 4.0 Hz, 1 H), 3.50 (s, 3 
H), 3.48 (s, 3 H), 2.45 (td, J = 13.2, 5.2 Hz, 1 H), 2.34 – 1.32 (m, 11 H), 1.14 (s, 3 H), 
1.12 (s, 3 H), 1.01 (s, 3 H) [Note: the material subjected to biological testing was 
repurified by preparatory chromatography first, a 1H NMR spectrum of this purified 
compound could not be located]. 
 
Deoxegenated Arylated Bicycle 96.  Formed by the reductive deoxygenation 
of 95, as described in the synthesis of 76.  96: Rf = 0.52 (silica gel, hexanes:EtOAc, 
4:1); IR (film) νmax 2948, 1489, 1380, 1217, 1151, 1081, 999 cm–1; 1H NMR (400 
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MHz, CDCl3) δ 7.23 (s, 1 H), 6.78 (s, 1 H), 5.12 (d, J = 1.6 Hz, 2 H), 5.08 (s, 2 H), 
4.49 (t, J = 2.0 Hz, 1 H), 4.09 (t, J = 2.0 Hz, 1 H), 4.05 (dd, J = 12.4, 4.0 Hz, 1 H), 
3.50 (s, 3 H), 3.47 (s, 3 H), 2.91 (dd, J = 13.2, 4.0 Hz, 1 H), 2.53 (dd, J = 12.4, 11.2 
Hz, 1 H), 2.35 – 2.12 (m, 4 H), 1.98 – 1.86 (m, 2 H), 1.75 (m, 1 H), 1.58 – 1.41 (m, 2 
H), 1.28 (dt, J = 13.6, 3.6 Hz, 1 H), 1.13 (s, 3 H), 0.98 (s, 6 H); 13C NMR (75 MHz, 
CDCl3) δ 150.9, 148.3, 146.5, 131.2, 119.6, 119.0, 111.1, 110.2, 96.2, 95.4, 69.6, 
58.2, 56.4, 56.2, 46.8, 39.9, 38.3, 37.9, 31.6, 31.4, 31.0, 27.9, 25.1, 22.6, 18.6; HRMS 
(FAB) calcd for C25H36Br2O4 [M]+ 558.0980, found 558.1001.  
 
Tetracyclic Aldehyde 97.  A solution of n-BuLi (0.301 mL, 1.4 M in 
hexanes, 0.42 mmol, 1.2 equiv) was added dropwise to a solution of 31 (0.159 g, 
0.456 mmol, 1.30 equiv) in THF (7 mL) at –78 °C.  After 20 min at –78 °C, the 
resultant aryllithium solution was cannulated quickly into a solution of (2Z,6E)-
farnesyl bromide [ see the synthesis of 79] (0.100 g, 0.351 mmol, 1.00 equiv) in THF 
(3 mL) at –40 °C.  The reaction solution was allowed to warm slowly to 0 °C over the 
course of 1 h, then quenched by the addition of 10% aqueous ammonium chloride (20 
mL) and extracted with hexanes:EtOAc (1:1, 3 × 10 mL).  The combined organic 
layers were washed with brine (20 mL), dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1) to afford 
the desired polyene (0.112 g, 67% yield) as a colorless viscous oil.  Next, a cold 
solution of BDSB (0.143 g, 0.260 mmol, 1.10 equiv) in MeNO2 (1 mL) was syringed 
quickly into a solution of this polyene (0.112 g, 0.236 mmol, 1.00 equiv) in MeNO2 
(23 mL) at –25 °C.  After 2 min at –25 °C, H2O (0.043 mL, 2.4 mmol, 10 equiv) was 
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added and the reaction mixture was allowed to warm to 25 °C and stirred vigorously 
for an additional 1 h (to facilitate complete deprotection of the phenol).  Upon 
completion, the reaction mixture was quenched by the careful addition of saturated 
aqueous sodium bicarbonate (20 mL) and 5% aqueous sodium sulfite (10 mL); this 
biphasic mixture was stirred vigorously for 20 min, then extracted with EtOAc (3 × 
50 mL).  The combined organic layers were washed with brine (50 mL), dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 9:1) to afford 97 (0.060 g, 60% yield) as a light yellow 
crystalline solid.  97: Rf = 0.45 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (400 MHz, 
CDCl3) δ 10.51 (s, 1 H), 9.75 (s, 1 H), 6.92 (s, 1 H), 6.68 (s, 1 H), 3.97 (dd, J = 12.4, 
4.4 H, 1 H), 2.85 – 2.69 (m, 2 H), 2.32 (qd, J = 13.2, 3.6 Hz, 1 H), 2.16 (dq, J = 13.6, 
4.0 Hz, 1 H), 1.86 – 0.92 (m, 8 H), 1.57 (s, 3 H), 1.23 (s, 3 H), 1.08 (s, 3 H), 0.97 (s, 3 
H).  
 
Peyssonol A Geometric Isomers 98/99.  A solution of boron trichloride 
(0.093 mL, 1.0 M in CH2Cl2, 0.093 mmol, 3.0 equiv) was added dropwise to a 
solution of 97 (0.013 g, 0.031 mmol, 1.0 equiv) in CH2Cl2 (1 mL) at 0 °C.  After 45 
min at 0 °C, the red reaction solution was quenched by the addition of water (5 mL) 
and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by preparatory thin layer 
chromatography (silica gel, hexanes:EtOAc, 2:1) to afford 98 (7.8 mg, 60% yield) 
and 99 (1.7 mg, 13% yield), both as colorless amorphous solids. 98: Rf = 0.43 (silica 
gel, hexanes:EtOAc, 2:1); 1H NMR (400 MHz, CDCl3) δ 10.62 (s, 1 H), 9.77 (s, 1 H), 
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6.93 (s, 1 H), 6.82 (s, 1 H), 5.42 (br s, 1 H), 4.80 (s, 1 H), 4.01 (dd, J = 12.4, 3.6 Hz, 1 
H), 2.96 (dd, J = 14.0, 6.0 Hz, 1 H), 2.48 (dd, J = 14.0, 6.8 Hz, 1 H), 2.28 – 1.95 (m, 
4 H), 1.87 (t J = 6.8 Hz, 1 H), 1.75 – 1.62 (m, 2 H), 1.46 (s, 3 H), 1.21 (dt, J = 13.2, 
3.2 Hz, 1 H), 1.08 (s, 3 H), 1.05 (s, 3 H), 0.94 (s, 3 H).  99: Rf = 0.39 (silica gel, 
hexanes:EtOAc, 2:1); 1H NMR (400 MHz, CDCl3) δ 10.70 (s, 1 H), 9.77 (s, 1 H), 
6.90 (s, 1 H), 6.68 (s, 1 H), 4.83 (s, 1 H), 3.94 (dd, J = 12.4, 4.4 Hz, 1 H), 3.34 (AB 
quartet, J = 18.4, 27.6 Hz, 2 H), 2.32 – 0.98 (m, 9 H), 1.53 (s, 3 H), 1.11 (s, 3 H), 1.05 
(s, 3 H), 0.97 (s, 3 H).  
 
Bicyclic Acetate 100.  Formed by the BDSB cyclization of 63, as described in 
the synthesis of 64.  100: Rf = 0.46 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 
3490 (br), 2936, 1736, 1367, 1243, 1028 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.44 
(dd, J = 12.0, 4.0 Hz, 1 H), 4.29 (app t, J = 4.0 Hz, 1 H), 4.25 (dd, J = 12.4, 3.2 Hz, 1 
H), 2.12 – 2.00 (m, 2 H), 2.04 (s, 3 H), 1.90 – 1.75 (m, 5 H), 1.67 (dd, J = 5.2, 3.6 Hz, 
1 H), 1.63 – 1.48 (m, 2 H), 1.29 (s, 1 H), 1.27 (s, 3 H), 1.23 (s, 3 H), 1.19 (s, 3 H), 
1.16 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 171.0, 72.1, 70.8, 63.3, 47.0, 45.4, 39.5, 
38.3, 36.9, 33.5, 33.0, 32.1, 28.1 (2 C), 27.6, 21.4, 18.0; HRMS (FAB) calcd for 
C17H28BrO3 [M–H]+ 359.1222, found 359.1206 [Note: As for the stereochemistry at 
the hydroxyl group, the production of a significant amount of tetrasubstituted alkene 
product upon dehydration of this product, even at very low temperature, indicates that 
the C-8 hydroxyl group should be trans-diaxial to the C-9 hydrogen.  Since the 
bromine in this structure is axial, as is apparent from the chemical shift and J-values 
of the geminal C-3 proton in the 1H NMR, the likely chair-chair conformation of the 
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cis-decalin structure would result in an axial C-9 hydrogen trans to an axial OH only 
if it were on the β-face of C-8].  
 
Tricyclic Carbonate 101.  Boc-protection of (2Z,6Z)-farnesol was carried out 
according to the procedure used to access 59, affording the desired cyclization 
precursor (0.139 g, 91% yield) as a colorless viscous oil.  Subsequent BDSB 
cyclization was carried out according to the procedure used to access 60, affording 
101 (0.040 g, 28% yield) as a white crystalline solid.  101: Rf = 0.38 (silica gel, 
hexanes:EtOAc, 2:3); IR (film) νmax 2976, 2939, 2884, 1736, 1231, 1218, 1128, 1109 
cm–1; 1H NMR (400 MHz, CDCl3) δ 4.62 (dd, J = 12.4, 6.0 Hz, 1 H), 4.50 (dd, J = 
12.0, 2.8 Hz, 1 H), 4.24 (dd, J = 4.8, 3.2 Hz, 1 H), 2.14 – 1.81 (m, 7 H), 1.75 (dt, J = 
14.4, 4.4 Hz, 1 H), 1.72 – 1.62 (m, 2 H), 1.51 (s, 3 H), 1.19 (s, 3 H), 1.18 (s, 3 H), 
1.17 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 149.4, 82.0, 68.4, 66.6, 44.2, 39.6, 39.2, 
35.8, 34.4, 33.0, 32.2, 29.2, 28.1, 27.8, 27.6, 17.9; HRMS (FAB) calcd for 
C16H26BrO3 [M+H]+ 345.1065, found 345.1077. 
 
Tricyclic Carbonate 102.  Boc-protection of (2E,6E)-farnesol was carried out 
according to the procedure used to access 59, affording the desired cyclization 
precursor (0.139 g, 91% yield) as a colorless viscous oil.  Subsequent BDSB 
cyclization was carried out according to the procedure used to access 60, affording 
102 (0.064 g, 45% yield) as a white crystalline solid.  102: Rf = 0.43 (silica gel, 
hexanes:EtOAc, 2:3); IR (film) νmax 2948, 1746, 1221, 1126, 1092 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 4.38 – 4.31 (m, 2 H), 3.96 (dd, J = 12.0, 5.6 Hz, 1 H), 2.26 – 
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2.11 (m, 2 H), 2.06 (dt, J = 12.8, 3.2 Hz, 1 H), 1.94 – 1.82 (m, 2 H), 1.68 (dt, J = 4.4, 
13.6 Hz, 1 H), 1.54 (dt, J = 13.2, 3.6 Hz, 1 H), 1.48 (s, 3 H), 1.44 (m, 1 H), 1.31 (dt, J 
= 4.8, 12.8 Hz, 1 H), 1.18 (dd, J = 12.0, 2.0 Hz, 1 H), 1.10 (s, 3 H), 0.94 (s, 6 H); 13C 
NMR (75 MHz, CDCl3) δ 148.8, 81.6, 67.0, 66.5, 56.0, 51.1, 40.1, 39.9, 39.7, 36.5, 
30.6, 30.3, 21.7, 21.1, 18.3, 15.6; HRMS (FAB) calcd for C16H26BrO3 [M+H]+ 
345.1065, found 345.1057. 
 
Boc-Protected Cyclization Precursor 103.  Carbonate protection of 73 was 
carried out as described in the synthesis of 77, affording 103 (1.12 g, 96% yield) as a 
colorless viscous oil.  103: Rf = 0.67 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 
2970, 2930, 1740, 1369, 1277, 1254, 1168 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.37 
(dt, J = 1.2, 7.2 Hz, 1 H), 5.14 – 5.05 (m, 2 H), 4.55 (dd, J = 7.2, 0.8 Hz, 2 H), 2.16 – 
1.94 (m, 8 H), 1.75 (s, 3 H), 1.67 (s, 3 H), 1.59 (s, 6 H), 1.47 (s, 9 H); 13C NMR (75 
MHz, CDCl3) δ 154.0, 142.6, 136.0, 131.3, 124.7, 123.9, 119.7, 81.7, 63.7, 39.9, 
32.5, 28.1 (3 C), 27.1, 26.9, 25.6, 23.4, 17.7, 16.1; HRMS (FAB) calcd for C20H35O3 
[M+H]+ 323.2586, found 323.2578. 
 
Chlorinated Tricyclic Carbonate 104.  A solution of 103 (0.100 g, 0.31 
mmol, 1.0 equiv) in CH2Cl2:MeCN (1:1, 2 mL) was syringed rapidly into a solution 
of Hg(OTf)2 (0.17 g, 0.34 mmol, 1.1 equiv) in MeCN (14 mL) at –20 °C.  After 15 
min at –20 °C, the reaction solution was quenched by the addition of brine (10 mL) 
and the resultant heterogeneous mixture was stirred vigorously for 1 h at 25 °C.  This 
biphasic mixture was poured into water (20 mL) and extracted with CH2Cl2 (2 × 30 
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mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:1 → 0:1) to 
afford the tricyclic organomercurial chloride (0.048 g, 31% yield) as a white 
crystalline solid.  This organomercurial intermediate was subsequently dissolved in 
anhydrous pyridine (2 mL) and the resultant solution was cooled to –40 °C and stirred 
under an oxygen atmosphere.  A saturated solution of chlorine in CH2Cl2 (freshly 
prepared, ~1 M) was added in increments of 0.05 mL until starting material was 
consumed, as determined by TLC analysis (silica gel, hexanes:EtOAc, 1:1, Rf[SM] = 
0.33, Rf[prod] = 0.43; total chlorine solution added: 0.3 mL).  Upon completion, the 
reaction mixture was quenched by the addition of 5% aqueous sodium sulfite (5 mL) 
and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and pushed through a silica gel plug (eluent: 1:1 
hexanes:EtOAc, 30 mL).  Recrystallization by slow evaporation from a solution of 
the crude product in a mixture of CH2Cl2:hexanes (1:4, 5 mL) afforded pure 104 
(0.021 g, 62% yield) as a white crystalline solid (a preparatory chromatography step 
and two additional recrystallizations were carried out prior to biological testing to 
rigorously ensure the removal of any residual mercury).  104: Rf = 0.43 (silica gel, 
hexanes:EtOAc, 1:1); IR (film) νmax 2951, 2877, 1748, 1295, 1233, 1117, 1091 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.38 (dd, J = 11.2, 4.8 Hz, 1 H), 4.29 (t, J = 11.6 Hz, 1 
H), 3.65 (dd, J = 12.0, 4.4 Hz, 1 H), 2.17 – 1.97 (m, 3 H), 1.95 – 1.78 (m, 3 H), 1.65 
(s, 3 H), 1.53 – 1.40 (m, 2 H), 1.22 (s, 3 H), 1.13 (dd, J = 12.0, 2.8 Hz, 1 H), 1.08 (s, 
3 H), 0.91 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 149.6, 86.3, 71.4, 65.9, 50.8, 49.1, 
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40.0, 37.3, 36.6, 36.1, 30.6, 29.4, 29.3, 24.0, 21.1, 17.1; HRMS (FAB) calcd for 
C16H26ClO3 [M+H]+ 301.1570, found 301.1572. 
 
Iodinated Tricyclic Carbonate 105.  A solution of IDSI (0.27 g, 0.34 mmol, 
1.1 equiv) in MeNO2 (2 mL) was syringed quickly into a solution of 103 (0.100 g, 
0.31 mmol, 1.0 equiv) in MeNO2 (29 mL) at 0 °C.  After 5 min at 0 °C, the reaction 
flask was removed from the cold bath and stirred for 15 min at 25 °C.  Upon 
completion, the reaction mixture was quenched by the addition of saturated aqueous 
sodium bicarbonate (20 mL) and 5% aqueous sodium sulfite (10 mL); this biphasic 
mixture was stirred vigorously for 20 min, then extracted with EtOAc (3 × 50 mL).  
The combined organic layers were washed with brine (50 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:1) to afford 105 (0.038 g, 31% yield) as a white crystalline solid.  
Analytically pure material was afforded by recrystallization from hexanes:CH2Cl2 
(3:1, 4 mL) with slow evaporation.  105: Rf = 0.45 (silica gel, hexanes:EtOAc, 1:1); 
IR (film) νmax 2960, 2875, 1747, 1243, 1149, 1117, 1086 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 4.37 (dd, J = 11.2, 4.8 Hz, 1 H), 4.30 (t, J = 11.2 Hz, 1 H), 4.10 (dd, J = 
12.8, 4.0 Hz, 1 H), 2.48 (qd, J = 13.2, 3.6 Hz, 1 H), 2.32 (dq, J = 14.0, 4.0 Hz, 1 H), 
2.02 (m, 1 H), 1.95 – 1.79 (m, 3 H), 1.64 (s, 3 H), 1.54 – 1.40 (m, 2 H), 1.31 – 1.20 
(m, 2 H), 1.22 (s, 3 H), 1.06 (s, 3 H), 0.97 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
149.5, 86.2, 65.9, 50.7, 50.6, 47.5, 39.7, 39.5, 37.7, 36.2, 33.4, 33.2, 30.5, 23.9, 22.8, 
21.5; HRMS (FAB) calcd for C16H26IO3 [M+H]+ 393.0927, found 393.0932. 
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Dehalogenated Tricyclic Carbonate (106).  A solution of 77 (10.5 mg, 0.030 
mmol, 1.0 equiv), AIBN (1.0 mg, 0.0061 mmol, 0.20 equiv), and n-Bu3SnH (0.040 
mL, 0.15 mmol, 5.0 equiv) in degassed toluene (1 mL) was heated to 85 °C for 1 h.  
The reaction solution was allowed to cool to 25 °C, then concentrated by rotary 
evaporation and purified directly by flash column chromatography (silica gel, 
hexanes:EtOAc, 4:1) to afford 106 (7.3 mg, 90% yield) as a white crystalline solid.  
Analytically pure material was afforded by recrystallization from hexanes:CH2Cl2 
(9:1, 1 mL) with slow evaporation.  106: Rf = 0.53 (silica gel, hexanes:EtOAc, 1:1); 
IR (film) νmax 2945, 2873, 1751, 1296, 1238, 1123 cm–1; 1H NMR (400 MHz, CDCl3) 
δ 4.41 (dd, J = 11.2, 4.8 Hz, 1 H), 4.33 (t J = 11.6 Hz, 1 H), 2.03 (dtd, J = 13.2, 3.6, 
1.2 Hz, 1 H), 1.88 (td, J = 13.2, 4.4, Hz, 1 H), 1.83 – 1.65 (m, 3 H), 1.64 (s, 3 H), 
1.53 – 1.21 (m, 5 H), 1.17 (s, 3 H), 1.12 (td, J = 13.6, 4.0 Hz, 1 H), 1.05 (dd, J = 12.4, 
2.8 Hz, 1 H), 0.89 (s, 3 H), 0.82 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 150.0, 86.9, 
66.3, 51.2, 48.7, 42.0, 37.5, 37.2, 36.5, 33.6, 33.4, 30.7, 23.9, 22.0, 20.4, 18.5; HRMS 
(FAB) calcd for C16H27O3 [M+H]+ 267.1960, found 267.1953. 
 
Methylated Protected Bromohydroquinone 107.  A solution of n-BuLi 
(1.25 mL, 1.6 M in hexanes, 2.0 mmol, 1.0 equiv) was added dropwise to a solution 
of 20 (0.712 g, 2.00 mmol, 1.0 equiv) in degassed THF (20 mL) at –78 °C.  After 20 
min at –78 °C, iodomethane (0.25 mL, 4.0 mmol, 2.0 equiv) was syringed into the 
reaction solution, which was allowed to warm slowly to 25 °C over 1 h.  Upon 
completion, the reaction mixture was quenched by the addition of 10% aqueous 
ammonium chloride (30 mL) and extracted with EtOAc (3 × 20 mL).  The combined 
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organic layers were washed with brine (30 mL), dried (MgSO4), filtered, 
concentrated, and purified by recrystallization from boiling hexanes (4 mL) to afford 
107 (0.415 g, 74% yield) as a white crystalline solid.  107: Rf = 0.53 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 7.25 (s, 1 H), 6.96 (s, 1 H), 5.16 
(s, 2 H), 5.12 (s, 2 H), 3.53 (s, 3 H), 3.48 (s, 3 H), 2.19 (s, 3 H).  
 
Peyssonol A Aromatic Analogue 108.  A solution of n-BuLi (0.69 mL, 1.6 
M in hexanes, 1.1 mmol, 1.1 equiv) was added dropwise into a solution of 107 (0.280 
g, 1.00 mmol, 1.00 equiv) in degassed THF (10 mL) at –78 °C.  After 20 min at –78 
°C, degassed DMF (0.231 mL, 3.00 mmol, 3.00 equiv) was syringed quickly into the 
reaction solution.  After an additional 1 h at –78 °C, the reaction flask was removed 
from the cold bath and aqueous 12 M HCl (0.8 mL, 10 mmol, 10 equiv) was added 
dropwise.  The resultant solution was slowly heated to 60 °C and maintained at that 
temperature for 1 h.  Upon completion, the reaction contents were allowed to cool to 
25 °C, poured into water (20 mL) and extracted with EtOAc (3 × 20 mL).  The 
combined organic layers were dried (MgSO4), filtered, and concentrated.  
Recrystallization by slow diffusion of hexanes (5 mL) into a solution of crude product 
in CH2Cl2 (8 mL) at –20°C afforded pure 108 (0.097 g, 64% yield) as a yellow 
crystalline solid.  108: Rf = 0.30 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3389 
(br), 1649, 1492, 1355, 1252, 1154 cm–1; 1H NMR (400 MHz, CDCl3) δ 10.63 (s, 1 
H), 9.76 (s, 1 H), 6.90 (s, 1 H), 6.79 (s, 1 H), 4.56 (s, 1 H), 2.30 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 195.4, 156.2, 147.1, 136.7, 119.7, 118.8, 117.3, 17.0; HRMS 
(FAB) calcd for C8H8O3 [M]+ 152.0473, found 152.0479. 
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Benzylic Alcohol 109.  A solution of n-BuLi (1.25 mL, 1.6 M in hexanes, 2.0 
mmol, 1.0 equiv) was added dropwise to a solution of 20 (0.712 g, 2.00 mmol, 1.00 
equiv) in degassed THF (20 mL) at –78 °C.  After 20 min at –78 °C, 
cyclohexanecarboxaldehyde (0.362 mL, 3.00 mmol, 1.50 equiv) was syringed quickly 
into the reaction solution, which was maintained at –78 °C for 5 min.  The reaction 
flask was then removed from the cold bath and stirred at 25 °C for 15 min.  Upon 
completion, the reaction mixture was quenched by the addition of 10% aqueous 
ammonium chloride (100 mL) and extracted with EtOAc (3 × 100 mL).  The 
combined organic layers were washed with brine (100 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 4:1) to afford 109 (0.585 g, 75% yield) as a colorless oil.  109: Rf = 
0.37 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 7.30 (s, 1 H), 
7.11 (s, 1 H), 5.17 (d, J = 1.5 Hz, 2 H), 5.13 (d, J = 1.5 Hz, 2 H), 4.60 (d, J = 6.9 Hz, 
1 H), 3.53 (s, 3 H), 3.48 (s, 3 H), 2.17 (br s, 1 H), 2.01 – 0.98 (11 H, m) [Note: The 
attached 1H NMR spectrum is contaminated with EtOAc; this NMR was taken prior 
to vacuum drying of 109; as such, the yield above is of pure, dry material; a dry 1H 
NMR for 109 could not be located]. 
 
Peyssonol A Aromatic Analogue 110.  TFA (0.344 mL, 4.47 mmol, 3.00 
equiv) was added to a solution of 109 (0.580 g, 1.49 mmol, 1.00 equiv) and 
triethylsilane (1.42 mL, 8.94 mmol, 6.00 equiv) in CH2Cl2 (15 mL) at 0 °C.  After 8 h 
at 0 °C, the reaction mixture was quenched by the careful addition of saturated 
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aqueous sodium bicarbonate (30 mL) and extracted with CH2Cl2 (3 × 20 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 9:1) to afford the 
deoxygenated product (0.456 g), contaminated with about 25% of an uncharacterized 
byproduct.  Subsequently, a solution of n-BuLi (0.63 mL, 1.6 M in hexanes, 1.0 
mmol, 1.1 equiv) was added dropwise into a solution of the deoxygenated product 
(0.34 g [estimated], 0.92 mmol, 1.0 equiv) in degassed THF (9 mL) at –78 °C.  After 
20 min at –78 °C, degassed DMF (0.21 mL, 2.8 mmol, 3.0 equiv) was syringed 
quickly into the reaction solution.  After an additional 1 h at –78 °C, the reaction flask 
was removed from the cold bath and aqueous 12 M HCl (0.7 mL, 9 mmol, 10 equiv) 
was added dropwise.  The resultant solution was slowly heated to 60 °C and 
maintained at that temperature for 1 h.  Upon completion, the reaction contents was 
allowed to cool to 25 °C, poured into water (20 mL) and extracted with EtOAc (3 × 
20 mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, 
and purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1) to 
afford 110 (0.108 g, 50% yield) as a dark yellow crystalline solid.  Analytically pure 
material was afforded by recrystallization from hexanes:CH2Cl2 (3:1, 8 mL) at –20 
°C.  110: Rf = 0.42 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3403 (br), 2924, 
2851, 1653, 1447, 1350, 1217, 1172 cm–1; 1H NMR (400 MHz, CDCl3) δ 10.61 (s, 1 
H), 9.73 (s, 1 H), 6.91 (s, 1 H), 6.74 (s, 1 H), 4.97 (s, 1 H), 2.51 (d, J = 7.2 Hz, 2 H), 
1.72 – 1.55 (m, 6 H), 1.26 –1.08 (m, 3 H), 1.05 – 0.91 (m, 2 H); 13C NMR (100 MHz, 
CDCl3) δ 195.5, 155.7, 147.2, 140.2, 119.8, 118.7, 117.8, 38.7, 38.2, 33.4 (2 C), 26.5, 
26.3 (2 C); HRMS (FAB) calcd for C14H18O3 [M]+ 234.1256, found 234.1254. 
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Analysis of Biological Activity:  A recombinant NL4-3 derived virus, termed 
Rep-Rluc Sac II, was constructed, in which a section of the nef gene from NL4-3 was 
replaced with the Renilla luciferase gene. This CXCR4-tropic virus is replication 
competent in cell culture and expresses the Renilla luciferase gene as a means of 
measuring virus growth. Virus was used to infect MT-2 cells in the presence of 
compounds, and after 5 days of incubation, cells are processed and quantitated for 
virus growth by the amount of expressed luciferase. Luciferase was quantitated using 
the Dual Luciferase kit from Promega (Madison, WI) according to manufacturer’s 
instructions and luciferase activity was measured on a Wallac TriLux (Perkin-Elmer).  
Susceptibility of viruses to compounds was determined by incubation in the presence 
of serial dilutions of the compounds. The 50% effective concentration (EC50) and 
50% cytotoxicity concentration were calculated by using the exponential form of the 
median effect equation where (Fa) = 1/[1+ (ED50/drug conc.)m]. Compound 
cytotoxicity was assayed in parallel by exposing uninfected MT-2 cells to serially 
diluted compounds, and measuring cell viability in an XTT assay, according to the 




Biological Assay Raw Data: 
  
Compound EC50 (µM) CC50 (µM) 
 Expt 1 Expt 2 Expt 3 Expt 4 Expt 1 Expt 2 Expt 3 Expt 4 
6 0.8 1.3   1.1 6.5   
8 52.9 28.4   >100 >100   
9 27.9 16.5 27.0 16.6 >100 77.6 65.5 34.0 
10 7.7 14.8 18.4 14.6 10.0 68.0 38.0 41.3 
11 9.3 15.3   88.9 96.8   
12 7.2 11.1   >100 >100   
13 7.1 6.4   5.1 >100 >100  
14 11.3 8.2   >100 >100   
15 1.6 5.5   >100 82.5   
16 0.6 0.7   2.0 7.7   
17 0.3 0.7   1.2 6.8   
18 0.5 0.4   3.4 1.5   
20 58.9 43.6   >100 >100   
23 0.7 1.4   2.7 7.8   
24 0.6 1.2   1.0 6.6   
25 0.7 0.9   0.9 7.0   
26 1.2 3.3   >100 75.9   
27 2.5 1.5   35.9 32.3   
29 6.9 15.5   50.6 28.7   
30 5.6 4.7   31.0 27.7   
34 13.3 9.6   42.8 21.7   




































































































































4.1  Introduction 
As discussed extensively in Section 4 of Chapter 1, enantioselective 
halogenation has been a problem vexing organic chemists for decades.  The first 
solutions to this problem began to appear in the late 20th century, but only very 
recently have there been significant advances in highly asymmetric halogenation 
reactions of alkenes (see Table 2 of Chapter 1).1  All of these successful approaches 
were published since 2007, when we began undertaking the work described in the 
following sections.   
Notwithstanding the excitement generated by recent successes, there still 
remain many unsolved challenges in asymmetric halogenation.  For example, there 
are currently no published methods for enantioselective bromonium-induced polyene 
cyclization (as described previously, even efforts towards inducing this reaction in a 
racemic fashion were difficult with traditional reagents).  Although there is one report 
of a highly enantioselective iodocyclization of polyene substrates, this procedure was 
significantly limited in its substrate scope (only three substrates were reacted 
successfully) and the method could not be effectively extended to asymmetric 
bromonium-induced cyclization.2  With the efficacy of BDSB well established for 
such cyclizations in racemic fashion, we next hoped to expand our method to include 
an enantioselective variant.  We also hoped that perhaps related reagents could 
initiate asymmetric alkene dihalogenation, another reaction for which there are 
presently very few available approaches.3  
The following sections will detail our forays into asymmetric halonium-
induced polyene cyclization, as well as our efforts towards enantioselective 
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dihalogenation and halohydrin formation.  Specifically, our work with chiral 
halosulfonium salts will be discussed, in addition to our development of a two-step 
surrogate for asymmetric halonium-induced polyene cyclization.4   
 
4.2  Chiral Variants of BDSB 
In Section 2 of Chapter 2, syntheses of simple dialkylbromosulfonium 
hexahaloantimonate salts were discussed.  Once it was established that the 
diethylsulfide-derived variant (BDSB) had the desired stability and solubility profile, 
the synthesis of other analogues was shelved during the investigation of substrate 
scope and subsequent total syntheses of the natural products 4-isocymobarbatol, 
peyssonol A, and peyssonoic acid A.5  However, upon completion of these 
experiments, we returned to investigate bromonium-induced polyene cyclization 
initiators of the general formula R2SBr•SbX6; in particular, we wished to investigate 
those complexes where R2S was a chiral sulfide.  
One of the reasons halosulfonium salts were initially pursued as halonium 
equivalents was the perceived potential for generating chiral reagents from chiral 
sulfides.  However, during our experimentation with BDSB, it was determined that 
the highly reactive nature of these bromodialkylsulfonium salts would impose strict 
limits on the functionality of potential chiral sulfides employed.  Solvent and 
substrate investigations suggested that alcohols, ethers, amines, alkenes, non-
deactivated aromatic rings and enolizable carbonyls would not be tolerated.  With 
these limitations in mind, the ideal chiral appendages were deemed to be simple 
aliphatic hydrocarbons. 
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Fortunately, there has been extensive interest in synthesizing chiral sulfides, 
driven mostly by their potential as ligands for asymmetric metal-catalyzed processes6 
and their utility in facilitating asymmetric epoxidation reactions via sulfur ylid 
chemistry.7  We initially narrowed down the hundreds of chiral sulfides in the 
literature to only those that were C2 symmetric.  This requirement was put in place 
because bromination at sulfur produces a tetrahedral sulfonium ion that is asymmetric 
at sulfur in the absence of C2 symmetry.  As depicted graphically in Scheme 1, a non-
C2 symmetric sulfide (i.e. 4) could lead to an undesired mixture of diastereomeric 
bromosulfonium ions (5 and 6).  The simplest C2 symmetric chiral sulfides reported 
in the literature are the 2,5-disubstituted thiolanes (tetrahydrothiophenes), pioneered 
by the Metzner group to facilitate asymmetric Corey-Chaykovsky epoxidation.7d  We 
wondered whether these dialkyl thiolanes could afford a chiral variant of BDSB that 




































The most readily accessible C2 symmetric chiral thiolane is (2R,5R)-
dimethyltetrahydrothiophene (9), which can be synthesized in two steps from (2S,5S)-
hexanediol (8), as shown in Scheme 2.  This chiral diol (8) can be purchased, but due 
to its expense it was preferable to synthesize 8 by an enzyme-mediated asymmetric 
reduction of 2,5-hexanedione (7) carried out by baker’s yeast.8  This enzymatic 
reduction could be performed on large scale to produce batches of up to 30 grams of 
the requisite diol with 95% e.e. (as determined by its optical rotatation).  Bis-
mesylation of 8, followed by nucleophilic cyclization with Na2S•9H2O, afforded 
desired thiolane 9.7d  The moderate yield observed for the sulfide cyclization is not 
due to the reaction efficiency (it is nearly quantitative), but rather the difficulty in 









Reagents and Conditions: (a) Baker's yeast, glucose, H2O, 20
h, 35 oC, 63% yield, 95% e.e. (b) MsCl (4.0 eq), Et3N (6.0 eq),
CH2Cl2, 1 h, -20 to 0
oC. (c) Na2S
.9H2O (2.0 eq), EtOH, 44 h,
0 to 25 oC, ~65% yield over 2 steps, 65% e.e. (d) Br2 (1.1 eq),
SbCl5 (1.2 eq), CH2Cl2, 15 min, -30
oC; recrystallize, 40%
yield. (e) aq NaHCO3, MeNO2, 5 min, 25
oC. (f) (COCl)2 (1.5
eq), NaI (2.0 eq), MeCN, 15 min, 0 oC, 66% yield over 2 steps,















Unfortunately, during the sodium sulfide cyclization step there is some 
erosion of e.e., likely due to undesired SN1 processes competing with desired SN2 
processes under the reaction conditions.  Nonetheless, we proceeded to treat the 
resultant enantioenriched thiolane (65% e.e.) with Br2 and SbCl5.  This procedure 
fortuitously led to formation of an orange crystalline solid, which was subsequently 
recrystallized to afford pure 10.  Since we could not measure the e.e. of this 
bromosulfonium salt directly (there was no published optical rotation value with 
which to compare it, in contrast to 8 and 9), we instead hydrolyzed 10 to sulfoxide 11, 
which in turn could be reduced back to 9 in the presence of (COCl)2 and NaI 
(although in retrospect, the mechanism proposed for this reduction suggests that 
perhaps NaI addition to 10 would have directly resulted in reduction to the sulfide).9  
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We were pleasantly surprised to discover that the recovered sulfide was now nearly 
enantiopure (97% e.e.), suggesting that the recrystallization process used to purify 
bromosulfonium salt 10 was enriching the e.e. of the product by selective 
crystallization of the major enantiomer. 
With this chiral analogue of BDSB in hand, we attempted an asymmetric 
bromonium-induced polyene cyclization of homogeranylbenzene (12), the model 
substrate that had served so well during our discovery and reaction optimization of 
BDSB.  As depicted in Entry 1 of Table 1, under typical conditions (MeNO2 solvent, 
5 min, –25 °C), 10 was capable of inducing the desired bromocyclization in good 
yield (~75%), but unfortunately the resultant product was racemic.  Again, based on 
the discussion in Section 4 of Chapter 1, this lack of enantioselectivity could be due 
to bromonium-transfer events eroding enantioselectivity, or one could infer that the 
chirality of 10 is too far removed from the reactive alkene of 12 to induce asymmetry 








































5 min, -25 oC
Table 1. Investigating chiral bromosulfonium 10 for
enantioselective bromonium-induced polyene cyclization.
 
 
In order to probe which of these reasons was to blame for the lack of 
enantioselectivity observed, we attempted to suppress bromonium-transfer.  As 
shown in Table 1 (Entries 2, 3, and 4), initial modifications involved higher dilution 
or lower temperature (using EtNO2 as solvent, since MeNO2 freezes at –29 °C); 
unfortunately, no enantioselectivity was observed under these conditions either.  We 
attempted reversing the typical order of addition by adding substrate slowly to a cold 
solution of 10 (Entry 5), hoping to minimize bromonium transfer by reducing the 
concentration of unreacted homogeranylbenzene in the presence of its bromonium 
ion; once again, however, only racemic product was formed.  Our final experiment 
was to conduct the reaction of homogeranylbenzene in a biphasic solvent mixture of 
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hexanes and MeNO2.  As illustrated in Scheme 3, hydrophobic 12 should prefer to 
remain in the hexanes layer, while ionic 10 should prefer the MeNO2 layer.  Ideally, 
upon reaction between 10 and 12, the resultant bromonium ion (14) would prefer the 
MeNO2 layer (or at least desire to orient the bromonium portion of the structure into 
the MeNO2 layer).  Since the MeNO2 layer has a very low effective concentration of 
homogeranylbenzene, bromonium transfer would hopefully be discouraged prior to 
cyclization of 14 to 13.  Nonetheless, these biphasic attempts (Table 1, Entries 6, 7, 
and 8) still afforded only racemic bromocyclized product.  Taken as a whole, the 
results in Table 1 suggest that bromonium transfer was probably not responsible for 
the lack of enantioselectivity observed during our bromocyclization reactions using 





































Scheme 3. A biphasic system to try to discourage bromonium-transfer reactions by
manipulating effective concentrations.
 
If bromonium transfer was not responsible for the lack of enantioselectivity 
observed, the alternative explanation was that our “chiral BDSB” (10) was in fact not 
sufficiently chiral.  This statement is predicated on the 180° angle between the 
incoming alkene and the sulfide (with respect to the bromine atom), which effectively 
minimizes interaction between the two, as do the lengthy sulfur-bromine and nascent 
carbon-bromine bonds.  As such, subsequent attempts were focused on building 
sulfides with larger substituents appended to the chiral centers, in the hope that 
interactions with the polyene would induce bromination to occur preferentially, if not 
exclusively, on one face of the reacting alkene.  
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Our initial investigations involved increasing the steric bulk of the alkyl 
groups at positions 2 and 5 on thiolane 9, as shown in Table 2.  Enantioenriched 2,5-
di-ethyl (16),7f di-isopropyl (18),10 and di-tert-butyl (20)10 thiolanes were approached 
(the requisite chiral diols could be purchased in the case of 15 and 17, while the di-
tert-butyl variant (19) was synthesized via Corey-Bakshi-Shibata [CBS] reduction of 
the corresponding dione).10  As expected, the sodium sulfide cyclizations of the 
resultant mesylates were more sluggish with increased bulk at the adjacent carbon.  
As such, even though bulkier thiolanes could be accessed by this method (16, 18, and 
20), it was presumed that these cyclic products were significantly racemized (since 
even the dimethyl variant lost 30% of its e.e. to competing SN1 processes during the 
Na2S•9H2O cyclization reaction).  This hypothesis seemed more likely after attempts 
to utilize the bromosulfonium hexahaloantimonate salts derived from sulfides 16, 18, 
and 20 for the bromocyclization of 12 afforded only racemic 13.  Although it was not 
determined whether or not these materials were in fact chiral, if they were, their 











EtOH, 0 to 25 oC, 40 h
EtOH, 25 oC, 22 h
EtOH, 25 oC, 7 d
EtOH, 25 oC, 24 h




















8: R = Me
15: R = Et
17: R = i-Pr
19: R = t-Bu
9: R = Me
16: R = Et
18: R = i-Pr












Table 2. Synthesis of bulkier 2,5-dialkylthiolanes, as well as
camphor-derived 21 and BINAS-derived 22.
 
 
Since we were unsuccessful in initiating asymmetric bromonium-induced 
polyene cyclizations using reagents derived from chiral thiolanes, we next turned our 
attention to reagents derived from other chiral sulfides.  There are numerous literature 
precedents for camphor-derived sulfides being used for asymmetric synthesis.6  As 
such, we synthesized known sulfide 21 (see the bottom portion of Table 2).7c  Upon 
treatment with Br2 and SbCl5, a promising orange crystalline solid was formed.  As 
with most of the bromosulfonium salts we produced, this product was not amenable 
to characterization, but presumably it was not simply the bromosulfonium derivative 
of 21, since the thioacetal moiety should be very sensitive to electrophilic activation 
at sulfur.  Further attempts to elucidate the structure of this orange solid were deemed 
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unnecessary after a test bromocyclization of homogeranylbenzene (12) initiated by 
this material afforded only racemic 13.   
Another markedly different sulfide investigated was BINAS derivative 22, 
which could be prepared in 4 steps from (R)-(+)-BINOL.11  We recognized that the 
naphthyl portion would likely undergo bromination under the conditions typically 
employed during the synthesis of bromosulfonium salts (Br2 and SbCl5, –30 to ~30 
°C).  Due to this concern, we instead attempted to form the bromonium salt in-situ by 
adding Br2 and SbCl5 to 22 at –78°C, followed by homogeranylbenzene (12).  
Apparently the in-situ reagent formation was successful, because a reasonably good 
yield of 13 could be isolated (~60%); unfortunately, this material proved to be 
racemic.  
At this point, we envisioned that perhaps moving the chiral centers closer to 
the reactive atom would have greater effect.  That is, rather than generating 
bromosulfonium complexes that have chiral carbons adjacent to sulfur, we hoped to 
synthesize a bromosulfonium complex that was chiral at sulfur.  This would result 
from an asymmetrically substituted but achiral sulfide in which the sulfur atom 
engaged bromine selectively using only one its two lone pairs.  The resultant 
bromosulfonium ion would hopefully resist racemization (to the best of our 
knowledge, such chiral-at-sulfur bromosulfonium complexes have never been 
investigated; however, related chiral tricoordinate sulfonium species such as 
alkoxysulfonium salts are conformationally stable).12  While no published methods 
exist for asymmetric bromination at sulfur, there are many examples of 
enantioselective oxidations of sulfides to sulfoxides.13  We envisioned that treatment 
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of a chiral sulfoxide with SOBr2 should stereoselectively (via inversion) afford the 
chiral bromosulfonium bromide, which could in turn react with SbCl5 to afford the 
desired bromosulfonium hexahaloantimonate salt.  Although this is not a known 
procedure, the analogous chlorosulfonium chloride syntheses from reactions of 
sulfoxides with SOCl2 are well documented.14   
In practice, we began by brominating thioanisole to afford p-bromothioanisole 
(24), as shown in Scheme 4.  This bromination step was undertaken to deactivate the 
aromatic ring in order to allow formation of the desired bromosulfonium without 
competing electrophilic aromatic bromination.  Asymmetric Kagan sulfoxidation of 
24 afforded the desired sulfoxide (25) in 60% yield and 83% e.e..15  Subsequent 
treatment with SOBr2 followed by SbCl5 did in fact result in an orange crystalline 
solid, which we tentatively assigned to be 26.  Unfortunately, efforts utilizing this 






By this time, although admittedly we had barely scratched the surface in terms 
of the number of chiral bromosulfonium salts we had employed, we felt that this 
approach was no longer worth pursuing.  Had we observed any enantioselectivity at 
all, we likely would have made additional attempts to optimize the reagent and/or 
conditions in order to investigate further, but unfortunately bromonium-induced 
polyene cyclizations using the chiral reagents we synthesized afforded only racemic 
product.  By this time, we had also realized the goal of an indirect two-step method to 
effect halonium-induced polyene cyclization (described in the following section).  
 
4.3  Asymmetric Mercury-Induced Polyene Cyclization: a Two-Step Surrogate 
for Asymmetric Halonium-Induced Polyene Cyclization 
Upon my introduction to the halogenation project in the summer of 2007, I 
was initially tasked with developing a two-step surrogate for enantioselective 
halonium-induced polyene cyclizations.  Professor Snyder recognized that literature 
precedent (at that time) suggested that chiral halonium reagents were incapable of 
initiating electrophilic cyclization reactions with meaningful enantioselectivity, and 
that perhaps the best solution would involve two steps: a cyclization induced by a 
chiral electrophilic metal complex followed by replacement of the carbon-metal bond 
with a carbon-halogen bond.  
The ideal electrophilic metal species was envisioned to be Hg(II), due to its 
well-documented ability to initiate racemic polyene cyclizations (see Scheme 5).16  In 
addition, a recent series of publications involving mercury-induced intramolecular 
cycloetherification of unsaturated alcohols had employed chiral bisoxazoline 
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complexes of Hg(II) to obtain cyclic ethers with up to 95% e.e..17  There are also 
well-established protocols for stereoselectively replacing the carbon-mercury bond 
with a carbon-bromine bond.16a  Given these precedents (depicted in Scheme 5), we 
were confident that we could develop a 2-step surrogate for enantioselective 
halonium-induced polyene cyclization.  One benefit of using mercury for this process 
is that the resultant organomercurials, unlike most organometallic compounds, are 
stable to air and water and can even be purified by silica gel chromatography.18  
Additionally, although volatile low molecular weight organomercurial halides (and 
related dialkylmercurials) are exceedingly toxic,19 their heavier analogues are 




Based on literature precedent, it was initially surmised that Hg(OTf)2 would 
represent the ideal electrophilic mercury(II) source, and that bisoxazoline ligands 
could be used to confer enantioselectivity.21  As illustrated in Scheme 6, these 
reagents provided a promising initial result using model substrate homogeranyl-3,5-
dimethoxybenzene (34).  Cyclization initiated by the complex formed from admixing 
Hg(OTf)2 with commercial bisoxazoline 37 afforded the desired organomercury 
triflate, which was subsequently transformed into the more stable, crystalline 
organomercury bromide 35 by stirring with aqueous NaBr.16a  Organomercurial 35 
was then reated with elemental bromine and lithium bromide in pyridine under an 
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oxygen atmosphere in the dark to afford the resultant bromide (these optimal 
conditions were developed by Hoye and Kurth for the stereoretentive replacement of 
HgX with Br, purported to occur by an SE2 reaction involving a 4-membered 
transition state).16a  Under these bromodemercuration conditions, the rate of 
bromination of the electron-rich aromatic ring was competitive, so excess bromine 
was employed in order to funnel the material to a single, dibrominated product (36).  
Brief optimization of solvent, temperature, reaction time, and concentration led to 
high yields observed for both the cyclization and bromination reactions.  More 
importantly, HPLC analysis of tricycle 36 was encouraging in that modest levels of 
enantioselectivity were observed.  Subsequent X-ray crystallography (Aaron Sattler, 


















Reagents and Conditions: (a) Hg(OTf)2 (1.2 eq), 37 (1.3 eq), MeCN/CH2Cl2, 5 min, 25
oC, then 34 (1.0 eq), 2 h, -78 oC, then aq. NaBr, 10 min, 25 oC. (b) Br2 (3.0 eq), LiBr (5.0
eq), pyridine (1 atm O2), 2 h, 25
oC, 75% yield, 28% e.e. over 2 steps. Hg(OTf)2 =
mercury(II) trifluoromethanesulfonate.
34 35 36
Scheme 6. Proof of principle: asymmetric mercury-induced polyene cyclization of 34
followed by bromodemercuration to afford 36 in 28% e.e.
 
We next wished to improve upon these initial results by investigating other 
chiral ligands.  Forays by my colleague (Dr. Andreas Schall) into non-bisoxazoline 
ligands (i.e. semicorrin, PyBox, Salen, diimine, or many sulfur- or phosphorous-based 
ligands) revealed that all were either incompatible with the reaction or facilitated 
product formation without enantioselection.  As such, efforts towards improving the 
enantioselectivity of the reaction (34 → 35) were focused on synthesizing and 
screening a diverse library of bisoxazoline ligands (only a handful are commercially 
available), with an emphasis on determining the optimal substituents on the ligand 
backbone, as well as both the 4-position and the 5-position of the oxazoline rings. 
As shown in Table 3, utilizing model substrate 34 to investigate ligand 
variation at the 4-position of the oxazoline ring revealed marked differences in 
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observed enantioselectivity.  Bulkier substituents resulted in increased 
enantioselectivity, but size alone might not explain the results observed in Table 3.  
Electronic factors may also be important, given that the steric differences between an 
isopropyl group (Entry 3) and a phenyl group (Entry 1) are presumably not so large as 
to explain the observed discrepancies in enantioselectivity.  Similarly, an adamantyl 
group (Entry 5) is presumably bulkier than a naphthyl substituent, but the naphthyl-














































Table 3. Ligand optimization: initial investigation of ligand
bulk for the asymmetric cyclization of 34.
 
 
For subsequent experiments, the oxazoline C4 substituent was kept constant 
as phenyl (although this substituent did not afford the highest e.e. in Table 3, it 
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allowed for the most expedient syntheses of the requisite ligands), while the C5 and 
backbone substituents were varied.  As shown in Table 4, the effect of introducing 
additional substituents at C5 is ambiguous; the resultant ligand either works as well, 
better, or worse than the analogous C5-H compound (compare Entries 1 through 6).  
However, backbone substitution exhibited an obvious trend towards increasing 
enantioselection with increasing size (Entries 1, 3, 5).  Additionally, comparing 
Entries 3 and 5 with Entries 7 and 8 suggests that a cyclic backbone is less effective 
than an acyclic backbone, again pointing to the importance of enantiodiscriminating 

































































Table 4. Ligand optimization: investigating ligands with smaller/larger




With preliminary optimization of the ligand undertaken, we next returned to 
optimization of the reaction conditions while employing the best ligand from Table 4 
(46).  We were delighted to find that changing the solvent from MeCN/CH2Cl2 to 
CH2Cl2 resulted in a significant increase in the observed enantioselectivity (40% e.e. 
→ 59% e.e.), without a significant drop in reaction yield.  As discussed previously 
(Chapter 2, Section 2), traditional polyene cyclizations employ highly polar aprotic 
solvents such as MeCN and MeNO2; the use of CH2Cl2 is less common for these 
types of reactions.22  However, upon consideration, the erosion of enantioselectivity 
observed in traditional polar solvents is likely due to their mercury-solvating 
effects,16g in which the metal center can partially or wholly escape the ligand 
framework (at which time it is presumed to be both more electrophilic and in a less 
chiral environment).  Hg(OTf)2 exhibits some solubility in MeCN and MeNO2, but is 
completely insoluble in CH2Cl2; thus it is perhaps more likely that only the fully 
ligated species is present in CH2Cl2 solution.   
With a newfound solvent of choice, further investigations were undertaken to 
determine the impact of continued increasing size at the backbone position of the 
ligand.  As illustrated in Table 5 (Entries 1 through 8), simple linear extension of the 
alkyl chains on the backbone resulted in increased e.e., up a point.  Further extension 
beyond the di-pentyl analogue actually resulted in slightly decreased enantioselection.  
This trend is difficult to explain, especially given that by traditional measurements 
(i.e. cyclohexane A values), longer alkyl chains are not significantly sterically bulkier 
than a simple methyl substituent.23  Perhaps these long chain alkyl groups are 
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important for hydrophobic interactions between the nonpolar polyene substrate and 































































Table 5. Ligand optimization: investigating longer alkyl chains on
the ligand backbone (using CH2Cl2 solvent)
 
 
The addition of aromatic moieties to the ligand backbone (Table 5, Entry 9) 
was detrimental to e.e., implying that both the electronic and steric properties of the 
backbone substituents are important for enantioselectivity.  Additionally, branched 
alkyl chains versus linear counterparts exhibited very similar levels of 
enantioselectivity (compare Entries 5 and 10).  A chiral tartrate-derived backbone, 
which exhibited better enantioselectivity for the asymmetric mercury-induced 
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etherification reaction reported by Kang et al.,17 was also synthesized; however, this 
chiral backbone proved inferior to the achiral dialkylated versions.  Ligands with 
even bulkier backbones where branching occurs closer to the central carbon (such as 
the variant where R1 is isopropyl) were targeted; however, after multiple failed 
attempts these were deemed too difficult to synthesize, likely due to the extent of 
steric congestion involved.  
With the optimal di-pentyl ligand backbone in hand (i.e. 51), we revisited the 
substituents on the oxazoline subunits of the ligand.  As shown in Table 6, addition of 
a second phenyl group to carbon 5 of the oxazoline (Entry 2) proved detrimental to 
the enantioselectivity, as did installing a more electron-deficient aromatic ring at the 
C4-position (Entry 3).  Meanwhile, increasing the electron density of the aromatic 
ring at the C4-position had no impact on e.e. (Entry 4).  Increasing the size of the C4 
substituent from phenyl to 2-naphthyl likewise had little impact on the 
enantioselectivity (Entry 5).  At this point, we were satisfied that our modified 
diphenylbisoxazoline ligand with pentyl backbone chains (51) was sufficiently 
optimized.  Ultimately, this ligand could be synthesized inexpensively and in gram-
quantities from diethylmalonate, 1-iodopentane, and (R)-phenylglycinol in 68% yield 
over 4 steps.  Alternatively, it could be synthesized in a single step by bis-alkylation 


















































Table 6. Ligand optimization: revisiting oxazoline substituents with optimal pentyl
backbone substituents.
 
With ligand 51, our optimized two step asymmetric cyclization/bromination 
protocol was capable of producing tricycle 36 in 79% yield and 72% e.e. (6.1:1 er).  
The intermediate organomercury bromide (35) was a remarkably crystalline solid 
such that the formation of large needles was often observed in the test tubes used to 
collect product-containing fractions during flash column chromatography.  Upon 
isolating these crystals, subsequent bromination and HPLC analysis revealed that the 
resultant 36 was nearly racemic.  Meanwhile, concentration of the mother liquor 
followed by bromination afforded 36 in 99% e.e..  Thus, by selective crystallization 
of the racemate of 35, enantiopure 36 could be isolated in 53% yield from 34.  
Another realization we made at this time was that perhaps the low solubility of 
Hg(OTf)2 in CH2Cl2, in conjunction with the higher solubility of its ligand-bound 
form, could facilitate the use of substoichiometric amounts of ligand 51.  This indeed 
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proved to be the case; as illustrated in Table 7, reducing the ligand loading by a factor 
of four (Entry 3) still afforded the desired product in 56% e.e. (3.5:1 er).  We also 
investigated superstoichiometric ligand loadings (Entries 8 and 9), but were 
disappointed to see that these resulted in a significant drop in enantioselectivity, 
likely indicating that a 1:1 ligand:metal complex affords the highest levels of 












































Table 7. Investigating the stoichiometry of optimized ligand 51.
 
 
With the optimal reagents and conditions required to effect a two step 
surrogate for asymmetric bromonium-induced polyene cyclization well understood, 
further efforts focused on substrate variation.  As depicted in Table 8, we were able to 
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successfully extend the developed method to a number of geraniol-derived substrates 
with various terminating groups.  An added benefit of the two-step mercury 
cyclization/halogenation protocol is that not only can enantioselectivity be observed, 
but installation of chlorine, bromine, or iodine is possible in the second step.  This 
potential is showcased by entries 3, 4, and 5, wherein homogeranylbenzene (12) can 
be transformed into chlorocycle 61, bromocycle 13, or iodocycle 62.  Fortuitously, 
the stereoselective halogen replacement procedure (elemental halogen, LiX, pyridine, 
O2 atmosphere)18 could be extended to chlorine without any erosion in 
diastereoselectivity; with iodine, however, competing radical iodination resulted in 
the formation of small amounts of the undesired diastereomer; this outcome is in line 
with previous examples of such a reaction.18  Also worth noting is that with 
homogeranylbenzene (12, Entries 3,4, and 5), termination of the cyclization by 
Friedel-Crafts alkylation is sluggish; it was discovered that added triflic acid was 
required to encourage this final ring closure and boost the yield of the desired 
tricycle.  This additional step was not necessary in more polar solvents like 
acetonitrile, but unfortunately the enantioselectivity of the cyclization is much lower 




















































4b 61: X = Cl






a: e.e. enhanced by recrystallization.
b: TfOH added at the end of the mercury step to facilitate conversion to the desired tricycle.






69 70: protected 4-isocymobarbatol




Additionally, Entries 6 through 10 in Table 8 reveal that ester and ketone 
terminating groups are tolerated, as are MOM-protected phenols.  In entry 6, the 
intermediate organomercurial was reduced to alkane 64 with NaBH4, since the enol-
ether functionality proved unstable to the halodemercuration conditions.  Overall, the 
yields and enantioselectivities of all products in Table 8 were generally moderate to 
good with the exception of Entry 7.  As a whole, these results (especially Entries 7 
and 9) suggest that steric bulk in the vicinity of the distal alkene may be detrimental 
to the enantioselectivity of the reaction.   
Entries 9 and 10 of Table 8 represent a formal asymmetric total synthesis of 4-
isocymobarbatol (see Section 2 of Chapter 3).24  The enantioselectivity of the 
cyclization step is rather modest (approximately 3:1 in favor of the naturally 
occurring enantiomer, although recrystallization could improve this er to 19:1), 
perhaps due to the steric bulk in proximity to the distal alkene.  Experimentation with 
the group ortho- to the geranyl fragment (a MOM-protected phenol in 69) reinforced 
this hypothesis; the e.e. was higher (although the yield was much lower) when this 
group was hydroxy (~60%) or methoxy (59%); meanwhile, the e.e. was lower if this 
group was a benzyl ether (43%).  
In conclusion, we developed a two step surrogate for enantioselective 
halonium-induced polyene cyclization using a chiral mercury electrophile to initiate 
the cyclization.  Extensive optimization of the chiral ligand employed resulted in a 
procedure that afforded moderate to good enantioselection for a variety of polyene 
substrates.  The use of an uncharacteristically nonpolar solvent and increased steric 
bulk at the achiral backbone portion of the bisoxazoline ligand were crucial to 
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obtaining the enantioselectivities observed.  Although this method is stoichiometric in 
mercury and not highly enantioselective, it nonetheless represents the first published 
means to access a variety of architectures of this type enantioselectively.  The 
developed reaction is also currently the only method capable of enantioselectively 
introducing three different halogen atoms with equal facility. 
 
4.4  Chiral Halosulfonium Salts for Asymmetric Dihalogenation 
The experimental results described thus far in this chapter (as well as those of 
Chapter 2 and Chapter 3) have focused on halonium-induced polyene cyclizations, 
reactions which were difficult to undertake even in racemic fashion prior to our 
efforts.  Meanwhile, dihalogenations of alkenes are reactions that have been 
successfully employed for well over a century and for which dozens of methods have 
been utilized.25  Yet, the development of effective enantioselective dihalogenations 
has proven incredibly difficult.  Although there have been a handful of successful 
methods that apply to a narrow range of substrates,3 no general solution to this 
problem currently exists.  In 2007, at the outset of this research program, there were 
only two published examples of significantly asymmetric alkene dihalogenations.3ab   
We were drawn to investigate asymmetric dihalogenation not only because it 
was an area in which there were few successful methods, but also because we felt it 
would allow us to avoid some of the perceived issues involved in asymmetric 
halonium-induced polyene cyclizations.  One such obviated circumstance might be 
halonium transfer, which could be less facile with a potent halide nucleophile present 
to attack the halonium ion.  Although the intramolecular attack of a second alkene on 
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the halonium ion is favored entropically, the intermolecular attack of a halide anion 
should be highly favored enthalpically; as such, this halonium ion quenching would 
hopefully occur more rapidly than halonium transfer (this hypothesis necessarily 
invokes the Hammond Postulate to correlate highly exothermic thermodynamic 
effects to rapid kinetic effects).26  In addition to this, we recognized that although we 
were largely concerned with bromine for halonium-induced polyene cyclization (due 
to the prevalence of cyclic bromides among the halogenated natural products), in the 
arena of asymmetric dihalogenation we would be equally pleased with a successful 
protocol for chlorine or iodine.  This was promising from the standpoint of observing 
enantioselectivity because it has been established that halonium-transfer processes are 
slower for chlorine than bromine.27  Additionally promising from the standpoint of 
using a chiral halosulfonium complex, carbon-chlorine and sulfur-chlorine bonds are 
shorter than the corresponding bromine analogues, allowing for a shorter distance 
between the chiral centers of the halonium species and the reactive alkene.  
With these distinctions in mind, we set about attempting to use chiral sulfides 
to initiate asymmetric dichlorination of alkenes.  Experimentally, we selected 1,2-
dihydronaphthalene (71) as our model substrate for a number of reasons: 
1. The aromatic chromophore of the dichloro-product (72) was 
amenable HPLC analysis using a standard UV-detector. 
2. We believed that the conformational stability of the cyclic alkene 
would provide us with a greater chance of observing 
enantioselectivity than would an acyclic alkene. 
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3. The benzylic nature of the chloronium formed would lead to 
regiospecific capture of halide to complete the dihalogenation, 
which is a necessary requirement for enantioselectivity.  If the 
halonium and halide are derived from the same halogen atom, 
halide capture at the other position would produce the enantiomer. 
4. Racemic chlorination of 1,2-dihydronaphthalene with Cl2 is a 
clean, high-yielding reaction.   
We initially expected that asymmetric chlorination reactions could be initiated 
by chlorosulfonium chloride complexes synthesized from the combination of chiral 
sulfides and elemental chlorine.28  Since it is known that most chlorosulfonium 
chlorides are not stable at room temperature (i.e. chlorodimethylsulfonium chloride: 
the Swern reagent produced from the combination of dimethylsulfoxide and oxalyl 
chloride),29 we did not expect to isolate these compounds, instead desiring to form 
them in-situ.  The chiral sulfides we chose to use initially were the same 
dialkylthiolanes we had attempted to use for asymmetric bromonium-induced polyene 
cyclization, due to both their C2 symmetry and ease of synthesis.   
As shown in Table 9, treatment of 1,2-dihydronapthalene (71) with Cl2 (Entry 
1) afforded dichloride 72 quite efficiently.  However, as indicated by Entries 2 
through 5, attempts to utilize the chlorosulfonium chloride derived from the reaction 
of chlorine and thiolane 9 resulted in no detectable yield of the desired dichloride.  By 
the immediate disappearance of the distinctive yellow chlorine color upon addition of 
the sulfide, we presume that we are indeed forming the desired chlorosulfonium 
chloride.  Quenching this clear solution with aqueous sodium sulfite affords the 
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sulfoxide derived from 9 (11), which provides further evidence for chlorosulfonium 
formation.  In terms of the reaction with 71, at –78 °C (Entry 2), no consumption of 
the alkene occurs and the thiolane can be recovered as sulfoxide 11 after aqueous 
quench.  Meanwhile, if the reaction is allowed to warm (Entry 3), the alkene similarly 
fails to react; however, upon quench the thiolane has been degraded.  As a whole, 
these results suggest that the temperature required for the alkene to attack the 
chlorosulfonium chloride is higher than the temperature at which the chlorosulfonium 
chloride decomposes.  Varying the reaction solvent (Entries 4 and 5) unfortunately 
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Table 9. Initial forays into asymmetric dichlorination using chiral halosulfonium salts.
 
Although we expected to obtain an unpleasant mixture of products (mostly 
polymerized or oligomerized), we also attempted to react 1,2-dihydronaphthalene 
with the chlorosulfonium hexachloroantimonate complex derived from our chiral 
thiolane, Cl2, and SbCl5 (Table 9, Entry 6).  We were surprised to find that not only 
was the predominant product dichloride 72, but also that it was produced with small 
amounts of e.e. (the enantiomer drawn is for illustrative purposes only; we did not 
determine the absolute configuration of the major enantiomer for this reaction or any 
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described in the remainder of this section).  Apparently, the hexahaloantimonate 
counterion can serve as a halide source in cases where the halonium ion formed 
cannot undergo an intramolecular reaction (i.e. cyclization).  
Following up on this initial result, we briefly examined temperature (Table 9, 
Entries 6 and 7) and solvent effects (Entries 10 through 12).  Higher 
enantioselectivities were observed in more polar solvents, but at the expense of yield; 
meanwhile, temperature seemed to play a small but significant role in the 
enantioselectivity of the reaction.  Additionally, as shown in Entries 8 and 9, utilizing 
excess thiolane afforded product 72 with higher e.e..  Entry 13 describes addition of 
the crystalline salt (73) formed separately by combining chiral thiolane 9, Cl2, and 
SbCl5, then recrystallizing the resultant white solid.  This purified chlorosulfonium 
salt affords the desired product in higher yield but with slightly lower e.e. than when 
prepared in-situ (compare Entries 7 and 13).  Additionally, the reaction between 71 
and 73 in the presence of added 9 failed to produce product with higher e.e. than that 
shown in Entry 13 (compare to Entries 8 and 9).  These observations suggest that 
preparation of the reagent in-situ may generate a subtly different halogenating reagent 
(perhaps with a different ratio of thiolanes to bromonium ions) that effects a more 
enantioselective reaction.  Alternatively, it is also possible that in-situ reagent 
formation simply results in the formation of a byproduct that happens to have the 
same silica gel Rf and HPLC retention time as the major enantiomer, leading to 
artificially high e.e. values in these cases.  We are confident, however, in the 14% e.e. 
value observed for Entry 13 (which was verified by optical rotation measurements).  
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We should note that at this point, having observed some success in initiating 
chlorination enantioselectively, we returned to the chloronium-induced polyene 
cyclization of homogeranylbenzene (12).  However, using 73 as the initiator for this 
reaction unfortunately afforded only racemic chlorocyclized product 61 (in the 
expected low yield and as a mixture of diastereomers).  
Prior to further optimization of the asymmetric chlorination results showcased 
in Table 9, we wished to briefly investigate the other halogens.  As such, the 
bromonium and iodonium hexahaloantimonate complexes of thiolane 9 were 
prepared (10 and 74), as shown in Scheme 7.  Interestingly, upon reaction with 
bromonium variant 10, 1,2-dihydronaphthalene (71) afforded almost exclusively the 
BrCl addition product, with only trace amounts of the BrBr addition product 
observed.  Statistically, one should expect a 5:1 mixture of BrCl addition to BrBr 
addition, given that the halide is captured from the SbBrCl5 counterion.  However, the 
actual ratio may be governed by the higher electronegativity of chloride; that is, the 
charge on the counterion is localized more on the chlorine atoms than the bromine 
atom, making chloride easier to abstract than bromide.  The resultant bromochloride 
(75) was not especially stable (which accounts for the low yield of the isolated 
product), but we were able to determine by HPLC that it was racemic or at least very 

















Reagents and Conditions: (a) Br2 (1.0 eq), SbCl5 (1.1 eq), CH2Cl2, 15 min, -30
oC,
recrystallize, 40% yield. (b) ICl (1.0 eq), SbCl5 (1.1 eq), CH2ClCH2Cl, 30 min, -25
oC, recrystallize, 76% yield. (c) 10 (1.2 eq), MeNO2/CH2Cl2, 10 min, -30
oC, ~15%
yield, <5% e.e. (d) 74 (1.2 eq), CH2Cl2, 10 min, -30
oC, 0% yield. (e) 74 (2.2 eq),
MeCN, 20 min, -20 oC, then H2O, 20 min, 25














Scheme 7. Investigating asymmetric bromochlorination and iodochlorination of 71.
 
The iodonium variant (74) of the chiral halosulfonium salt proved more 
amenable to synthesis when ICl was used as the iodine source rather than I2; as such, 
the resulting complex has a hexachloroantimonate counterion.  Upon reaction of 74 
with 1,2-dihydronapthalene (71), we were dismayed to find that the resultant ICl 
addition product (76) was highly unstable and decomposed rapidly on silica gel.  The 
observed stability trend (72 > 75 > 76) likely reflects both the nucleophilicity and 
electropositivity of the non-benzylic halide; the highly nucleophilic, more 
electropositive I of 76 can easily expel the adjacent benzylic chloride by anchimeric 
assistance, resulting in an iodonium ion that can decompose by any number of 
pathways.  Meanwhile, this process is less facile with Br (75) and much less so with 
Cl (72).  However, we found that simply adding water at conclusion of the 
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iodochlorination reaction permitted isolation of stable iodohydrin 77 in 68% yield and 
as a single diastereomer (anchimeric assistance facilitates substitution with retention 
in this case).  We were also delighted to find that this compound was produced with 
38% e.e..   
At this junction, we decided to continue our investigations of asymmetric 
halogenation using the iodination reaction (71 → 77), since it consistently afforded 
higher e.e. than the analogous chlorination reaction (71 → 72).  Since we questions as 
to the veracity of some of the e.e. values observed during our enantioselective 
dichlorination, we first ensured that the purity of 77 could be guaranteed to provide 
reproducible data; thankfully, this was the case.  Next, extensive optimization efforts 
were undertaken, as depicted in Table 10.  We determined initially (Entries 1 through 
7) that the highest enantioselectivities were observed when using 2-3 equivalents of 
initiator 74 (which may suggest that a more enantioselective initiator is formed in 
solution by the aggregation of two or more monomeric 74 components; alternatively, 
the presence of adventitious water could require a superstoichiometric loading [vide 
infra]).  Furthermore, we determined that the reaction was complete after 1-5 
minutes, as quenching prior to the 5-minute mark afforded material with significantly 
lower e.e. (Entry 8).  In this case, the yield was still equally high, presumably because 
the IOH formed upon aqueous quenching of 74 readily adds across the alkene of 1,2-
dihydronaphthalene (71);30 this hypothesis was supported by the observation that 






















































































































































































a: pre-stir initiator for 1 h (-78 to -20 oC) prior to adding starting material.
b: 50 mg powdered 3A molecular sieves added.



























Table 10. Optimization efforts for the asymmetric iodohydroxylation of 71.
 
With the optimal reaction time and initiator equivalents determined, we next 
varied concentration, reaction temperature, and solvent (Table 10, Entries 12 through 
19).  The optimal concentration of 71 was determined to be approximately 5 mg/mL 
(0.04 M), and the enantioselectivity improved with both lower temperatures and less 
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polar solvent mixtures.  However, reaction yields suffered considerably if solvent 
polarity was too low (Entries 18 and 19).  With these results in hand, we next 
investigated the combination of very low temperatures in a less polar solvent mixture 
(Entries 20 and 21).  At –78 °C, the reaction was very slow, such that even after two 
hours, quenching provided product with significantly reduced enantioselectivity 
(again, presumably due to IOH production leading to racemic iodohydrin formation).  
Slow warming over 1 hour provided 77 with 53% e.e., a significant improvement 
over our initial hit of 38%.  Pre-stirring the initiator (Entry 22) or addition of 
powdered molecular sieves (Entry 23) failed to improve upon this result.  However, 
as seen in Entry 24, utilizing the diethyl variant of 74 as the iodonium source afforded 
another boost in enantioselectivity, up to 63% (e.r. = 4.4:1).  This result suggests that 
further optimization of the initiator structure could produce highly enantioenriched 
product.  
At this point, with a significantly optimized procedure in hand, we next set out 
to investigate the substrate scope for this asymmetric iodohydroxylation reaction.  
Several 1,2-dihydronaphthalene analogues were purchased or synthesized and reacted 
with 74, as illustrated in Scheme 8.  Unfortunately, the results were not encouraging.  
Even very similar substrates such as indene (78) or monomethylated variants of 71 
(80 and 82) afforded the desired iodohydrin products in very low yields.  When 
enough pure product could be obtained to check the enantioselectivity by HPLC, the 
results were similarly disappointing.  Attempts to re-optimize the asymmetric 




































71 78 80 82
74 74 74
77 79 81 83
84 86 88
85 87 89
74; H2O 74; H2O 74; H2O
Scheme 8. Investigating other substrates for asymmetric
iodohydroxylation or iodolactonization.
 
   
We next examined variants of 1,2-dihydronaphthalene with carboxylic acids 
appropriately located to afford iodolactones upon iodonium activation of the alkene.  
We were hoping these might afford a more successful reaction since their reaction 
profile should be fundamentally different – that is, the rate-determining step for 
iodolactonization of these substrates would hopefully by iodonium formation (as 
opposed to nucleophilic capture, which is presumed to be the rate-determining step 
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for the iodochlorination reaction).  As shown in the bottom portion of Scheme 8, three 
such substrates (84, 86, and 88) were reacted with chiral iodonium 74;31 in all three 
cases the desired product was afforded in moderate to good yield, but 
enantioselectivity was not observed.  From the results observed in Scheme 8, it was 
clear that the enantioselectivity of the developed iodohydroxylation reaction was 
highly sensitive to steric and electronic modifications of the substrate. 
At this point we recognized that we had developed a moderately 
enantioselective iodohydroxylation of 1,2-dihydronaphthalene, but this was of little 
use since the method could not be extended to other substrates, even very similar 
ones.  We decided to move on to other endeavors, keeping in mind that it might one 
day be worthwhile to revisit this chemistry and attempt to further develop it. 
 
4.5  Conclusion 
Overall, our results in the arena of asymmetric halogenation were less 
successful than we would have liked.  As discussed extensively in Section 4 of 
Chapter 1, there are only a handful of effective asymmetric halogenation protocols, 
most of which were developed in the last few years.  The majority of these published 
methods rely on complex bifunctional catalysts that likely coordinate to both the 
substrate and the halogen source to afford a highly organized transition state.  In 
hindsight, the chiral halosulfonium complexes we synthesized were likely too simple 
to facilitate such complicated interactions.  This could potentially explain their failure 
to effect halonium-induced polyene cyclizations enantioselectively.  Nonetheless, we 
did have some success in this arena; our developed asymmetric mercury-induced 
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polyene cyclization served as an effective two-step surrogate for this desired 
reactivity.  Although products were not produced with very high enantioselectivity, 
this method still represents one of the only viable solutions to this problem.  
Meanwhile, our efforts to explore asymmetric dihalogenation using simple 
chiral BDSB, CDSC, and IDSI analogues also fared with some success.  Modest 
enantioselection was observed for both chlorination and iodination reactions.  
Although the substrate scope of the developed asymmetric iodohydroxylation 
reaction is extremely narrow at present, we were able to asymmetrically iodinate an 
alkene in 63% e.e. using a remarkably simple chiral halonium source.  To the best of 
our knowledge, there have only been three prior reports of significantly asymmetric 
(i.e. >50% e.e.) iodination in the literature; all three are intramolecular 
iodocyclization reactions that have relied on substantially more complex initiators.32  
Although preliminary, these results certainly indicate that chiral halosulfonium salts 
merit further study as initiators for enantioselective halogenation reactions.  
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Veitch, G. E.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2010, 49, 7332.  
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4.7  Experimental Section 
 
General Procedures.  All reactions were carried out under an argon 
atmosphere with dry solvents under anhydrous conditions, unless otherwise noted.  
Dry methylene chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and 
tetrahydrofuran (THF) were obtained by passing commercially available pre-dried, 
oxygen-free formulations through activated alumina columns; acetonitrile (MeCN) 
and nitromethane (MeNO2) were stored over 3 Å molecular sieves, pyridine was 
distilled from CaH2 and stored over 3 Å molecular sieves; diisopropylamine (iPr2NH) 
was distilled from KOH and stored over 3 Å molecular sieves; triethylamine (Et3N) 
was distilled from KOH; 1,2-dichloroethane, acetone, and methanol (MeOH) were 
purchased in anhydrous form from Sigma-Aldrich and used as received.  Yields refer 
to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated.  
Reactions were magnetically stirred and monitored by thin-layer chromatography 
(TLC) carried out on 0.25 mm E. Merck silica gel plates (60F-254) using UV light 
and/or I2 on silica as visualizing agents and an aqueous solution of phosphomolybdic 
acid and cerium sulfate or a solution of KMnO4 in aqueous sodium bicarbonate with 
heat as developing agents.  Preparative thin-layer chromatography was carried out on 
0.50 mm E. Merck silica gel plates (60F-254).  SiliCycle silica gel (60, academic 
grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
NMR spectra were recorded on Bruker DRX-300, DRX-400, and 500 ASCEND 
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instruments and calibrated using residual undeuterated solvent as an internal 
reference.  The following abbreviations were used to explain the multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent.  
IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR spectrometer. 
High-resolution mass spectra (HRMS) were recorded in the Columbia University 
Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (Fast 
Atom Bombardment) and EI (Electron Ionization) techniques.  Characterization data 
are not provided for known compounds. 
 
Abbreviations.  BDSB = bromodiethylsulfonium 
bromopentachloroantimonate, DBU = 1,8-diazobicycloundec-7-ene, DMF = N,N-
dimethylformamide, i-Pr2NH = diisopropylamine, MOMCl = chloromethyl methyl 
ether, MsCl = methanesulfonyl chloride, n-BuLi = n-butyllithium, (n-Bu)4NCl = 
tetrabutylammonium chloride, t-BuLi = tert-butyllithium, TfOH = 
trifluoromethanesulfonic acid, TMSCHN2 = trimethylsilyldiazomethane. 
 
(S,S)-2,5-Hexanediol (8).  (Procedure adapted from: Lieser, J. K. Synth. 
Commun. 1983, 13, 765).  In 2 5-L beakers: glucose (90 g) and 2,5-hexanedione (6.0 
mL) were dissolved in water (600 mL) and the resultant solution was gently stirred at 
35 °C.  Baker’s yeast (120 g) was added and within 5 min there was evolution of a 
large amount of CO2 (near-constant agitation of the foam above the reaction was 
necessary to prevent it from spilling out of the beaker).  Once CO2 evolution had 
ceased (~2 h), a solution of glucose (24 g), yeast (10 g) and 2,5-hexanedione (~3 mL) 
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were added to each beaker, followed by aqueous 0.1 M KOH (50 mL).  These 
additions were repeated every hour for 6 hours (total 2,5-hexanedione added: 25.5 mL 
per reaction vessel), with constant attention required to prevent the reaction from 
foaming out of the beakers.  One final aliquot of yeast (20 g) and glucose (40 g) in 
water (300 mL) was added and the resultant mixture was allowed to react for 12 
additional h at 35 °C.  Upon completion, NaCl (300 g) was added to each reaction 
vessel, which was stirred vigorously for 15 min.  The reaction solution was extracted 
in 250 mL portions with EtOAc (2 × 500 mL).  The combined organic layers were 
washed with brine (300 mL), dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:EtOAc:MeOH, 1:0:0 → 0:1:0 → 
0:4:1) to afford 8 (32.3 g, 63% yield) as a colorless crystalline solid.  Optical rotation: 
[α]D23 = 34.2 (c = 5.25, CHCl3), 95% e.e.; lit. = 36.0 for enantiopure material. 
 
(2R,5R)-Dimethylthiolane (9).  (Procedure adapted from: Zanardi, J.; 
Leriverend, C.; Aubert, D.; Julienne, K.; Metzner, P. J. Org. Chem. 2001, 66, 5620).  
MsCl (7.86 mL, 102 mmol, 4.00 equiv) was added dropwise to a solution of 8 (3.00 
g, 25.4 mmol, 1.00 equiv) and Et3N (21.1 mL, 152 mmol, 6.00 equiv) in CH2Cl2 (50 
mL) at –20 °C.  The resultant light orange solution was allowed to warm to 0 °C over 
the course of 1 h, then quenched by the addition of aqueous 1 M HCl (100 mL) and 
extracted with CH2Cl2 (3 × 100 mL).  The combined organic layers were washed with 
brine (100 mL), dried (MgSO4), filtered, and concentrated to afford the crude bis-
mesylate product.  Powdered sodium sulfide nonahdryate (12.2 g, 50.8 mmol, 2.00 
equiv) was dissolved in EtOH (80 mL) and the resultant solution was cooled to 0 °C.  
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The bis-mesylate (25.4 mmol assumed, 1.00 equiv) was added and the resultant 
yellow solution was reacted for 4 h at 0 °C, then allowed to warm slowly to 25 °C 
over the course of 4 h and stirred at that temperature for an additional 36 h.  Upon 
completion, the reaction mixture was poured into water (150 mL) and extracted with 
pentane (4 × 150 mL).  The combined organic layers were washed with water (3 × 
100 mL), then brine (2 × 100 mL), dried (MgSO4), filtered, and carefully 
concentrated by rotary evaporation (→250 torr @ 15 °C).  The desired product was 
purified by vacuum distillation (→ 120 °C @ 100 torr) to afford 9 (2.70 mL, 
contaminated with diethylsulfide and pentane, ~65% yield) as a colorless malodorous 
liquid. Optical rotation (redistilled, pure aliquot): [α]D23 = 109.1 (c = 1.74, Et2O), 65% 
e.e.  
 
“Chiral BDSB” (10).  Thiolane 9 (0.26 g, 2.2 mmol, 1.0 equiv) was added 
dropwise to a solution of Br2 (0.126 mL, 2.5 mmol, 1.1 equiv) in CH2Cl2 (2 mL) at –
30 °C.  Next, a solution of SbCl5 (2.69 mL, 1.0 M in CH2Cl2, 2.7 mmol, 1.2 equiv) 
was added dropwise.  The resultant heterogeneous orange mixture was stirred for 15 
min at –30 °C, then warmed gently until all solids had dissolved (~35 °C) and 
allowed to cool slowly to 25 °C, then cooled slowly to 4 °C, then cooled slowly to –
20 °C.  After 16 h at –20 °C, the filtrate was removed via pipet and the resultant 
crystals were rinsed with cold CH2Cl2 (2 × 1 mL) and dried to afford 10 (0.52 g, 40% 
yield) as a yellow crystalline solid.  Optical rotation: [α]D23 = 25.7 (c = 1.30, MeNO2).  
As with most of the halosulfonium salts produced, spectral data was not obtained for 
this compound.  
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Chiral Sulfoxide 11.  Saturated aqueous sodium bicarbonate (10 mL) was 
added to a solution of 10 (0.30 g, 0.52 mmol) in MeNO2 (5 mL) at 25 °C.  After 10 
min of vigorous stirring at 25 °C, this heterogeneous mixture was extracted with 
EtOAc (4 × 10 mL) and the combined organic layers were dried (MgSO4), filtered, 
and concentrated to afford crude 11.  Reduction to sulfide 9: Sodium iodide (0.16 g, 
1.0 mmol, 2.0 equiv) was added to a solution of 11 (0.52 mmol assumed) in MeCN (2 
mL) at 0 °C.  Next, oxalyl chloride (0.068 mL, 0.78 mmol, 1.5 equiv) was added 
dropwise (with a vent needle – gas evolution occurs).  After 15 min at 0 °C, the 
reaction mixture was quenched by the careful addition of 5% aqueous sodium sulfite 
(5 mL) and the resultant heterogeneous mixture was stirred vigorously at 25 °C for 20 
min.  This mixture was extracted with pentane (4 × 5 mL) and the combined organic 
layers were washed with water (10 mL), saturated aqueous sodium bicarbonate (10 
mL), and brine (20 mL), then dried (MgSO4), filtered, and purified by vacuum 
distillation (see synthesis of 9) to afford 9 (0.040 g, 66% yield) as a colorless liquid.  
Optical rotation: [α]D23 = 163.8 (c = 1.33, Et2O), 97% e.e.; lit. = 169.6 for enantiopure 
material.  11: Rf  = nd; 1H NMR (300 MHz, (CD3)2CO) δ 3.08 (sextet, J = 7.5 Hz, 1 
H), 2.79 (m, 1 H), 2.48 (m, 1 H), 2.23 – 2.04 (m, 3 H), 1.37 (t, J = 7.5 Hz, 6 H). 
 
Homogeranylbenzene (12).  (Procedure adapted from: Araki, S.; Sato, T.; 
Butsugan, Y. J. Org. Chem. 1982, 47, 285).  Diethyl chlorophosphate (6.20 mL, 42.8 
mmol, 1.50 equiv) was added dropwise to a solution of geraniol (5.00 mL, 28.5 
mmol, 1.00 equiv) and pyridine (6.90 mL, 85.5 mmol, 3.00 equiv) in Et2O (15 mL) at 
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–15 °C.  The reaction mixture was allowed to warm slowly to 25 °C over the course 
of 3 h, then quenched by the addition of aqueous 1 M HCl (75 mL) and extracted with 
EtOAc (3 × 50 mL).  The combined organic layers were washed with saturated 
aqueous sodium bicarbonate (2 × 30 mL) and brine (30 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:3) to afford geranyl diethyl phosphate (7.28 g, 88% yield) 
as a light yellow oil.  Next, a solution of benzyl chloride (0.23 mL, 2.0 mmol, 2.0 
equiv) in THF (5 mL) was added dropwise to Mg turnings (activated with an acidic 
rinse and thoroughly flame dried, 0.097 g, 4.0 mmol, 4.0 equiv) at 0 °C.  After 1 h at 
0 °C, the resultant benzylmagnesium chloride solution was cooled to –40 °C and 
added quickly via syringe to a solution of geranyl diethyl phosphate (0.29 g, 1.0 
mmol, 1.0 equiv) in THF (1 mL) at –40 °C.  The resultant reaction mixture was then 
allowed to warm slowly to 25 °C over 12 h, then quenched by the addition of 10% 
aqueous ammonium chloride (15 mL) and extracted with hexanes:EtOAc (2:1, 3 × 20 
mL).  The combined organic layers were washed with brine (20 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 9:1) to afford 12 (0.21 g, 92% yield) as a colorless oil. 
 
Bromocyclized Homogeranylbenzene (13).  A pre-cooled solution of chiral 
initiator 10 (28 mg, 0.048 mmol, 1.1 equiv) in MeNO2 (1 mL) was added quickly via 
syringe to a solution of 12 (10 mg, 0.044 mmol, 1.0 equiv) in MeNO2 (3 mL) at –25 
°C.  After 5 min at –25 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 10 mL).  
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This heterogeneous mixture was stirred vigorously for 20 min at 25 °C, then poured 
into brine (10 mL), and extracted with hexanes
 
(4 × 10 mL).  The combined organic 
layers were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 9:1) to afford mostly pure 13 (11 mg, 
~80% yield) as a white crystalline solid.  13: m.p. 100.0 – 101.5 °C; Rf = 0.49 (silica 
gel, hexanes:CH2Cl2, 4:1); IR (film) νmax 3058, 2968, 2947, 2838, 1488, 1476, 1448, 
1377, 764, 723 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.24 – 7.04 (m, 4 H), 4.06 (dd, J 
= 12.8, 4.4 Hz, 1 H), 3.02 – 2.85 (m, 2 H), 2.44 – 2.23 (m, 3 H), 1.99 (m, 1 H), 1.82 
(m, 1 H), 1.61 (dt, J = 13.6, 3.6 Hz, 1 H), 1.48 (dd, J = 12.0, 2.4 Hz, 1 H), 1.26 (s, 3 
H), 1.17 (s, 3 H), 1.08 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 148.8, 134.9, 129.2, 
126.0, 125.7, 124.6, 69.0, 51.4, 40.2, 40.0, 38.0, 31.7, 30.9, 30.7, 25.0, 20.7, 18.4; 
HRMS (FAB) calcd for C17H23Br+ [M]+ 306.0983, found 306.0981; HPLC (OD 
column, 2.0% 2-propanol in hexanes, 1.0 mL/min, 30 °C, 265 nm) tR = 6.92, 9.43 
min.  
 
(2R,5R)-Diethylthiolane (16).  (Procedure adapted from: Zanardi, J.; 
Leriverend, C.; Aubert, D.; Julienne, K.; Metzner, P. J. Org. Chem. 2001, 66, 5620).  
Prepared according to the procedure used for the synthesis of 9 [except that the Na2S 
cyclization step was performed at 25 °C for 22 h], affording 16 (0.28 g, contaminated 
with some pentane and minor impurities, ~75% yield) as a colorless malodorous 
liquid.  The bromosulfonium complex derived from 16 was prepared according to the 
procedure used for the synthesis of 10, affording the desired product (0.15 g, 50% 
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yield) as a yellow crystalline solid.  As with most of the halosulfonium salts 
produced, spectral data was not obtained for this compound. 
 
(2S,5S)-Diisopropylthiolane (18).  (Procedure adapted from: Piccinini, A.; 
Kavanagh, S. A.; Connon, P. B.; Connon, S. J. Org. Lett. 2010, 12, 608).  Prepared 
according to the procedure used for the synthesis of 9 [except that the Na2S 
cyclization step was performed at 25 °C for 7 days, and purification was effected by 
flash column chromatography (silica gel, pentane) rather than vacuum distillation], 
affording 18 (0.60 g, contaminated with some pentane and minor impurities, ~50% 
yield) as a colorless malodorous liquid.  The bromosulfonium complex derived from 
18 was prepared according to the procedure used for the synthesis of 10, affording the 
desired product (0.40 g, 35% yield) as a yellow crystalline solid.  As with most of the 
halosulfonium salts produced, spectral data was not obtained for this compound. 
 
2,2,7,7-Tetramethyl-(3R,6R)-Octanediol (19).  Prepared according to the 
following reference: Piccinini, A.; Kavanagh, S. A.; Connon, P. B.; Connon, S. J. 
Org. Lett. 2010, 12, 608. 
 
(2S,5S)-Di-tert-butylthiolane (20).  Attempted preparation of 20 from 19 
according to the procedure used for the synthesis of 9 afforded only a very small 
amount of desired product.  As such, an alternate protocol was utilized:  A solution of 
the bis-mesylate derived from 19 (1.7 mmol assumed, 1.0 equiv) in DMF (2 mL) was 
added to a suspension of anhydrous sodium sulfide (0.27 g, 3.4 mmol, 2.0 equiv) in 
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DMF (3 mL) at 50 °C.  After 24 h, the reaction mixture was poured into water (10 
mL) and extracted with hexanes (3 × 10 mL).  The combined organic layers were 
washed with water (2 × 10 mL) and brine (2 × 10 mL), dried (MgSO4), filtered, 
concentrated carefully by rotary evaporation (→ 50 torr @ 20 °C) and purified by 
flash column chromatography (silica gel, hexanes:CH2Cl2, 9:1) to afford 20 (0.040 g, 
12% yield) as a white crystalline solid.  The bromosulfonium complex derived from 
20 was prepared according to the procedure used for the synthesis of 10, affording the 
desired product (0.055 g, 38% yield) as a yellow crystalline solid.  As with most of 
the halosulfonium salts produced, spectral data was not obtained for this compound.  
20: Rf  = 0.7 (silica gel, hexanes:CH2Cl2, 3:1); 1H NMR (300 MHz, CDCl3) δ 3.28 
(m, 2 H), 2.03 (m, 2 H), 1.54 (m, 2 H), 0.96 (s, 18 H). 
 
Menthol-Derived Sulfide 21.  Prepared according to the following reference: 
Aggarwal, V. K.; Ford, J. G.; Thompson, A.; Jones, R. V. H.; Standen, M. C. H. J. 
Am. Chem. Soc. 1996, 118, 7004.  The corresponding bromosulfonium complex was 
synthesized as follows: Br2 (0.28 mL, 5.4 mmol, 1.0 equiv) was added dropwise to a 
solution of sulfide 21 (1.14 g, 5.4 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at –78 °C.  
Next, a solution of SbCl5 (5.4 mL, 1.0 M in CH2Cl2, 5.4 mmol, 1.0 equiv) was added 
dropwise.  The resultant heterogeneous orange mixture was stirred for 10 min at –78 
°C, then warmed to 25 °C.  Gentle heating did not induce dissolution of the observed 
orange solid, but the reaction flask was moved to –20 °C anyway.  After 16 h at –20 
°C, the resultant orange powder was rinsed with cold CH2Cl2 (2 × 1 mL) and dried.  
As with most of the halosulfonium salts produced, spectral data was not obtained for 
 454 
this compound.  A test cyclization of 12 using this material as the initiator afforded 13 
in ~60% yield, but HPLC analysis of the product determined it was racemic.  
 
BINAS-Derived Sulfide 22.  Prepared according to the following reference: 
Fabbri, D.; Delogu, G.; De Lucchi, O. J. Org. Chem. 1993, 58, 1748.  The 
corresponding bromosulfonium complex was synthesized and tested in situ as 
follows: A solution of Br2 (16 mg, 0.10 mmol, 1.0 equiv) in CH2Cl2 (0.3 mL) was 
added dropwise to a solution of sulfide 22 (35 mg, 0.10 mmol, 1.0 equiv) in EtNO2 (5 
mL) at –78 °C.  Next, a solution of SbCl5 (0.10 mL, 1.0 M in CH2Cl2, 0.10 mmol, 1.0 
equiv) was added dropwise.  The resultant homogeneous red solution was stirred for 
10 min at –78 °C, and then a solution of 12 (23 mg, 0.10 mmol, 1.0 equiv) in EtNO2 
(2 mL) was added quickly.  After 10 min at –78 °C, the reaction mixture was 
quenched by the addition of saturated aqueous sodium bicarbonate and 5% aqueous 
sodium sulfite (1:1, 10 mL).  The resultant heterogeneous mixture was stirred 
vigorously for 20 min at 25 °C, then poured into brine (10 mL) and extracted with 
hexanes
 
(4 × 10 mL).  The combined organic layers were dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 9:1) to afford mostly pure 13 (22 mg, ~70% yield) as a white 
crystalline solid.  HPLC analysis of this product determined it was racemic.  
 
p-Bromothioanisole (24).  Br2 (3.3 mL, 65 mmol, 1.3 equiv) was added 
dropwise to a solution of thioanisole (5.86 mL, 50.0 mmol, 1.0 equiv) in CH2Cl2 (60 
mL) buffered with calcium carbonate (5.0 g, 50 mmol, 1.0 equiv) at –20 °C, with a 
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vent hose leading to an HBr trap (significant amounts of gas evolution).  The reaction 
mixture was allowed to warm slowly to 25 °C over the course of 2.5 h, then quenched 
by the addition of 5% aqueous sodium sulfite and saturated aqueous sodium 
bicarbonate (1:1, 100 mL).  The resultant biphasic mixture was stirred vigorously for 
10 min at 25 °C, then extracted with CH2Cl2 (3 × 75 mL).  The combined organic 
layers were dried (MgSO4), filtered, and concentrated to afford 24 (9.87 g, 97% yield) 
as a white crystalline solid. 
 
Chiral Sulfoxide 25.  Prepared according to the following reference: Pitchen, 
P.; Kagan, H. B. Tetrahedron Lett. 1984, 25, 1049.  Flash column chromatography of 
the resultant product (silica gel, hexanes:EtOAc, 1:2) afforded 25 (1.57 g, 60% yield) 
as a light yellow crystalline solid.  Optical rotation: [α]D23 = 81.5 (c = 2.55, Me2CO), 
83% e.e.; lit. = 98.3 for enantiopure material (Ref: Capozzi, M.; Cardellicchio, C.; 
Naso, F.; Tortorella, P. J. Org. Chem. 2000, 65, 2843).  [Note: recrystallization from 
boiling hexanes failed to significantly increase the e.e. of this product]. 
 
Chiral-At-Sulfur Bromosulfonium 26.  Thionyl bromide (0.54 mL, 6.9 
mmol, 1.0 equiv) was added dropwise to a solution of 25 (1.52 g, 6.94 mmol, 1.00 
equiv) in CH2Cl2 (20 mL) at –78 °C.  Next, a solution of SbCl5 (6.94 mL, 1.0 M in 
CH2Cl2, 6.9 mmol, 1.0 equiv) was added slowly.  The resultant heterogeneous orange 
solution was allowed to warm to 25 °C, at which time a significant amount of 
precipitate remained.  As such, the solution was re-cooled to –78 °C and vacuum 
filtered under argon to afford crude 26 as an orange powder.  Several test reactions 
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with 12 consistently afforded 13 (~10 mg, ~70% yield) that was racemic by HPLC 
analysis.  Intriguingly, this reagent afforded a large amount (~20% yield) of a 
diastereomer of 12 during these reactions; the reason for this observation is unknown.  
26: Rf  = N/A; 1H NMR (400 MHz, (CD3)2SO) δ 7.80 (m, 2 H), 7.65 (m, 2 H), 2.76 
(s, 3 H) [Note: contaminated with significant amounts of what is either the sulfide or 
sulfoxide]. 
 
3,5-Dimethoxyhomogeranylbenzene (34).  (Procedure adapted from: Araki, 
S.; Sato, T.; Butsugan, Y. J. Org. Chem. 1982, 47, 285).  A solution of 3,5-
dimethoxybenzyl chloride (0.37 mL, 2.0 mmol, 2.0 equiv) in THF (5 mL) was added 
dropwise to Mg turnings (activated with an acidic rinse and thoroughly flame dried, 
0.097 g, 4.0 mmol, 4.0 equiv) at 0 °C.  After 1 h at 0 °C, the resultant 3,5-
dimethoxybenzylmagnesium chloride solution was cooled to –40 °C and added 
quickly via syringe to a solution of geranyl diethyl phosphate [see synthesis of 12] 
(0.29 g, 1.0 mmol, 1.0 equiv) in THF (1 mL) at –40 °C.  The resultant reaction 
mixture was allowed to warm slowly to 25 °C over the course of 16 h, then quenched 
by the addition of 10% aqueous ammonium chloride (15 mL) and extracted with 
hexanes:EtOAc (2:1, 3 × 20 mL).  The combined organic layers were washed with 
brine (20 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 1:0 → 2:1).  The resultant product was 
dried for 1 h at 100 °C under vacuum to remove residual 3,5-dimethoxytoluene in 
order to afford pure 34 (0.27 g, 95% yield) as a colorless oil.  34: Rf = 0.41 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2928, 2855, 2837, 1596, 1462, 1428, 1205, 1155, 
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1068, 829 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.37 (d, J = 2.0 Hz, 2 H), 6.30 (t, J = 
2.0 Hz, 1 H), 5.19 (dt, J = 1.2, 7.2 Hz, 1 H), 5.10 (tt, J = 6.8, 1.2 Hz, 1 H), 3.78 (s, 6 
H), 2.59 (t, J = 8.0 Hz, 2 H), 2.30 (q, J = 7.6 Hz, 2 H), 2.12 – 1.96 (m, 4 H), 1.69 (s, 3 
H), 1.61 (s, 3 H), 1.59 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 160.8 (2 C), 145.0, 
135.9, 131.5, 124.5, 123.7, 106.7 (2 C), 97.8, 55.4 (2 C), 39.9, 36.6, 29.9, 26.9, 25.8, 
17.8, 16.2; HRMS (FAB) calcd for C19H28O2+ [M]+  288.2089, found 288.2086.  
 
Tricyclic Organomercurial 35.  HgOTf (15.6 mg, 0.0312 mmol, 1.20 equiv) 
was added to a solution of 37 (11.3 mg, 0.0338 mmol, 1.30 equiv) in CH2Cl2/MeCN 
(1:1, 1 mL) at 25 °C.  After 5 min at 25 °C, the resultant homogeneous solution was 
cooled to –78 °C and a solution of 34 (7.5 mg, 0.0260 mmol, 1.00 equiv) in 
CH2Cl2/MeCN (1:1, 1 mL) was added slowly.  After 2 h at –78 °C, the reaction 
mixture was quenched by the addition of saturated aqueous sodium bromide (1 mL) 
and the resultant biphasic mixture was stirred vigorously at 25 °C for 10 min, then 
extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:CH2Cl2, 1:2) to afford 35 (13.3 mg, 90% yield) as a white crystalline 
solid.  35: Rf = 0.40 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2979, 2924, 2848, 
2831, 1607, 1577, 1460, 1292, 1157, 1087, 1015 cm–1; 1H NMR (400 MHz, CDCl3) δ 
6.27 (d, J = 1.8 Hz, 1 H), 6.18 (d, J = 1.8 Hz, 1 H), 3.75 (s, 6 H), 3.18 (dt, J = 10.7, 
2.7 Hz, 1 H), 2.86 (m, 3 H), 2.27 (dq, J = 10.2, 2.7 Hz, 1 H), 1.97 (dq, J = 10.5, 2.7 
Hz, 1 H), 1.81 (dd, J = 8.4, 4.2 Hz, 1 H), 1.62 (m, 1 H), 1.38 (d, J = 8.4 Hz, 1 H), 
1.21 (dt, J = 9.9, 2.7 Hz, 1 H), 1.15 (s, 3 H), 1.13 (s, 3 H); 13C NMR (75 MHz, 
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CDCl3) δ 159.6, 158.2, 138.7, 129.3, 104.9, 97.8, 77.4, 56.6, 55.3, 55.2, 40.3, 39.9, 
38.9, 37.2, 33.6, 27.7, 26.5, 20.9, 19.9; HRMS (FAB) calcd for C19H27BrHgO2+ [M]+ 
567.0881, found 567.0903. 
 
Tricyclic Dibromide 36.  (Procedure adapted from: Hoye, T. R.; Kurth, M. J. 
J. Org. Chem. 1979, 44, 3461).  Organomercurial 35 (13.3 mg, 0.0234 mmol, 1.0 
equiv) and anhydrous LiBr (11 mg, 0.12 mmol, 5.0 equiv) were sealed under an O2 
atmosphere.  Anhydrous pyridine (0.4 mL) was then added and the resultant mixture 
was stirred for 10 min at 25 °C.  The reaction flask was then covered with aluminum 
foil, and a freshly prepared solution of Br2 (0.13 mL, 0.56 M in pyridine, 0.070 mmol, 
3.0 equiv) was added dropwise via syringe.  The resultant mixture was stirred at 25 
°C for 2 h in the dark, then quenched by the addition of 5% aqueous sodium sulfite
 
(5 
mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 9:1) to afford 36 (8.8 mg, 84% yield) as a white crystalline solid.  
36: Rf = 0.40 (silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 2943, 2871, 2838, 1589, 
1456, 1434, 1344, 1312, 1201, 1179, 1073, 1022, 696 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 6.38 (s, 1 H), 4.04 (dd, J = 12.8, 4.4 Hz, 1 H), 3.87 (s, 3 H), 3.81 (s, 3 H), 
3.09 (dt, J = 3.6, 14.0 Hz, 1 H), 2.96 (dd, J = 17.6, 3.6 Hz, 1 H), 2.67 (ddd, J = 19.2, 
12.4, 6.8 Hz, 1 H), 2.30 (dq, J = 3.6, 13.2 Hz, 1 H), 2.13 (dq, J = 13.6, 4.0 Hz, 1 H), 
1.96 (dd, J = 13.2, 6.8 Hz, 1 H), 1.62 (dq, J = 5.6, 12.4 Hz, 1 H), 1.32 (s, 3 H), 1.28 
(m, 2 H), 1.16 (s, 3 H), 1.05 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 158.3, 154.4, 
138.0, 131.0, 106.1, 95.6, 69.4, 56.4, 55.5, 53.8, 40.4, 39.6, 38.4, 35.2, 32.0, 31.0, 
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20.6, 19.6, 19.0; HRMS (FAB) calcd for C19H26Br2O2+ [M]+ 444.0300, found 
444.0304; HPLC (OD column, 1.5% 2-propanol in hexanes, 1.0 mL/min, 30 °C, 288 
nm), tr (major) = 6.21 min, tr (minor) = 6.94 min. 
 
Diadamantyl Bisoxazoline Dimethyl Backbone (41).  The requisite chiral 
amino alcohol was prepared from 1-adamantaneacetic acid according to the following 
reference: Takacs, J. M.; Jaber, M. R.; Vellekoop, A. S. J. Org. Chem. 1998, 63, 
2742.  Next, a solution of dimethylmalonyl dichloride (0.73 mL, 0.22 M in CH2Cl2, 
0.16 mmol, 1.0 equiv) was added dropwise very slowly to a solution of the amino 
alcohol (0.063 g, 0.32 mmol, 2.0 equiv) and triethylamine (0.11 mL, 0.81 mmol, 5.0 
equiv) in CH2Cl2 (5 mL) at 0 °C.  After 1 h at 0 °C, the reaction mixture was 
quenched by the addition of aqueous 1 M HCl (5 mL) and extracted with CH2Cl2 (3 × 
5 mL).  The combined organic layers were washed with saturated aqueous sodium 
bicarbonate (10 mL; back-extract with 10 mL CH2Cl2), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc:MeOH, 1:0:0 → 0:1:0 → 0:9:1) to afford the desired diamide (0.052 
g, 66% yield) as a white crystalline solid.  Next, MsCl (0.027 mL, 0.35 mmol, 3.0 
equiv) as added to a solution of the diamide (0.052 g, 0.12 mmol, 1.0 equiv) and 
triethylamine (0.16 mL, 1.2 mmol, 10 equiv) in CH2Cl2 (5 mL) at 0 °C.  After 15 min 
at 0 °C, the reaction mixture was quenched by the addition of 10% aqueous 
ammonium chloride (10 mL) and extracted with EtOAc (3 × 10 mL).  The combined 
organic layers were washed with brine (15 mL), dried (MgSO4), filtered, and 
concentrated to afford the corresponding bis-mesylate, which was subsequently 
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dissolved in THF/MeOH (1:1, 4 mL) and treated with aqueous 1 M NaOH (2 mL) at 
25 °C.  After 1 h at 25 °C, the reaction mixture was quenched by the addition of 10% 
aqueous ammonium chloride (10 mL) and extracted with EtOAc (3 × 10 mL).  The 
combined organic layers were washed with brine, dried (MgSO4), filtered, and 
purified by flash column chromatography (silica gel, hexanes:EtOAc, 1:1) to afford 
41 (0.028 g, 53% yield) as a white crystalline solid.  41: Rf  = 0.4 (silica gel, 
hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 4.18 (dd, J = 8.4, 7.2 Hz, 2 H), 
4.07 (dd, J = 9.9, 8,7 Hz, 2 H), 3.68 (dd, J = 9.9, 7.2 Hz, 2 H), 2.02 – 1.93 (m, 6 H), 
1.76 – 1.54 (m, 18 H), 1.50 (s, 6 H), 1.44 – 1.35 (m, 6 H). 
 
Dinaphthyl Bisoxazoline Dimethyl Backbone (42).  The requisite chiral 
amino alcohol was prepared according to the following reference: Bandini, M.; Cozzi, 
P. G.; Gazzano, M.; Umani-Ronchi, A. Eur. J. Org. Chem. 2001, 1937.  From this 
amino alcohol, bisoxazoline synthesis was carried out following the same procedure 
used to access 41, affording 42 (0.092 g, 27% yield over 3 steps) as a white 
crystalline solid. 42: Rf  = 0.3 (silica gel, hexanes:EtOAc, 1:1); 1H NMR (400 MHz, 
CDCl3) δ 7.83 – 7.69 (m, 8 H), 7.47 – 7.35 (m, 6 H), 5.43 (dd, J = 10.0, 7.2 Hz, 2 H), 
4.77 (dd, J = 10.0, 8.4 Hz, 2 H), 4.28 (t, J = 8.0 Hz, 2 H), 1.75 (s, 6 H). 
 
Tetraphenyl Bisoxazoline Dimethyl Backbone (45).  Commercially 
available dihydro-backbone ligand 44 was bis-alkylated according to the following 
reference: Davies, I. W.; Gerena, L.; Castonguay, L.; Senanayake, C. H.; Larsen, R. 
D.; Verhoeven, T. R.; Reider, P. J. Chem Commun. 1996, 1753.  The desired ligand 
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(45, 0.047 g, 89% yield) was obtained as a light yellow crystalline solid.  45: Rf  = 0.2 
(silica gel, hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.02 (s, 10 H), 6.96 
(s, 10 H), 5.97 (d, J = 10.2 Hz, 2 H), 5.60 (d, J = 9.9 Hz, 2 H), 1.93 (s, 6 H). 
 
Diphenyl Bisoxazoline Diethyl Backbone (46).  Diethyl malonate (2.00 mL, 
13.2 mmol, 1.00 equiv) was added dropwise under a constant flow of argon to a 
suspension of NaH (0.64 g, 60% in mineral oil, 15.8 mmol, 1.20 equiv) in THF (20 
mL) at 0 °C.  Iodoethane (1.17 mL, 14.5 mmol, 1.1 equiv) was then added and the 
solution was refluxed at 75 °C for 3 h.  Upon completion, the reaction mixture was 
cooled to 0 °C and quenched by the careful addition of aqueous 1 M HCl (10 mL).  
The resultant biphasic mixture was poured into brine (20 mL) and extracted with 
EtOAc (3 × 20 mL).  The combined organic layers were washed with saturated 
aqueous sodium bicarbonate (20 mL) and brine (20 mL), dried (MgSO4), filtered, and 
concentrated.  This mostly monoalkylated material was resubjected to the alkylation 
procedure outlined above (longer reaction time: 4 d @ 75 °C).  The resultant material 
was purified by flash column chromatography (silica gel, hexanes:EtOAc, 9:1) to 
afford diethyl diethylmalonate (1.50 g, 53% yield) as a light yellow oil.  A portion of 
this compound (0.50 g, 2.3 mmol, 1.0 equiv) was then dissolved in MeOH/EtOH (1:1, 
4 mL) and treated with aqueous 3 M NaOH (4 mL, 12 mmol, 5 equiv).  The resultant 
heterogeneous mixture was refluxed at 70 °C with vigorous stirring for 16 h.  Upon 
completion, the reaction contents washed with CH2Cl2 (2 × 2 mL), then cooled to 0 
°C and acidified by the slow addition of aqueous 12 M HCl (~3 mL).  The resultant 
mixture was poured into brine (10 mL) and extracted with EtOAc (5 × 30 mL).  The 
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combined organic layers were dried (MgSO4), filtered, and concentrated to afford 
diethylmalonic acid (0.36 g, 97% yield) as a light yellow solid.  Next, oxalyl chloride 
(0.58 mL, 6.9 mmol, 3.0 equiv) was added dropwise to a solution of diethylmalonic 
acid (0.36 g, 2.3 mmol, 1.0 equiv) and DMF (0.036 mL, 0.46 mmol, 0.2 equiv) in 
CH2Cl2 (8 mL) at 0 °C, with continuous venting of the gas produced.  The reaction 
mixture was allowed to warm to 25 °C and stirred at that temperature for 16 h, then 
concentrated by rotary evaporation in a fume hood and redissolved in CH2Cl2 (~9 
mL) to afford a 0.23 M solution of dethylmalonyl dichloride.  Amidation with 
commercially available (R)-phenylglycinol followed by cyclodehydration were 
undertaken according to the procedure used to synthesize 41, affording 46 (0.265 g, 
37% yield over 3 steps) as a light yellow amorphous solid.  46: Rf  = 0.4 (silica gel, 
hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.25 (m, 10 H),  5.28 (dd, 
J = 9.9, 8.1 Hz, 2 H), 4.69 (dd, J = 10.2, 8.4 Hz, 2 H), 4.14 (t, J = 8.1 Hz, 2 H), 2.18 
(m, 4 H), 0.98 (t, J = 7.5 Hz, 6 H) [Note: the attached 1H NMR spectrum is 
contaminated with acetone – this is from the tube, not the sample itself]. 
 
Tetraphenyl Bisoxazoline Diethyl Backbone (47).  Prepared according to 
the procedure used to synthesize 45, affording 47 (0.051 g, 91% yield) as a light 
yellow crystalline solid.  47: Rf  = 0.5 (silica gel, hexanes:EtOAc, 1:1); 1H NMR (300 
MHz, CDCl3) δ 7.06 – 6.88 (m, 20 H), 5.95 (d, J = 10.2 Hz, 2 H), 5.60 (d, J = 9.9 Hz, 
2 H), 2.55 – 2.22 (m, 4 H), 1.14 (t, J = 7.5 Hz, 6 H).  
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Diphenyl Bisoxazoline Cyclobutyl Backbone (48).  Prepared as in the 
synthesis of 46; starting from diethyl malonate and 1,3-dibromopropane, the same 
steps afforded 48 (0.176 g, 8% yield over 6 steps) as a light yellow amorphous solid.  
48: Rf  = 0.5 (silica gel, hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.40 – 
7.23 (m, 10 H), 5.30 (dd, J = 9.9, 7.5 Hz, 2 H), 4.74 (dd, J = 10.2, 8.4 Hz, 2 H), 4.22 
(t, J = 7.8 Hz, 2 H), 2.79 (t, J = 7.8 Hz, 4 H), 2.18 (m, 2 H) [Note: the attached 1H 
NMR spectrum is contaminated with acetone – this is from the tube, not the sample 
itself]. 
 
Diphenyl Bisoxazoline Cyclopentyl Backbone (49).  Prepared as in the 
synthesis of 46; starting from diethyl malonate and 1,4-dibromobutane, the same 
steps afforded 49 (0.602 g, 38% yield over 6 steps) as a light yellow amorphous solid.  
49: Rf  = 0.4 (silica gel, hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.40 – 
7.23 (m, 10 H), 5.26 (dd, J = 10.2, 7.5 Hz, 2 H), 4.70 (dd, J = 10.2, 8.4 Hz, 2 H), 4.19 
(t, J = 7.8 Hz, 2 H), 2.44 (m, 4 H), 1.85 (m, 4 H) [Note: the attached 1H NMR 
spectrum is contaminated with acetone – this is from the tube, not the sample itself]. 
 
Diphenyl Bisoxazoline Dibutyl Backbone (50).  Prepared as in the synthesis 
of 46; starting from diethyl malonate and 1-bromobutane, the same steps afforded 50 
(0.150 g, 49% yield over 6 steps) as a light yellow amorphous solid.  50: Rf  = 0.3 
(silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 7.40 – 7.25 (m, 10 
H), 5.27 (dd, J = 9.9, 8.1 Hz, 2 H), 4.68 (dd, J = 9.9, 8.4 Hz, 2 H), 4.14 (t, J = 8.1 Hz, 
2 H), 2.13 (m, 4 H), 1.41 – 1.29 (m, 8 H), 0.95 (t, J = 6.9 Hz, 6 H). 
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Diphenyl Bisoxazoline Dipentyl Backbone (51).  First Generation Synthesis: 
Prepared as in the synthesis of 46; starting from diethyl malonate and 1-
bromopentane, the same steps afforded 51 (0.098 g, 30% yield over 6 steps) as a light 
yellow amorphous solid.  Second Generation Synthesis: Diethyl malonate (3.00 mL, 
13.2 mmol, 1.00 equiv) was added dropwise under a constant flow of argon to a 
suspension of NaH (1.03 g, 60% in mineral oil, 25.7 mmol, 1.30 equiv) in THF (20 
mL) at 0 °C.  1-Iodopentane (3.88 mL, 29.6 mmol, 1.50 equiv) was then added and 
the solution was refluxed at 75 °C for 12 h.  Upon completion, the reaction mixture 
was cooled to 0 °C and quenched by the careful addition of aqueous 1 M HCl (40 
mL).  The resultant biphasic mixture was poured into brine (20 mL) and extracted 
with EtOAc (3 × 30 mL).  The combined organic layers were washed with saturated 
aqueous sodium bicarbonate (40 mL) and brine (40 mL), dried (MgSO4), filtered, and 
concentrated.  This mostly monoalkylated material was resubjected to the exact same 
alkylation procedure outlined above.  The resultant material was purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 19:1) to afford diethyl 
dipentylmalonate (4.78 g, 80% yield) as a light yellow oil.  Next, aqueous 6 M NaOH 
(40 mL, 240 mmol, 15 equiv) was added to a solution of diethyl dipentylmalonate 
(4.78 g, 15.9 mmol, 1.00 equiv) in 1-propanol (20 mL).  The resultant heterogeneous 
mixture was refluxed with vigorous stirring at 110 °C for 16 h.  Upon completion, the 
top layer was concentrated by rotary evaporation and returned to the reaction mixture, 
which was then cooled to 0 °C and acidified by the slow addition of aqueous 12 M 
HCl (~35 mL).  The resultant mixture was poured into brine (50 mL) and extracted 
 465 
with Et2O (5 × 100 mL).  The combined organic layers were dried (MgSO4), filtered, 
concentrated, and recrystallized from boiling hexanes (crop 1: 15 mL; crop 2: 3 mL) 
to afford dipentylmalonic acid (3.83 g, 99% yield) as a white crystalline solid.  Next, 
a portion of this dipentylmalonic acid (1.00 g, 4.09 mmol, 1.00 equiv) and DMF 
(0.064 mL, 0.82 mmol, 0.20 equiv) were dissolved in CH2Cl2 (25 mL).  Oxalyl 
chloride (1.73 mL, 20.5 mmol, 5.00 equiv) was added dropwise at 25 °C under a 
constant flow of argon.  The reaction solution was heated to 40 °C for 1 h, then 
cooled and concentrated by rotary evaporation in a fume hood.  The crude diacid 
chloride was redissolved in CH2Cl2 (20 mL) and added via addition funnel (over 
approximately 30 min) to a suspension of (R)-phenylglycinol (1.23 g, 9.00 mmol, 
2.20 equiv) and Et3N (2.84 mL, 20.5 mmol, 5.00 equiv) in CH2Cl2 (75 mL) at –78 °C.  
Once the addition was complete, the reaction mixture was allowed to warm slowly to 
0 °C over the course of 2 h, then quenched by the addition of aqueous 1 M HCl (50 
mL) and extracted with CH2Cl2 (3 × 150 mL).  The combined organic layers were 
washed with a mixture of saturated aqueous sodium bicarbonate and brine (1:1, 100 
mL) which was back-extracted with CH2Cl2 (100 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and recrystallized from boiling EtOAc 
(crop 1: 40 mL; crop 2: 10 mL) to afford the desired diamide product (1.79 g, 91% 
yield) as a white crystalline solid.  Lastly, MsCl (1.24 mL, 16.0 mmol, 5.00 equiv) 
was added dropwise to a solution of the diamide (1.54 g, 3.19 mmol, 1.00 equiv) and 
Et3N (4.4 mL, 32 mmol, 10 equiv) in CH2Cl2 (60 mL) at –78 °C.  After 10 min at –78 
°C, the reaction contents were allowed to warm to 25 °C, and aqueous 4 M KOH (20 
mL) and (n-Bu)4NCl (0.20 g, 0.80 mmol, 0.25 equiv) were added sequentially.  After 
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3 h of vigorous stirring at 25 °C, the organic layer was separated and the aqueous 
layer was extracted with additional CH2Cl2 (2 × 15 mL).  The combined organic 
layers were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 4:1) to afford 51 (1.36 g, 95% yield) as a 
colorless amorphous solid.  Overall: 68% yield over 5 steps.  51: Rf = 0.55 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2952, 2922, 2865, 1652, 1491, 1448, 698 cm–1; 
1H NMR (400 MHz, CDCl3) δ 7.37 – 7.24 (m, 10 H), 5.24 (dd, J = 10.0, 8.0 Hz, 2 H), 
4.65 (dd, J = 10.0, 8.4 Hz, 2 H), 4.12 (t, J = 8.0 Hz, 2 H), 2.11 (m, 4 H), 1.33 (br s, 12 
H), 0.88 (t, J = 6.4 Hz, 6 H); 13C NMR (75 MHz, CDCl3) δ 169.3 (2 C), 142.6 (2 C), 
128.8 (4 C), 127.6 (2 C), 126.9 (4 C), 75.1 (2 C), 69.7 (2 C), 46.4, 32.7 (2 C), 32.1 (2 
C), 27.8 (2 C), 22.6 (2 C), 14.1 (2 C); HRMS (FAB) calcd for C29H39N2O2+ [M+H]+ 
447.3012, found 447.2991. 
 
Diphenyl Bisoxazoline Dihexyl Backbone (52).  Prepared as in the synthesis 
of 46; starting from diethyl malonate and 1-bromohexane, the same steps afforded 52 
(0.33 g, 44% yield over 6 steps) as a light yellow amorphous solid.  52: Rf  = 0.3 
(silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.25 (m, 10 
H), 5.27 (dd, J = 9.9, 7.8 Hz, 2 H), 4.68 (dd, J = 10.2, 8.4 Hz, 2 H), 4.14 (t, J = 8.1 
Hz, 2 H), 2.13 (m, 4 H), 1.42 – 1.25 (m, 16 H), 0.90 (t, J = 6.9 Hz, 6 H). 
 
Diphenyl Bisoxazoline Dioctyl Backbone (53).  Prepared as in the synthesis 
of 46; starting from diethyl malonate and 1-bromooctane, the same steps afforded 53 
(0.20 g, 33% yield over 6 steps) as a light yellow amorphous solid.  53: Rf  = 0.4 
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(silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.26 (m, 10 
H), 5.26 (dd, J = 9.9, 7.8 Hz, 2 H), 4.68 (dd, J = 10.2, 8.4 Hz, 2 H), 4.14 (t, J = 8.1 
Hz, 2 H), 2.12 (m, 4 H), 1.38 – 1.24 (m, 24 H), 0.89 (t, J = 6.9 Hz, 6 H). 
 
Diphenyl Bisoxazoline Didecyl Backbone (54).  Prepared as in the synthesis 
of 46; starting from diethyl malonate and 1-bromodecane, the same steps afforded 54 
(0.22 g, 40% yield over 6 steps) as a light yellow amorphous solid.  54: Rf  = 0.5 
(silica gel, hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.25 (m, 10 
H), 5.26 (dd, J = 9.9, 7.8 Hz, 2 H), 4.67 (dd, J = 10.2, 8.4 Hz, 2 H), 4.13 (t, J = 8.1 
Hz, 2 H), 2.12 (m, 4 H), 1.40 – 1.21 (m, 32 H), 0.90 (t, J = 6.9 Hz, 6 H). 
 
Diphenyl Bisoxazoline Dibenzyl Backbone (55).  Prepared as in the 
synthesis of 46; starting from diethyl malonate and benzyl bromide, the same steps 
afforded 55 (0.14 g, 17% yield over 6 steps) as a light yellow amorphous solid.  55: 
Rf  = 0.3 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (300 MHz, CDCl3) δ 7.48 – 7.25 
(m, 16 H), 7.06 – 7.00 (m, 4 H), 5.21 (t, J = 8.7 Hz, 2 H), 4.67 (dd, J = 10.2, 8.4 Hz, 2 
H), 4.06 (t, J = 8.7 Hz, 2 H), 3.54 (AB q, J = 23.1, 14.1 Hz, 4 H). 
 
Diphenyl Bisoxazoline Diisopentyl Backbone (56).  Prepared as in the 
synthesis of 51 (second generation synthesis); starting from diethyl malonate and 1-
iodo-3-methylbutane, the same steps afforded 56 (0.40 g, 40% yield over 5 steps) as a 
colorless amorphous solid.  56: Rf  = 0.6 (silica gel, hexanes:EtOAc, 1:1); 1H NMR 
(300 MHz, CDCl3) δ 7.39 – 7.26 (m, 10 H), 5.27 (dd, J = 9.9, 8.1 Hz, 2 H), 4.67 (dd, 
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J = 10.2, 8.4 Hz, 2 H), 4.14 (t, J = 8.4 Hz, 2 H), 2.12 (m, 4 H), 1.59 (m, 2 H), 1.22 
(m, 4 H), 0.94 (dd, J = 6.6, 1.5 Hz, 6 H). 
 
Tetraphenyl Bisoxazoline Dipentyl Backbone (57).  Prepared according to 
the procedure used to synthesize 45, affording 57 (0.064 g, 97% yield) as a light 
yellow crystalline solid.  57: Rf  = 0.5 (silica gel, hexanes:EtOAc, 2:1); 1H NMR (300 
MHz, CDCl3) δ 7.10 – 6.92 (m, 20 H), 5.97 (d, J = 10.2 Hz, 2 H), 5.62 (d, J = 9.9 Hz, 
2 H), 2.50 – 2.23 (m, 4 H), 1.63 – 1.42 (m, 12 H), 0.97 (t, J = 6.9 Hz, 6 H).  
 
 Di-4-Trifluoromethylphenyl Bisoxazoline Diisopentyl Backbone (58).  
The requisite chiral amino-alcohol was prepared according to the following reference: 
Bandini, M.; Cozzi, P. G.; Gazzano, M.; Umani-Ronchi, A. Eur. J. Org. Chem. 2001, 
1937.  From this amino alcohol, bisoxazoline synthesis was carried out following the 
same procedure used to access 51 (second generation synthesis), affording 58 (0.094 
g, 69% yield over 2 steps) as a light yellow amorphous solid.  58: Rf  = 0.5 (silica gel, 
hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.58 (d, J = 8.1 Hz, 2 H), 7.39 
(d, J = 7.8 Hz, 2 H), 5.31 (dd, J = 9.9, 7.8 Hz, 2 H), 4.67 (dd, J = 10.2, 8.4 Hz, 2 H), 
4.09 (t, J = 8.1 Hz, 2 H), 2.09 (m, 4 H), 1.56 (m, 2 H), 1.18 (m, 4 H), 0.91 (dd, J = 
6.6, 2.4 Hz, 6 H). 
 
Di-4-Methoxyphenyl Bisoxazoline Diisopentyl Backbone (59).  The 
requisite chiral amino-alcohol was prepared according to the following reference: 
Bandini, M.; Cozzi, P. G.; Gazzano, M.; Umani-Ronchi, A. Eur. J. Org. Chem. 2001, 
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1937.  From this amino alcohol, bisoxazoline synthesis was carried out following the 
same procedure used to access 51 (second generation synthesis), affording 59 (0.078 
g, 49% yield over 2 steps) as a light yellow amorphous solid.  59: Rf  = 0.3 (silica gel, 
hexanes:EtOAc, 1:1); 1H NMR (300 MHz, CDCl3) δ 7.19 (d, J = 8.7 Hz, 2 H), 6.86 
(d, J = 9.0 Hz, 2 H), 5.19 (dd, J = 10.2, 7.8 Hz, 2 H), 4.61 (dd, J = 10.2, 8.4 Hz, 2 H), 
4.09 (t, J = 7.8 Hz, 2 H), 2.09 (m, 4 H), 1.56 (m, 2 H), 1.18 (m, 4 H), 0.91 (d, J = 6.6 
Hz, 6 H). 
 
Dinaphthyl Bisoxazoline Dipentyl Backbone (60).  The requisite chiral 
amino-alcohol was prepared according to the following reference: Bandini, M.; 
Cozzi, P. G.; Gazzano, M.; Umani-Ronchi, A. Eur. J. Org. Chem. 2001, 1937.  From 
this amino alcohol, bisoxazoline synthesis was carried out following the same 
procedure used to access 51 (second generation synthesis), affording 60 (0.061 g, 
55% yield over 2 steps) as a light yellow amorphous solid.  60: Rf  = 0.5 (silica gel, 
hexanes:EtOAc, 2:1); 1H NMR (300 MHz, CDCl3) δ 7.87 – 7.76 (m, 8 H), 7.50 – 
7.38 (m, 6 H), 5.47 (dd, J = 9.9, 7.8 Hz, 2 H), 4.77 (dd, J = 9.9, 8.4 Hz, 2 H), 4.26 (t, 
J = 8.1 Hz, 2 H), 2.19 (m, 4 H), 1.46 – 1.33 (m, 12 H), 0.92 (t, J = 6.6 Hz, 6 H).  
 
Chlorocyclized Homogeranylbenzene (61).  (Chlorination procedure 
adapted from bromination procedure found in: Hoye, T. R.; Kurth, M. J. J. Org. 
Chem. 1979, 44, 3461).  HgOTf (0.0788 g, 0.158 mmol, 1.20 equiv) was added to a 
solution of 51 (0.0761 g, 0.170 mmol, 1.30 equiv) in CH2Cl2 (5 mL) at 25 °C.  After 
10 min at 25 °C, the resultant homogeneous solution was cooled to –78 °C and a 
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solution of 12 (0.0300 g, 0.131 mmol, 1.00 equiv) in CH2Cl2 (1 mL) was added 
slowly.  After 1 h at –78 °C, the reaction mixture was allowed to warm very slowly to 
0 °C over the course of 2 h, then quenched by the addition of saturated aqueous 
sodium bromide (1 mL).  The resultant biphasic mixture was stirred vigorously at 25 
°C for 10 min, then extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:CH2Cl2, 1:2) to recover 51 (0.074 g, 97% yield).  
Next, a solution of the organomercurial product (at this point, not fully cyclized) in 
CH2Cl2 (10 mL) at –78 °C was treated with TfOH (0.034 mL, 0.393 mmol, 3.0 
equiv).  After 2 h at –78 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate (20 mL) and extracted with CH2Cl2 (3 × 10 
mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, and 
purified by flash column chromatography to afford the fully cyclized organomercurial 
product (0.055 g, 91% yield) as a white crystalline solid.  Next, Cl2 gas (7.4 mg, 
0.104 mmol, 2.0 equiv) was syringed into a solution of anhydrous LiCl (6.6 mg, 0.16 
mmol, 3.0 equiv) and the tricyclic organomercurial (0.024 g, 0.052 mmol, 1.0 equiv) 
in anhydrous pyridine (1 mL) at –40 °C.  After 20 min at –40 °C, the reaction 
contents were quenched by the addition of 5% aqueous sodium sulfite
 
(5 mL) and 
extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by preparative TLC (silica gel, hexanes, 
run up 2x) to afford 61 (0.012 g, 87% yield) as a white crystalline solid.  61: Rf = 0.48 
(silica gel, hexanes:EtOAc, 19:1); IR (film) νmax 3059, 2969, 2947, 1489, 1448, 1378, 
878, 770, 758, 722 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.23 – 7.02 (m, 4 H), 3.81 
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(dd, J = 12.0, 4.8 Hz, 1 H), 3.01 – 2.82 (m, 2 H), 2.36 (m, 1 H), 2.25 – 2.05 (m, 2 H), 
1.94 (m, 1 H), 1.80 (m, 1 H), 1.58 (dt, J = 12.8, 4.4 Hz, 1 H), 1.42 (dd, J = 12.0, 2.4 
Hz, 1 H), 1.23 (s, 3 H), 1.15 (s, 3 H), 1.02 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 
148.9, 134.9, 129.2, 126.0, 125.7, 124.6, 72.8, 51.4, 40.1, 38.9, 37.9, 30.8, 30.4, 29.4, 
25.0, 20.1, 16.9; HRMS (EI) calcd for C17H23Cl+ [M]+ 262.1488, found 262.1493; 
HPLC (OD column, 2.0% 2-propanol in hexanes, 1.0 mL/min, 30 °C, 265 nm), tr 
(minor) = 6.83 min, tr (major) = 9.33 min. 
 
Iodocyclized Homogeranylbenzene (62).  (Iodination procedure adapted 
from bromination procedure found in: Hoye, T. R.; Kurth, M. J. J. Org. Chem. 1979, 
44, 3461).  Prepared according to the procedure used in the synthesis of 61, but 
substituting iodination for chlorination in the final step:  A solution of the 
organomercurial (0.032 g, 0.058 mmol, 1.0 equiv) in pyridine (3 mL) at 25 °C was 
stirred for 1 h under an oxygen atmosphere in a reaction flask covered in aluminum 
foil.  Next, a solution of I2 (0.073 g, 0.29 mmol, 5.0 equiv) in pyridine (1 mL), also 
covered in foil, was added very slowly to the reaction mixture by syringe pump over 
the course of 5 h.  Once the addition was complete, the reaction contents were stirred 
for an additional 24 h at 25 °C in the dark, then quenched by the addition of 5% 
aqueous sodium sulfite
 
(10 mL) and extracted with CH2Cl2 (3 × 10 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:CH2Cl2, 4:1) to afford 62 (0.019 g, 
93% yield) as a colorless amorphous solid composed of a 3.4:1 mixture of 
diastereomers favoring the equatorial iodide.  62: Rf = 0.43 (silica gel, 
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hexanes:EtOAc, 19:1); IR (film) νmax 3058, 2963, 2943, 2853, 1488, 1448, 1376, 
1191, 737, 722 cm–1; 1H NMR (400 MHz, CDCl3, equatorial isomer) δ 7.20 – 7.02 
(m, 4 H), 4.28 (dd, J = 12.8, 4.0 Hz, 1 H), 2.95 – 2.87 (m, 2 H), 2.54 (dq, J = 3.6, 13.6 
Hz, 1 H), 2.45 (dq, J = 14.0, 4.0 Hz, 1 H), 2.18 (m, 1 H), 2.00 (m, 1 H), 1.81 (m, 1 
H), 1.63 – 1.54 (m, 2 H), 1.25 (s, 3 H), 1.14 (s, 3 H), 1.09 (s, 3 H); 1H NMR (400 
MHz, CDCl3, axial isomer) δ 7.27 (m, 1 H), 7.18 – 7.01 (m, 3 H), 4.69 (br s, 1 H), 
2.97 – 2.89 (m, 2 H), 2.25 – 2.10 (m, 4 H), 1.86 – 1.70 (m, 3 H), 1.23 (s, 3 H), 1.18 (s, 
3 H), 1.14 (s, 3 H); 13C NMR (75 MHz, CDCl3, equatorial isomer) δ 148.9, 134.8, 
129.2, 126.0, 125.7, 124.6, 53.6, 50.0, 42.0, 39.7, 38.3, 34.5, 33.2, 31.0, 25.0, 21.8, 
21.3; 13C NMR (75 MHz, CDCl3, axial isomer) δ 149.3, 135.0, 129.2, 126.0, 125.5, 
124.4, 55.4, 44.8, 38.1, 38.0, 37.9, 35.2, 31.0, 30.0, 26.4, 20.1, 18.6; HRMS (EI) 
calcd for C17H23I+ [M]+ 354.0845, found 354.0855; HPLC (OD column, 1.0% 2-
propanol in hexanes, 1.0 mL/min, 30 °C, 265 nm), axial iodine: tr (minor) = 4.39 min, 
tr (major) = 4.71 min; equatorial iodine: tr (minor) = 7.54 min, tr (major) = 10.99 min. 
 
 Geranylacetophenone (63).  Synthesized from acetophenone and geranyl 
bromide, following the procedure used to afford 65 (see below).  63: colorless viscous 
oil; Rf = 0.25 (silica gel, hexanes:CH2Cl2, 1:1); IR (film) νmax 2968, 2926, 2855, 
1675, 1468, 1445, 1386, 1198, 981, 961, 716, 699 cm–1; 1H NMR (400 MHz, CDCl3) 
δ 7.96 (m, 1 H), 7.55 (m, 1 H), 7.46 (m, 2 H), 5.19 (dt, J = 7.2, 1.2 Hz, 1 H), 5.08 (tt, 
J = 6.8, 1.4 Hz, 1 H), 3.00 (t, J = 7.6 Hz, 2 H), 2.43 (q, J = 7.2 Hz, 2 H), 2.11 – 1.96 
(m, 4 H), 1.67 (s, 3 H), 1.63 (s, 3 H), 1.59 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 
200.2, 137.2, 136.6, 133.0, 131.5, 128.7 (2 C), 128.2 (2 C), 124.4, 122.9, 39.8, 38.9, 
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26.8, 25.8, 23.0, 17.8, 16.2; HRMS (FAB) calcd for C18H24O+ [M]+ 257.1905, found 
257.1918. 
 
Reduced Cyclized Geranylacetophenone (64).  Asymmetric mercury-
induced cyclization of 63 was carried out following the same procedure used in the 
synthesis of 61, affording the desired bicyclic organomercurial (0.042 g, 77% yield) 
as a white crystalline solid.  Halogenation proved impossible in the presence of the 
enol-ether, so reduction was implemented instead: A solution of NaBH4 (7.4 mg, 0.20 
mmol, 2.5 equiv) in aqueous 4 M NaOH (0.1 mL) was added dropwise to a solution 
of the organomercurial (0.042 g, 0.078 mmol, 1.0 equiv) in deoxygenated 
CH2Cl2/EtOH (1:1, 4 mL) in the dark at 25 °C.  After 15 min at 25 °C, solid MgSO4 
(~0.5 g) was added to the reaction mixture, and the resultant mixture was filtered.  
The filtrate was concentrated, added to 10% aqueous ammonium chloride (10 mL), 
and extracted with hexanes (3 × 10 mL).  The combined organic layers were then 
dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:CH2Cl2, 4:1) to afford 64 (0.019 g, 96% yield) as a colorless 
amorphous solid.  64: Rf = 0.49 (silica gel, hexanes:CH2Cl2, 2:1); IR (film) νmax 2926, 
2865, 1651, 1447, 1376, 1326, 1098, 1061, 1051, 753 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 7.55 (app d, J = 8.0 Hz, 2 H), 7.32 – 7.21 (m, 3 H), 5.30 (dd, J = 5.6, 2.4 
Hz, 1 H), 2.17 (dt, J = 17.6, 5.2 Hz, 1 H), 2.06 – 1.93 (m, 2 H), 1.69 – 1.51 (m, 4 H), 
1.47 (app d, J = 11.6 Hz, 1 H), 1.32 (app t, J = 12.0 Hz, 1 H), 1.27 (s, 3 H), 0.97 (s, 3 
H), 0.88 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 149.2, 137.0, 128.2 (2 C), 127.7, 
124.8 (2 C), 97.0, 77.0, 48.6, 41.8, 40.1, 33.5, 32.4, 20.9, 20.0 (2 C), 19.2; HRMS 
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(FAB) calcd for C18H24O+ [M+] 256.1827, found 256.1812; HPLC (OD column, 0.2% 
2-propanol in hexanes, 1.0 mL/min, 30 °C, 261 nm), tr (minor) = 5.81 min, tr (major) 
= 6.88 min. 
 
Geranylisobutyrophenone (65).  A solution of n-BuLi (2.75 mL, 1.6 M in 
hexanes, 4.4 mmol, 2.2 equiv) was added dropwise to a solution of i-Pr2NH (0.703 
mL, 5.00 mmol, 2.50 equiv) in THF (10 mL) at –78 °C.  The resultant light yellow 
solution was allowed to warm to 25 °C over 20 min, then re-cooled to –78 °C.  
Isobutyrophenone (0.605 mL, 4.00 mmol, 2.00 equiv) was then added dropwise to the 
resultant LDA solution. The resultant orange enolate solution was stirred for 30 min 
at –78 °C, then cannulated into a solution of geranyl bromide (0.434 g, 2.00 mmol, 
1.0 equiv) in THF (3 mL) at –40 °C.  The reaction mixture was allowed to warm 
slowly to 25 °C over 15 h, then quenched by the addition of 10% aqueous ammonium 
chloride (30 mL).  The crude product was extracted into hexanes:EtOAc (2:1, 3 × 30 
mL) and the combined organic layers were washed with brine (30 mL), dried (MgSO-
4), filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0 → 2:1).  The resultant material was dried at 2 torr and 100 °C 
for 2 h (to remove residual isobutyrophenone) in order to afford pure 65 (0.405 g, 
71% yield) as a colorless viscous oil.  65: Rf = 0.30 (silica gel, hexanes:CH2Cl2, 1:1); 
IR (film) νmax 2966, 2915, 2855, 1687, 1448, 690 cm–1; 1H NMR (400 MHz, CDCl3) 
δ 7.63 (m, 2 H), 7.47 – 7.35 (m, 3 H), 5.11 – 5.01 (m, 2 H), 2.43 (d, J = 7.2 Hz, 2 H), 
2.08 – 1.94 (m, 4 H), 1.66 (s, 3 H), 1.58 (s, 3 H), 1.54 (s, 3 H), 1.30 (s, 6 H); 13C 
NMR (75 MHz, CDCl3) δ 209.6, 139.6, 138.0, 131.5, 130.7, 128.1 (2 C), 127.6 (2 C), 
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124.3, 119.9, 48.5, 40.1, 38.9, 26.7, 25.8 (3 C), 17.8, 16.3; HRMS (FAB) calcd for 
C20H28O+ [M]+ 284.2140, found 284.2142. 
 
Bromocyclized Geranylisobutyrophenone (66).  Asymmetric mercury-
induced cyclization of 65 was carried out following the same procedure used in the 
synthesis of 61; subsequent bromodemercuration was carried out following the same 
procedure used in the synthesis of 36, affording 66 (0.016 g, 80% yield over two 
steps) as a white crystalline solid.  66: Rf = 0.71 (silica gel, hexanes:EtOAc, 8:2); IR 
(film) νmax 3522 (br), 2968, 2948, 2870, 1478, 1447, 1379, 1149, 1043, 1020, 994, 
708 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.51 (dd, J = 8.4, 1.6 Hz, 2 H), 7.34 – 7.24 
(m, 3 H), 4.05 (dd, J = 12.4, 4.8 Hz, 1 H), 2.30 – 2.10 (m, 3 H), 2.06 (t, J = 12.8 Hz, 1 
H), 1.82 – 1.68 (m, 3 H), 1.51 (s, 3 H), 1.32 (dd, J = 12.8, 1.6 Hz, 1 H), 1.08 (s, 3 H), 
1.05 (s, 3 H), 0.96 (s, 3 H), 0.65 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 144.1, 127.8, 
127.4 (4 C), 101.9, 75.8, 67.2, 48.8, 42.1, 39.2, 38.7, 32.8, 32.1, 29.7, 26.2, 26.1, 
24.3, 17.9; HRMS (FAB) calcd for C20H28BrO2+ [M–H]+ 379.1273, found 379.1272; 
HPLC (OD column, 2.0% 2-propanol in hexanes, 1.0 mL/min, 30 °C, 257 nm), tr 
(major) = 4.60 min, tr (minor) = 5.74 min. 
 
Bromocyclized Geranyl Acetate (68).  Asymmetric mercury-induced 
cyclization of 67 was carried out following the same procedure used in the synthesis 
of 61; subsequent bromodemercuration was carried out following the same procedure 
used in the synthesis of 36, affording 68 (0.014 g, 65% yield over two steps) as a 
colorless amorphous solid.  68: Rf = 0.28 (silica gel, hexanes:EtOAc, 1:1); IR (film) 
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νmax 3456 (br), 2973, 2948, 2875, 1736, 1367, 1243, 1155, 1030 cm–1; 1H NMR (400 
MHz, CDCl3) δ 4.43 (dd, J = 12.0, 5.2 Hz, 1 H), 4.33 (dd, J = 12.0, 5.2 Hz, 1 H), 3.98 
(dd, J = 12.4, 4.0 Hz, 1 H), 2.50 (s, 1 H), 2.19 (dq, J = 14.0, 4.0 Hz, 1 H), 2.07 (s, 3 
H), 2.02 (dq, J = 3.6, 13.6 Hz, 1 H), 1.81 (dt, J = 13.6, 3.6 Hz, 1 H), 1.72 (t, J = 5.2 
Hz, 1 H), 1.59 (dt, J = 4.0, 14.0 Hz, 1 H), 1.24 (s, 3 H), 1.18 (s, 3 H), 1.00 (s, 3 H); 
13C NMR (75 MHz, CDCl3) δ 171.2, 71.9, 66.0, 63.6, 55.7, 43.1, 39.9, 32.2, 30.4, 
24.0, 21.3, 17.8; HRMS (FAB) calcd for C12H22BrO3+ [M+H]+ 293.0752, found 
293.0742; HPLC (OD column, 8.0% 2-propanol in hexanes, 1.0 mL/min, 30 °C, 209 
nm), tr (minor) = 7.84 min, tr (major) = 8.55 min.  
 
4-Isocymobarbatol Cyclization Precursor 69.  A solution of 2,5-
dibromohydroquinone (2.00 g, 7.47 mmol, 1.00 equiv) in THF (15 mL) was added 
dropwise to a suspension of NaH (rinsed with 3 × 5 ml hexanes to remove mineral 
oil, 0.449 g, 18.7 mmol, 2.50 equiv) in THF (10 mL) at 0 °C under a constant flow of 
argon.  After 5 min, MOMCl (1.70 mL, 22.4 mmol, 3.00 equiv) was added slowly 
and the reaction mixture was stirred for an additional 2 h at 0 °C, then quenched by 
the careful addition of water (30 mL) and extracted with EtOAc (3 × 30 mL).  The 
combined organic layers were washed with aqueous 1 M NaOH (2 × 30 mL) and 
brine (30 mL), dried (MgSO4), filtered, and concentrated to afford protected 2,5-
dibromohydroquinone (2.61 g, 98% yield) as a white crystalline solid.  Next, a 
solution of n-BuLi (0.74 mL, 1.3 M in hexanes, 0.96 mmol, 1.7 equiv) was added 
dropwise to a solution of the protected dibromohydroquinone (0.40 g, 1.12 mmol, 2.0 
equiv) in THF (15 mL) at –78 °C.  The resultant solution was stirred for 30 min at –
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78 °C, then quickly added via syringe to a solution of geranyl bromide (0.12 g, 0.56 
mmol, 1.0 equiv) in THF (2 mL) at –40 °C.  The reaction mixture was allowed to 
warm slowly to 0 °C over the course of 2 h, then quenched by the addition of 10% 
aqueous ammonium chloride (15 mL) and extracted with hexanes:EtOAc (2:1, 3 × 15 
mL).  The combined organic layers were washed with brine (15 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0 → 1:4) to afford 69 (0.17 g, 75% yield) as a light yellow viscous 
oil.  69: Rf = 0.55 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2960, 2913, 2853, 
2827, 1488, 1377, 1151, 1081, 999, 933 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 
1 H), 6.96 (s, 1 H), 5.27 (dt, J = 7.2, 1.2 Hz, 1 H), 5.15 (s, 2 H), 5.12 (s, 2 H), 5.10 (tt, 
J = 6.8, 1.2 Hz, 1 H), 3.53 (s, 3 H), 3.48 (s, 3 H), 3.28 (d, J = 7.2 Hz, 2 H), 2.13 – 
2.00 (m, 4 H), 1.70 (s, 3 H), 1.67 (s, 3 H), 1.60 (s, 3 H); 13C NMR (75 MHz, CDCl3) 
δ 150.6, 148.8, 137.0, 131.7, 131.6, 124.3, 121.8, 119.4, 118.5, 110.3, 96.2, 95.3, 
56.5, 56.2, 39.9, 28.6, 26.9, 25.8, 17.8, 16.3; HRMS (FAB) calcd for C20H29BrO4+ 
[M]+ 412.1249, found 412.1249. 
 
Protected 4-Isocymobarbatol (70).  Asymmetric mercury-induced 
cyclization of 69 was carried out following the same procedure used in the synthesis 
of 61; subsequent bromodemercuration was carried out following the same procedure 
used in the synthesis of 36, affording 70 (0.029 g, 81% yield over two steps) as a 
colorless amorphous solid.  Two consecutive recrystallizations from boiling hexanes 
(2 mL) afforded enantioenriched 70 (0.017 g, 58% yield) as a white crystalline solid.  
Subsequent phenol deprotection with 1 M HCl in THF/water (10:1) afforded 4-
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isocymobarbatol in 97% yield.  70: Rf = 0.3 (silica gel, hexanes:EtOAc, 9:1); 1H 
NMR (300 MHz, CDCl3) δ 6.96 (s, 1 H), 6.87 (s, 1 H), 5.13 (s, 2 H), 4.03 (dd, J = 
11.7, 4.2 Hz, 1 H), 3.53 (s, 3 H), 2.79 – 2.61 (m, 2 H), 2.28 (dq, J = 14.1, 3.9 Hz, 1 
H), 2.11 (qd, J = 14.1, 3.6 Hz, 1 H), 1.98 (dt, J = 13.8, 3.6 Hz, 1 H), 1.81 – 1.72 (m, 2 
H), 1.21 (s, 3 H), 1.16 (s, 3 H), 1.01 (s, 3 H). 
 
trans-1,2-Dichlorotetralin (72)  Representative procedure for asymmetric 
dichlorination (Entry 6, Table 9):  Chlorine gas (7.4 mg, 0.10 mmol, 0.90 equiv) was 
syringed into a solution of 9 (15 mg, 0.13 mmol, 1.1 equiv) in CH2Cl2 (1.7 equiv) at –
78 °C.  Next, a solution of SbCl5 (0.10 mL, 1.0 M in CH2Cl2, 0.10 mmol, 0.90 equiv) 
was added dropwise, and the resultant yellow solution was stirred for 5 min at 0 °C.  
Finally, a solution of 1,2-dihydronaphthalene (71, 15 mg, 0.12 mmol, 1.0 equiv) in 
CH2Cl2 (0.3 mL) was added dropwise.  After 15 min at 0 °C, the reaction mixture was 
quenched by the addition of saturated aqueous sodium bicarbonate and 5% aqueous 
sodium sulfite (1:1, 5 mL) and extracted with CH2Cl2 (3 × 5 mL).  The combined 
organic layers were dried (MgSO4), filtered, concentrated, and purified by 
preparatory TLC (silica gel, hexanes:EtOAc, 4:1) to afford 72 (8 mg, 35% yield) as a 
colorless amorphous solid.  72: Rf = 0.44 (silica gel, hexanes:CH2Cl2, 4:1); IR (film) 
νmax 3023, 2927, 1491, 813, 737, 678, 646 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.34 
(m, 1 H), 7.28 – 7.18 (m, 2 H), 7.13 (m, 1 H), 5.23 (d, J = 2.8 Hz, 1 H), 4.66 (m, 1 H), 
3.16 (ddd, J = 17.2, 11.2, 5.6 Hz, 1 H), 2.87 (ddd, J = 17.2, 6.0, 2.8 Hz, 1 H), 2.67 
(dddd, J = 17.2, 11.2, 6.0, 2.4 Hz, 1 H), 2.14 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 
135.0, 132.5, 131.2, 129.2, 129.0, 126.8, 59.9, 59.6, 25.2, 24.0; HRMS (EI) calcd for 
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C10H10Cl2 [M]+ 200.0160, found 200.0151.  HPLC (OD column, 1.0 mL/min, 250:1 
hexanes:2-propanol, 30 °C, 270 nm), tR (major) = 6.48 min, tR (minor) = 7.06 min. 
 
“Chiral CDSC” (73).  A saturated solution of chlorine (~1 M; ~1 mmol, 1 
equiv) was prepared by bubbling Cl2 through CH2Cl2 (1 mL) at 25 °C.  The resultant 
solution was cooled to –78 °C and 9 (0.12 g, 1.0 mmol, 1.0 equiv) and a solution of 
SbCl5 (1.1 mL, 1 M in CH2Cl2, 1.1 mmol, 1.1 equiv) were added sequentially.  After 
20 min at –78 °C, the reaction mixture was removed from the cold bath and allowed 
to warm to 25 °C.   Stirring was ceased, and the crude reaction mixture was diluted 
with CH2Cl2 (5 mL) and layered with hexanes (5 mL).  The resultant solution was 
moved to –20 °C for 16 h, after which residual solvent was removed and the crystals 
were washed with a cold solution of hexanes/CH2Cl2 (1:1, 2 × 1 mL) and dried to 
afford 73 (0.244 g, 50% yield) as a white crystalline solid.  As with most of the 
halosulfonium salts, spectral data were not obtained for this compound. 
 
“Chiral IDSI” (74).  ICl (1.42 mL, 28.4 mmol, 1.00 equiv) and a solution of 
SbCl5 (31 mL, 1.0 M in CH2Cl2, 31 mmol, 1.1 equiv) were added slowly and 
sequentially to a solution of 9 (3.30 g, 28.4 mmol, 1.00 equiv) in 1,2-dichloroethane 
(370 mL) at –25 °C.  After 30 min at –25 °C, the reaction mixture was allowed to 
warm to 25 °C.  Stirring was ceased and the reaction mixture was layered with 
hexanes (600 mL), then cooled to –20 °C for 1 week.  The filtrate was decanted and 
the resultant crystals were washed with cold CH2Cl2 (2 × 10 mL) and dried to afford 
74 (12.4 g, 76% yield) as an orange crystalline solid.  The diethyl variant was 
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prepared according to this same procedure, affording the desired iodosulfonium 
complex (0.58 g, 70% yield) as an orange crystalline solid.  As with most of the 
halosulfonium salts, spectral data were not obtained for either of these compounds. 
 
trans-1-Chloro-2-Bromotetralin (75).  A solution of 10 (26 mg, 0.046 mmol, 
1.2 equiv) in MeNO2 (0.15 mL) was added dropwise to a solution of 71 (5.0 mg, 
0.038 mmol, 1.0 equiv) in CH2Cl2 (0.6 mL) at –30 °C.  After 10 min at –30 °C, the 
reaction mixture was quenched by the addition of saturated aqueous sodium 
bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL).  The resultant biphasic 
mixture was extracted with CH2Cl2 (3 × 5 mL), and the combined organic layers were 
dried (MgSO4), filtered, concentrated, and purified by preparatory TLC (silica gel, 
hexanes:CH2Cl2, 4:1) to afford 75 (1.7 mg, contaminated with 2 minor impurities, 
~15% yield) as a colorless amorphous solid.   75: Rf  = 0.3 (silica gel, 
hexanes:CH2Cl2, 4:1); 1H NMR (400 MHz, CDCl3) δ 7.36 (m, 1 H), 7.28 – 7.19 (m, 2 
H), 7.15 (m, 1 H), 5.39 (m, 1 H), 4.78 (dt, J = 4.4, 2.8 Hz, 1 H), 3.17 (ddd, J = 17.6, 
11.6, 6.0 Hz, 1 H), 2.89 (ddd, J = 17.6, 6.0, 2.0 Hz, 1 H), 2.69 (m, 1 H), 2.17 (m, 1 
H); HPLC (OD column, 1.0 mL/min, hexanes, 30 °C, 270 nm), tR = 6.42 min, 6.98 
min. 
 
trans-1-Hydroxy-2-Iodotetralin (77).  A solution of 71 (5.0 mg, 0.038 mmol, 
1.0 equiv) in MeCN (0.25 mL) was syringed slowly into a solution of 74 (0.049 g, 
0.085 mmol, 2.2 equiv) in MeCN (0.75 mL) at –20 °C.  After 20 min at –20 °C, water 
(1 mL) was added and the resultant biphasic mixture was stirred vigorously at 25 °C 
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for 20 min.  Upon completion, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL), 
then extracted with CH2Cl2 (3 × 5 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:CH2Cl2, 2:1 → 0:1) to afford 77 (7.1 mg, 68% yield) as a white 
crystalline solid.  HPLC (OD column, 1.0 mL/min, 19:1 hexanes:2-propanol, 30 °C, 
265 nm), tR (major) = 9.94 min, tR (minor) = 12.31 min. 
 
trans-1-Hydroxy-2-Iodoindane (79).  Attempted iodohydroxylation of 
indene  (78) was carried out according to the procedure used for the synthesis of 77.  
Unfortunately, what resulted was a mixture of several products.  By crude 1H NMR, 
there appeared to be a small amount of the desired product, but attempted purification 
by flash column chromatography was unsuccessful.  Attempts to optimize the 
reaction by utilizing lower reaction temperatures were not successful. 
 
1-Methyl-3,4-Dihydronaphthalene (80).  A solution of MeMgCl (1.5 mL, 
3.0 M in THF, 4.5 mmol, 1.5 equiv) was added dropwise to a solution of α-tetralone 
(0.44 g, 3.0 mmol, 1.0 equiv) in THF (6 mL) at 0 °C.  The resultant reaction solution 
was allowed to warm to 25 °C and maintained at this temperature for an additional 30 
min, after which aqueous 12 M HCl (1.6 mL, 19 mmol, 6.4 equiv) was added and the 
resultant solution was heated to reflux (75 °C) for 30 min.  Upon completion, the 
reaction mixture was cooled to 25 °C, quenched by the careful addition of saturated 
aqueous sodium bicarbonate (20 mL) and extracted with Et2O (3 × 15 mL).  The 
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combined organic layers were washed with brine (20 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 9:1) to afford 80 (0.37 g, 86% yield) as a colorless oil.   
 
trans-1-Hydroxy-1-Methyl-2-Iodotetralin (81).  Iodohydroxylation of 80 
was carried out according to the procedure used for the synthesis of 77, affording 81 
(0.7 mg, 5% yield) as a colorless amorphous solid.  Attempts to optimize the reaction 
by utilizing lower reaction temperatures or changing solvents were not successful.  
81: Rf  = 0.1 (silica gel, hexanes:CH2Cl2, 1:1); 1H NMR (400 MHz, CDCl3) [Note: an 
NMR spectrum of this compound could not be located]; HPLC (OD column, 1.0 
mL/min, 19:1 hexanes:2-propanol, 30 °C, 263 nm), tR (minor) = 8.41 min, tR (major) 
= 13.81 min. 
 
2-Methyl-3,4-Dihydronaphthalene (82).  Sodium borohydride (0.076 g, 4.0 
mmol, 2.0 equiv) was added portionwise to a solution of 2-methyl-α-tetralone (0.34 g, 
2.0 mmol, 1.0 equiv) in MeOH (4 mL) at 0 °C.  After 1 h at 0 °C, the reaction 
solution was quenched by the careful addition of 10% aqueous ammonium chloride 
(10 mL) and extracted with Et2O (3 × 10 mL).  The combined organic layers were 
washed with brine (20 mL), dried (MgSO4), filtered, and concentrated to afford the 
crude desired benzylic alcohol (0.37 g, >100% yield) as a light yellow oil.  Next, a 
portion of this product (0.107 g, 0.66 mmol, 1.0 equiv) was treated with aqueous 12 
M HCl (2.0 mL, 24 mmol, 36 equiv) in THF (20 mL) for 1 h at 40 °C.  The resultant 
reaction mixture was cooled to 25 °C, quenched by the careful addition of saturated 
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aqueous sodium bicarbonate (30 mL), and extracted with Et2O (3 × 20 mL).  The 
combined organic layers were washed with brine (30 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 19:1) to afford 82 (0.036 g, 38% yield over 2 steps) as a light yellow 
oil.   
 
trans-1-Hydroxy-2-Iodo-2-Methyltetralin (83).  Iodohydroxylation of 82 
was carried out according to the procedure used for the synthesis of 77, affording 83 
(0.2 mg, contaminated with minor impurities, ~3% yield) as a colorless amorphous 
solid.  83: Rf  = 0.1 (silica gel, hexanes:CH2Cl2, 1:1); 1H NMR (400 MHz, CDCl3) δ 
7.43 (m, 1 H), 7.26 – 7.21 (m, 2 H), 7.13 (m, 1 H), 5.09 (d, J = 4.8 Hz, 1 H), 3.03 – 
2.86 (m, 2 H), 2.38 (dt, J = 14.4, 6.0 Hz, 1 H), 2.15 (m, 1 H), 2.14 (s, 3 H); HPLC 
(OD column, 1.0 mL/min, 19:1 hexanes:2-propanol, 30 °C, 263 nm), tR = 7.77 min, 
8.84 min. 
 
1,2-dihydro-5-naphthoic acid (84).  (Step 1 adapted from: Hung, T. V.; 
Mooney, B. A.; Prager, R. H.; Tippett, J. M. Aust. J. Chem. 1981, 34, 383).  A 
solution of t-BuLi (1.47 mL, 1.7 M in pentane, 2.5 mmol, 2.5 equiv) was added 
dropwise to a solution of α-naphthol (0.148 g, 1.00 mmol, 1.00 equiv) in hexanes (4 
mL) at 25 °C.  The resultant solution was stirred for 1 h at 25°C, then cooled to 0 °C.  
Solid carbon dioxide (excess) was added and the reaction mixture was maintained at 
0° C for 10 min.  Upon completion, the reaction mixture was quenched by the careful 
addition of aqueous 1 M HCl (10 mL) and extracted with EtOAc (3 × 10 mL).  The 
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combined organic layers were washed with brine (15 mL), dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc + 1% AcOH by volume, 4:1 → 0:1) to afford the desired 
carboxylated product (0.088 g, 46% yield) as a yellow crystalline solid.  Next, the 
corresponding methyl ester was formed by slow addition of TMSCHN2 (2.26 mL, 2.0 
M in hexanes, 4.5 mmol, 6.0 equiv) to the carboxylic acid (0.145 g, 0.754 mmol, 1.0 
equiv) in MeOH (5 mL) at 25 °C.  After 10 min at 25° C, the reaction mixture was 
quenched by the dropwise addition of AcOH (0.3 mL), then concentrated and purified 
directly by flash column chromatography (silica gel, hexanes:EtOAc, 1:4) to afford 
the methyl ester product (0.155 g, 95% yield) as a colorless amorphous solid.  Next, 
elimination of the benzylic alcohol was undertaken by the addition of MsCl (0.29 mL, 
3.8 mmol, 5.0 equiv) to a solution of the methyl ester (0.155 g, 0.75 mmol, 1.0 equiv) 
and triethylamine (0.52 mL, 3.8 mmol, 5.0 equiv) in CH2Cl2 (3 mL) at 0 °C.  After 30 
min at 0 °C, DBU (0.57 mL, 3.8 mmol, 5.0 equiv) was added and the resultant 
solution was reacted at 25 °C for 1 h, then poured into water (20 mL) and extracted 
with hexanes:EtOAc (1:1, 3 × 20 mL).  The combined organic layers were washed 
with aqueous 1 M HCl (2 × 20 mL), saturated aqueous sodium bicarbonate (20 mL) 
and brine (20 mL), then dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:Et2O, 19:1) to afford the methyl ester of 
84 (0.056 g, 40% yield) as a colorless amorphous solid.  Finally, a solution of lithium 
hydroxide (0.036 g, 1.5 mmol, 10 equiv) in water (1 mL) was added to a solution of 
the methyl ester (0.028 g, 0.15 mmol, 1.0 equiv) in THF (2 mL) at 50 °C.  After 48 h 
at 50 °C, the reaction mixture was cooled to 0 °C and quenched by the careful 
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addition of aqueous 1 M HCl.  This heterogeneous mixture was extracted with EtOAc 
(2 × 10 mL), and the combined organic layers were washed with brine (10 mL), dried 
(MgSO4), filtered and concentrated to afford 84 (0.025 g, contaminated with small 
amounts of minor impurities, ~90% yield) as a white crystalline solid.  84: Rf  = 0.2 
(silica gel, hexanes:EtOAc, 2:1); 1H NMR (400 MHz, (CD3)2CO) δ 7.76 (d, J = 8.0 
Hz, 1 H), 7.46 (d, J = 10.0 Hz, 1 H), 7.32 (d, J = 7.2 Hz, 1 H), 7.19 (t, J = 7.6 Hz, 1 
H), 6.19 (dt, J = 10.0, 4.4 Hz, 1 H), 2.79 (t, J = 8.4 Hz, 2 H), 2.25 (m, 2 H). 
 
Tricyclic Iodolactone 85.  A solution of 84 (5.0 mg, 0.029 mmol, 1.0 equiv) 
in CH2Cl2/MeCN (1:1, 0.2 mL) was syringed slowly into a solution of 74 (0.036 g, 
0.063 mmol, 2.2 equiv) in CH2Cl2/MeCN (0.8 mL) at –78 °C.  The reaction mixture 
was allowed to warm slowly to –20 °C over the course of 1 h.  Upon completion, the 
reaction mixture was quenched by the addition of saturated aqueous sodium 
bicarbonate and 5% aqueous sodium sulfite (1:1, 5 mL), then extracted with CH2Cl2 
(3 × 5 mL).  The combined organic layers were dried (MgSO4), filtered, concentrated, 
and purified by flash column chromatography (silica gel, hexanes:EtOAc, 4:1) to 
afford 85 (6.0 mg, 70% yield) as a white crystalline solid.  85: Rf  = 0.3 (silica gel, 
hexanes:EtOAc, 3:1); 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 7.6 Hz, 1 H), 7.52 – 
7.42 (m, 2 H), 5.49 (d, J = 9.2 Hz, 1 H), 3.91 (td, J = 8.8, 5.2 Hz, 1 H), 3.08 (m, 1 H), 
2.88 (m, 1 H), 2.77 (m, 1 H), 2.44 (m, 1 H); HPLC (AD-H column, 1.0 mL/min, 9:1 
hexanes:2-propanol, 30 °C, 240 nm), tR (major) = 10.1 min, tR (minor) = 13.6 min. 
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γ-Lactone 87.  trans-Styrylacetic acid (86) was subjected to iodolactonization 
following the procedure described above for the synthesis of 85, affording 87 (8.2 
mg, 57% yield) as a white crystalline solid.  87: Rf  = 0.4 (silica gel, hexanes:EtOAc, 
2:1); 1H NMR (400 MHz, CDCl3) δ 7.42 (s, 5 H), 5.69 (d, J = 7.6 Hz, 1 H), 4.25 (m, 
1 H), 3.27 (dd, J = 18.0, 7.6 Hz, 1 H), 3.04 (dd, J = 18.0, 9.2 Hz, 1 H); HPLC (AD-H 
column, 1.0 mL/min, 9:1 hexanes:2-propanol, 30 °C, 260 nm), tR = 9.9 min, 11.6 min 
[Note: The attached 1H NMR spectrum is that of crude 87, since the corresponding 
NMR of the pure material could not be located]. 
 
5-Phenyl-5-Hexenoic Acid (88).  This compound was synthesized from 
benzene and glutaric anhydride according to the following references: (a) Somerville, 
L. F.; Allen, C. F. H. Org. Synth. 1933, 13, 12.  (b) Takemiya, A.; Hartwig, J. F.; J. 
Am. Chem. Soc. 2006, 128, 6042.  
 
δ-Lactone 89.  Unsaturated acid 88 was subjected to iodolactonization 
following the procedure described above for the synthesis of 85, affording 89 (14.0 
mg, 89% yield) as a colorless amorphous solid.  89: Rf  = 0.3 (silica gel, 
hexanes:EtOAc, 2:1); 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.32 (m, 5 H), 3.57 (s, 2 
H), 2.54 – 2.30 (m, 4 H), 1.83 (m, 1 H), 1.59 (m, 1 H); HPLC (OD column, 1.0 





































































Bromonium-Induced Ring Expansion for Accessing 8-Membered Bromoethers 












5.1  Introduction 
The Laurencia medium-ring bromoethers represent a diverse class of nearly 
100 natural products, making them one of the single largest families of halogenated 
natural products.1  As discussed extensively in Section 5 of Chapter 1, nature’s 
enzymatic machinery appears to have mastered the synthesis of these strained 
medium-sized rings by bromonium-induced cycloetherification.2  While synthetic 
chemists have made valiant efforts to emulate this reactivity, there are currently no 
methods for efficiently and stereoselectively synthesizing medium-ring bromoethers 
like those of the Laurencia family through a bromonium-induced cyclization reaction.  
Based on a fortuitous result obtained during our studies towards members of 
the Laurencia medium-ring bromoethers, we were able to design a novel bromonium-
induced ring-expansion reaction, one capable of generating medium-ring bromoethers 
directly in high yields and with excellent stereoselectivity.  The following sections 
describe this discovery and our subsequent optimization, substrate scope 
investigations, and finally the application of this general approach to the synthesis of 
the natural products (E)- and (Z)-pinnatifidenyne.  The majority of the methodology 
discussed in the following sections has been published;3 the natural product total 







5.2  Our Fortuitous Discovery of Bromonium-Induced Bicyclic Oxonium 
Formation 
As discussed previously (see Section 5 of Chapter 1), efficient, wide-ranging 
methods for medium-ring bromoether formation by bromonium induced cyclization 
of linear unsaturated alcohols are largely nonexistent.4  However, we hoped that 
perhaps the unique reactivity of BDSB would allow us to initiate these entropically- 
and enthalpically-unfavorable cyclizations.5  Our optimisim was inspired by the fact 
that BDSB had proved itself in the realm of polyene cyclizations (see Chapters 2 and 
3) to be a cationic source of Br+ with only weakly basic or nucleophilic components.6  
As such, we hoped that this reactivity profile might allow for formation of 
bromonium intermediates that might eventually undergo the desired medium-ring 
formation in the absence of other nonproductive pathways.  Of all the medium-sized 
rings, we most strongly wished to access 8-membered bromoethers, since 8-
membered rings are the most common among the Laurencia medium-ring 
bromoethers.  These oxocane (8-membered cyclic ether) natural products, of which 
there are more than 50 in all, have been dubbed the “lauroxocanes.” 
My coworker, Alexandria Brucks, undertook the initial studies in this arena by 
examining simple linear substrates including those shown in Scheme 1.  Attempted 
BDSB-initiated bromocyclization of unsaturated alcohol 1 afforded only undesired 7-
exo product 2, with none of the desired 8-endo product (3) observed.  As such, 
Alexandria attempted to bias the cyclization to proceed via an 8-endo pathway by 
appending a second alkene onto substrate 4.  In the reaction of 4, the bromonium ion 
should be preferentially attacked at the position further from the alcohol, since the 
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adjacent pi-system should both stabilize positive charge and accelerate nucleophilic 
displacement;7 this technique was utilized extensively for regioselective epoxide 
openings by Nicolaou and coworkers during their syntheses of marine polyethers.8  
Unfortunately, cyclization of 4 with BDSB afforded mostly 1,4-addition product in 
the form of oxepane 7.9  Recognizing this, Alexandria attempted BDSB-induced 
cyclization of homologated substrate 8, hoping that similar 1,4-addition would afford 
oxocane 9.  Unfortunately, this reaction produced 10 as the predominant product, 
presumably via 1,4-addition of BrCl across the diene.  This result attests to the high 
degree of strain associated with 8-membered ring formation; the initially-formed 
bromonium ion derived from 8 would rather abstract Cl- from the relatively 
unreactive SbBrCl5- counterion of BDSB (as was observed for asymmetric 
dihalogenation of 1,2-dihydronaphthalene; see Chapter 4, Section 4) than undergo an 












































Scheme 1. Failed attempts to use BDSB for direct 8-membered ring formation via
intramolecular brometherif ication (work by Alexandria Brucks).
 
At this time, I joined this project with the intent to build upon the results of 
Rousseau et al., who discovered that the yields of medium-ring halocyclization 
reactions were improved by introduction of a rigidifying element into the intervening 
tether between the alkene and the oxygen nucleophile.4g  Analysis of the lauroxocane 
natural product family revealed that several members were bicyclic (including 11, 12, 
and 13; Figure 1), containing a bridged [5.2.1] core ring system.10  It was envisioned 
that constructing the 5-membered tetrahydrofuran ring prior to attempting medium-
ring formation would be more successful due to the reduced degrees of freedom 




With this idea in mind, compound 15 was synthesized using the route depicted 
in Scheme 2, hoping that bromonium-induced cycloetherification would afford 14, a 
model compound closely resembling natural products 11 – 13.  The synthesis of 
substrate 15 (and others to be discussed) relied heavily on two recently published 
protocols by Britton et al. for the facile synthesis of 2,5-dialkylated 
hydroxytetrahydrofurans from 1,3-diols.11  Our sequence commenced with the 
synthesis of ketone 19, generated by a Claisen rearrangement of enol ether 18, formed 
in-situ from allylic alcohol 16 and 2-methoxypropene (17) in the presence of a 
mercury(II) catalyst.12  Meanwhile, a proline-catalyzed α-chlorination of hexanal (20) 
afforded 2-chlorohexanal (21) in 79% yield.13  An aldol addition between the kinetic 
enolate formed from ketone 19 and aldehyde 21 resulted in β-hydroxyketone 22.  
Subsequent directed reduction with tetramethylammonium triacetoxyborohydride14 
afforded predominantly (~6:1 dr) the anti diol product (23).  Thermally-induced 
cyclization of 23 (purported to proceed via epoxide formation from the chlorohydrin, 
followed by regio- and stereoselective 5-endo intramolecular cyclization)11b afforded 






























Reagents and Conditions: (a) 16 (1.0 eq), 17 (5.0 eq), Hg(TFA)2 (0.02 eq), 2 h, 125
oC,
72%. (b) NCS (0.95 eq), L-proline (0.05 eq), CH2Cl2, 16 h, 0 to 25
oC, 79%. (c) 19 (1.0
eq), LDA (1.1 eq), THF, 1 h, -78 oC, then 21 (1.2 eq), 1 h, -78 oC, 54%. (d)
Me4N(OAc)3BH (5.0 eq), MeCN/AcOH, 16 h, -40 to 25
oC, 79%. (e) MeOH/H2O, 5 h, 130
oC, 71%. Hg(TFA)2 = mercury(II) trifluoroacetate, NCS = N-chlorosuccinimide, LDA =







Scheme 2. Synthesis of model substrate 15 with the intent of using intramolecular
bromoetherif ication to afford 14 (a model resembling several bicyclic
lauroxocane natural products).
 
As shown in Scheme 3, treatment of 15 with BDSB did not afford the desired 
8-membered bromoether, 14; this outcome was readily apparent from the 1H NMR of 
the isolated products.  Instead, this reaction resulted in the formation of two major 
products in approximately 30% yield each.  Intrigued by this result, we undertook 
COSY and NOESY NMR experiments to determine the structure of these 
unanticipated structures, ultimately assigning them to be 24 and 25.  The mechanism 
proposed for the formation of these rearranged byproducts is depicted in the bottom 
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portion of Scheme 3.  Presumably, initially formed bromonium 26 (two 
diastereomers, formed by bromination of either face of the alkene in 15) is attacked 
not by the alcohol (as in the desired pathway leading to medium-sized rings), but 
rather by the tetrahydrofuran oxygen in what must be a significantly more kinetically 
favorable 5-exo cyclization.  The resultant bicyclic oxonium ion (27) can fragment 
via semipinnacol rearrangement, whereby hydride transfer from the alcohol-
functionalized carbon to the adjacent ring junction opens the bicyclic oxonium 
species.  This event would form a new tetrahydrofuran appended to a protonated 
ketone (28), which should afford the observed products (24 and 25) upon 
deprotonation.  Related halonium-induced rearrangements of cyclic ethers via this 
same mechanistic pathway (hydride shifts facilitating ring-opening of a bicyclic 


















































Scheme 3. An unexpected rearrangement upon treatment of 15 with BDSB.
 
 
Initially, we were disappointed that our desired medium-ring formation failed 
(although somewhat placated by having uncovered an interesting rearrangement).  
However, we soon realized that perhaps such a pathway might afford access to 
medium-ring bromoethers after all.  Our critical insight came from thinking more 
broadly about bicyclic oxonium ions like structure 27.  As shown in Scheme 4, in the 
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absence of an intramolecular fragmentation pathway, a generic bicyclic oxonium such 
as 29 can be ring-opened by exogenous nucleophilic attack at three positions in order 
to return the central oxygen to neutrality.  Attack at either end of the bicyclic ion 
(positions A or C in Scheme 4) would lead to tetrahydrofuran products (30 and 32), 
but attack at the central position (position B) should lead to 8-membered cyclic 
bromoether 31.  Although there are literature precedents for ring-expansions of this 
type (see Scheme 5),16 no method for bromonium-induced ring-expansion has ever 
been reported to access oxocane systems.  The previously reported examples of 
halonium-induced ring expansion typically utilize epoxide or dioxolane starting 



























Scheme 4. Recognizing that bicyclic oxonium ions such as 29




From an experimental standpoint, we recognized that utilizing an external 
nucleophile to open the bicyclic oxonium intermediate would likely be inefficient, 
since one should expect to observe ring-opening at all three positions (A, B, and C in 
Scheme 4) to afford a mixture of products.  As shown in Scheme 5, literature 
examples of similar reactions that utilize external nucleophiles to open bicyclic 
oxonium ions of this type often result in both oxocane and tetrahydrofuran 
formation.16  In the face of these precedents, we postulated that appending an internal 
nucleophile onto the substrate, one that could only attack at the requisite position to 
induce ring-expansion, might be our desired pathway forward for exploring this 
reactivity.  We were encouraged to find that there are at least two literature 
precedents that successfully make use of an intramolecular nucleophilic attack on a 




5.3  Initial Investigations into Bromonium-Induced Ring Expansion 
Once we had decided to pursue a bromonium-induced ring-expansion 
strategy, we needed a way to access substituted tetrahydrofuran rings with internal 
nucleophiles poised to attack at only one of three potential electrophilic carbon 
centers that would form during the reaction (refer to Scheme 4).  Our extensive 
experimentation in the field of polyene cyclization (see Chapters 2 and 3) had 
repeatedly utilized esters and carbonates are potent intramolecular nucleophilic traps 
for carbocation intermediates, affording alcohols and cyclic carbonates upon workup.  
We therefore targeted the ester- and carbonate-appended compounds illustrated in the 
bottom portion of Scheme 6.  These substrates proved accessible by a route nearly 
identical to the one used previously to access hydroxytetrahydrofuran 15.11  We 
ultimately prepared six derivatives of alcohol 47 by varying both the identity and 






















(a) - (d) (e)
(f),(g)
(h)(i)
Reagents and Conditions: (a) NaH (1.0 eq), TBSCl (1.0 eq), THF, 2 h, 25 oC, 79%. (b)
(COCl)2 (1.2 eq), DMSO (2.0 eq), CH2Cl2, 5 min, -78
oC, then SM (1.0 eq), 5 min, -78 oC,
then Et3N (4.0 eq), 2 h, -78 to -40
oC. (c) PrPPh3 (1.2 eq), KOt-Bu (1.1 eq), THF, 1 h, 0
oC.
(d) TBAF (1.2 eq), THF, 4 h, 0 to 25 oC, 72% yield over 3 steps. (e) (COCl)2 (1.2 eq), DMSO
(2.0 eq), CH2Cl2, 5 min, -78
oC, then 43 (1.0 eq), 5 min, -78 oC, then Et3N (4.0 eq), 2 h, -78 to
-40 oC, 91%. (f) NCS (1.3 eq), L-proline (0.2 eq), CH2Cl2, 6 h, 0 to 18
oC, 63%. (g) Acetone
(1.0 eq), LDA (1.05 eq), THF, 30 min, -78 oC, then aldehyde (1.0 eq), 1 h, -78 oC, ~55%. (h)
Me4OAc3BH (4.0 eq), MeCN/AcOH, 12 h, -40 to 25
oC, 79%. (i) MeOH/H2O, 4 h, 130
oC,
80% yield. (j) Ac2O (2.0 eq), Et3N (4.0 eq), DMAP (0.1 eq), CH2Cl2, 1 h, 0
oC, 98%. (k) BzCl
(2.0 eq), Et3N (4.0 eq), DMAP (0.1 eq), CH2Cl2, 5 h, 0 to 25
oC, 76%. (l) n-BuLi (1.0 eq),
Boc2O (1.0 eq), THF, 1 h, 0 to 25
oC, 82%. (m) DIAD (1.2 eq), PPh3 (1.5 eq), AcOH (3.0 eq),
toluene, 5 h, 0 to 25 oC, 80%. (n) DIAD (1.2 eq), PPh3 (1.5 eq), BzOH (3.0 eq), toluene, 3 h,
0 to 50 oC, 81%. (o) LiOH (10 eq), H2O/MeOH/THF, 1 h, 25
oC, 98%. (p) n-BuLi (1.0 eq),
Boc2O (1.0 eq), THF, 1 h, 0 to 25
oC, 80%. TBSCl = tert-butylchlorodimethylsilane, DMSO =
dimethylsulfoxide, TBAF = tetrabutylammonium fluoride, NCS = N-chlorosuccinimide, LDA =
lithium diisopropylamide, AcOH = acetic acid, Ac2O = acetic anhydride, DMAP = 4-N,N-
dimethylaminopyridine, BzCl = benzoyl chloride, Boc2O = di-tert-butyldicarbonate, DIAD =








































Scheme 6. Synthesis of model substrates 48 - 53 with tethered internal nucleophiles
of differing identity and stereochemistry.
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To our delight, treatment of acetate 48 with BDSB in MeNO2 at low 
temperature afforded the desired ring-expanded oxocane in 74% yield.  This 
transformation, along with its purported mechanism, is depicted in Scheme 7.  
Bromonium activation of the alkene in 48 is presumably followed by attack by the 
tetrahydrofuran oxygen, forming oxonium intermediate 56.  Intramolecular ring-
opening by the acetate group should afford dioxocarbenium ion 57, which is 
quenched upon workup to afford two regioisomers of oxocane product (54 and 55).  
Based on previously published studies for how this dioxocarbenium hydrolysis 
occurs,19 as well as the stereochemistry of the observed products, we believe these 
regioisomers derive from nucleophilic attack of water at the dioxocarbenium carbon, 
rather than either of the carbons of the 8-membered ring.  As shown in the bottom 
portion of Scheme 7, diastereomeric 51 was cyclized in a similar fashion by BDSB to 
afford diastereomeric 8-membered bromoethers 58 and 59, also in good yield.  
Unfortunately, both sets of regioisomeric products (54/55 and 58/59) proved 
impossible to purify due to facile interconversion of the regioisomers by acetate 












































Scheme 7. Bromonium-induced ring expansion of diastereomeric acetate-appended




Thankfully, this ester migration was not observed for the products derived 
from the corresponding benzoates (49 and 52), which were ring-expanded with BDSB 
in similar fashion to afford the analogous 8-membered benzoylated bromoethers (60 – 
63, see Scheme 8).  It is known that migration of benzoyl groups is less facile than 
migration of acetate groups.20  Perhaps the most useful of the internal nucleophiles 
tested was the carbonate, since BDSB-induced ring expansion of 50 and 53 yielded 
cyclic carbonates 64 and 65 in higher yields than the analogous ester substrates and 
without the associated regioisomeric mixtures.  The relative stereochemistry of all 
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products in Schemes 7 and 8 were determined unambiguously by X-ray 
crystallography (performed by Wesley Sattler, Parkin group) of the crystalline diols 




































































Scheme 8. Bromonium-induced ring expansions of benzoate- and carbonate-appended model
substrates.
 
What was both fortuitous and remarkable about these cyclization reactions 
was that they were highly regioselective as well as diastereoselective.  The 
regioselectivity refers to the fact that the bromonium ion intermediate is opened by 
the tetrahydrofuran oxygen (as in the formation of 56) exclusively in a 5-exo fashion.  
The 9-endo bromoethers which would result from a competing 6-endo cyclization 
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were never observed.  This result is in line with the observation that 5-membered ring 
formation is typically kinetically favored over 6-membered ring formation.21   
The diastereoselectivity observed during the reaction, however, is not as 
simple to account for.  The resultant single diastereomer of product must derive from 
a bromonium ion formed on only one of the two faces of the alkene in the starting 
material.  Because this alkene is sufficiently remote from the stereocenters at the 
tetrahydrofuran ring, it is difficult to argue that this selectivity occurs because one 
face is more sterically accessible than the other.  Rather than rely on this 
unconvincing kinetic argument, we would argue instead that the outcome is explained 
by thermodynamics.   
As illustrated in Scheme 9, we suspect that both faces of the alkene in 50 are 
accessible; either bromonium ion (66 or 68) can likely form with similar frequency.  
However, envisioning the intramolecular nucleophilic attack to produce the bicyclic 
oxonium intermediate (67 or 69) reveals that there is likely a significant energy 
difference between the two pathways.  Oxonium 67 has the bromopropyl group 
located in an exo orientation on the convex face of the bicycle, while its diastereomer 
(69) has this large substituent located in an endo orientation on the concave face of 
the bicycle, resulting in a steric penalty.  In terms of the distribution of products 
observed, one explanation is that high-energy oxonium 69 readily reverts to 
bromonium 68.  Meanwhile, a second possibility is that the energy barrier to access 
69 is so high that this intermediate never actually forms.  In either case, the observed 
diastereoselectivity based on this argument requires that the pathway from 66 to 68 
must be reversible.  In this case, we believe that bromonium transfer processes 
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facilitate this reversibility.22  Interconversion of 66 and 68 (potentially via 50) would 
permit all the material to funnel through low-energy oxonium intermediate 67, 
resulting in the stereospecificity observed during the reaction.  Interestingly, this 
hypothesis suggests that bromonium transfer, often viewed as a nuisance in the field 







































Scheme 9. A hypothesis accounting for the observed stereochemistry: reversibility
facilitated by bromonium transfer.
or
 
Although we had developed the described bromonium-induced ring expansion 
reaction using BDSB as the initiator, we were interested to see if the reaction could be 
initiated by other bromonium sources.  These efforts are illustrated in Table 1.  Under 
optimized conditions, exposure of carbonate 50 to TBCO (2,4,4,6-
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tetrabromocyclohexa-2,5-dienone; Entry 2) or bis(collidine)bromonium triflate (Entry 
3) afforded the desired oxocane product, albeit in lower yield than the analogous 
BDSB reaction.  Meanwhile, NBS proved to be a very poor initiator for this reaction, 
affording only trace amounts of the desired products even after very long reaction 
times.  Additional modifications to solvent, reaction time, temperature, or the addition 
of nucleophilic additives (i.e. N,N-dimethylacetamide, used in similar reactions to 
enhance the reactivity of NBS)23 failed to significantly improve the yield of the NBS-
mediated process.  As a whole, the results of Table 1 suggest that the effectiveness of 
the bromonium-induced ring expansion correlates with the electrophilicity of the 





The six substrates discussed thus far (48 through 53) vary only in the 
stereochemistry and identity of their internal nucleophile.  However, in order to 
thoroughly investigate the utility of the developed bromonium-induced ring 
expansion, we would need to vary many more parameters.  As illustrated by Scheme 
10, the lauroxocane natural products exhibit significant variation in both the position 
and stereochemistry of their 8-membered ring substituents.  Ignoring additional 
functionality, of the eight possible diastereomeric outcomes for the bromoether core 
(4 for 8-exo lauroxocanes and 4 for 8-endo lauroxocanes), six are observed in natural 
product structures (73, 75, 77, 81, 83, and 85), while only two are not (71 and 79).  
Also shown in Scheme 10 are the requisite precursors that would be needed to 
approach these frameworks using the newly developed bromonium-induced ring 
expansion protocol.  We decided to synthesize and attempt ring-expansion of all 
seven additional variants (we had already investigated structures belonging to 72), 
even though one would lead to an oxocane core that did not map onto any known 




































































Scheme 10. Stereochemical variety observed in the lauroxocane natural products,
along with the stereochemistry and alkene geometry required to access such structures
using the newly developed method
 
The syntheses of the requisite tetrahydrofuran substrates proved remarkably 
straightforward, again relying heavily on the chemistry of Britton et al.,11 as 
illustrated in Scheme 11.  Each sequence began with an α-chloro aldehyde (differing 
in olefin geometry and/or of number of carbons), generated synthetically by α-
chlorination of the appropriate unsaturated aldehyde.  An aldol addition using the 
enolate derived from acetone afforded the resultant β-hydroxyketones (45, 91, 97, and 
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103).  At this stage, an intentionally nonselective reduction procedure 
(NaBH4/MeOH) provided access to both diastereomers of the resultant 1,3-diol 
(thankfully in all four cases these were separable by silica gel chromatography), each 
of which could be taken forward to afford a diastereomer of the desired 
hydroxytetrahydrofuran.  Each of these was subsequently functionalized as the tert-
butyl carbonate derivative in preparation for ring-expansion.  In this manner, we 
prepared eight cyclization precursors (including 50, which was previously discussed) 
that differed in their stereochemical configuration as well as the location and 










Reagents and Conditions: (a) Acetone, LDA, THF, 30 min, -78 oC, then aldehyde, 1 h, -78
oC. (b) NaBH4 (1.2 eq), MeOH, 15 min, -20
oC. (c) MeOH/H2O, 1 to 8 h, 130
oC. (d) n-
BuLi (1.0 eq), Boc2O (1.0 eq), THF, 1 h, 25
oC. LDA = lithium diisopropylamide, n-BuLi =












































































































Scheme 11. Efficient synthesis of eight stereochemically and/or regiochemically distinct
analogues of carbonate-appended ring-expansion precursors.
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As shown in Table 2, bromonium-induced ring expansion of the substrates 
prepared in Scheme 11 proved successful for five of the seven variants.  In these 
cases, each substrate provided the expected product in good yield and as a single 
stereoisomer (the stereochemistry of each product was established by X-ray 
















































Entry Starting Material Product Yield (%)
a: 1.2 equiv BDSB.
b: 1.5 equiv BDSB.
Table 2. Accessing stereochemically and regiochemically distinct
brominated oxocanes by bromonium-induced ring expansion.
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While all stereochemical variants of the 8-exo lauroxocane cores could be 
synthesized in this fashion, only two of the four variants of the 8-endo cores proved 
accessible.  As depicted in Scheme 12, the predominant products afforded during the 
attempted BDSB-induced ring-expansion of substrates 99 and 101 were fused 
bicycles 114 and 117.  These unexpected products were presumed to be the result of a 
direct bromoetherification of the hydroxytetrahydrofurans (115 and 118) formed by 
deprotection of the Boc group (which could be facilitated by the acidic reaction 
conditions).  Since 5-endo haloetherifications are known to be slower with Z-alkenes 
than E-alkenes,24 perhaps the rate of the desired cyclization (which would initially 
involve 5-endo bromoetherification) was retarded significantly enough that 
deprotection of the Boc group became the predominant pathway.  Overall, comparing 
Scheme 10 with Table 2 reveals that the developed ring-expanding 
bromoetherification reaction can be used to efficiently access the cores of 27 of the 28 
lauroxocane natural products with defined stereochemistry at the three positions 
investigated.  Meanwhile, the substrates with which our method failed (99 and 101) 













































Scheme 12. Two substrates for which bromonium-induced ring expansion did not succeed.
 
 
5.4  Honing in on More Natural Product-Like Structures 
At this point, we had established that we could use bromonium-induced ring 
expansion to access simple 8-membered bromoethers, but had yet to prove that this 
method was suitable for lauroxocane natural product total synthesis.  This effort was 
subsequently undertaken; my coworker Alexandria decided to pursue the total 
synthesis of an 8-endo lauroxocane, while I decided to go about synthesizing an 8-exo 
lauroxocane.  As shown in Figure 2, the 8-exo lauroxocanes, although diverse in 
stereochemical configuration and functionality, share a remarkably conserved core 
scaffold.  The three major differences between the model substrates thus far produced 








Of 30 8-exo natural products:
19 (63%) have a C9-C10 alkene.
The remaining 11 have an
oxidized alkene derivative
(epoxide, halohydrin, haloether, or
haloacetate) at C9/C10.
20 (67%) have X = Cl at C7
(always syn to adjacent group at
C6). The remaining 10 have X =
OH or X = OR at C7.















Backbone oxidation is shifted
one carbon over, and only diol
derivatives have been produced
(no alkenes).
None have functionality at what
is C7 in the natural products.
All have only a methyl group
appended rather than the 5-
carbon enyne-containing piece.




Figure 2. Characterizing the distinctions between the natural product
lauroxocanes and the brominated oxocane model compounds produced thus far
using our newly developed method.
 
 
Naturally, if we were going to use our ring-expanding bromoetherification in 
the key step of an 8-exo lauroxocane total synthesis, we would need to overcome 
these three final hurdles.  Rather than attempt a cyclization in which we introduced 
three new variables at once, we desired to approach these challenges one at a time.  
The first problem we investigated was that of the backbone functionalization.  As 
summarized in the top portion of Scheme 13, the internal nucleophile (carbonate or 
ester) of the previously reacted substrates had always been appended to the 
tetrahydrofuran ring, leading to functionalization of carbons 5 and 6 of the resultant 
oxocane ring (119 → 120).  However, to obtain the proper functionalization pattern 
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of the natural products (see Figure 2), this nucleophilic trap would need to be outside 
the ring.  For example, incorporating an ester or carbonate group outside the ring (as 
in 121) should allow for access to diol derivatives such as 122.  Although 122 is 
oxidized at the correct positions, we felt an even more useful variant would directly 
install the alkene present at this position in nearly two-thirds of the 8-exo lauroxocane 
natural products.  We envisioned that installation of a silyl group at the carbon 
adjacent to the tetrahydrofuran ring could allow for a β-elimination to access these 
alkenes directly, as shown in the hypothetical transformation of 123 to 124 in Scheme 
13.  Installation of a silyl group adjacent to a bicyclic oxonium ion has been utilized 
previously at least twice to obtain alkenes, including a recent case where this was 
used in a tetrahydrofuran-to-oxocene ring expansion (although this was a carbene-
















































Scheme 13. Proposed modifications to our model substrates
to facilitate the synthesis of compounds that better resemble
the 8-exo lauroxocanes.  
 
With the goal of generating an oxocene (unsaturated 8-membered cyclic ether) 
upon ring-expanding bromoetherification, our second generation model substrate 
would need to incorporate a silyl group on the carbon adjacent to the tetrahydrofuran 
ring.  In considering the synthesis of such a substrate, we were struck by the 
surprising dearth of reactions for aliphatic carbon-silicon bond formation.  Ultimately, 
however, we happened upon an α-silylation reaction that seemed suited to our 
proposed synthesis.  As described initially by Hudrlik and Kulkarni, the anion 
resulting from deprotonation of an acetaldehyde-derived imine can be 
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regiospecifically silylated at carbon (imine formation is necessary since the analogous 
reaction with enolates affords predominantly O-silylation).25  As illustrated in 
Scheme 14, our synthesis commenced with imine 125 (derived from the condensation 
of acetaldehyde and tert-butylamine).26  Deprotonation followed by addition of 
TBSCl (along with catalytic TBAI) afforded the α-TBS derivative.  In the same pot, a 
base-mediated alkylation with 12627 was undertaken; subsequent hydrolysis of the 
imine under weakly acidic conditions (to prevent hydrolysis of the dioxolane) 
afforded aldehyde 127.28  Addition of the organocerium reagent derived from 2-
butenylmagnesium chloride afforded mostly linear, α-addition product 128 (in the 
absence of CeCl3, addition of the Grignard reagent affords solely branched γ-addition 
products).29  This alkylation is highly stereoselective, affording only the anti-disposed 
product.  This stereochemical outcome is predicted by the Felkin model of addition to 
ketones,30 but at this junction we were unsure as to the relative disposition of the 
alcohol and silane on compound 128.  We therefore decided to take 128 through to 






















































Reagents and Conditions: (a) LDA (1.0 eq), 125 (1.0 eq), THF, 30 min, 0 oC, then
TBSCl (0.99 eq), Bu4NI (0.02 eq), 3 h, 25
oC, then n-BuLi (1.0 eq), 30 min, 0 oC, then
126 (1.5 eq), 12 h, 0 to 25 oC. (b) AcOH (1.3 eq), CH2Cl2/H2O, 1 h, 25
oC, 63% over 2
steps. (c) 2-butenylMgCl (1.2 eq), CeCl3 (1.5 eq), THF, 40 min, -78 to 0
oC, ~60%. (d)
NBS (1.1 eq), TMTU (0.1 eq), CH2Cl2, 2 h, -78 to -20
oC, ~50%. (e) AIBN (0.1 eq), n-
Bu3SnH (4 eq), toluene, 1 h, 90
oC, ~95%. (f) TFA (5.0 eq), THF/H2O, 3 h, 70
oC. (g)
PrPPh3 (2.0 eq), KOt-Bu (1.8 eq), THF, 30 min, 25
oC, then SM (1.0 eq), THF, 30 min, 0
oC, 67% over 2 steps. (h) BDSB (1.0 eq), MeNO2, 5 min, -25
oC. LDA = lithium
diisopropylamide, TBSCl = tert-butylchlorodimethylsilane, AcOH = acetic acid, NBS = N-
bromosuccinimide, TMTU = tetramethylthiourea, AIBN = azobisisobutyronitrile, TFA =
trifluoroacetic acid, BDSB = bromodiethylsulfonium bromopentachloroantimonate.
(h)
(h)
Scheme 14. Synthesis of silylated model substrate 131, attempted bromonium-induced





The requisite tetrahydrofuran core was generated by bromonium-induced 
cyclization (utilizing a Lewis base-catalyzed NBS mediated bromoetherification 
procedure recently introduced by Denmark & Burk).31  Subsequently, radical 
conditions were employed for reduction of bromide 129 to 130; overall, this two-step 
analogue for acid-induced cyclization proved necessary because addition of acid to 
128 afforded only the corresponding diene by ionization of the alcohol and 
elimination of the adjacent silane.  At this stage, the dioxolane was hydrolyzed to the 
aldehyde, which was subjected to Wittig olefination to afford desired cyclization 
precursor 131.  However, reacting 131 with BDSB afforded none of the desired 
oxocene ring (132).  At this point, NOESY analysis suggested that one of the 
stereocenters in 131 was incorrect; as illustrated by the Newman projection at the 
bottom of Scheme X, proper alignment of the C-O and C-Si bonds to facilitate β-
elimination of bicyclic oxonium ion 133 would result in the formation of an undesired 
trans-alkene.  This trans-oxocene (134), even if can form, is likely highly unstable in 
the acidic reaction medium.32  
Given this observation, efforts were undertaken to invert the stereocenter 
adjacent to the carbon-silicon bond, which was initially set with high fidelity during 
the aldehyde crotylation step.  Mitsunobu inversions of alcohol 128 proved 
impossible,33 likely due to the steric bulk of the adjacent TBS group.  However, as 
shown in Scheme 15, a two-step oxidation/reduction protocol afforded desired syn 
diastereomer 135.  Following the same sequence undertaken previously from anti 
isomer 128 afforded the desired diastereomer of the cyclization precursor (136).  We 
were delighted to observe that BDSB cyclization of this compound afforded expected 
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oxocene 132.  The yield of the bromonium-induced ring expansion was quite low, but 











(a),(b) (c) - (f) (g)
135 136
132
Reagents and Conditions: (a) (COCl)2 (1.5 eq), DMSO (3.0 eq), CH2Cl2, 5 min, -78
oC,
then 128 (1.0 eq), 5 min, -78 oC, then Et3N (6.0 eq), 2 h, -78 to -30
oC. (b) DIBAL (1.5
eq), THF, 6 h, -78 to -20 oC, ~70% yield over 2 steps. (c) Coll2BrOTf (1.2 eq), MeNO2,
20 min, -25 oC, ~80%. (d) AIBN (0.1 eq), n-Bu3SnH (3.0 eq), toluene, 1 h, 90
oC. (e)
TFA (4 eq), THF/H2O, 2 h, 50
oC. (f) PrPPh3 (5.0 eq), KOt-Bu (4.0 eq), THF, 30 min, 25
oC, then SM (1.0 eq), THF, 15 min, -20 oC, 35% over 3 steps. (g) BDSB (1.2 eq),
CH2Cl2/MeNO2, 5 min, -25
oC, 30%. DMSO = dimethylsulfoxide, DIBAL =
diisobutylaluminum hydride, Coll2BrOTf = bis(collidine)bromonium
trifluoromethanesulfonate, AIBN = azobisisobutyronitrile, TFA = trifluoroacetic acid,
BDSB = bromodiethylsulfonium bromopentachloroantimonate.
Scheme 15. Synthesis of 136 (epimeric to failed substrate 131) and successful oxocene
formation by bromonium-induced ring expansion.
 
Referring back to the contrasts described in Figure 2, our next task was to 
attempt a cyclization in which there was functionality at the position adjacent to the 
methyl group in our tetrahydrofuran substrates.  Because this position contains a 
chlorine atom in two-thirds of the natural products in the family, we initially hoped to 
test a chloride-containing substrate.  A reexamination of Scheme 15 reveals that the 
tetrahydrofuran intermediate produced after step (c) (i.e. the diastereomer of 129) 
contains a bromine atom at this desired position.  Unfortunately, the stereochemistry 
at bromine is incorrect; in the 8-exo lauroxocanes, the halogen atom at C7 is always 
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on the same face as the neighboring alkyl group (or, in the case of the model 
substrate, the methyl group).  In order to access this cis stereochemistry, we would 
need to perform the same 5-endo haloetherification used to access the tetrahydrofuran 
ring using the cis-alkene analogue of 135.   
Fortunately, a crotylation procedure of aldehyde 127 affording mostly the 
desired cis-alkene was available.34  As depicted in Scheme 16, replacing CeCl3 with 
AlCl3 during the crotylation step afforded predominantly α-adduct 137 with 2.4:1 Z:E 
olefin selectivity; unfortunately, these alkene isomers were inseparable by 
chromatography and were carried forward as a mixture.  Following the same 
oxidation/reduction protocol utilized in Scheme 15 afforded the requisite syn isomer 
of the α-silyl alcohol (138).  Several attempted chloronium-induced 
cycloetherifications of 138 proved fruitless; however, we were able to successfully 
effect a bromonium-induced cycloetherification, albeit in low yield.  As alluded to 
before, 5-endo haloetherifications are known to be more difficult with Z-olefin 
substrates, which probably accounts for the low yield observed for this cyclization.24  
Nonetheless, enough bromocyclized material was isolated to proceed with dioxolane 
hydrolysis and Wittig olefination, affording halogenated cyclization precursor 139.  
We were delighted to find that subsequent BDSB-induced ring-expansion generated 






















Reagents and Conditions: (a) 2-butenylMgCl (1.3 eq), AlCl3 (4.0 eq),
Et2O, 5 min, -78
oC, then 127 (1.0 eq), 1 h, -78 oC, ~40% yield, 2.4:1
Z:E. (b) (COCl)2 (1.5 eq), DMSO (3.0 eq), CH2Cl2, 5 min, -78
oC, then
137 (1.0 eq), 5 min, -78 oC, then Et3N (6.0 eq), 3 h, -78 to -40
oC. (c)
DIBAL (2.0 eq), THF, 7 h, -78 to -30 oC, ~50% over 2 steps. (d)
Coll2BrOTf (1.5 eq), MeNO2, 1 min, 25
oC, ~20%. (e) TFA (excess),
THF/H2O, 2.5 h, 55
oC. (f) PrPPh3 (3.0 eq), KOt-Bu (2.5 eq), THF, 30
min, 25 oC, then SM (1.0 eq), THF, h, 0 to 25 oC, ~90% over 2 steps.
(g) BDSB (1.1 eq), CH2Cl2/MeNO2, 5 min, -25
oC, ~75%. DMSO =
dimethylsulfoxide, DIBAL = diisobutylaluminum hydride, Coll2BrOTf =
bis(collidine)bromonium trifluoromethanesulfonate, TFA = trifluoroacetic
acid, BDSB = bromodiethylsulfonium bromopentachloroantimonate.
Scheme 16. A more natural product-like model substrate incorporating a
halogen syn to the adjacent methyl group (139).
 
 
At this point, we had realized two of our three goals along the way to 
synthesizing an 8-exo lauroxocane natural product (alkene incorporation at C9/C10 
and halogen atom incorporation at C6).  Consequently, we were prepared to introduce 
the final variable (the enyne side chain), which would hopefully result in a total 





5.5  The Formal Total Syntheses of (E)- and (Z)-Pinnatifidenyne 
Since we now felt prepared to undertake a synthesis of one of the Laurencia 
8-exo bromoethers, our initial task was deciding which one to target.  Of the 30 
natural products of this type, the simplest structures are the pinnatifidenynes (141, 
142) and the dihydrorhodophytins (145, 146), both of which were isolated from the 
producing organisms as both cis and trans isomers about the alkene of the pendant 
enyne unit (see Scheme 17).35  In terms of functionality, these compounds possess the 
bare minimum (see Figure 2): an 8-exo unsaturated bromoether core with an alkyl 
chloride adjacent to a pendant terminal enyne.  In addition to their sparse 
functionality, (Z)-dihydrorhodophytin and both (E)- and (Z)-pinnatifidenyne have 
been synthesized previously, in both cases by the Kim group in Korea.36  These 
previous syntheses did not deter us from targeting these molecules; rather, we 
believed that they could provide a benchmark for the efficiency of our own total 












































Scheme 17. The pinnatif idenyne and dihydrorhodophytin lauroxocane natural
products, along with a retrosynthetic analysis of each oxocene core.
 
 
As illustrated in Scheme 17, if we were to use our method to approach these 
natural products, the stereochemical outcomes required retrosynthetically derive from 
tetrahydrofurans 144 and 148.  That is, bromonium-induced ring expansion of 144 
(where R is probably not the enyne motif, but perhaps some precursor that is less 
likely to interact with BDSB) could afford the pinnatifidenynes, while the 
bromonium-induced ring expansion of diastereromer 148 could afford the 
dihydrorhodophytins.  Since previous investigations had revealed that 5-endo 
chloroetherifications of substrates such as 138 (See Scheme 16) do not afford the 
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desired chlorinated tetrahydrofuran products, a new route was sought out, eschewing 
the previous syntheses used to access model compounds 136 and 139.  
Initially, we were drawn to the dihydrorhodophytin precursor due to the all-cis 
configuration of the tetrahydrofuran substituents, which we felt could be generated by 
hydrogenation of an appropriately substituted furan.37  However, preliminary forays 
into furan chemistry were met with little success, with installation of both the 
requisite chlorine atom and the silyl group proving difficult with these substrates.  
Faced with these results, we then turned to the pinnatifidenynes (141 and 142).   
As mentioned above, both pinnatifidenynes had been synthesized previously 
by the Kim group; in 2003 they disclosed their divergent route, which required 24 
steps to access either natural product as a single enantiomer and proceeded in 7 – 
10% overall yield.36a  A summary of Kim’s route is shown in Scheme 18.  The key 
step was a high-yielding and highly stereoselective intramolecular alkylation of amide 
150 to afford oxocene 151.  From 151, a number of manipulations afforded aldehyde 
152, which was the last common intermediate along the way to the two natural 
products; three additional steps from 152 could afford either natural product.  Despite 
the high yield and stereoselectivity of the key oxocene-forming step, Kim’s route 
required more than a dozen steps to access substrate 150 as well as ten additional 
transformations to elaborate 151 to the natural products.  Using this synthesis as a 
benchmark, we believed that our bromonium-induced ring expansion could afford 
more expedient access to the pinnatifidenynes.  We also recognized that if we could 






























Scheme 18. A brief overview of the single previous total synthesis of the













Our retrosynthetic analysis, illustrated in Scheme 19, began with Kim’s 
aldehyde intermediate (152).  We envisioned that this compound could arise directly 
from a BDSB-induced ring-expansion of tetrahydrofuran 153.  This key intermediate, 
in turn, could be built by 5-exo cyclization and subsequent functionalization of an 
appropriately substituted vinylsilane (155).  This requisite vinylsilane could derive 
from the hydrosilylation of alkyne precursor 156.   
The retrosynthetic disconnections from key intermediate 153 were actually 
inspired by a recently-developed regioselective alkyne hydrosilylation reaction.  
Typically, the regioselectivity of metal-catalyzed (generally Pd or Pt) addition of R3Si 
and H across an alkyne is difficult to control; that is, the silane usually has a nearly 
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equal propensity to add to either end of an internal alkyne.38  However, as depicted in 
the bottom portion of Scheme 19, in late 2011 the Tomooka group in Japan 
discovered that protection of propargylic or homopropargylic alcohols as 
dimethylvinylsilyl (DMVS) groups facilitates directed hydrosilylation reactions that 
occur with very high regiocontrol.39  With this reaction in mind, we thought that if we 
could access alkyne 156, selective protection of the primary alcohol as ODMVS 


















"Directing Group-Controlled Hydrosilylation: Regioselective Functionalization of Alkyne"























Scheme 19. Retrosynthetic analysis of Kim's intermediate (152) based on a BDSB-





With confidence in our ability to intercept Kim’s intermediate (152) from 
alkyne 156, we thus required an efficient synthesis to access this material.  As 
depicted retrosynthetically in Scheme 20, we thought the syn chlorohydrin motif 
could arise from stereoselective reduction of α-chloroketone 159, which in turn could 
potentially be formed by a Michael addition of the acetylide anion of 161 into enone 
162, perhaps with subsequent one-pot oxidation of resultant enolate 160 by a 
chloronium source.  We envisioned that such an approach would rapidly build the 
carbon framework required to access the pinnatifidenynes.  
 
 
The synthesis commenced in the forward direction with readily available 3-
butyn-1-ol (163) and 3-buten-2-one (methyl vinyl ketone, 165).  As shown in Scheme 
21, protection of 163 as the tetrahydropyranyl ether afforded 164, whereas a 
Mukaiyama Claisen reaction between 166 (the TMS enol ether derived from 165)40 
and triethyl orthoformate afforded enone 167.41  Unfortunately, addition of the 
cuprate formed from 164 to enone 167 and subsequent NCS addition did not afford 
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desired α-chloroketone 168, but instead gave predominantly recovered starting 
material along with alkynyl chloride 169.  Literature searches involving alkynyl 
cuprate additions of this type revealed that they typically succeed only when the 
enone system is activated by a Lewis acid.42  Consequently, addition of TBSOTf to 
the cuprate/enone reaction afforded two geometrical isomers of silyl enol ether 170.  
Without purification, this crude silyl enol ether mixture was exposed to TBAF in the 
presence of NCS to afford desired α-chloroketone 168.  Efforts to increase the 
efficiency of this two step process by undertaking a one-pot 1,4-











Reagents and Conditions: (a) DHP (3.0 eq), CSA (0.02 eq), CH2Cl2, 30 min, 0
oC, 96%.
(b) TMSCl (1.5 eq), LiBr (2.0 eq), Et3N (1.5 eq), THF, 17 h, 0 to 40
oC. (c) (OEt)3CH
(1.2 eq), TMSOTf (0.1 eq), CH2Cl2, 6 h, -78
oC, 59% over 2 steps. (d) 164 (1.0 eq), n-
BuLi (1.0 eq), THF, 15 min, -78 to 0oC, then CuI (1.1 eq), 1 h, 0 oC, then 167 (1.0 eq),
then NCS (1.3 eq), 1.5 h, -78 to 0 oC, 0% of 168, ~80% of 169. (e) 164 (1.0 eq), n-BuLi
(1.0 eq), THF, 15 min, -78 to 0oC, then CuI (1.1 eq), 1 h, 0 oC, then 167 (1.2 eq), then
TBSOTf (0.95 eq), 12 h, -70 to 5 oC. (f) NCS (1.5 eq), TBAF (1.2 eq), THF, 3 h, -78 oC,
50% over 2 steps. DHP = 3,4-dihydro-2H-pyran, CSA = camphorsufonic acid, TMSCl =
chlorotrimethylsilane, TMSOTf = trimethylsilyl trifluoromethanesulfonate, NCS = N-

















Scheme 21. Assembling alkyne 168 f rom commercially available reagents (163 and 165).
 
Subsequently, a number of reagents were investigated for the reduction of α-
chloroketone 168 to the desired syn chlorohydrin (171, see Scheme 22).  NaBH4 and 
LiAlH4 were reasonably efficient, providing mostly the desired syn isomer (3:1 and 
6:1 dr, respectively).  Investigations into bulkier reducing agents revealed that L-
selectride (lithium tri-sec-butyl borohydride)43 effected the most stereoselective 
reduction, affording 171 with greater than 20:1 dr.  The next operation called for 
protection of the primary alcohol as the DMVS ether for the intended directed 
hydrosilylation reaction; as such, the THP ether first needed to be removed (171 → 
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172).  Unfortunately, aqueous Brönsted acids or Lewis acids effected competitive 
deprotection of both the THP and the diethyl acetal (an unsurprising result, 
considering both protecting groups are acetals); no selectivity was ever observed.  
This difficulty was overcome by utilizing sulfuric acid in absolute ethanol for the 
THP deprotection, since under these conditions deprotection of the diethyl acetal 
cannot occur.  We also discovered that reduction and deprotection could be 
undertaken sequentially in a single pot, directly affording chlorohydrin 172 in 89% 
yield from 168.  
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Reagents and Conditions: (a) L-Selectride (1.2 eq), THF, 15 min, -78 oC,
~95%. (b) H2SO4 (10 eq), EtOH, 2 h, 50
oC, ~95%. (c) L-Selectride (1.2
eq), THF, 15 min, -78 oC, then H2SO4 (10 eq), EtOH, 2 h, 25
oC, 89%. (d)
DMVSCl (1.2 eq), pyridine (5.0 eq), Et2O, 30 min, -78
oC. (e) TBSH (1.3 eq),
174 (0.02 eq), THF, 3 h, 40 oC, then TBAF (1.5 eq), 10 min, 0 oC, 95% over
2 steps. L-Selectride = lithium tri-sec-butylborohydride, DMVSCl =

































Scheme 22. Reduction and hydrosylilation of alkyne 168.
 
 
For the desired directed hydrosilylation reaction to succeed, conditions were 
required to regioselectively protect only the primary alcohol of diol 172.  Under the 
standard silylation conditions reported by the authors (DMVSCl, imidazole, THF)39 
with 1 equivalent of chlorosilane, the silylation of 172 was only mostly selective, 
affording a substantial amount of disilylated material in addition to unreacted starting 
material (even at –78 °C).  Optimization attempts revealed that changing the solvent 
to Et2O and the base to pyridine resulted in a slower, more controlled reaction that 
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afforded exclusively the desired monosilylated product, even in the presence of 
excess silyl chloride.  At the conclusion of this reaction, removal of pyridinium salts 
by filtration followed by concentration cleanly afforded monoprotected 173.  
Subsequent hydrosilylation of 173 using tert-butyldimethylsilane and Karstedt’s 
catalyst (174)44 followed by same-pot deprotection of the DMVS group afforded the 
desired hydrosilylated alkene regioisomer 175 in excellent yield.  Only very small 
amounts (<2%) of what was presumed to be the undesired regioisomer were observed 
by 1H NMR.  This methodology could also be utilized to vary the identity of the 
vinylsilane moiety; TIPS (triisopropylsilyl) and TES (triethylsilyl) groups were also 
introduced at this stage.  However, subsequent chemistry revealed the TBS group to 
be superior.  
With vinylsilane 175 in hand, the next major hurdle was to induce 
tetrahydrofuran formation by some intramolecular cyclization.  Unfortunately, 
literature precedent suggested that initiating this cyclization directly with acid would 
be unsuccessful.45  As shown in the top portion of Scheme 23, cyclization of 
vinylsilane 176 in the presence of catalytic Lewis acid affords predominantly 
rearranged tetrahydropyran 178 (similar reactions initiated by p-TsOH or HCl 
likewise afforded tetrahydropyran rings as the major products).45  This outcome is 
purported to be the result of facile silyl migration/ring expansion from kinetic product 
177 to thermodynamically favored 178/179 under the acidic reaction conditions.  
With this precedent in mind, we recognized that perhaps a halocyclization/reduction 
(as used in the synthesis of 130; see Scheme 14) could be used as a two-step surrogate 
for the desired proton-induced cyclization.  Screening a number of 
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bromoetherification conditions revealed that NBS in the presence of catalytic Ph3PS 
afforded bromoether 180 most efficiently and with high diastereoselectivity.31  
Although 180 has the incorrect stereochemical configuration at the silyl group, radical 
reduction using Et3B and Bu3SnH proceeds mostly with inversion, presumably via 
equilibration to the most thermodynamically stable radical.  Reduced tetrahydrofuran 
181 could be isolated a 2.4:1 mixture of chromatographically inseparable 
diastereomers, favoring of the desired isomer.  Fortunately, reduction of the alkyl 
chloride was not competitive under these conditions.  Experiments using other 
reduction conditions (including those involving non-radical pathways) were carried 






From 181, only two more steps were required to access the desired ring 
expanding bromoetherification substrate.  As shown in Scheme 25, Swern oxidation 
followed by Wittig olefination afforded acetal 182 in good yield and with excellent 
Z:E selectivity.  However, upon BDSB-induced ring expansion, this material 
underwent only partial deprotection of the acetal moiety.  In order to avoid mixtures 
of products, it was decided instead to deprotect the acetal prior to BDSB cyclization.  
This deprotection could be carried out in the same step as the Wittig olefination by 
simply adding aqueous acid to the crude reaction mixture.  An additional benefit to 
generating aldehyde 183 was that the minor isomer (epimeric at the silyl group) could 
finally be removed by column chromatography at this stage.  
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Reagents and Conditions: (a) (COCl)2 (1.5 eq), DMSO (2.5 eq), CH2Cl2, 5 min, -78
oC,
then 181, 5 min, -78 oC, then Et3N (5.0 eq), 1 h, -78 to -30
oC. (b) PrPPh3 (2.2 eq), KOt-
Bu (2.0 eq), THF, 20 min, 25 oC, then SM, 1 h, 0 oC, ~70% yield over 2 steps. (c)
PrPPh3 (2.2 eq), KOt-Bu (2.0 eq), THF, 20 min, 25
oC, then SM, 1 h, 0 oC, then aq 1M
HCl (10 eq), 2 h, 50 oC, 57% yield over 2 steps (81% from desired diastereomer of 181).
(d) BDSB (1.0 eq), MeNO2/CH2Cl2, 10 min, -25
oC, 61% of 152, ~25% of 184. DMSO =
































Scheme 24. Completion of the formal total synthesis of the pinnatif idenynes by the
synthesis of Kim's intermediate (152).
 
With cyclization precursor 183 in hand, we next attempted the key 
bromonium-induced ring-expansion initiated by BDSB.  Fortunately, this reaction 
worked well, providing Kim’s aldehyde (152) in 61% yield; although spectral data 
were unavailable for this intermediate, reduction to the corresponding alcohol, which 
was characterized during Kim’s synthesis, provided proof that we had in fact 
produced the desired product.  Surprisingly, however, the ring-expansion reaction 
was not fully diastereoselective, also affording diastereomer 184 in 25% yield.  Our 
hypothesis explaining this observed decrease in stereoselectivity is that perhaps the 
electron-donating silyl group accelerates bicyclic oxonium formation and subsequent 
fragmentation.  If these steps become fast enough, the reversibility of the reaction 
pathway may be partially or wholly shut down (see Scheme 9).  In the absence of 
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reversibility, not all material can proceed through the less hindered bicyclic oxonium 
structure to afford one diastereomer of product.  Future studies should certainly be 
directed at confirming or rejecting this hypothesis.  
Ultimately, the route described above affords access to aldehyde 152 (3 steps 
removed from both pinnatifidenynes) in 11 linear steps (4.3% overall yield) from 
commercially available materials (although we utilized 12 linear steps, silyl enol ether 
166 is in fact commercially available).  This compares favorably with the 21 linear 
steps required by Kim et al. to access this same compound (albeit enantioselectively).  
To the best of our knowledge, the 14 linear steps required to access either (E)- or (Z)-
pinnatifidenyne renders our route more expedient than any of the more than two 
dozen other published total syntheses of lauroxocane natural products to date.46  
Similarly, my coworker Alexandria Brucks has utilized this methodology to 
synthesize laurefucin (11) in only 13 linear steps.  These levels of efficiency 
underscore the utility of the developed bromonium-induced ring-expansion protocol.  
On the whole, it is much easier to stereoselectively construct functionalized 
tetrahydrofuran rings than the corresponding oxocanes or oxocenes, which is why we 
believe this methodology should allow for efficient access to many other Laurencia 
medium-ring bromoether natural products as well.  
 
5.6  Conclusion 
Chapters 2, 3, and 4 focused largely on the development of new reagents to 
access halogenated natural product architectures.  In contrast, this chapter focused not 
on reagents, but on the application of a novel strategy to accomplish a similar goal.  
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Key to this strategy was the recognition that olefin-appended tetrahydrofuran systems 
react with bromonium sources to produce rearranged products via bicyclic oxonium 
species.  With this knowledge, and the appropriate brominating reagent, we were able 
to design a method to access medium-ring bromoethers highly efficiently and 
stereoselectively.  In fact, our results indicate that nearly any desired stereochemistry 
can be accessed by this ring-expanding bromoetherification, and that it can afford 
both 8-endo and 8-exo products in good yields.  This research culminated with the 
formal total synthesis of both (E)- and (Z)-pinnatifidenyne.  The utility of the 
developed method was highlighted by the fact that this synthesis was more step-
economical than any previous total synthesis of a lauroxocane natural product.   
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5.8  Experimental Section 
 
General Procedures.  All reactions were carried out under an argon 
atmosphere with dry solvents under anhydrous conditions, unless otherwise noted.  
Dry methylene chloride (CH2Cl2), benzene, toluene, diethyl ether (Et2O) and 
tetrahydrofuran (THF) were obtained by passing commercially available pre-dried, 
oxygen-free formulations through activated alumina columns; acetonitrile (MeCN) 
and nitromethane (MeNO2) were stored over 3 Å molecular sieves, pyridine was 
distilled from CaH2 and stored over 3 Å molecular sieves; diisopropylamine (iPr2NH) 
was distilled from KOH and stored over 3 Å molecular sieves; triethylamine (Et3N) 
was distilled from KOH; 1,2-dichloroethane, acetone, and methanol (MeOH) were 
purchased in anhydrous form from Sigma-Aldrich and used as received.  Yields refer 
to chromatographically and spectroscopically (1H and 13C NMR) homogeneous 
materials, unless otherwise stated.  Reagents were purchased at the highest 
commercial quality and used without further purification, unless otherwise stated.  
Reactions were magnetically stirred and monitored by thin-layer chromatography 
(TLC) carried out on 0.25 mm E. Merck silica gel plates (60F-254) using UV light 
and/or I2 on silica as visualizing agents and an aqueous solution of phosphomolybdic 
acid and cerium sulfate or a solution of KMnO4 in aqueous sodium bicarbonate with 
heat as developing agents.  Preparative thin-layer chromatography was carried out on 
0.50 mm E. Merck silica gel plates (60F-254).  SiliCycle silica gel (60, academic 
grade, particle size 0.040–0.063 mm) was used for flash column chromatography.  
NMR spectra were recorded on Bruker DRX-300, DRX-400, and 500 ASCEND 
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instruments and calibrated using residual undeuterated solvent as an internal 
reference.  The following abbreviations were used to explain the multiplicities: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent.  
IR spectra were recorded on a Nicolet Avatar 370 DTGS series FT-IR spectrometer. 
High-resolution mass spectra (HRMS) were recorded in the Columbia University 
Mass Spectral Core facility on a JOEL HX110 mass spectrometer using FAB (Fast 
Atom Bombardment) and EI (Electron Ionization) techniques.  Characterization data 
are not provided for known compounds. 
 
Abbreviations.  Ac2O = acetic anhydride, AcOH = acetic acid, AIBN = 
azobisisobutyronitrile,  Boc2O = di-tert-butyl dicarbonate, BDSB = 
bromodiethylsulfonium bromopentachloroantimonate, n-BuLi = n-butyllithium, 
(coll)2BrOTf = bis(collidine) bromonium trifluoromethanesulfonate, DIAD = 
diisopropyl azodicarboxylate, DIBAL-H = di-iso-butylaluminum hydride, DMAP = 
4-dimethylaminopyridine, DMSO = dimethylsulfoxide, EtOAc = ethyl acetate, EtOH 
= ethyl alcohol, Hg(TFA)2 = mercury(II) trifluoroacetate, KOt-Bu = potassium tert-
butoxide, LDA = lithium diisopropylamide, NBS = N-bromosuccinimide, NCS = N-
chlorosuccinimide, Ph3PS = triphenylphosphine sulfide, TBAF = tetra-n-butyl 
ammonium fluoride, TBAI = tetrabutylammonium iodide, TBCO = 2,4,4,6-
tetrabromocyclohexa-2,5-dienone, TBSCl = tert-butylchlorodimethylsilane, TBSH = 
tert-butyldimethylsilane, TBSOTf = tert-butyldimethylsilyl 
trifluoromethanesulfonate, TFA trifluoroacetic acid, TMSCl = chlorotrimethylsilane, 
TMSOTf = trimethylsilyl trifluoromethanesulfonate, TMTU = tetramethylthiourea. 
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Hydroxytetrahydrofuran Cyclization Precursor 15.  (Procedure adapted 
from: Kang, B.; Chang, S.; Decker, S.; Britton, R. Org. Lett. 2010, 12, 1716–1719).  
Diol 23 (0.100 g, 0.380 mmol, 1.0 equiv) was dissolved in MeOH (8 mL) and water 
(4 mL) in a high-pressure sealed tube.  The tube was sealed and heated to 130 °C for 
5 h.  The reaction contents were then allowed to cool to 25 °C and quenched by the 
addition of saturated aqueous sodium bicarbonate (10 mL) and water (10 mL) and 
extracted with EtOAc (3 × 20 mL).  The combined organic layers were washed with 
brine (40 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0 → 4:1) to afford 15 (0.061 g, 71% 
yield) as a colorless viscous oil.  15: Rf = 0.36 (silica gel, hexanes:EtOAc, 9:1); IR 
(film) νmax 3415 (br), 2959, 2933, 2858, 1458, 1088, 967 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 5.52 – 5.34 (m, 2 H), 4.15 (m, 1 H), 3.76 (m, 1 H), 3.48 (td, J = 6.8, 3.2 Hz, 
1 H), 2.37 (ddd, J = 14.0, 8.0, 6.4 Hz, 1 H), 2.16 – 1.94 (m, 4 H), 1.76 (m, 1 H), 1.71 
– 1.48 (m, 5 H), 1.46 – 1.30 (m, 4 H), 0.95 (t, J = 7.2 Hz, 3 H), 0.91 (t, J = 7.2 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 132.4, 128.4, 83.1, 77.2, 72.9, 41.7, 36.5, 29.1, 
28.5, 28.4, 25.6, 22.9, 14.0, 13.9; HRMS: No molecular ion peak could be observed.  
 
trans-5-Octen-2-one (19).  (Procedure adapted from: Reddy, D. S. Org. Lett. 
2004, 6, 3345–3347).  At 0 °C, 1-Penten-3-ol (1.00 mL, 9.76 mmol, 1.00 equiv), 2-
methoxypropene (4.69 mL, 48.8 mmol, 5.00 equiv), and Hg(TFA)2 (0.083 g, 0.20 
mmol, 0.020 equiv) were combined and sealed in a high-pressure sealed tube.  The 
reaction mixture was heated to 125 °C for 2 h, then allowed to cool to 25 °C, poured 
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into water (30 mL), and extracted with Et2O (3 × 20 mL).  The combined organic 
layers were washed with water (30 mL), saturated aqueous sodium bicarbonate (30 
mL), and brine (30 mL), then dried (MgSO4), filtered, and carefully concentrated 
(→50 mm Hg at 20 °C).  The crude residue was purified by flash column 
chromatography (silica gel, hexanes:Et2O, 9:1) to afford 19 (0.854 g, 72% yield) as a 
moderately volatile light yellow oil. 
 
2-Chlorohexanal (21).  (Procedure adapted from: Kang, B.; Mowat, J.; 
Pinter, T.; Britton, R. Org. Lett. 2009, 11, 1717–1720).  A suspension of NCS (6.34 
g, 47.5 mmol, 0.950 equiv) and L-proline (0.29 g, 2.5 mmol, 0.050 equiv) in CH2Cl2 
(150 mL) was cooled to 0 °C.  Hexanal (6.04 mL, 50.0 mmol, 1.00 equiv) was then 
added and the reaction mixture was allowed to warm very slowly to 25 °C over the 
course of 8 h.  After stirring for an additional 8 h at 25 °C, the reaction mixture was 
poured into aqueous 0.05 M HCl (200 mL) and extracted with CH2Cl2 (3 × 100 mL).  
The combined organic layers were washed with water (200 mL), then brine (200 mL), 
dried (MgSO4), filtered, and carefully concentrated (→150 mm Hg at 20 °C).  The 
resultant crude yellow oil was distilled under reduced pressure (10 mm Hg at 60 °C) 
to afford 21 (5.32 g, 79% yield) as a colorless oil [Note: this material was not 
particularly stable and was used immediately]. 
 
Aldol Addition Product 22.  (Procedure adapted from: Kang, B.; Mowat, J.; 
Pinter, T.; Britton, R. Org. Lett. 2009, 11, 1717–1720).  A solution of n-BuLi (4.83 
mL, 1.5 M in hexanes, 7.2 mmol, 1.1 equiv) was added dropwise to a solution of 
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iPr2NH (1.11 mL, 7.89 mmol, 1.20 equiv) in THF (22 mL) at –78 °C.  The resultant 
colorless solution was removed from the cold bath and allowed to warm (to ~0 °C) 
over 15 min, then re-cooled to –78 °C.  Ketone 19 (0.830 g, 6.58 mmol, 1.0 equiv) 
was added dropwise and the resultant colorless solution was stirred for 1 h at –78 °C.  
Finally, a solution of 21 (1.06 g, 7.89 mmol, 1.2 equiv) in THF (8 mL) was added 
slowly.  After 60 min at –78 °C, the reaction mixture was quenched by the addition of 
10% aqueous ammonium chloride (40 mL) and extracted with hexanes/EtOAc (1:1, 3 
× 50 mL).  The combined organic layers were washed with brine (100 mL), dried 
(MgSO4), filtered, concentrated, and purified by careful flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0 → 7:1) to afford β-hydroxy ketone 
22 (0.925 g, 54% yield) as a colorless viscous oil.  22: Rf = 0.4 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 5.49 (m, 1 H), 5.37 (m, 1 H), 
4.09 (m, 1 H), 3.90 (m, 1 H), 3.29 (d, J = 5.2 Hz, 1 H), 2.85 – 2.71 (m, 2 H), 2.54 (t, J 
= 7.2 Hz, 2 H), 2.28 (q, J = 7.2 Hz, 2 H), 2.03 – 1.85 (m, 3 H), 1.68 – 1.54 (m, 2 H), 
1.41 – 1.25 (m, 4 H), 0.95 (t, J = 7.2 Hz, 3 H), 0.92 (t, J = 7.2 Hz, 3 H).  
 
trans-Diol 23.  (Procedure adapted from: Kang, B.; Mowat, J.; Pinter, T.; 
Britton, R. Org. Lett. 2009, 11, 1717–1720).  A solution of tetramethylammonium 
triacetoxyborohydride (2.42 g, 9.20 mmol, 5.0 equiv) in MeCN (30 mL) and AcOH 
(18 mL) was stirred for 10 min at 25 °C, then cooled to –40 °C.  A solution of β-
hydroxy ketone 22 (0.480 g, 1.84 mmol, 1.0 equiv) in MeCN (6 mL) was added, and 
the reaction mixture was allowed to warm very slowly to 25 °C over 16 h.  Upon 
completion, the reaction mixture was quenched by the addition of aqueous 1 M 
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sodium/potassium tartrate (30 mL) and water (70 mL) and extracted with Et2O (3 × 
75 mL).  The combined organic layers were washed with water (2 × 50 mL) and brine 
(50 mL), dried (MgSO4), filtered, and concentrated (with the addition of toluene to 
help remove any residual AcOH by coevaporation).  The resultant oil was purified by 
two successive recrystallizations from CH2Cl2:hexanes (1:4, crop 1: 30 mL, crop 2: 
10 mL) to afford 23 (0.380 g, 79% yield) as a white crystalline solid.  23: Rf = 0.57 
(silica gel, hexanes:EtOAc, 7:3); IR (film) νmax 3314 (br), 2957, 2931, 2872, 1445, 
1046, 964, 738 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.52 (m, 1 H), 5.42 (m, 1 H), 
4.50 – 3.93 (m, 3 H), 2.13 (m, 2 H), 2.00 (m, 2 H), 1.88 – 1.75 (m, 2 H), 1.73 – 1.52 
(m, 4 H), 1.43 – 1.27 (m, 4 H), 0.97 (t, J = 7.2 Hz, 3 H), 0.92 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 133.1, 128.4, 71.9, 69.0, 68.1, 38.3, 37.2, 33.1, 29.1, 28.8, 
25.6, 22.2, 13.9 (2 C); HRMS (FAB) calcd for C14H28ClO2 [M+H]+ 263.1778, found 
263.1773. 
 
Rearranged Tetrahydrofurans 24/25.  A cold solution of BDSB (0.0659 g, 
0.120 mmol, 1.20 equiv) in MeNO2 (0.5 mL) was added rapidly via syringe to a 
solution of 15 (0.0226 g, 0.100 mmol, 1.0 equiv) in MeNO2 (4.5 mL) at –25 °C.  
After 10 min at –25 °C, the reaction mixture was quenched by the addition of 
saturated aqueous sodium bicarbonate and 5% aqueous Na2SO3 (1:1, 5 mL).  The 
resultant biphasic mixture was stirred vigorously for 20 min at 25 °C, then added to 
water (10 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by careful flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0→12:1) to afford 24 (12.3 mg)  and 
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25 (9.1 mg) as colorless viscous oils, both contaminated with small amounts of 
inseparable impurities (estimated pure yields: 35% and 25%, respectively).  
Connectivity and stereochemistry were determined by COSY and NOESY NMR 
experiments.  24: Rf = 0.53 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2958, 
2928, 2872, 1713, 1461, 1379, 1045 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.39 (m, 1 
H), 4.04 (ddd, J = 14.0, 8.0, 6.4 Hz, 1 H), 3.88 (ddd, J = 10.8, 9.6, 3.2 Hz, 1 H), 2.73 
(dd, J = 15.6, 6.8 Hz, 1 H), 2.50 (dd, J = 15.6, 6.0 Hz, 1 H), 2.43 (t, J = 7.2 Hz, 2 H), 
2.23 – 2.12 (m, 2 H), 2.02 (sextet of doublets, J = 7.2, 3.2 Hz, 1 H), 1.88 (m, 1 H), 
1.72 (m, 1 H), 1.61 – 1.48 (m, 3 H), 1.35 – 1.22 (m, 4 H), 1.05 (t, J = 7.6 Hz, 3 H), 
0.88 (t, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 209.5, 81.4, 76.2, 62.3, 48.7, 
43.7, 32.5, 31.5, 31.1, 28.7, 23.4, 22.6, 14.1, 12.1; HRMS (FAB) calcd for 
C14H26BrO2 [M+H]+ 305.1116, found 305.1108.  25: Rf = 0.45 (silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 3.87 (m, 1 H), 3.69 (ddd, J = 
14.4, 10.0, 4.4 Hz, 1 H), 3.31 (m, 1 H), 2.65 (dd, J = 15.6, 8.0 Hz, 1 H), 2.46 – 2.32 
(m, 4 H), 2.08 – 1.95 (m, 2 H), 1.72 (app d, 1 H), 1.60 – 1.20 (m, 8 H), 0.90 (t, J = 7.2 
Hz, 3 H), 0.88 (t, J = 7.2 Hz, 3 H).  
 
cis-5-Octen-1-ol (43).  (Procedure adapted from: McDougal, P. G.; Rico, J. 
G.; Oh, Y. -I.; Condon, B. D. J. Org. Chem. 1986, 51, 3388–3390).  1,5-Pentanediol 
(6.3 mL, 60. mmol, 1.0 equiv) was added dropwise to a suspension of NaH (2.4 g, 
60% dispersion in mineral oil, 60 mmol, 1.0 equiv) in THF (120 mL) at 25 °C (while 
venting the H2 produced).  After 45 min at 25 °C, TBSCl (9.0 g, 60 mmol, 1.0 equiv) 
was added in a single portion and the resultant mixture was maintained at 25 °C for 
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an additional 2 h.  Upon completion, the reaction contents were quenched by the 
careful addition of saturated aqueous sodium bicarbonate (100 mL) and extracted 
with EtOAc (3 × 50 mL).  The combined organic layers were then dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 4:1) to afford the desired monoprotected alcohol (10.3 g, 79% yield) 
as a colorless viscous oil.  Next, DMSO (3.75 mL, 52.8 mmol, 2.00 equiv) was added 
dropwise over the course of 5 min to a solution of oxalyl chloride (2.76 mL, 31.7 
mmol, 1.20 equiv) in CH2Cl2 (264 mL) at –78 °C, and the resultant colorless solution 
was stirred at –78 °C for 5 min.  A solution of monoprotected alcohol produced above 
(5.77 g, 26.4 mmol, 1.00 equiv) in CH2Cl2 (50 mL) was then added slowly over the 
course of 10 min, and the resultant colorless solution was stirred for an additional 5 
min at –78 °C.  Finally, Et3N (14.6 mL, 106 mmol, 4.00 equiv) was added slowly via 
syringe.  The reaction contents were allowed to warm slowly to –40 °C over the 
course of 2 h, then quenched by the addition of water (200 mL) and extracted with 
CH2Cl2 (2 × 100 mL).  The combined organic layers were washed with aqueous 1 M 
HCl (100 mL), dried (MgSO4), filtered, and concentrated to afford the desired 
aldehyde as a light yellow oil, which was carried forward without any additional 
purification.  Next, a solution of KOt-Bu (29.0 mL, 1.0 M in THF, 29 mmol, 1.1 
equiv) was added slowly to a suspension of propyltriphenylphosphonium bromide 
(12.2 g, 31.7 mmol, 1.20 equiv) in THF (86 mL) at 0 °C.  The resultant orange 
solution was allowed to warm to 25 °C and stirred for an additional 30 min, then re-
cooled to 0 °C and a solution of the aldehyde produced above (26.4 mmol assumed, 
1.00 equiv) in THF (20 mL) was cannulated in slowly.  After 1 h at 0 °C, the reaction 
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contents were quenched by the addition of 10% aqueous ammonium chloride (100 
mL) and extracted with Et2O (3 × 100 mL).  The combined organic layers were 
washed with brine (200 mL), dried (MgSO4), filtered, and concentrated.  The bulk of 
the triphenylphosphine oxide byproduct was removed by slowly concentrating (by 
rotary evaporation) the resultant crude product from a solution of CH2Cl2:hexanes 
(1:1, 200 mL) until approximately 50 mL solvent remained.  The resultant slurry was 
filtered, and the precipitate was rinsed with hexanes (2 × 30 mL); the combined 
filtrate and rinses were concentrated to afford protected 43 as a light yellow oil, 
which was carried forward without any additional purification. [Note: The Wittig 
reaction was not entirely stereospecific; the desired Z-alkene was contaminated with, 
and inseparable from, about 8% of the undesired E-alkene. This undesired isomer was 
carried through all steps, at no stage being separable by chromatography, as such 
resulting in a slight impurity in bromoetherification substrates 48 - 53].  Finally, a 
solution of TBAF (31.7 mL, 1.0 M in THF, 32 mmol, 1.2 equiv) was added to a 
solution of this protected alcohol (26.4 mmol assumed, 1.0 equiv) in THF (94 mL) at 
0 °C, and the resultant reaction mixture was stirred at 0 °C for 1 h before being 
warmed to 25 °C.  After an additional 3 h at 25 °C, the reaction contents were 
quenched by the addition of 10% aqueous ammonium chloride (100 mL) and 
extracted with Et2O (3 × 100 mL).  The combined organic layers were washed with 
brine (200 mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 19:1→4:1) to afford 43 (2.44 g, 72% 
yield over 3 steps) as a colorless viscous oil.  43: Rf = 0.44 (silica gel, 
hexanes:EtOAc, 4:1); IR (film) νmax 3332 (br), 3005, 2934, 1458, 1276, 1261, 1062, 
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750 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.42 – 5.28 (m, 2 H), 3.65 (t, J = 6.8 Hz, 2 
H), 2.10 – 2.00 (m, 4 H), 1.58 (m, 2 H), 1.44 (m, 2 H), 1.35 (br s, 1 H), 0.96 (t, J = 
7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 132.2, 128.9, 63.1, 32.5, 26.9, 26.0, 
20.7, 14.5; HRMS (EI) calcd for C8H16O [M]+ 128.1201, found 128.1199. 
 
cis-5-Octenal (44).  Swern oxidation of 43 was carried out utilizing the same 
procedure described above in the synthesis of 43, affording 44 (2.18 g, 91% yield) as 
a light yellow oil.  44: Rf = 0.36 (silica gel, hexanes:EtOAc, 19:1); IR (film) νmax 
3005, 2962, 2934, 1748, 1242 cm–1; 1H NMR (400 MHz, CDCl3) δ 9.77 (t, J = 2.0 
Hz, 1 H), 5.42 (m, 1 H), 5.27 (m, 1 H), 2.43 (td, J = 7.2, 2.0 Hz, 2 H), 2.12–1.97 (m, 
4 H), 1.70 (quintet, J = 7.2 Hz, 2 H), 0.96 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 202.8, 133.1, 127.8, 43.4, 26.5, 22.2, 20.7, 14.4; HRMS (FAB) calcd for 
C8H13O [M–H]+ 125.0966, found 125.0965. 
 
β-Hydroxyketone 45.  (Procedure adapted from: Kang, B.; Mowat, J.; Pinter, 
T.; Britton, R. Org. Lett. 2009, 11, 1717–1720).  A suspension of NCS (3.47 g, 26.0 
mmol, 1.30 equiv) and L-proline (0.23 g, 2.0 mmol, 0.10 equiv) in CH2Cl2 (60 mL) 
was cooled to 0 °C, and 44 (2.52 g, 20.0 mmol, 1.00 equiv) was added.  The resultant 
reaction mixture was allowed to warm very slowly, approaching 25 °C.  Once the 
reaction had reached ~50% conversion as judged by NMR analysis of reaction 
aliquots (after ~3 h, temp. = 9 °C), a second portion of L-proline (0.23 g, 2.0 mmol, 
0.10 equiv) was added and the reaction was stirred for an additional 3 h with 
continued slow warming.  Upon completion (final reaction temperature: 18 °C), the 
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reaction contents were diluted with hexanes (120 mL) and cooled to –78 °C.  The 
resultant slurry was filtered (precipitate was rinsed with 2 × 15 mL of cold hexanes) 
and the combined filtrate and rinses were concentrated (→150 mm Hg at 20 °C) to a 
total volume of ~20 mL.  The reaction contents were then maintained at –20 °C for 16 
h, during which time more precipitate formed.  The filtrate was decanted and 
concentrated (→100 mm Hg at 20 °C), and the resultant yellow oil was purified by 
distillation under reduced pressure (2 mm Hg at 60 °C) to afford (5Z)-2-chloro-5-
octenal (2.01 g, 63% yield) as a fragrant colorless viscous oil [Note: this unsaturated 
β-chloro aldehyde, as with all others produced by this procedure, was rather unstable 
and was used immediately].  Pressing forward, n-BuLi (7.28 mL, 1.5 M in hexanes, 
10.9 mmol, 1.05 equiv) was added dropwise to a solution of iPr2NH (1.76 mL, 12.5 
mmol, 1.20 equiv) in THF (52 mL) at –78 °C.  The resultant colorless solution was 
removed from the cold bath and allowed to warm (to ~0 °C) for 15 min, then re-
cooled to –78 °C.  Acetone (0.766 mL, 10.4 mmol, 1.00 equiv) was added dropwise 
to the resultant LDA solution.  After 30 min at –78 °C, the aldehyde produced above, 
(5Z)-2-chloro-5-octenal (2.01 g, 12.5 mmol, 1.20 equiv), was added dropwise to the 
reaction solution.  After an additional 60 min at –78 °C, the reaction contents were 
quenched by the addition of 10% aqueous ammonium chloride (60 mL) and extracted 
with hexanes:EtOAc (1:1, 3 × 80 mL).  The combined organic layers were washed 
with brine (150 mL), dried (MgSO4), filtered, concentrated, and purified by careful 
flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 7:3) to afford 45 
(1.38 g, contaminated with a small amount of an unknown byproduct, ~55% yield) as 
a colorless viscous oil [Note: although stable to silica gel, 45 decomposed over time 
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and as such was taken forward immediately].  45: Rf = 0.3 (silica gel, hexanes:EtOAc, 
2:1); 1H NMR (400 MHz, CDCl3) δ 5.44 (m, 1 H), 5.28 (m, 1 H), 4.11 (m, 1 H), 3.91 
(ddd, J = 10.0, 6.4, 3.2 Hz, 1 H), 3.22 (d, J = 5.2 Hz, 1 H), 2.88 – 2.72 (m, 2 H), 2.32 
– 2.20 (m, 2 H), 2.22 (s, 3 H), 2.07 (quintet, J = 7.2 Hz, 2 H), 1.92 (m, 1 H), 1.70 (m, 
1 H), 0.97 (t, J = 7.6 Hz, 3 H). 
 
trans-Diol 46.  (Procedure adapted from: Kang, B.; Mowat, J.; Pinter, T.; 
Britton, R. Org. Lett. 2009, 11, 1717–1720).  A solution of tetramethylammonium 
triacetoxyborohydride (3.75 g, 14.3 mmol, 4.00 equiv) in MeCN (60 mL) and AcOH 
(35 mL) was stirred for 10 min at 25 °C, then cooled to –40 °C.  Next, a solution of 
ketone 45 (0.780 g, 3.57 mmol, 1.00 equiv) in MeCN (10 mL) was added, and the 
reaction mixture was allowed to warm very slowly to 25 °C over the course of 12 h.  
Upon completion, the reaction contents were quenched by the addition of aqueous 1 
M sodium potassium tartrate (60 mL) and water (150 mL), and extracted with Et2O (3 
× 150 mL).  The combined organic layers were washed with water (2 × 200 mL) and 
brine (200 mL), dried (MgSO4), filtered, and concentrated (with the addition of 
toluene to help remove any residual AcOH by coevaporation).  The resultant crude oil 
was purified by careful flash column chromatography (silica gel, hexanes:EtOAc, 1:0 
→ 1:1) to afford 46 (0.622 g, 79% yield) as a colorless amorphous solid.  46: Rf = 
0.36 (silica gel, hexanes:EtOAc, 1:1); IR (Film) νmax 3362 (br), 2965, 2933, 2874, 
1455, 1069 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.44 (m, 1 H), 5.28 (m, 1 H), 4.19 
(m, 1 H), 4.06 – 3.95 (m, 2 H), 2.82 (d, J = 6.4 Hz, 1 H), 2.34 – 2.18 (m, 2 H), 2.07 
(quintet, J = 7.2 Hz, 2 H), 1.95 (d, J = 4.4 Hz, 1 H), 1.93 – 1.70 (m, 3 H), 1.63 (ddd, J 
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= 14.8, 8.8, 2.4 Hz, 1 H), 1.27 (d, J = 6.4 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 133.5, 127.2, 72.0, 67.5, 65.5, 40.2, 33.4, 24.2, 24.0, 20.7, 
14.5; HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 221.1308, found 221.1307. 
 
Hydroxytetrahdrofuran 47.  (Procedure adapted from: Kang, B.; Chang, S.; 
Decker, S.; Britton, R. Org. Lett. 2010, 12, 1716–1719).  Diol 46 (0.274 g, 1.24 
mmol, 1.00 equiv) was dissolved in MeOH (24 mL) and water (12 mL) in a high-
pressure sealed tube.  The reaction vessel was then sealed and heated at 130 °C for 4 
h.  Upon completion, the reaction mixture was allowed to cool to 25 °C, quenched by 
the addition of saturated aqueous sodium bicarbonate (30 mL) and water (30 mL), 
and extracted with EtOAc (3 × 40 mL).  The combined organic layers were washed 
with brine (50 mL), dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 1:0 → 7:3) to afford 47 (0.183 g, 
80% yield) as a colorless viscous oil.  47: Rf = 0.46 (silica gel, hexanes:EtOAc, 3:2); 
IR (film) νmax 3419 (br), 3004, 2965, 2933, 2870, 1453, 1072 cm–1; 1H NMR (400 
MHz, CDCl3) δ 5.45 – 5.31 (m, 2 H), 4.16 (m, 1 H), 3.90 (sextet, J = 6.4 Hz, 1 H), 
3.52 (td, J = 6.8, 3.6 Hz, 1 H), 2.41 (m, 1 H), 2.22 – 2.10 (m, 2 H), 2.05 (quintet, J = 
7.2 Hz, 2 H), 1.81 – 1.62 (m, 2 H), 1.53 (d, J = 7.6 Hz, 1 H), 1.48 (ddd, J = 14.0, 6.8, 
2.0 Hz, 1 H), 1.33 (d, J = 6.4 Hz, 3 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 132.6, 128.5, 83.0, 73.5, 73.4, 43.7, 28.9, 24.0, 22.3, 20.7, 14.4; HRMS 
(FAB) calcd for C11H21O2 [M+H]+ 185.1542, found 185.1549.   
 
Acetylated Tetrahydrofuran 48.  Ac2O (0.095 mL, 1.0 mmol, 2.0 equiv) 
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was added dropwise to a solution containing 47 (0.092 g, 0.50 mmol, 1.0 equiv), 
DMAP (6.1 mg, 0.050 mmol, 0.10 equiv) and Et3N (0.28 mL, 2.0 mmol, 4.0 equiv) in 
CH2Cl2 (2.5 mL) at 0 °C.  The resultant colorless solution was stirred for 1 h at 0 °C, 
then quenched by the addition of MeOH (0.1 mL).  The crude mixture was purified 
by filtration through a silica gel plug (eluted with 2:1 hexanes:EtOAc, 50 mL) to 
afford acetylated product 48 (0.111 g, 98% yield) as a colorless viscous oil [Note: as 
mentioned above, the Wittig reaction used in the synthesis of 43 was not entirely 
stereoselective, as such 48 was contaminated with approximately 8% of the undesired 
E-alkene].  48: Rf = 0.47 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2967, 2934, 
2871, 1739, 1374, 1242, 1080 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.41 – 5.25 (m, 2 
H), 5.21 (m, 1 H), 3.93 (sextet, J = 6.8 Hz, 1 H), 3.67 (m, 1 H), 2.49 (quintet, J = 7.2 
Hz, 1 H), 2.18 – 1.97 (m, 4 H), 2.06 (s, 3 H), 1.72 (m, 1 H), 1.60 (m, 1 H), 1.50 (ddd, 
J = 14.4, 7.2, 2.4 Hz, 1 H), 1.31 (d, J = 6.4 Hz, 3 H), 0.95 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 170.8, 132.6, 128.3, 81.3, 75.5, 73.7, 41.2, 29.1, 24.1, 
21.6, 21.2, 20.6, 14.5; HRMS (FAB) calcd for C13H23O3 [M+H]+ 227.1647, found 
227.1645. 
 
Benzoylated Tetrahydrofuran 49.  Benzoyl chloride (0.070 mL, 0.60 mmol, 
2.0 equiv) was added dropwise to a solution containing 47 (0.055 g, 0.30 mmol, 1.0 
equiv), DMAP (3.7 mg, 0.030 mmol, 0.10 equiv), and Et3N (0.17 mL, 1.2 mmol, 4.0 
equiv) in CH2Cl2 (1.5 mL) at 0 °C.  The resultant colorless solution was allowed to 
warm to 25 °C and maintained at that temperature for 5 h, then was quenched by the 
addition of water (10 mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined 
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organic layers were washed sequentially with aqueous 1 M HCl (20 mL), saturated 
aqueous sodium bicarbonate (20 mL), and brine (20 mL), then dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 20:1 + 2% Et3N) to afford 49 (0.066 g, 76% yield) as a colorless 
viscous oil [Note: as mentioned above, the Wittig reaction used in the synthesis of 43 
was not entirely stereoselective, as such 49 was contaminated with approximately 8% 
of the undesired E-alkene].  49: Rf = 0.52 (silica gel, hexanes:EtOAc, 4:1); IR (film) 
νmax 2967, 2933, 2869, 1719, 1273, 1113, 711 cm–1; 1H NMR (400 MHz, CDCl3) δ 
8.06 (d, J = 7.6 Hz, 2 H), 7.57 (t, J = 7.6 Hz, 1 H), 7.45 (t, J = 7.6 Hz, 2 H), 5.49 (m, 
1 H), 5.41 – 5.25 (m, 2 H), 4.03 (sextet, J = 6.4 Hz, 1 H), 3.82 (m, 1 H), 2.61 (quintet, 
J = 7.2 Hz, 1 H), 2.22 – 2.13 (m, 2 H), 1.99 (quintet, J = 7.2 Hz, 2 H), 1.91 – 1.62 (m, 
3 H), 1.36 (d, J = 6.4 Hz, 3 H), 0.89 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 166.2, 133.2, 132.6, 130.3, 129.8 (2 C), 128.6 (2 C), 128.2, 81.6, 76.0, 73.8, 41.3, 
29.4, 24.1, 21.9, 20.6, 14.4; HRMS (FAB) calcd for C18H25O3 [M+H]+ 289.1804, 
found 289.1795. 
 
Boc-Protected Tetrahydrofuran 50.  A solution of n-BuLi (0.662 mL, 1.5 M 
in hexanes, 0.99 mmol, 1.0 equiv) was added slowly to a solution of 47 (0.183 g, 
0.993 mmol, 1.00 equiv) in THF (8 mL) at 0 °C.  After 5 min at 0 °C, a solution of 
Boc2O (0.217 g, 0.993 mmol, 1.00 equiv) in THF (2 mL) was added slowly, and the 
resultant colorless solution was warmed to 25 °C for 1 h.  Upon completion, the 
reaction mixture was quenched by the addition of 10% aqueous ammonium chloride 
(20 mL) and extracted with Et2O (3 × 15 mL).  The combined organic layers were 
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washed with brine (30 mL), dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 19:1) to afford 50 (0.232 g, 
82% yield) as a colorless viscous oil [Note: as mentioned above, the Wittig reaction 
used in the synthesis of 43 was not entirely stereoselective, as such 50 was 
contaminated with approximately 8% of undesired E-alkene 93].  50: Rf = 0.43 (silica 
gel, hexanes:EtOAc, 9:1); IR (film) νmax 2973, 2935, 2872, 1738, 1280, 1256, 1167 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.42 – 5.28 (m, 2 H), 5.07 (m, 1 H), 3.90 (sextet, 
J = 6.4 Hz, 1 H), 3.67 (m, 1 H), 2.48 (app quintet, 1 H), 2.20 – 2.10 (m, 2 H), 2.04 
(quintet, J = 7.2 Hz, 2 H), 1.79 – 1.55 (m, 3 H), 1.47 (s, 9 H), 1.31 (d, J = 6.0 Hz, 3 
H), 0.94 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.6, 132.5, 128.4, 
82.1, 81.4, 78.2, 73.6, 41.0, 29.0, 27.9 (3 C), 24.1, 21.4, 20.6, 14.5; HRMS (FAB) 
calcd for C16H29O4 [M+H]+ 285.2066, found 285.2065. 
 
Inverted Acetylated Tetrahydrofuran 51.  AcOH (0.052 mL, 0.90 mmol, 
3.0 equiv) was added to a solution of 47 (0.055 g, 0.30 mmol, 1.0 equiv) and Ph3P 
(0.12 g, 0.45 mmol, 1.5 equiv) in toluene (3.0 mL) at 0 °C.  Next, DIAD (0.071 mL, 
0.36 mmol, 1.2 equiv) was added dropwise, and the resultant light yellow solution 
was allowed to warm to 25 °C and stirred at that temperature for 5 h, during which 
time significant amounts of white precipitate formed.  Upon completion, the reaction 
mixture was quenched by the addition of saturated aqueous sodium bicarbonate (10 
mL) and extracted with Et2O (3 × 10 mL).  The combined organic layers were washed 
with brine (20 mL), dried (MgSO4), filtered, concentrated, and purified by flash 
column chromatography (silica gel, hexanes:EtOAc, 10:1) to afford 51 (0.054 g, 80% 
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yield) as a colorless viscous oil [Note: as mentioned above, the Wittig reaction used 
in the synthesis of 43 was not entirely stereoselective, as such 51 was contaminated 
with approximately 8% of the undesired E-alkene].  51: Rf = 0.50 (silica gel, 
hexanes:EtOAc, 4:1); IR (film) νmax 2968, 2932, 2872, 1741, 1241, 1098, 1022 cm–1; 
1H NMR (400 MHz, CDCl3) δ 5.42 – 5.28 (m, 2 H), 4.93 (ddd, J = 6.4, 2.4, 1.2 Hz, 1 
H), 4.12 (septet, J = 5.6 Hz, 1 H), 3.80 (ddd, J = 8.8, 6.0, 3.2 Hz, 1 H), 2.20 – 1.99 
(m, 4 H), 2.05 (s, 3 H), 1.96 (ddd, J = 13.6, 5.6, 1.6 Hz, 1 H), 1.76 – 1.52 (m, 3 H), 
1.27 (d, J = 6.0 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
170.8, 132.5, 128.3, 83.9, 79.4, 74.4, 40.4, 34.5, 23.5, 21.3, 20.8, 20.6, 14.4; HRMS 
(FAB) calcd for C13H23O3 [M+H]+ 227.1647, found 227.1657. 
 
Inverted Benzoylated Tetrahydrofuran 52.  DIAD (0.236 mL, 1.20 mmol, 
1.2 equiv) was added dropwise to a solution containing 47 (0.184 g, 1.00 mmol, 1.00 
equiv), Ph3P (0.393 g, 1.50 mmol, 1.50 equiv), and benzoic acid (0.366 g, 3.00 mmol, 
3.00 equiv) in toluene (10 mL) at 0 °C.  The resultant light yellow solution was 
allowed to warm to 25 °C and stirred at that temperature for 2 h, then heated to 50 °C 
for 1 h.  The reaction mixture was then allowed to cool to 25 °C and quenched by the 
addition of saturated aqueous sodium bicarbonate (20 mL).  After stirring vigorously 
for 1 h at 25 °C, the resultant biphasic mixture was extracted with Et2O (3 × 20 mL).  
The combined organic layers were washed with brine (30 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0 → 0:1) to afford 52 (0.234 g, 81% yield) as a colorless viscous 
oil [Note: as mentioned above, the Wittig reaction used in the synthesis of 43 was not 
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entirely stereoselective, as such 52 was contaminated with approximately 8% of the 
undesired E-alkene].  52: Rf = 0.53 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 
2967, 2931, 2872, 1719, 1273, 1112, 1098, 711 cm–1; 1H NMR (400 MHz, CDCl3) δ 
8.04 (d, J = 7.2 Hz, 2 H), 7.57 (t, J = 7.6 Hz, 1 H), 7.44 (t, J = 7.6 Hz, 2 H), 5.42 – 
5.30 (m, 2 H), 5.20 (m, 1 H), 4.24 (septet, J = 5.6 Hz, 1 H), 3.99 (ddd, J = 8.4, 6.0, 
2.8 Hz, 1 H), 2.26 – 2.10 (m, 3 H), 2.04 (quintet, J = 7.2 Hz, 2 H), 1.82 (ddd, J = 
17.2, 10.4, 6.8 Hz, 1 H), 1.77 – 1.61 (m, 2 H), 1.32 (d, J = 6.0 Hz, 3 H), 0.93 (t, J = 
7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 166.2, 133.2, 132.5, 130.3, 129.7 (2 C), 
128.5 (2 C), 128.2, 84.0, 79.9, 74.6, 40.5, 34.6, 23.5, 20.7, 20.6, 14.4; HRMS (FAB) 
calcd for C18H25O3 [M+H]+ 289.1804, found 289.1807. 
 
Inverted Boc-Protected Tetrahydrofuran 53.  A solution of LiOH (0.108 g, 
4.5 mmol, 10 equiv) in water (2 mL) was added to a solution of benzoate 52 (0.130 g, 
0.450 mmol, 1.00 equiv) in THF (12 mL) and MeOH (4 mL).  After 1h at 25 °C, the 
reaction solution was poured into water (20 mL) and extracted with Et2O (3 × 30 
mL).  The combined organic layers were washed with brine (50 mL), dried (MgSO4), 
filtered, concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:1) to afford the corresponding alcohol (0.081 g, 98% yield) 
as a colorless viscous oil.  Next, a solution of n-BuLi (0.27 mL, 1.6 M in hexanes, 
0.44 mmol, 1.0 equiv) was added slowly to a solution of the alcohol produced above 
(0.081 g, 0.44 mmol, 1.0 equiv) in THF (4 mL) at 0 °C.  After 5 min at 0 °C, a 
solution of Boc2O (0.096 g, 0.44 mmol, 1.0 equiv) in THF (1 mL) was added slowly, 
and the resultant colorless solution was warmed to 25 °C for 1 h.  Upon completion, 
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the reaction mixture was quenched by the addition of 10% aqueous ammonium 
chloride (10 mL) and extracted with Et2O (3 × 10 mL).  The combined organic layers 
were washed with brine (20 mL), dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 19:1) to afford 53 
(0.100 g, 80% yield) as a colorless viscous oil [Note: as mentioned above, the Wittig 
reaction used in the synthesis of 43 was not entirely stereoselective, as such 53 was 
contaminated with approximately 8% of the undesired E-alkene].  53: Rf = 0.45 (silica 
gel, hexanes:EtOAc, 9:1); IR (film) νmax 2973, 2933, 2873, 1740, 1279, 1255, 1165 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.43 – 5.28 (m, 2 H), 4.78 (ddd, J = 6.8, 2.8, 1.2 
Hz, 1 H), 4.14 (septet, J = 5.6 Hz, 1 H), 3.86 (ddd, J = 7.6, 5.6, 2.8 Hz, 1 H), 2.22 – 
1.97 (m, 5 H), 1.75 – 1.57 (m, 3 H), 1.49 (s, 9 H), 1.27 (d, J = 6.0 Hz, 3 H), 0.95 (t, J 
= 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.1, 132.3, 128.1, 83.6, 82.4, 81.8, 
74.2, 40.3, 34.3, 27.8 (3 C), 23.3, 20.5 (2 C), 14.3; HRMS (FAB) calcd for C16H29O4 
[M+H]+ 285.2066, found 285.2059. 
 
Ring Expanded Acetate Regioisomers 54/55.  A cold solution of BDSB 
(0.0714 g, 0.130 mmol, 1.20 equiv) in MeNO2 (0.5 mL) was added rapidly via 
syringe to a solution of 48 (0.0244 g, 0.108 mmol, 1.00 equiv) [Note: this is 0.100 
mmol of the desired cis-alkene] in MeNO2 (4.5 mL) at –25 °C.  After 5 min at –25 
°C, the reaction mixture was quenched by the addition of saturated aqueous sodium 
bicarbonate and 5% aqueous Na2SO3 (1:1, 5 mL).  The resultant biphasic mixture was 
stirred vigorously for 20 min at 25 °C, then added to brine (10 mL) and extracted with 
EtOAc (3 × 15 mL).  The combined organic layers were washed with brine (20 mL), 
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dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 1:0→1:1) to afford a 3.6:1 mixture of 54 and 55 (0.0238 
g, 74% yield) as a colorless amorphous solid.  These two acetate regioisomers were 
only mostly separable on silica gel, a separation hindered by their facile 
interconversion, presumably by intramolecular transfer of the acetate group.  [Note: 
while this tranfer seemed to occur quickly on silica, it also occurred in solution or 
neat (even at –20 °C), albeit more slowly].  The minor isomer (55) appeared to be the 
more thermodynamically stable of the two, since it tended to predominate in mixtures 
that were allowed to interconvert over a long period of time.  Analysis of COSY 
spectra clearly indicated the position of the acetate on each of the two isomers.  Major 
Isomer 54: Rf = 0.34 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3450 (br), 2966, 
2937, 2876, 1731, 1371, 1247, 1057, 1037 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.01 
(ddd, J = 11.2, 4.4, 2.0 Hz, 1 H), 4.20 (sextet of doublets, J = 6.4, 2.0 Hz, 1 H), 4.11 
(m, 1 H), 3.88 – 3.79 (m, 2 H), 3.15 (d, J = 10.0 Hz, 1 H), 2.07 (s, 3 H), 2.05–1.75 
(m, 7 H), 1.72 (ddd, J = 14.4, 4.4, 2.0 Hz, 1 H), 1.26 (d, J = 6.0 Hz, 3 H), 1.06 (t, J = 
7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 171.0, 76.4, 75.4, 72.2, 67.6, 62.1, 36.3, 
31.7, 27.9, 26.3, 22.1, 21.5, 12.8; HRMS (FAB) calcd for C13H24BrO4 [M+H]+ 
323.0858, found 323.0846.  Minor Isomer 55: Rf = 0.32 (silica gel, hexanes:EtOAc, 
1:1); IR (film) νmax 3452 (br), 2966, 2938, 2876, 1729, 1371, 1248, 1058, 1036 cm–1; 
1H NMR (400 MHz, CDCl3) δ 5.22 (dd, J = 8.0, 3.2 Hz, 1 H), 4.05 – 3.95 (m, 2 H), 
3.83 – 3.72 (m, 2 H), 2.28 (d, J = 2.4 Hz, 1 H), 2.08 (s, 3 H), 2.13–1.59 (m, 7 H), 1.52 
(dt, J = 14.8, 4.0 Hz, 1 H), 1.18 (d, J = 6.4 Hz, 3 H), 1.05 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 170.1, 77.2, 74.1, 70.5, 69.3, 62.0, 37.0, 26.5, 26.4, 25.9, 
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21.5, 21.1, 13.3. 
 
Ring-Expanded Acetate Regioisomers 58/59.  Synthesized from 51 by 
following the same procedure utilized for the synthesis of 54/55, affording a 1:1.7 
mixture of 58 and 59 (0.0250 g, 77% yield, completely inseparable by 
chromatography) as a colorless amorphous solid.  As with diastereomers 54 and 55, 
acetate transfer between these two regioisomers was observed on silica gel as well as 
in solution and with neat compounds.  Analysis of a COSY spectrum of the mixture 
clearly indicated the position of the acetate on each of the two isomers.  58 and 59: Rf 
= 0.36 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3432 (br), 2966, 2934, 1725, 
1373, 1251, 1124, 1070, 1031 cm–1; HRMS (FAB) calcd for C13H22BrO4 [M–H]+ 
321.0701, found 321.0712. Minor Isomer (58): 1H NMR (400 MHz, CDCl3, 
identifiable peaks only) δ 4.80 (m, 1 H), 4.26 (t, J = 7.2 Hz, 1 H), 4.15 (sextet of 
doublets, J = 6.4, 2.4 Hz, 1 H), 3.78 – 3.70 (m, 2 H), 2.40 (br s, 1 H), 2.09 (s, 3 H), 
1.13 (d, J = 6.8 Hz, 3 H), 1.04 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
171.5, 78.9, 73.9, 73.7, 67.6, 61.9, 34.4, 32.1, 27.6, 25.9, 21.4, 20.3, 13.3.  Major 
Isomer (59): 1H NMR (400 MHz, CDCl3, identifiable peaks only) δ 5.16 (t, J = 8.0 
Hz, 1 H), 4.32 (sextet of doublets, J = 6.4, 2.0 Hz, 1 H), 3.82 (m, 1 H), 3.78 – 3.70 
(m, 2 H), 2.59 (br s, 1 H), 2.07 (s, 3 H), 1.14 (d, J = 6.8 Hz, 3 H), 1.04 (t, J = 7.2 Hz, 
3 H); 13C NMR (100 MHz, CDCl3) δ 171.8, 81.3, 73.4, 72.7, 67.3, 61.9, 36.0, 30.5, 
27.0, 25.5, 21.6, 20.1, 13.3. 
 
Ring-Expanded Benzoate Regioisomers 60/61.  Synthesized from 49 by 
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following the same procedure utilized for the synthesis of 54/55, affording 60 (0.0266 
g, 69% yield) and 61 (2.8 mg, 7% yield) as colorless amorphous solids that were 
separable by preparative thin-layer chromatography (silica gel, hexanes:EtOAc, 3:2, 
run up 2X).  Unlike the acetate regioisomers described above, these two benzoate 
regioisomers did not appear to interconvert on silica, in solution, or neat.  Analysis of 
the COSY spectrum clearly indicated the position of the benzoate on major isomer 
60.  Major Isomer 60: Rf = 0.52 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 3441 
(br), 2966, 2934, 1712, 1276, 1114, 1069, 713 cm–1; 1H NMR (400 MHz, CDCl3) δ 
8.04 (m, 2 H), 7.57 (tt, J = 7.2, 1.2 Hz, 1 H), 7.44 (t, J  = 7.6 Hz, 2 H), 5.28 (ddd, J = 
11.2, 4.4, 2.0 Hz, 1 H), 4.30 – 4.20 (m, 2 H), 3.90 – 3.81 (m, 2 H), 3.21 (d, J = 10.0 
Hz, 1 H), 2.17 (m, 1 H), 2.08 – 1.74 (m, 7 H), 1.29 (d, J = 6.4 Hz, 3 H), 1.08 (t, J = 
7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 166.4, 133.3, 130.3, 129.8 (2 C), 128.5 
(2 C), 77.4, 75.9, 72.3, 67.7, 62.1, 36.4, 31.8, 27.8, 26.4, 22.1, 12.8; HRMS (FAB) 
calcd for C18H26BrO4 [M+H]+ 385.1014, found 385.1028.  Minor Isomer 61: Rf = 0.48 
(silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 3481 (br), 2965, 2876, 1711, 1273, 
1116, 1058, 713 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.03 (m, 2 H), 7.58 (tt, J = 7.6, 
1.2 Hz, 1 H), 7.46 (t, J = 7.6 Hz, 2 H), 5.51 (dd, J = 8.0, 3.2 Hz, 1 H), 4.19 (m, 1 H), 
4.06 (sextet of doublets, J = 6.4, 2.4 Hz, 1 H), 3.85 (m, 1 H), 3.78 (dt, J = 11.2, 2.8 
Hz, 1 H), 2.37 (d, J = 2.4 Hz, 1 H), 2.22 (m, 1 H), 2.12 – 1.79 (m, 5 H), 1.75 – 1.60 
(m, 2 H), 1.22 (d, J = 6.8 Hz, 3 H), 1.07 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 165.8, 133.3, 130.5, 129.7 (2 C), 128.6 (2 C), 77.9, 74.1, 70.7, 69.4, 62.0, 
37.2, 26.5 (2 C), 25.9, 21.1, 13.3; HRMS (FAB) calcd for C18H26BrO4 [M+H]+ 
385.1014, found 385.1009. 
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Ring-Expanded Benzoate Regioisomers 62/63.  Synthesized from 52 by 
following the same procedure utilized for the synthesis of 54/55, affording an 
inseparable mixture (1:1.2) of 62 and 63 (0.0280 g, 73%) as a colorless amorphous 
solid.  As with 60 and 61, these two benzoate regioisomers did not appear to 
interconvert on silica, in solution, or neat.  Analysis of a COSY spectrum of the 
mixture clearly indicates the position of the benzoate on each of the two isomers.  
62/63: Rf = 0.48 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 3461 (br), 2966, 
2933, 2875, 1712, 1276, 1113, 1068, 713 cm–1; HRMS (FAB) calcd for C18H25BrO4 
[M–H]+ 383.0858, found 383.0865. Minor Isomer (62): 1H NMR (400 MHz, CDCl3, 
identifiable peaks only) δ 5.10 (ddd, J = 8.0, 4.0, 2.4 Hz, 1 H), 4.47 (m, 1 H), 4.29 
(sextet of d, J = 6.8, 2.4 Hz, 1 H), 2.37 (d, J = 4.0 Hz, 1 H), 1.16 (d, J = 6.8 Hz, 3 H); 
13C NMR (100 MHz, CDCl3, identifiable peaks only) δ 166.7, 79.4, 73.9, 67.9, 20.5.  
Major Isomer (63): 1H NMR (400 MHz, CDCl3, identifiable peaks only) δ 5.46 (t, J = 
8.4 Hz, 1 H), 4.41 (sextet of d, J = 6.4, 2.0 Hz, 1 H), 4.04 (m, 1 H), 2.61 (s, 1 H), 1.19 
(d, J = 6.4 Hz, 3 H); 13C NMR (100 MHz, CDCl3, identifiable peaks only) δ 
167.3, 82.1, 72.9, 67.4, 20.2. 
 
Ring-Expanded Carbonate 64.  BDSB Procedure: A cold solution of BDSB 
(0.0714 g, 0.130 mmol, 1.20 equiv) in MeNO2 (0.5 mL) was added rapidly via 
syringe to a solution of 50 (0.0307 g, 0.108 mmol, 1.00 equiv) [Note: this is 0.100 
mmol of the desired cis-alkene] in MeNO2 (4.5 mL) at –25 °C.  After 5 min at –25 
°C, the reaction flask was removed from the cold bath and stirred for an additional 5 
 621 
min at 25 °C.  Upon completion, the reaction mixture was quenched by the addition 
of saturated aqueous sodium bicarbonate and 5% aqueous Na2SO3 (1:1, 5 mL).  The 
resultant biphasic mixture was stirred vigorously for 20 min at 25 °C, then added to 
brine (10 mL) and extracted with EtOAc (3 × 15 mL).  The combined organic layers 
were washed with brine (20 mL), dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:EtOAc, 4:1) to afford 64 
(0.0244 g, 79% yield) as a white crystalline solid.  (Coll)2BrOTf Procedure: (Reagent 
was prepared according to: Neverov, A. A.; Brown, R. S. J. Org. Chem. 1998, 63, 
5977–5982).  A solution of (coll)2BrOTf (0.057 g, 0.12 mmol, 1.1 equiv) in MeNO2 
(0.5 mL) was syringed into a solution of 50 (0.0307 g, 0.108 mmol, 1.00 equiv) in 
MeNO2 (4.5 mL) at 0 °C.  After 5 min at 0 °C, the reaction mixture was removed 
from the ice bath and stirred at 25 °C for an additional 5 min.  Upon completion, the 
reaction mixture was quenched by the addition of 5% aqueous Na2SO3 (10 mL) and 
extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were dried 
(MgSO4), filtered, concentrated, and purified by flash column chromatography (silica 
gel, hexanes:EtOAc, 1:0 → 7:3) to afford 64 (0.0199 g, contaminated by two minor 
inseparable impurities, ~52% yield).  TBCO Procedure:  (Reagent was prepared 
according to: Dogo-Isonagie, C.; Bekele, T.; France, S.; Wolfer, J.; Weatherwax, A.; 
Taggi, A. E.; Lectka, T. J. Org. Chem. 2006, 71, 8946–8949).  Solid TBCO (0.049 g, 
0.12 mmol, 1.1 equiv) was added in one portion to a solution of 50 (0.0307 g, 0.108 
mmol, 1.00 equiv) in MeCN (5 mL) at 25 °C.  After 10 min at 25 °C, the reaction 
mixture was quenched by the addition of saturated aqueous sodium bicarbonate and 
5% aqueous Na2SO3 (1:1, 5 mL) and extracted with CH2Cl2 (3 × 10 mL).  The 
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combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 7:3) to afford 64 
(0.0190 g, 62% yield).  NBS Procedure: NBS (0.021 g, 0.12 mmol, 1.1 equiv) was 
added in one portion to a solution of 60 (0.0307 g, 0.108 mmol, 1.00 equiv) in 
CH2Cl2 (0.5 mL) at 25 °C.  After 48 h, the solvent was removed under vacuum and 
the residue subjected to flash column chromatography (silica gel, hexanes:EtOAc, 1:0 
→ 1:1) to afford 64 (3.8 mg, approximately 75% pure by NMR, ~9% yield).  The 
remaining mass balance contained approximately 50% starting material in addition to 
numerous unidentified byproducts.  Performing the reaction at lower temperatures or 
higher dilution led to only recovered starting material.  Utilizing excess NBS or 3 
equivalents of N,N-dimethylacetamide as a nucleophilic promoter resulted in faster 
reactions, but with increased side product formation such that even less desired 
product was formed.  More polar solvents such as THF and DMF resulted in an 
increased rate of consumption of starting material, but with no product formation at 
all.  64: Rf = 0.46 (silica gel, hexanes:EtOAc, 3:2); IR (film) νmax 2969, 2937, 2877, 
1800, 1192, 1041 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.85 – 4.72 (m, 2 H), 4.00 
(sextet of doublets, J = 6.4, 2.8 Hz, 1 H), 3.75 – 3.68 (app d, 2 H), 2.22 – 2.12 (m, 2 
H), 2.04 – 1.89 (m, 4 H), 1.66 – 1.44 (m, 2 H), 1.26 (d, J = 6.4 Hz, 3 H), 1.05 (t, J = 
7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 154.2, 82.2, 79.0, 74.3, 70.5, 60.7, 33.9, 
27.8, 26.2, 25.4, 19.1, 13.3; HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, 
found 307.0536. 
 
Ring-Expanded Carbonate 65.  Synthesized from 53 by following the same 
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procedure (“BDSB procedure”) utilized for the synthesis of 64, affording 65 (0.0283 
g, contaminated with a small amount of an inseparable impurity, ~85% yield) as a 
colorless amorphous solid.  65: Rf  = 0.52 (silica gel, hexanes:EtOAc, 3:2); IR (film) 
νmax 2970, 2933, 1805, 1210, 1076, 1055 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.57 
(td, J = 10.4, 5.6 Hz, 1 H), 4.36 (m, 1 H), 4.09 (septet, J = 5.6 Hz, 1 H), 3.86 – 3.78 
(m, 2 H), 2.45 (ddt, J = 14.0, 7.6, 2.0 Hz, 1 H), 2.28 (ddd, J = 15.6, 10.0, 5.2 Hz, 1 
H), 2.12 (m, 1 H), 1.99–1.72 (m, 5 H), 1.37 (d, J = 6.4 Hz, 3 H), 1.06 (t, J = 7.2 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 154.0, 83.4, 81.6, 79.6, 64.3, 63.0, 39.6, 30.8, 
28.6, 27.2, 22.6, 12.4; HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, found 
307.0530. 
 
(5Z)-2-Chloro-5-Octenal (87).  See the synthesis of 45  [Note: this product 
was unstable and was used immediately – spectral characterization of pure compound 
was not feasible].   
 
cis-Diol 88.  Solid NaBH4 (0.195 g, 5.16 mmol, 1.20 equiv) was added in a 
single portion to a solution of ketone 45 (0.940 g, 4.30 mmol, 1.00 equiv) in MeOH 
(43 mL) at –20 °C.  After 15 min at –20 °C, the reaction solution was quenched by 
the careful addition of 10%  aqueous ammonium chloride (80 mL) and extracted with 
EtOAc (3 × 60 mL).  The combined organic layers were washed with brine (100 mL), 
dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 1:0 → 1:1) to afford cis-diol 88 (0.604 g, contaminated 
with minor inseparable impurities, ~60% yield) as a colorless amorphous solid, along 
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with separable trans-diol 46 (0.247 g, 26% yield).  88: Rf = 0.46 (silica gel, 
hexanes:EtOAc, 1:1); IR (film) νmax 3363 (br), 2965, 2933, 2874, 1455, 1136, 1073 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.43 (m, 1 H), 5.28 (m, 1 H), 4.06 (m, 1 H), 3.97 
(m, 1 H), 3.90 (ddd, J = 10.4, 4.8, 3.2 Hz, 1 H), 3.40 (d, J = 4.0 Hz, 1 H), 2.87 (d, J = 
2.4 Hz, 1 H), 2.34 – 2.18 (m, 2 H), 2.07 (quintet of doublets, J = 7.6, 0.8 Hz, 2 H), 
1.89 – 1.58 (m, 4 H), 1.24 (d, J = 6.4 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 133.6, 127.2, 75.8, 68.8, 67.3, 40.5, 32.9, 24.3, 24.1, 20.7, 14.5; 
HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 221.1308, found 221.1306. 
 
Boc-Protected Tetrahydrofuran 89.  According to the procedure utilized for 
the synthesis of 47, cyclization of cis-diol 88 at 130 °C for 1 h afforded the desired 
hydroxytetrahydrofuran (0.430 g, 87% yield) as a colorless viscous oil.  Subsequent 
carbonate formation using a portion of this material afforded 89 (0.111 g, 78% yield) 
as a colorless viscous oil [Note: as mentioned above, the Wittig reaction for the 
synthesis of 43 was not entirely stereoselective, as such 89 was contaminated with 
approximately 8% of undesired E-alkene 95].   89: Rf = 0.44 (silica gel, 
hexanes:EtOAc, 9:1); IR (film) νmax 2969, 2933, 2872, 1739, 1369, 1280, 1254, 1165 
cm–1; 1H NMR (400 MHz, CDCl3) δ 5.41 – 5.27 (m, 2 H), 5.15 (t, J = 4.0 Hz, 1 H), 
4.31 (m, 1 H), 4.00 (ddd, J = 9.6, 5.6, 3.6 Hz, 1 H), 2.23 – 1.96 (m, 5 H), 1.78 (ddd, J 
= 14.4, 9.2, 5.2 Hz, 1 H), 1.74 – 1.50 (m, 2 H), 1.48 (s, 9 H), 1.23 (d, J = 6.4 Hz, 3 
H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.5, 132.5, 128.4, 
82.3, 80.2, 78.6, 73.0, 41.1, 29.3, 27.9 (3 C), 24.0, 21.5, 20.6, 14.5; HRMS (FAB) 
calcd for C16H29O4 [M+H]+ 285.2066, found 285.2055. 
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(5E)-2-Chloro-5-Octenal (90).  (Step 1 adapted from: Shakhmaev, R. N.; 
Ishbaeva, A. U.; Shayakhmetova, I. S. Russ. J. Gen. Chem. 2009, 79, 1171–1174; 
step 3 adapted from: Uyanik, M.; Ishihara, K.; Yamamoto, H. Org. Lett. 2006, 8, 
5649–5652). Bromine (1.08 mL, 21.0 mmol, 1.05 equiv) was added dropwise to a 
solution of Ph3P (6.30 g, 24.0 mmol, 1.20 equiv) in CH2Cl2 (120 mL) at 0 °C, and the 
resultant colorless solution was stirred for 5 min, then cooled to –20 °C.  trans-4-
Hepten-1-ol (see synthesis of 102, 2.28 g, 20.0 mmol, 1.00 equiv) was added 
dropwise and the resultant solution was allowed to warm slowly over 2 h to 25 °C.  
Upon completion, the reaction contents were concentrated by rotary evaporation to a 
volume of ~20 mL, then purified directly by flash column chromatography (silica gel, 
pentane:Et2O, 19:1) to afford the desired alkyl bromide (2.82 g, 75% yield) as a 
colorless volatile oil.  Next, a portion of this bromide (2.15 g, 12.1 mmol, 1.00 equiv) 
was added to a suspension of NaCN (0.892 g, 18.2 mmol, 1.50 equiv) in DMSO (18 
mL) at 25 °C.  After 3 h at 25 °C, the reaction contents were poured into water (150 
mL) and extracted with hexanes/Et2O (1:1, 3 × 75 mL).  The combined organic layers 
were washed with water (3 × 50 mL) and brine (50 mL), dried (MgSO4), filtered, and 
concentrated to afford the desired nitrile, which was carried forward without 
additional purification.  Next, DIBAL-H (14.6 mL, 1.0 M in toluene, 14.6 mmol, 1.2 
equiv) was added dropwise over the course of 10 min to a solution of the crude nitrile 
produced above (12.1 mmol assumed, 1.00 equiv) in CH2Cl2 (61 mL) at –78 °C.  The 
resultant colorless reaction mixture was allowed to warm slowly to –50 °C over 90 
min, and was then quenched by the sequential addition of acetone (120 mL), saturated 
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aqueous ammonium chloride (10 mL), and 1 M sodium potassium tartrate (30 mL).  
The resultant biphasic mixture was stirred vigorously for 12 h at 25 °C, then poured 
into brine (200 mL) and extracted with Et2O (3 × 100 mL).  The combined organic 
layers were washed with brine (200 mL), dried (MgSO4), filtered, and concentrated to 
afford (5E)-octenal (1.26 g, 83% yield) as a light yellow viscous oil which was 
carried forward without additional purification [Note: this product was unstable to 
silica gel].  Finally, the (5E)-Octenal was α-chlorinated according to the same 
procedure used in the synthesis of 45, affording 90 (0.60 g, 37% yield) as a fragrant 
colorless oil [Note: this product was unstable and was used immediately – spectral 
characterization of pure compound was not feasible].   
 
β-Hydroxyketone 91.  Addition of the enolate derived from acetone to 
aldehyde 90 was carried out as in the synthesis of 45, affording 91 (0.383 g, 56% 
yield) as a colorless viscous oil.  91: Rf = 0.3 (silica gel, hexanes:EtOAc, 2:1); 1H 
NMR (400 MHz, CDCl3) δ 5.53 (m, 1 H), 5.36 (m, 1 H), 4.12 (m, 1 H), 3.92 (ddd, J = 
9.6, 6.0, 2.8 Hz, 1 H), 3.21 (d, J = 5.2 Hz, 1 H), 2.88 – 2.73 (m, 2 H), 2.28 (m, 1 H), 
2.22 (s, 3 H), 2.12 (m, 1 H), 2.05 – 1.90 (m, 3 H), 1.69 (m, 1 H), 0.97 (t, J = 7.6 Hz, 3 
H). 
 
cis/trans-Diols 92/94.  Sodium borohydride reduction of 91 was carried out as 
in the synthesis of 88, affording separable trans-diol 92 (0.062 g, 26% yield) and cis-
diol 94 (0.128 g, 54% yield), both as a colorless amorphous solids.  92: Rf = 0.35 
(silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3368 (br), 2964, 2931, 1451, 1376, 
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1065, 968 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.54 (m, 1 H), 5.35 (m, 1 H), 4.19 (m, 
1 H), 4.06 – 3.97 (m, 2 H), 2.72 (br s, 1 H), 2.29 (m, 1 H), 2.11 (sextet, J = 7.6 Hz, 1 
H), 2.00 (quintet, J = 7.2 Hz, 2 H), 1.93 – 1.72 (m, 3 H), 1.62 (ddd, J = 14.4, 8.4, 2.4 
Hz, 1 H), 1.58 (br s, 1 H), 1.28 (d, J = 6.4 Hz, 3 H), 0.97 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 133.8, 127.3, 72.0, 67.5, 65.5, 40.2, 33.3, 29.5, 25.7, 24.0, 
14.0; HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 221.1308, found 221.1306.  94: Rf 
= 0.42 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3367 (br), 2964, 2931, 1449, 
1076, 968 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.53 (m, 1 H), 5.35 (m, 1 H), 4.07 (m, 
1 H), 4.01 – 3.88 (m, 2 H), 2.86 (br s, 2 H), 2.29 (m, 1 H), 2.10 (sextet, J = 7.2 Hz, 1 
H), 2.00 (quintet, J = 7.2 Hz, 2 H), 1.90 – 1.59 (m, 4 H), 1.24 (d, J = 6.0 Hz, 3 H), 
0.97 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 133.9, 127.3, 75.8, 68.9, 
67.3, 40.5, 32.9, 29.5, 25.7, 24.3, 14.0; HRMS (FAB) calcd for C11H22ClO2 [M+H]+ 
221.1308, found 221.1300. 
 
Boc-Protected Tetrahydrofuran 93.  According to the procedure utilized for 
the synthesis of 47, cyclization of trans-diol 92 at 130 °C for 8 h afforded the desired 
hydroxytetrahydrofuran (0.118 g, 72% yield) as a colorless viscous oil.  Subsequent 
carbonate formation using a portion of this material afforded 93 (0.105 g, 74% yield) 
as a colorless viscous oil.  93: Rf = 0.39 (silica gel, hexanes:EtOAc, 9:1); IR (film) 
νmax 2977, 2934, 2872, 1739, 1369, 1280, 1255, 1167 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 5.52–5.34 (m, 2 H), 5.07 (ddd, J = 7.2, 4.0, 2.8 Hz, 1 H), 3.89 (m, 1 H), 
3.66 (ddd, J = 10.0, 5.6, 3.6 Hz, 1 H), 2.47 (quintet, J = 7.2 Hz, 1 H), 2.19 – 1.93 (m, 
4 H), 1.79 – 1.63 (m, 2 H), 1.58 (ddd, J = 14.0, 7.6, 2.8 Hz, 1 H), 1.47 (s, 9 H), 1.30 
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(d, J = 6.4 Hz, 3 H), 0.94 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.6, 
132.7, 128.5, 82.1, 81.4, 78.2, 73.5, 40.9, 29.4, 28.8, 27.9 (3 C), 25.7, 21.4, 14.0; 
HRMS (FAB) calcd for C16H29O4 [M+H]+ 285.2066, found 285.2063. 
 
Boc-Protected Tetrahydrofuran 95.  According to the procedure utilized for 
the synthesis of 47, cyclization of cis-diol 94 at 130 °C for 2 h afforded the desired 
hydroxytetrahydrofuran (0.101 g, 94% yield) as a colorless viscous oil.  Subsequent 
carbonate formation using a portion of this material afforded 95 (0.108 g, 76% yield) 
as a colorless viscous oil.  95: Rf = 0.39 (silica gel, hexanes:EtOAc, 9:1); IR (film) 
νmax 2967, 2932, 2873, 1739, 1369, 1279, 1255, 1166 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 5.51 – 5.33 (m, 2 H), 5.15 (t, J = 4.0 Hz, 1 H), 4.29 (m, 1 H), 4.00 (ddd, J = 
9.6, 6.0, 4.0 Hz, 1 H), 2.21 – 1.94 (m, 5 H), 1.77 (ddd, J = 14.0, 9.2, 5.2 Hz, 1 H), 
1.71 – 1.51 (m, 2 H), 1.47 (s, 9 H), 1.22 (d, J = 6.4 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 153.4, 132.7, 128.5, 82.2, 80.2, 78.6, 73.0, 41.1, 29.3, 
29.1, 27.9 (3 C), 25.7, 21.5, 14.0; HRMS (FAB) calcd for C16H29O4 [M+H]+ 
285.2066, found 285.2073. 
 
(4Z)-2-Chloro-4-Heptenal (96).  Commercially available (4Z)-Heptenal was 
α-chlorinated according to the same procedure used in the synthesis of 45, affording 
96 (2.23 g, 76% yield) as a fragrant colorless oil [Note: this product was unstable and 
was used immediately – spectral characterization of pure compound was not feasible].   
 
β-Hydroxyketone 97.  Addition of the enolate derived from acetone to 
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aldehyde 96 was carried out as in the synthesis of 45, affording 97 (1.56 g, 60% 
yield) as a colorless viscous oil.  97: Rf = 0.3 (silica gel, hexanes:EtOAc, 2:1); 1H 
NMR (400 MHz, CDCl3) δ 5.56 (m, 1 H), 5.41 (m, 1 H), 4.13 (m, 1 H), 3.91 (ddd, J = 
10.8, 6.4, 3.6 Hz, 1 H), 3.27 (d, J = 4.8 Hz, 1 H), 2.93 – 2.73 (m, 2 H), 2.66 (m, 1 H), 
2.50 (m, 1 H), 2.20 (s, 3 H), 2.07 (quintet, J = 7.2 Hz, 2 H), 0.98 (t, J = 7.6 Hz, 3 H). 
 
cis/trans-Diols 98/100.  Sodium borohydride reduction of 97 was carried out 
as in the synthesis of 88, affording separable trans-diol 98 (0.153 g, 35% yield, white 
crystalline solid) and cis-diol 100 (0.232 g, 53% yield, colorless amorphous solid).  
98: Rf = 0.36 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3372 (br), 2966, 2934, 
2876, 1458, 1376, 1069 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.51 (m, 1 H), 5.39 (m, 
1 H), 4.18 (m, 1 H), 4.05 – 3.89 (m, 2 H), 2.74 (br s, 2 H), 2.65 – 2.41 (m, 2 H), 2.06 
(quintet, J = 7.6 Hz, 2 H), 1.81 (ddd, J = 14.4, 8.8, 2.8 Hz, 1 H), 1.66 (ddd, J = 14.4, 
8.8, 2.4 Hz, 1 H), 1.26 (d, J = 6.4 Hz, 3 H), 0.97 (t, J = 7.6 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 134.9, 124.2, 71.7, 67.0, 65.4, 40.1, 31.5, 23.9, 20.9, 14.2; HRMS 
(FAB) calcd for C10H20ClO2 [M+H]+ 207.1152, found 207.1143.  100: Rf = 0.46 
(silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3362 (br), 2967, 2933, 2875, 1457, 
1134, 1074 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.55 (m, 1 H), 5.41 (m, 1 H), 4.09 
(m, 1 H), 3.99 (ddd, J = 10.0, 4.8, 2.0 Hz, 1 H), 3.90 (m, 1 H), 2.82 (br s, 2 H), 2.65 – 
2.45 (m, 2 H), 2.06 (quintet, J = 7.6 Hz, 2 H), 1.81 (dt, J = 14.4, 2.4 Hz, 1 H), 1.63 
(m, 1 H), 1.25 (d, J = 6.0 Hz, 3 H), 0.98 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 135.0, 124.1, 75.4, 68.9, 67.0, 40.5, 31.1, 24.4, 21.0, 14.2; HRMS (FAB) 
calcd for C10H20ClO2 [M+H]+ 207.1152, found 207.1157. 
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Boc-Protected Tetrahydrofuran 99.  According to the procedure utilized for 
the synthesis of 47, cyclization of trans-diol 98 at 130 °C for 4 h afforded the desired 
hydroxytetrahydrofuran (0.155 g, 72% yield) as a colorless viscous oil.  Subsequent 
carbonate formation using a portion of this material afforded 99 (0.068 g, 84% yield) 
as a colorless viscous oil.  99: Rf = 0.34 (silica gel, hexanes:EtOAc, 9:1); IR (film) 
νmax 2975, 2934, 2873, 1739, 1282, 1256, 1166 cm–1; 1H NMR (400 MHz, CDCl3) δ 
5.48 (m, 1 H), 5.36 (m, 1 H), 5.08 (m, 1 H), 3.93 (m, 1 H), 3.70 (td, J = 7.2, 4.4 Hz, 1 
H), 2.48 (quintet, J = 7.2 Hz, 1 H), 2.41 (t, J = 7.2 Hz, 2 H), 2.11 – 2.00 (m, 2 H), 
1.60 (ddd, J = 14.0, 7.2, 2.8 Hz, 1 H), 1.47 (s, 9 H), 1.31 (d, J = 6.0 Hz, 3 H), 0.95 (t, 
J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.5, 134.1, 124.4, 82.2, 81.7, 
77.9, 73.7, 40.9, 27.9 (3 C), 27.2, 21.4, 20.8, 14.3; HRMS (FAB) calcd for C15H27O4 
[M+H]+ 271.1909, found 271.1899. 
 
Boc-Protected Tetrahydrofuran 101.  According to the procedure utilized 
for the synthesis of 47, cyclization of cis-diol 100 at 130 °C for 5 h afforded the 
desired hydroxytetrahydrofuran (0.153 g, 86% yield) as a colorless viscous oil.  
Subsequent carbonate formation using a portion of this material afforded 101 (0.067 
g, 83% yield) as a colorless viscous oil.  101: Rf = 0.34 (silica gel, hexanes:EtOAc, 
9:1); IR (film) νmax 2973, 2932, 2874, 1740, 1281, 1254, 1165 cm–1; 1H NMR (400 
MHz, CDCl3) δ 5.48 (m, 1 H), 5.31 (m, 1 H), 5.14 (t, J = 4.4 Hz, 1 H), 4.32 (m, 1 H), 
4.03 (td, J = 7.2, 4.0 Hz, 1 H), 2.42 – 2.28 (m, 2 H), 2.19 (dd, J = 13.6, 5.6 Hz, 1 H), 
2.11 – 1.98 (m, 2 H), 1.77 (ddd, J = 14.4, 9.6, 5.2 Hz, 1 H), 1.48 (s, 9 H), 1.24 (d, J = 
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6.4 Hz, 3 H), 0.95 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.4, 134.1, 
124.3, 82.3, 80.6, 78.3, 73.3, 41.1, 27.9 (3 C), 27.5, 21.5, 20.8, 14.3; HRMS (FAB) 
calcd for C15H27O4 [M+H]+ 271.1909, found 271.1900. 
 
(4E)-2-Chloro-4-Heptenal (102).  (Procedure adapted from: Shakhmaev, R. 
N.; Ishbaeva, A. U.; Shayakhmetova, I. S. Russ. J. Gen. Chem. 2009, 79, 1171–1174).  
1-Penten-3-ol (10.0 g, 116 mmol, 1.00 equiv), propionic acid (0.44 mL, 5.8 mmol, 
0.050 equiv), and trimethyl orthoacetate (43.6 mL, 348 mmol, 3.00 equiv) were added 
to a high-pressure sealed tube.  The reaction vessel was sealed and heated to 120 °C 
for 12 h.  Upon completion, the reaction contents were cooled to 25 °C, the cap was 
removed, and the reaction contents were re-heated to 120 °C for 2 h, open to the 
atmosphere, in order to distill off the MeOH byproduct.  The resultant yellow oil was 
then dissolved in Et2O (20 mL) and cannulated dropwise into a suspension of LiAlH4 
(4.41 g, 116 mmol, 1.00 equiv) in Et2O (440 mL) at 0 °C.  The resultant slurry was 
stirred at 0 °C for 60 min and then quenched by the careful dropwise addition of 
saturated aqueous ammonium chloride (20 mL).  An aqueous solution of 1 M sodium 
potassium tartrate (300 mL) was added and the resultant biphasic mixture was stirred 
vigorously for 16 h at 25 °C.  The layers were then allowed to separate and the 
aqueous layer was extracted with additional Et2O (2 × 200 mL).  The combined 
organic layers were washed with brine (200 mL), dried (MgSO4), filtered, and 
concentrated (→100 mm Hg at 20 °C).  The resultant crude oil was purified by flash 
column chromatography (silica gel, hexanes:Et2O, 1:0 → 4:1) to afford (4E)-hepten-
1-ol (11.1 g, 84% yield) as a moderately volatile colorless oil.  This product was 
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oxidized according to the Swern oxidation procedure utilized during the synthesis of 
43, affording (4E)-heptenal (2.36 g, 72% yield) as a colorless oil [Note: this product 
was unstable to silica gel and was carried forward crude].  This (4E)-Heptenal was α-
chlorinated according to the same procedure used in the synthesis of 45, affording 
102 (1.88 g, 79% yield) as a fragrant colorless oil [Note: this product was unstable 
and was used immediately – spectral characterization of pure compound was not 
feasible].   
 
β-Hydroxyketone 103.  Addition of enolate derived from acetone to aldehyde 
102 was carried out as in the synthesis of 45, affording 103 (1.35 g, 62% yield) as a 
colorless viscous oil.  103: Rf = 0.3 (silica gel, hexanes:EtOAc, 2:1); 1H NMR (400 
MHz, CDCl3) δ 5.60 (m, 1 H), 5.45 (m, 1 H), 4.12 (m, 1 H), 3.90 (ddd, J = 10.8, 6.4, 
4.4 Hz, 1 H), 3.23 (d, J = 5.2 Hz, 1 H), 2.91 – 2.73 (m, 2 H), 2.59 (m, 1 H), 2.43 (m, 1 
H), 2.22 (s, 3 H), 2.04 (quintet, J = 7.6 Hz, 2 H), 0.98 (t, J = 7.2 Hz, 3 H). 
 
cis/trans-Diols 104/106.  Sodium borohydride reduction of 103 was carried 
out as in the synthesis of 88, affording separable trans-diol 104 (0.397 g, 30% yield) 
and cis-diol 106 (0.460 g, 35% yield), both as a white crystalline solids.  104: Rf = 
0.39 (silica gel, hexanes:EtOAc, 1:1); IR (film) νmax 3363 (br), 2965, 2932, 2874, 
1459, 1376, 1067, 967 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.60 (m, 1 H), 5.45 (m, 1 
H), 4.18 (m, 1 H), 4.02 (m, 1 H), 3.95 (m, 1 H), 2.97 (d, J = 6.0 Hz, 1 H), 2.56 (m, 1 
H), 2.42 (m, 1 H), 2.14 (br s, 1 H), 2.04 (quintet, J = 7.2 Hz, 2 H), 1.81 (ddd, J = 
14.4, 8.8, 2.8 Hz, 1 H), 1.67 (ddd, J = 14.4, 8.4, 2.8 Hz, 1 H), 1.26 (d, J = 6.0 Hz, 3 
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H), 0.98 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 136.1, 124.3, 71.5, 67.0, 
65.5, 40.0, 37.0, 25.7, 23.9, 13.8; HRMS (FAB) calcd for C10H20ClO2 [M+H]+ 
207.1152, found 207.1160.  106: Rf = 0.43 (silica gel, hexanes:EtOAc, 1:1); IR (film) 
νmax 3363 (br), 2966, 2933, 1458, 1429, 1133, 1080, 968 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 5.60 (m, 1 H), 5.45 (m, 1 H), 4.07 (m, 1 H), 3.98 (m, 1 H), 3.87 (m, 1 H), 
3.12 (br s, 2 H), 2.58 – 2.39 (m, 2 H), 2.04 (quintet, J = 7.2 Hz, 2 H), 1.80 (dt, J = 
14.4, 2.4 Hz, 1 H), 1.62 (m, 1 H), 1.24 (d, J = 6.4 Hz, 3 H), 0.98 (t, J = 7.6 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 136.1, 124.2, 75.2, 68.8, 67.0, 40.4, 36.6, 25.7, 24.3, 
13.8; HRMS (FAB) calcd for C10H20ClO2 [M+H]+ 207.1152, found 207.1154. 
 
Boc-Protected Tetrahydrofuran 105.  According to the procedure utilized 
for the synthesis of 47, cyclization of trans-diol 104 at 130 °C for 2 h afforded the 
desired hydroxytetrahydrofuran (0.122 g, 57% yield) as a colorless viscous oil.  
Subsequent carbonate formation using a portion of this material afforded 105 (0.104 
g, 77% yield) as a colorless viscous oil.  105: Rf = 0.44 (silica gel, hexanes:EtOAc, 
9:1); IR (film) νmax 2974, 2934, 2873, 1739, 1369, 1281, 1256, 1167 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 5.55 (m, 1 H), 5.39 (m, 1 H), 5.08 (m, 1 H), 3.92 (m, 1 H), 3.68 
(td, J = 6.8, 4.0 Hz, 1 H), 2.47 (quintet, J = 7.2 Hz, 1 H), 2.41 – 2.29 (m, 2 H), 2.00 
(m, 2 H), 1.58 (ddd, J = 14.0, 7.6, 2.8 Hz, 1 H), 1.47 (s, 9 H), 1.31 (d, J = 6.4 Hz, 3 
H), 0.95 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.5, 134.9, 124.7, 
82.1, 82.0, 77.9, 73.7, 40.8, 32.4, 27.9 (3 C), 25.7, 21.5, 13.8; HRMS (FAB) calcd for 
C15H27O4 [M+H]+ 271.1909, found 271.1912. 
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Boc-Protected Tetrahydrofuran 107.  According to the procedure utilized 
for the synthesis of 47, cyclization of cis-diol 106 at 130 °C for 2 h afforded the 
desired hydroxytetrahydrofuran (0.316 g, 83% yield) as a colorless viscous oil.  
Subsequent carbonate formation using a portion of this material afforded 107 (0.100 
g, 74% yield) as a colorless viscous oil.  107: Rf = 0.46 (silica gel, hexanes:EtOAc, 
9:1); IR (film) νmax 2969, 2931, 2874, 1740, 1369, 1280, 1254, 1166 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 5.55 (m, 1 H), 5.37 (m, 1 H), 5.15 (t, J = 4.0 Hz, 1 H), 4.32 (m, 
1 H), 4.01 (td, J = 7.2, 3.6 Hz, 1 H), 2.37 – 2.21 (m, 2 H), 2.17 (ddd, J = 14.0, 6.0, 1.2 
Hz, 1 H), 1.99 (m, 2 H), 1.76 (ddd, J = 14.0, 9.2, 5.2 Hz, 1 H), 1.47 (s, 9 H), 1.23 (d, 
J = 6.0 Hz, 3 H), 0.94 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.3, 
134.9, 124.7, 82.2, 80.8, 78.3, 73.4, 41.1, 32.8, 27.9 (3 C), 25.7, 21.5, 13.8; HRMS 
(FAB) calcd for C15H27O4 [M+H]+ 271.1909, found 271.1901. 
 
8-exo Oxocane 108.  Synthesized by BDSB-induced ring-expansion of 89 
(according to the procedure for the synthesis of 64), affording 108 (0.0257 g, 84% 
yield) as a white crystalline solid.  108: Rf = 0.46 (silica gel, hexanes:EtOAc, 3:2); IR 
(film) νmax 2972, 2940, 2879, 1802, 1188, 1048, 1029 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 5.00 (ddd, J = 12.4, 7.2, 3.2 Hz, 1 H), 4.81 (ddd, J = 10.8, 7.2, 1.2 Hz, 1 H), 
3.91 (quintet, J = 6.4 Hz, 1 H), 3.83 (m, 1 H), 3.40 (ddd, J = 11.6, 5.2, 2.0 Hz, 1 H), 
2.44 (ddd, J = 18.0, 12.4, 5.6 Hz, 1 H), 2.13 – 1.84 (m, 5 H), 1.68 – 1.54 (m, 2 H), 
1.31 (d, J = 6.4 Hz, 3 H), 1.07 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
154.3, 82.3, 81.7, 75.7, 72.7, 62.1, 32.6, 29.7, 27.6, 27.4, 19.9, 12.5; HRMS (FAB) 
calcd for C12H20BrO4 [M+H]+ 307.0545, found 307.0545. 
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8-exo Oxocane 109.  Synthesized by BDSB-induced ring-expansion of 93 
(according to the procedure for the synthesis of 64), affording 109 (0.0183 g, 60% 
yield) as a white crystalline solid.  109: Rf = 0.44 (silica gel, hexanes:EtOAc, 3:2); IR 
(film) νmax 2969, 2937, 2877, 1797, 1192, 1040 cm–1; 1H NMR (400 MHz, CDCl3) δ 
4.89 – 4.80 (m, 2 H), 4.11 (sextet of doublets, J = 6.8, 3.2 Hz, 1 H), 3.84 (ddd, J = 
10.0, 4.4, 3.6 Hz, 1 H), 3.43 (dt, J = 10.4, 2.8 Hz, 1 H), 2.22 – 1.94 (m, 4 H), 1.89 – 
1.68 (m, 4 H), 1.27 (d, J = 6.8 Hz, 3 H), 1.08 (t, J = 7.2 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 154.2, 82.0, 78.9, 72.9, 70.5, 64.8, 34.3, 29.4, 28.3, 27.4, 19.0, 13.1; 
HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, found 307.0545. 
 
8-exo Oxocane 110.  Synthesized by BDSB-induced ring-expansion of 95 
(according to the procedure for the synthesis of 64), affording 110 (0.0254 g, 83% 
yield) as a colorless amorphous solid.  110: Rf = 0.53 (silica gel, hexanes:EtOAc, 3:2); 
IR (film) νmax 2973, 2938, 2878, 1804, 1188, 1050, 1034 cm–1; 1H NMR (400 MHz, 
CDCl3) δ 4.98 (ddd, J = 12.4, 7.6, 3.2 Hz, 1 H), 4.79 (ddd, J = 10.8, 7.2, 1.2 Hz, 1 H), 
3.91 (quintet, J = 6.4 Hz, 1 H), 3.72 (ddd, J = 10.4, 6.4, 2.8 Hz, 1 H), 3.45 (ddd, J = 
11.6, 6.4, 2.0 Hz, 1 H), 2.45 (ddd, J = 18.4, 12.4, 5.6 Hz, 1 H), 2.22 – 1.90 (m, 5 H), 
1.68 (m, 1 H), 1.51 (m, 1 H), 1.29 (d, J = 6.8 Hz, 3 H), 1.07 (t, J = 7.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 154.3, 82.5, 82.3, 75.6, 73.0, 61.8, 32.6, 30.9, 27.5, 26.8, 
19.8, 12.8; HRMS (FAB) calcd for C12H20BrO4 [M+H]+ 307.0545, found 307.0556. 
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8-endo Oxocane 111.  Synthesized by BDSB-induced ring-expansion of 105 
following a procedure modified from the synthesis of 64 (since the 8-endo 
cyclizations were more sluggish than the corresponding 8-exo cyclizations, 1.5 
equivalents of BDSB were employed and the reaction time was doubled), affording 
111 (0.0198 g, 68% yield) as a colorless amorphous solid.  111: Rf = 0.49 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2971, 2939, 2881, 1805, 1192, 1041 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 4.86–4.77 (m, 2 H), 4.02 (sextet of doublets, J = 6.4, 2.8 
Hz, 1 H), 3.81 (m, 1 H), 3.62 (td, J = 10.8, 4.0 Hz, 1 H), 2.60 – 2.47 (m, 2 H), 2.19 
(m, 1 H), 2.06 (dt, J = 14.4, 3.2 Hz, 1 H), 1.91 (sextet of doublets, J = 7.2, 4.0 Hz, 1 
H), 1.70 (sextet of doublets, J = 7.2, 3.6 Hz, 1 H), 1.27 (d, J = 6.8 Hz, 3 H), 0.89 (t, J 
= 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.8, 79.7, 78.8, 74.1, 70.6, 48.1, 
39.3, 34.1, 27.6, 18.7, 6.9; HRMS (FAB) calcd for C11H18BrO4 [M+H]+ 293.0388, 
found 293.0395. 
 
8-endo Oxocane 112.  Synthesized by BDSB-induced ring-expansion of 107 
following a procedure modified from the synthesis of 64 (since the 8-endo 
cyclizations were more sluggish than the corresponding 8-exo cyclizations, 1.5 
equivalents of BDSB were employed and the reaction time was doubled), affording 
112 (0.0195 g, 67% yield) as a white crystalline solid.  112: Rf = 0.54 (silica gel, 
hexanes:EtOAc, 3:2); IR (film) νmax 2973, 2939, 2881, 1807, 1188, 1052, 1034 cm–1; 
1H NMR (400 MHz, CDCl3) δ 4.98 (ddd, J = 12.4, 7.2, 3.6 Hz, 1 H), 4.83 (ddd, J = 
10.8, 7.2, 1.2 Hz, 1 H), 3.79 (quintet, J = 6.4 Hz, 1 H), 3.72 (m, 1 H), 3.26 (m, 1 H), 
2.59 (m, 1 H), 2.52 – 2.42 (m, 2 H), 2.12 (sextet of doublets, J = 7.2, 2.4 Hz, 1 H), 
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2.02 (dd, J = 14.4, 3.6 Hz, 1 H), 1.44 (m, 1 H), 1.29 (d, J = 6.4 Hz, 3 H), 0.94 (t, J = 
7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.9, 84.4, 80.0, 75.6, 73.4, 49.3, 39.1, 
32.5, 28.0, 20.1, 9.3; HRMS (FAB) calcd for C11H18BrO4 [M+H]+ 293.0388, found 
293.0395. 
 
[3.3.0] Fused Bicycle 114.  Attempted BDSB-induced ring-expansion of 99 
following the procedure for the synthesis of 64 instead afforded a mixture of several 
products, of which the predominant one was 114 (11.6 mg, 47% yield, colorless 
amorphous solid).  Connectivity and stereochemistry were determined by COSY and 
NOESY NMR experiments.  As additional evidence for the structure of 114, 
cyclization of the alcohol precursor to 99 using BDSB afforded 114 in >90% yield.  
114: Rf = 0.40 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2970, 2934, 2877, 
1384, 1117, 1083 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.79 (quintet, J = 4.0 Hz, 1 H), 
4.46 (t, J = 4.8 Hz, 1 H), 4.22 (quintet, J = 5.2 Hz, 1 H), 3.92 – 3.84 (m, 2 H), 2.35 
(m, 1 H), 2.17 (dd, J = 13.2, 5.2 Hz, 1 H), 1.98 – 1.73 (m, 3 H), 1.55 (ddd, J = 13.2, 
9.6, 4.0 Hz, 1 H), 1.30 (d, J = 6.0 Hz, 3 H), 1.09 (t, J = 7.2 Hz, 3 H); 13C NMR (75 
MHz, CDCl3) δ 85.0, 83.8, 80.4, 76.0, 60.8, 42.0, 37.5, 28.9, 20.6, 12.6; HRMS (EI) 
calcd for C10H16BrO2 [M–H]+ 247.0334, found 247.0328. 
 
[3.3.0] Fused Bicycle 117.  Attempted BDSB-induced ring-expansion of 101 
following the procedure for the synthesis of 64 instead afforded a mixture of several 
products, of which the predominant one was 117 (8.9 mg, 36% yield, colorless 
amorphous solid).  Connectivity and stereochemistry were determined by COSY and 
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NOESY NMR experiments.  As additional evidence for the structure of 117, 
cyclization of the alcohol precursor to 101 using BDSB afforded 117 in >90% yield.  
117: Rf = 0.40 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2969, 2933, 2875, 
1381, 1123, 1089, 1047 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.80 – 4.72 (m, 2 H), 
4.26 – 4.13 (m, 2 H), 3.86 (quintet, J = 4.4 Hz, 1 H), 2.27 – 2.15 (m, 2 H), 1.96 – 1.78 
(m, 3 H), 1.54 (ddd, J = 14.8, 10.0, 4.4 Hz, 1 H), 1.24 (d, J = 6.0 Hz, 3 H), 1.08 (t, J = 
7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 85.4, 83.6, 82.6, 75.9, 61.7, 43.0, 39.3, 
28.7, 20.8, 12.6; HRMS (EI) calcd for C10H16BrO2 [M–H]+ 247.0334, found 
247.0327. 
 
Acetaldehyde t-Butylimine (125).  Prepared according to the following 
reference: Campbell, K. N.; Sommers, A. H.; Campbell, B. K. J. Am. Chem. Soc. 
1944, 66, 82. 
 
2-Iodomethyl-1,3-Dioxolane (126).  (Procedure adapted from: Pudleiner, H.; 
Laatsch, H. Liebigs Ann. Chem. 1990, 423).  Sodium iodide (17.2 g, 115 mmol, 1.15 
equiv) was added to a solution of 2-bromomethyl-1,3-dioxolane (10.4 mL, 100 mmol, 
1.00 equiv) in acetone (50 mL) in a high-pressure sealed tube.  The reaction vessel 
was sealed at reflux and heated to 120 °C for 8 h.  Upon completion, the reaction 
contents were allowed to cool to 25 °C, then poured into 1% aqueous Na2SO3 (100 
mL).  The resultant mixture was extracted with Et2O (3 × 100 mL) and the combined 
organic layers were washed with water (3 × 100 mL) then brine (100 mL), dried 
(MgSO4), filtered, and concentrated to afford the desired product (18.2 g, 85% yield) 
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as a light yellow oil.  
  
α-Silyl Aldehyde 127.  (Procedure adapted from: Tietze, L. F.; Neumann, T.; 
Kajino, M.; Pretor, M. Synthesis 1995, 1003).  A solution of n-BuLi (33.6 mL, 1.4 M 
in hexanes, 47 mmol, 1.0 equiv) was added slowly to a solution of iPr2NH (7.28 mL, 
51.8 mmol, 1.10 equiv) in THF (75 mL) at 0 °C.  After 10 min at 0 °C, 125 (4.67 g, 
47.1 mmol, 1.00 equiv) was added and the resultant yellow solution was stirred for an 
additional 30 min at 0 °C.  A solution of TBSCl (7.03 g, 46.6 mmol, 0.990 equiv) in 
THF (20 mL) was added slowly, followed by solid TBAI (0.35 g, 0.94 mmol, 0.020 
equiv).  The resultant mixture was allowed to warm to 25 °C and reacted for 3 h at 25 
°C, then the dark red solution was re-cooled to 0 °C, and a second solution of n-BuLi 
(33.6 mL, 1.4 M in hexanes, 47 mmol, 1.0 equiv) was added slowly.  After 30 min at 
0 °C, the solution was cooled to -50 °C and 126 (16.8 g, 70.7 mmol, 1.5 equiv) was 
added.  The reaction mixture was allowed to warm slowly to 25 °C over the course of 
12 h, then quenched by the addition of water (200 mL) and extracted with Et2O (3 × 
100 mL).  The combined organic layers were washed with water (100 mL) and brine 
(100 mL), dried (MgSO4), filtered, and concentrated to provide the crude imine 
product.  A solution of this crude product in CH2Cl2 (100 mL) was stirred vigorously 
with aqueous 1 M AcOH (60 mL, 1.2 equiv) for 1 h at 25 °C.  Upon completion, the 
reaction mixture was poured into a separatory funnel.  The organic layer was 
collected and the aqueous layer was extracted with additional CH2Cl2 (2 × 10 mL).  
The combined organic layers were diluted with Et2O (200 mL), then washed with 
water (2 × 100 mL) and brine (100 mL), dried (MgSO4), filtered, and concentrated by 
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rotary evaporation.  Purification by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:1) afforded the desired product (7.28 g, 63% yield) as a 
yellow oil.  127: Rf = 0.55 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 2932, 2859, 
2716, 1696, 1139, 940, 825, 771 cm–1; 1H NMR (500 MHz, CDCl3) δ 9.62 (d, J = 4.0 
Hz, 1 H), 4.87 (dd, J = 4.5, 3.5 Hz, 1 H), 3.98 – 3.77 (m, 4 H), 2.60 (ddd, J = 11.5, 
3.5, 1.5 Hz, 1 H), 2.48 (m, 1 H), 1.78 (ddd, J = 14.0, 4.0, 1.5 Hz, 1 H), 0.93 (s, 9 H), 
0.08 (s, 3 H), 0.04 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 202.5, 103.4, 65.3, 64.9, 
41.5, 29.5, 27.0 (3 C), 18.0, –6.3 (2 C). 
 
Crotylated Alcohol  128.  (Procedure adapted from: Matsukawa, S.; 
Funabashi, Y.; Imamoto, T. Tetrahedron Lett. 2003, 44, 1007).  A THF suspension of 
activated CeCl3 was first prepared as follows:  
CeCl3 (pre-dried for 12 h at 140 °C under 2 torr vacuum, 1.11 g, 4.50 
mmol, 1.50 equiv) was slowly flame-dried (until no longer ‘jumping’) 
and sealed under argon.  THF (18 mL) was added and the resultant 
suspension was stirred vigorously for 2 h at 50 °C, then cooled to 0 °C.  
A solution of n-BuLi (~0.6 mL, 2.5 M in hexanes) was added 
dropwise until a light yellow color persisted [Note: in the absence of 
this precise activation procedure, the reaction will fail completely].   
 
To this activated CeCl3 suspension was added 2-butenylmagnesium chloride 
(7.2 mL, 0.5 M in hexanes, 3.6 mmol, 1.2 equiv).  The resultant orange solution was 
stirred at 0 °C for 1 h, then cooled to –78 °C.  Aldehyde 127 (0.733 g, 3.00 mmol, 
1.00 equiv) was added dropwise, and the resultant mixture was maintained at –78 °C 
for 30 min, then removed from the cold bath and stirred for an additional 10 min (→ 
~0 °C).  The reaction mixture was quenched by the addition of cold aqueous 1 M 
AcOH (20 mL), then extracted with Et2O (3 × 20 mL).  The combined organic layers 
 641 
were washed sequentially with water (20 mL), saturated aqueous sodium bicarbonate 
(20 mL) and brine (20 mL), then dried (MgSO4), filtered, concentrated, and purified 
by careful flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 5:1) to 
afford the desired linear isomer of 128 (0.591 g, contaminated with ~5% of an 
unknown side product, ~60% yield) as a colorless viscous oil.  128: Rf = 0.44 (silica 
gel, hexanes:EtOAc, 4:1); IR (film) νmax 3496 (br), 2931, 2857, 1129, 968, 830, 771 
cm–1; 1H NMR (500 MHz, CDCl3) δ 5.52 (m, 1 H), 5.44 (m, 1 H), 4.94 (dd, J = 5.5, 
4.0 Hz, 1 H), 3.97 (m, 2 H), 3.84 (m, 2 H), 3.78 (m, 1 H), 2.43 (d, J = 6.0 Hz, 1 H), 
2.25 – 2.12 (m, 2 H), 1.97 (ddd, J = 15.5, 8.0, 4.5 Hz, 1 H), 1.82 (ddd, J = 15.5, 5.5, 
3.5 Hz, 1 H), 1.67 (dd, J = 6.0, 1.0 Hz, 3 H), 1.20 (quintet, J = 3.5 Hz, 1 H), 0.91 (s, 9 
H), 0.05 (s, 3 H), 0.02 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 128.5, 128.3, 105.3, 
71.8, 65.0, 64.9, 41.5, 30.3, 27.4 (3 C), 25.1, 18.2, 17.8, –5.2, –5.4. 
 
Brominated Tetrahydrofuran (129).  (Procedure adapted from: Denmark, S. 
E.; Burk, M. T. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 20655).  A solution of NBS 
(0.217 g, 1.22 mmol, 1.10 equiv) in CH2Cl2 (5 mL) was added slowly to a solution of 
128 (0.333 g, 1.11 mmol, 1.00 equiv) and TMTU (0.015 g, 0.11 mmol, 0.10 equiv) in 
CH2Cl2 (17 mL) at –78 °C.  The resultant solution was allowed to warm slowly to –
20 °C over the course of 2 h, then quenched by the addition of 5% aqueous sodium 
sulfite (50 mL) and extracted with CH2Cl2 (3 × 20 mL).  The combined organic layers 
were dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 9:1) to afford 129 (0.227 g, 
contaminated with a small amount of an unknown byproduct, ~50% yield) as a 
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colorless amorphous solid.  Connectivity and stereochemistry were established by 
COSY and NOESY analysis.  129: Rf = 0.5 (silica gel, hexanes:EtOAc, 4:1); 1H 
NMR (500 MHz, CDCl3) δ 5.03 (dd, J = 6.5, 3.5 Hz, 1 H), 4.17 (ddd, J = 12.5, 6.5, 
4.5 Hz, 1 H), 4.02 (m, 1 H), 3.98 – 3.90 (m, 2 H), 3.86 – 3.80 (m, 2 H), 3.73 (m, 1 H), 
2.54 (m, 1 H), 2.09 (m, 1 H), 1.86 (ddd, J = 14.5, 8.0, 4.0 Hz, 1 H), 1.74 (ddd, J = 
14.5, 6.5, 3.0 Hz, 1 H), 1.33 (m, 1 H), 1.25 (d, J = 6.0 Hz, 3 H), 0.91 (s, 9 H), 0.02 (s, 
3 H), 0.01 (s, 3 H). 
 
Reduced Tetrahydrofuran (130).  A solution containing 129 (0.027 g, 0.071 
mmol, 1.0 equiv), AIBN (1.2 mg, 0.0071 mmol, 0.10 equiv), and n-Bu3SnH (0.074 
mL, 0.28 mmol, 4.0 equiv) in toluene (2 mL) was heated at 90 °C for 1 h.  Upon 
completion, the reaction mixture was concentrated by rotary evaporation and purified 
directly by flash column chromatography (silica gel, hexanes:Et2O, 1:0 → 2:1) to 
afford 130 (0.023 g, contaminated with a small amount of n-BuSn-derived 
byproducts, ~95% yield) as a colorless amorphous solid.  130: Rf = 0.45(silica gel, 
hexanes:EtOAc, 4:1); 1H NMR (400 MHz, CDCl3) δ 5.06 (dd, J = 7.2, 4.0 Hz, 1 H), 
4.17 – 4.04 (m, 2 H), 3.98 – 3.90 (m, 2 H), 3.86 – 3.80 (m, 2 H), 2.06 – 1.83 (m, 3 H), 
1.73 – 1.57 (m, 2 H), 1.47 – 1.24 (m, 2 H), 1.16 (d, J = 6.4 Hz, 3 H), 0.91 (s, 9 H), 
0.02 (s, 3 H), 0.00 (s, 3 H).  
 
Cyclization Precursor 131.  TFA (0.026 mL, 0.34 mmol, 5.0 equiv) was 
added to a solution of 130 (0.023 g, 0.068 mmol, 1.0 equiv) in 9:1 THF:H2O (3 mL) 
at 70 °C.  After 3 h at 70 °C, the reaction solution was allowed to cool to 25 °C and 
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quenched by the careful addition of saturated aqueous sodium bicarbonate (5 mL).  
The resultant mixture was extracted with CH2Cl2 (3 × 5 mL) and the combined 
organic layers were dried (MgSO4), filtered, and concentrated to afford the desired 
aldehyde (0.016 g, 91% yield) as a colorless amorphous solid.  This aldehyde was 
coevaporated with anhydrous toluene and used without further purification for the 
subsequent step.  Next, a solution of KOt-Bu (0.11 mL, 1.0 M in THF, 0.11 mmol, 
1.8 equiv) was added dropwise to a suspension of propyltriphenylphosphonium 
bromide (0.048 g, 0.13 mmol, 2.0 equiv) in THF (1 mL) at 25 °C.  After stirring 
vigorously for 30 min at 25 °C, the resultant orange heterogeneous ylid solution was 
cooled to 0 °C, and a solution of the aldehyde produced above (0.016 g, 0.062 mmol, 
1.0 equiv) in THF (1 mL) was added slowly.  After 30 min at 0 °C, the reaction 
mixture was quenched by the addition of 10% aqueous ammonium chloride (5 mL) 
and extracted with Et2O (3 × 5 mL).  The combined organic layers were washed with 
water (10 mL) and brine (10 mL), dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:CH2Cl2, 2:1) to afford 131 
(0.013 g, 74% yield) as a colorless viscous oil.  131: Rf = 0.5 (silica gel, 
hexanes:CH2Cl2, 1:1); 1H NMR (500 MHz, CDCl3) δ 5.38 (m, 1 H), 5.28 (m, 1 H), 
4.16 – 4.05 (m, 2 H), 2.20 (t, J = 6.5 Hz, 2 H), 2.08 – 1.98 (m, 3 H), 1.85 (m, 1 H), 
1.68 (m, 1 H), 1.43 (m, 1 H), 1.16 (d, J = 6.0 Hz, 3 H), 1.08 (q, J = 5.5 Hz, 1 H), 0.95 
(t, J = 7.5 Hz, 3 H), 0.90 (s, 9 H), 0.03 (s, 3 H), 0.00 (s, 3 H). 
 
Ring-Expanded Oxocene 132.  A cold solution of BDSB (0.021 g, 0.038 
mmol, 1.0 equiv) in MeNO2 (0.3 mL) was syringed quickly into a solution of 136 (9.0 
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mg, 0.031 mmol, 1.0 equiv) in a mixture of CH2Cl2 (1.5 mL) and MeNO2 (1.2 mL) at 
–25 °C.  After 10 min at –25 °C, the reaction mixture was quenched by the addition 
of 5% aqueous Na2SO3 (2 mL), saturated aqueous sodium bicarbonate (2 mL), and 
saturated aqueous sodium/potassium tartrate (2 mL).  After stirring vigorously for 5 
min at 25 °C, the resultant mixture was extracted with CH2Cl2 (3 × 5 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated, and purified by 
flash column chromatography (silica gel, hexanes:CH2Cl2, 1:4 → 0:1) to afford 132 
(2.0 mg, 30% yield) as a colorless amorphous solid.  Connectivity and 
stereochemistry were established by COSY and NOESY NMR experiments.  132:  Rf 
= 0.19 (silica gel, hexanes: CH2Cl2, 9:1); IR (film) νmax 2967, 2927, 1456, 1124, 
1092, 1061, 724 cm–1; 1H NMR (400 MHz, CDCl3) δ 5.81 – 5.67 (m, 2 H), 3.88 
(quintet, J = 3.6 Hz, 1 H), 3.59 (m, 1 H), 3.34 (ddd, J = 10.0, 3.6, 1.2 Hz, 1 H), 2.66 – 
2.50 (m, 2 H), 2.13 (ddd, J = 14.0, 8.0, 1.6 Hz, 1 H), 2.04 – 1.85 (m, 3 H), 1.68 (m, 1 
H), 1.50 (m, 1 H), 1.15 (d, J = 6.0 Hz, 3 H), 1.06 (t, J = 7.2 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 131.8, 127.5, 82.8, 76.0, 63.0, 37.2, 32.4, 28.7, 23.5, 21.7, 12.6. 
 
Inverted Crotylated Alcohol (135).  Oxalyl chloride (0.098 mL, 1.1 mmol, 
1.5 equiv) was added dropwise to a solution of DMSO (0.16 mL, 2.2 mmol, 3.0 
equiv) in CH2Cl2 (10 mL) at –78 °C.  After 5 min at –78 °C, a solution of 128 (0.225 
g, 0.749 mmol, 1.00 equiv) in CH2Cl2 (3 mL) was added slowly.  After an additional 
5 min at –78 °C, Et3N (0.62 mL, 4.5 mmol, 6.0 equiv) was added.  The resultant 
colorless solution was allowed to warm slowly from –78 °C to –30 °C over the course 
of 2 h.  Upon completion, the reaction contents were quenched by the addition of 
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saturated aqueous sodium bicarbonate (10 mL) and water (10 mL), then extracted 
with CH2Cl2 (3 × 15 mL).  The combined organic layers were dried (MgSO4), 
filtered, and concentrated to afford the desired ketone, which was co-evaporated with 
dry toluene and used immediately without further purification in the following step.  
Next, a solution of DIBAL-H (1.12 mL, 1.0 M in CH2Cl2, 1.1 mmol, 1.5 equiv) was 
added dropwise to a solution of the ketone (0.749 mmol assumed, 1.0 equiv) in THF 
(8 mL) at –78 °C.  The resultant solution was stirred for 3 h at –78 °C, then allowed 
to warm slowly to –20 °C over 3 h.  Upon completion, the reaction mixture was 
quenched by the careful addition of 10% aqueous ammonium chloride (5 mL).  An 
aqueous solution of 1 M sodium/potassium tartrate (5 mL) was added and the 
resultant mixture was stirred vigorously for 2 h at 25 °C, then extracted into Et2O (3 × 
10 mL).  The combined organic layers were washed with brine (15 mL), dried 
(MgSO4), filtered, and concentrated to afford 135 (0.198 g, contaminated with small 
amounts of starting material and unidentified side products [no trace of the anti-
diastereomer was observed], ~70% yield).  Purification by flash column 
chromatography led to decomposition, so this material was used without purification 
in the following step.  135: Rf = 0.4 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (500 
MHz, CDCl3) δ 5.55 – 5.51 (m, 2 H), 4.99 (dd, J = 5.5, 4.0 Hz, 1 H), 4.04 – 3.80 (m, 
5 H), 2.18 (m, 1 H), 2.05 (m, 1 H), 1.89 (ddd, J = 15.0, 10.0, 5.0 Hz, 1 H), 1.81 (ddd, 
J = 15.0, 4.0, 2.5 Hz, 1 H), 1.69 (d, J = 4.5 Hz, 3 H), 1.54 (dt, J = 10.0, 2.5 Hz, 1 H), 
0.92 (s, 9 H), 0.01 (s, 3 H), –0.01 (s, 3 H).  
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Cyclization Precursor 136.  A solution of Coll2BrOTf (0.066 g, 0.14 mmol, 
1.2 equiv) in MeNO2 (0.5 mL) was added dropwise to a solution of 135 (0.035 g, 0.12 
mmol, 1.0 equiv) in MeNO2 (4.5 mL) at –25 °C.  After 20 min at –25 °C, the yellow 
reaction solution was quenched by the addition of 5% aqueous sodium sulfite (10 
mL) and extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were 
dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 9:1) to afford the desired brominated tetrahydrofuran 
(0.035 g, contaminated with an unknown minor product, ~80% yield) as a colorless 
amorphous solid.  Next, reduction was carried out as in the synthesis of 130, and 
deprotection and Wittig olefination were carried out as in the synthesis of 131, 
affording 136 (9.0 mg, 35% yield over 3 steps) as a colorless amorphous solid.  136: 
Rf = 0.59 (silica gel, hexanes: CH2Cl2, 1:1); IR (film) νmax 2960, 2857, 1465, 1250, 
1080, 827, 766 cm–1; 1H NMR (500 MHz, CDCl3) δ 5.39 (m, 1 H), 5.27 (m, 1 H), 
4.19 (td, J = 10.5, 6.0 Hz, 1 H), 4.04 (m, 1 H), 2.18 (t, J = 6.0 Hz, 2 H), 2.07 – 1.97 
(m, 3 H), 1.88 (m, 1 H), 1.63 (m, 1 H), 1.45 (m, 1 H), 1.32 (q, J = 5.5 Hz, 1 H), 1.17 
(d, J = 6.0 Hz, 3 H), 0.96 (t, J = 8.0 Hz, 3 H), 0.90 (s, 9 H), –0.01 (s, 6 H); 13C NMR 
(125 MHz, CDCl3) δ 131.1, 130.4, 80.4, 74.5, 34.7, 30.7, 29.4, 27.3 (3 C), 24.3, 21.6, 
20.6, 17.3, 14.2, –5.4, –5.5; HRMS (FAB) calcd for C17H35OSi [M+H]+ 283.2453, 
found 283.2457. 
 
Crotylated Alcohol (cis-Alkene) 137.  A freshly prepared solution of 
aluminum trichloride (4.0 mL, 2.0 M in Et2O, 8.0 mmol, 4.0 equiv) was added 
dropwise to a solution of 2-butenylmagnesium chloride (5.2 mL, 0.5 M in THF, 2.6 
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mmol, 1.3 equiv) in Et2O (11 mL) at –78 °C.  After 5 min at – 78 °C, aldehyde 127 
(0.489 g, 2.00 mmol, 1.00 equiv) was added and the resultant mixture was reacted for 
1 h at –78 °C, then quenched by the careful addition of cold aqueous 1 M AcOH (20 
mL) and extracted with Et2O (3 × 20 mL).  The combined organic layers were washed 
sequentially with water (20 mL), saturated aqueous sodium bicarbonate (20 mL) and 
brine (20 mL), then dried (MgSO4), filtered, concentrated, and purified by careful 
flash column chromatography (silica gel, hexanes:EtOAc, 1:0 → 3:1) to afford the 
desired crotylated alcohol (0.335 g, contaminated with ~20% unidentified byproduct, 
~40% yield) as an inseparable mixture composed of 2.4:1 cis:trans alkene isomers 
(137:128).  137: Rf = 0.44 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (500 MHz, 
CDCl3, selected peaks only) δ 5.61 (m, 1 H),  5.45 (m, 1 H), 4.96 (m, 1 H), 4.04 – 
3.80 (m, 5 H), 2.49 (d, J = 6.5 Hz, 1 H), 1.64 (dt, J = 6.5, 1.0 Hz, 3 H), 0.93 (s, 9 H), 
0.07 (s, 3 H), 0.04 (s, 3 H). 
 
Inverted Crotylated Alcohol 138.  The mixture containing predominantly 
137 was subjected to oxidation and reduction as in the synthesis of 135, affording the 
desired inversion product (0.309 g, contaminated with ~10% unidentified byproduct, 
~50% yield), still as an inseperable mixture of 2.4:1 cis:trans alkene isomers 
(138:135).  138: Rf = 0.4 (silica gel, hexanes:EtOAc, 4:1); 1H NMR (500 MHz, 
CDCl3, selected peaks only) δ 5.62 – 5.51 (m, 2 H), 5.00 (dd, J = 5.5, 4.0 Hz, 1 H), 
4.05 – 3.81 (m, 5 H), 2.05 (m, 1 H), 1.87 (m, 1 H), 1.64 (app d, 3 H), 1.56 (dt, J = 
10.5, 2.5 Hz, 1 H), 0.92 (s, 9 H), 0.03 (s, 3 H), 0.01 (s, 3 H). 
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Brominated Cyclization Precursor 139.  Alcohol 138 was subjected to 
bromocyclization, deprotection, and Wittig olefination as in the synthesis of 136 
(omitting the reductive debromination step), affording 139 (9.0 mg, contaminated 
with some minor impurities, ~18% yield over 3 steps) as a light yellow amorphous 
solid.  139: Rf = 0.5 (silica gel, hexanes:EtOAc, 9:1); 1H NMR (400 MHz, CDCl3, 
selected peaks only) δ 5.42 – 5.23 (m, 2 H), 4.43 (quintet, J = 4.0 Hz, 1 H), 3.94 (m, 1 
H), 3.81 (m, 1 H), 2.65 (dt, J = 14.4, 7.2 Hz, 1 H), 1.31 (d, J = 6.0 Hz, 3 H), 0.90 (s, 9 
H), –0.01 (s, 3 H), –0.03 (s, 3 H) [Note: the attached 1H NMR spectrum is of crude 
material; no spectrum could be located for purified 139].  
 
Brominated Ring-Expanded Oxocene 140.  Cyclization precursor 139 was 
subjected to BDSB-induced ring-expansion according to the procedure used to 
synthesize 132, affording 140 (6.0 mg, ~75% yield) as a white crystalline solid.  
Connectivity and stereochemistry were established by COSY and NOESY NMR 
experiments.  140: Rf = 0.3 (silica gel, hexanes:CH2Cl2, 1:2); 1H NMR (500 MHz, 
CDCl3) δ 5.90 – 5.77 (m, 2 H), 4.35 (q, J = 6.5 Hz, 1 H), 4.13 (ddd, J = 6.5, 3.0, 1.0 
Hz, 1 H), 4.01 – 3.92 (m, 2 H), 2.82 – 2.72 (m, 2 H), 2.66 (ddd, J = 19.5, 11.0, 8.0 
Hz, 1 H), 2.16 (ddd, J = 14.5, 6.5, 3.0 Hz, 1 H), 2.06 – 1.89 (m, 2 H), 1.36 (d, J = 6.5 
Hz, 3 H), 1.09 (t, J = 7.5 Hz, 3 H).  
 
Ring-Expanded Aldehyde 152.  A cold solution of BDSB (0.0255 g, 0.0464 
mmol, 1.00 equiv) in MeNO2 (0.4 mL) was syringed quickly into a solution of 183 
(0.0160 g, 0.0464 mmol, 1.00 equiv) in a mixture of CH2Cl2 (0.8 mL) and MeNO2 
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(1.2 mL) at –25 °C.  After 10 min at –25 °C, the reaction mixture was quenched by 
the addition of 5% aqueous Na2SO3 (3 mL), saturated aqueous sodium bicarbonate (3 
mL), and saturated aqueous sodium/potassium tartrate (3 mL).  The resultant mixture 
was stirred vigorously for 5 min at 25 °C, then extracted with CH2Cl2 (3 × 10 mL).  
The combined organic layers were dried (MgSO4), filtered, concentrated, and purified 
by flash column chromatography (silica gel, hexanes:CH2Cl2, 1:4 → 0:1) to afford 
major (desired) isomer 152 (8.8 mg, 61% yield) as a colorless amorphous solid, along 
with separable minor (undesired) diastereomer 184 (4.0 mg, contaminated with 10% 
of an inseparable, unidentified byproduct, ~25% yield) as a colorless amorphous solid  
[Note: Since aldehyde 152 was not characterized by Kim et al., we subsequently 
reduced a portion of this material (NaBH4, MeOH) to the corresponding alcohol, 
which was a perfect spectroscopic match with the alcohol precursor used to access 
152 in Kim’s synthesis: Kim, H.; Choi, W. J.; Jung, J.; Kim, S.; Kim, D. J. Am. 
Chem. Soc. 2003, 125, 10238].  152:  Rf = 0.54 (silica gel, CH2Cl2); IR (film) νmax 
3024, 2968, 2935, 2728, 1722, 1452, 1382, 1109, 1045 cm–1; 1H NMR (500 MHz, 
CDCl3) δ 9.81 (s, 1 H), 5.96 (m, 1 H), 5.72 (m, 1 H), 4.45 (m, 1 H), 4.00 (ddd, J = 
12.0, 5.0, 3.0 Hz, 1 H), 3.85 (dt, J = 10.5, 3.5 Hz, 1 H), 3.67 (dd, J = 10.0, 3.0 Hz, 1 
H), 3.09 (ddd, J = 18.5, 8.0, 1.0 Hz, 1 H), 2.97 (app q, 1 H), 2.71 (dd, J = 18.5, 4.0 
Hz, 1 H), 2.64 (m, 1 H), 2.53 (quintet, J = 6.0 Hz, 1 H), 2.32 (ddd, J = 14.0, 8.0, 1.0 
Hz, 1 H), 1.91 (m, 1 H), 1.74 (m, 1 H), 1.04 (t, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 200.1, 131.3, 128.7, 83.4, 74.3, 65.4, 61.8, 49.1, 34.4, 31.2, 27.7, 12.7; 
HRMS (FAB) calcd for C12H19BrClO2 [M+H]+ 309.0257, found 309.0261.   
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Protected 3-Butyn-1-ol (164).  Camphorsulfonic acid (0.25 g, 1.1 mmol, 
0.020 equiv) was added to a solution of 3-butyn-1-ol (4.10 mL, 54.4 mmol, 1.00 
equiv) and 3,4-dihydro-2H-pyran (14.8 mL, 163 mmol, 3.00 equiv) in CH2Cl2 (110 
mL) at 0 °C.  After 30 min at 0 °C, the resultant homogeneous purple solution was 
quenched by the addition of Et3N (0.5 mL) and concentrated by rotary evaporation.  
Purification of the resultant yellow oil by flash column chromatography (silica gel, 
hexanes:Et2O, 1:0 → 4:1) afforded 164 (8.02 g, 96% yield) as a fragrant colorless oil.  
 
2-Trimethylsiloxy-1,3-butadiene (166).  Anhydrous THF (75 mL) was added 
slowly to powdered anhydrous LiBr (8.86 g, 100 mmol, 2.00 equiv; dried in vacuum 
at 150 °C for 2 h) at 0 °C (caution: exotherm).  3-Buten-2-one (4.08 mL, 50.0 mmol, 
1.00 equiv), TMSCl (9.47 mL, 75.0 mmol, 1.50 equiv), and Et3N (10.4 mL, 75.0 
mmol, 1.50 equiv) were added sequentially to the resultant solution.  After an 
additional 60 min at 0 °C, the heterogeneous reaction mixture was heated to 40 °C 
and maintained at this temperature for 16 h, then cooled to –20 °C.  Pentane (150 mL) 
was added to the reaction mixture, which was poured into a separatory funnel 
containing an ice-cold mixture of saturated aqueous sodium bicarbonate (50 mL), 
brine (50 mL), and water (100 mL).  After a brief extraction, the organic layer was 
separated and the aqueous layer was extracted with additional cold pentane (2 × 75 
mL).  The combined organic layers were then washed with cold water (4 × 100 mL) 
and cold brine (200 mL), dried (MgSO4), filtered, and carefully concentrated by 
rotary evaporation (100 torr @ 0 °C) to a volume of approximately 25 mL.  This 
crude orange oil was used immediately in the following step. 
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Enone 167.  TMSOTf (0.90 mL, 5.0 mmol, 0.10 equiv) was added dropwise 
to a solution of crude silyl enol ether 166 (50 mmol assumed, 1.0 equiv) and triethyl 
orthoformate (9.98 mL, 60.0 mmol, 1.20 equiv) in CH2Cl2 (100 mL) at –78 °C.  After 
6 h at –78 °C, the reaction mixture was quenched by the addition of saturated aqueous 
sodium bicarbonate (200 mL) and extracted with CH2Cl2 (3 × 100 mL).  The 
combined organic layers were dried (MgSO4), filtered, concentrated (rotary 
evaporation only) and purified by flash column chromatography (silica gel, 
hexanes:Et2O, 1:0 → 2:1) to afford 167 (5.11 g, 59% yield over 2 steps) as a 
moderately volatile light yellow oil.  167:  Rf = 0.43 (silica gel, hexanes:Et2O, 3:2); IR 
(film) νmax 2977, 2931, 1688, 1615, 1401, 1374, 1124, 1060 cm–1; 1H NMR (400 
MHz, CDCl3) δ 6.36 (dd, J = 17.6, 10.4 Hz, 1 H), 6.22 (dd, J = 17.6, 1.2 Hz, 1 H), 
5.86 (dd, J = 10.4, 1.2 Hz, 1 H), 4.96 (t, J = 5.6 Hz, 1 H), 3.68 (m, 2 H), 3.54 (m, 2 
H), 2.92 (d, J = 5.6 Hz, 2 H), 1.18 (t, J = 7.2 Hz, 6 H); 13C NMR (100 MHz, CDCl3) δ 
197.8, 137.2, 129.1, 100.3, 62.7 (2 C), 44.6, 15.4 (2 C); HRMS (EI) calcd for 
C9H16O3 [M–H]+ 171.1021, found 171.1026. 
 
α-Chloroketone 168.  A solution of NCS (2.00 g, 15.0 mmol, 1.50 equiv) in 
THF (50 mL) was added slowly to a solution of 170 (10 mmol assumed, 1.0 equiv) in 
THF (50 mL) at –78 °C.  After 5 min at –78 °C, a solution of TBAF (12.0 mL, 1.0 M 
in THF, 12 mmol, 1.2 equiv) was added dropwise, and the resultant colorless solution 
was allowed to react for an additional 3 h at –78 °C.  Upon completion, the reaction 
mixture was quenched by the addition of 5% aqueous Na2SO3 (50 mL) and 10% 
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aqueous ammonium chloride (50 mL), then extracted with Et2O (3 × 100 mL).  The 
combined organic layers were washed with water (2 × 100 mL) and brine (100 mL), 
dried (MgSO4), filtered, concentrated, and purified by flash column chromatography 
(silica gel, hexanes:EtOAc, 1:0 → 2:1) to afford 168 (1.79 g, 50% yield over 2 steps) 
as a colorless viscous oil [Note: although technically a mixture of diastereomers due 
to the THP sterocenter, spectroscopically the product appeared to be one compound].  
168: Rf = 0.37 (silica gel, hexanes:EtOAc, 4:1); IR (film) νmax 2974, 2940, 2874, 
1725, 1374, 1352, 1121, 1059, 1033 cm–1; 1H NMR (400 MHz, CDCl3) δ 4.92 (t J = 
5.6 Hz, 1 H), 4.63 (app t, 1 H), 4.37 (t, J = 6.8 Hz, 1 H), 3.88 (m, 1 H), 3.78 (m, 1 H), 
3.73 – 3.62 (m, 2 H), 3.58 – 3.47 (m, 4 H), 3.04 (dd, J = 15.6, 6.0 Hz, 1 H), 2.95 (dd, 
J = 15.6, 5.2 Hz, 1 H), 2.84 (ddt, J = 17.2, 6.4, 2.4 Hz, 1 H), 2.71 (ddt, J = 17.2, 7.2, 
2.4 Hz, 1 H), 2.48 – 2.41 (m, 2 H), 1.82 (m, 1 H), 1.71 (m, 1 H), 1.62 – 1.48 (m, 4 H), 
0.99 (t, J = 7.2 Hz, 3 H), 0.98 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
200.4, 99.9, 98.9, 80.5, 75.6, 65.9, 62.9, 62.4 (2 C), 60.9, 44.5, 30.7, 25.6, 24.1, 20.3, 
19.6, 15.4, 15.3; HRMS (FAB) calcd for C18H29ClO5 [M–H]+ 359.1625, found 
359.1620. 
 
Alkynyl Chloride 169.  A solution of n-BuLi (0.464 mL, 1.4 M in hexanes, 
0.65 mmol, 1.0 equiv) was added dropwise to a solution of 164 (0.100 g, 0.65 mmol, 
1.0 equiv) in THF (3 mL) at –78 °C.  After 15 min at 0 °C, the resultant solution was 
cannulated into a second flask at 0 °C containing CuI (0.136 g, 0.71 mmol, 1.1 
equiv).  This mixture was stirred vigorously for 1 h at 0 °C, then cooled to –70 °C.  
To this mixture was added 167 (0.112 g, 0.65 mmol, 1.0 equiv), followed by NCS 
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(0.113 g, 0.84 mmol, 1.3 equiv).  The resultant reaction mixture was then allowed to 
warm slowly to 0 °C over 1.5 h, then quenched by the addition of triethylamine (10 
mL), water (100 mL), and saturated aqueous ammonium chloride (50 mL), and 
extracted with CH2Cl2 (3 × 75 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated (rotary evaporation only).  By crude 1H NMR, 
the resultant material was largely recovered 167 along with alkynyl chloride 169.  An 
adaptation of this procedure whereby the enone and cuprate were allowed to warm 
slowly to 0 °C over 1.5 h prior to NCS addition was attempted, but was similarly 
unsusccessful.  169: Rf = nd; 1H NMR (400 MHz, CDCl3, selected peaks only) δ 4.63 
(t, J = 4.0 Hz, 1 H), 2.66 (t, J = 7.2 Hz, 2 H) [these propargylic protons are shifted 
downfield more than 0.1 ppm from the starting alkyne]. 
 
TBS-Enol Ether 170.  (Procedure adapted from: Takeishi, K.; Sugishima, K.; 
Sasaki, K.; Tanaka, K. Chem. Eur. J. 2004, 10, 5681).  A solution of n-BuLi (4.00 
mL, 2.5 M in hexanes, 10 mmol, 1.0 equiv) was added dropwise to a solution of 164 
(1.54 g, 10.0 mmol, 1.00 equiv) in THF (50 mL) at –78 °C.  After 15 min at 0 °C, the 
resultant solution was cannulated into a second flask at 0 °C containing CuI (2.10 g, 
11.0 mmol, 1.10 equiv).  This mixture was stirred vigorously for 1 h at 0 °C, then 
cooled to –70 °C.  Enone 167 (2.07 g, 12.0 mmol, 1.20 equiv) and TBSOTf (2.18 mL, 
9.50 mmol, 0.950 equiv) were added dropwise sequentially to the yellow cuprate 
mixture, which was then allowed to warm very slowly to 5 °C over 12 h.  Upon 
completion, the reaction mixture was quenched by the addition of triethylamine (10 
mL), water (100 mL), and saturated aqueous ammonium chloride (50 mL), then 
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extracted with CH2Cl2 (3 × 75 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated to afford the crude silyl enol ether, which was 
dissolved in toluene, filtered, and re-concentrated to remove residual copper salts 
[Note: this product was prone to air-oxidation, and as such was used immediately in 
synthesis of 168; spectral characterization was not feasible]. 
 
THP-protected Chlorohydrin 172.  Optimized Procedure: A solution of 168 
(0.260 g, 0.720 mmol, 1.00 equiv) in THF (2 mL) was syringed dropwise into a 
solution of L-Selectride (0.865 mL, 1.0 M in THF, 0.87 mmol, 1.2 equiv) in THF (5 
mL) at –78 °C.  After 15 min at –78 °C, EtOH (200 pr, 4 mL) was added slowly, 
followed by H2SO4 (0.38 mL, 7.2 mmol, 10 equiv).  The resultant solution was 
warmed to 25 °C and stirred for an additional 2 h, then cooled to 0 °C and neutralized 
by careful addition of Et3N (2.5 mL, 18 mmol, 25 equiv).  The resultant cloudy 
mixture was poured into saturated aqueous sodium bicarbonate (15 mL) and extracted 
with EtOAc (3 × 20 mL).  The combined organic layers were washed with brine (20 
mL), dried (MgSO4), filtered, concentrated, and purified by flash column 
chromatography (silica gel, hexanes:EtOAc, 1:0 → 1:4) to afford 172 (0.179 g, 89% 
yield) as a colorless viscous oil [Note: These two steps could also be performed 
separately, proceeding via isolation of intermediate 171]. 172: Rf = 0.45 (silica gel, 
hexanes:EtOAc, 1:4); IR (film) νmax 3400 (br), 2975, 2930, 2885, 1377, 1125, 1052 
cm–1; 1H NMR (400 MHz, CDCl3) δ 4.73 (t, J = 5.2 Hz, 1 H), 4.15 (app d, 1 H), 3.96 
(td, J = 6.8, 2.8 Hz, 1 H), 3.76 – 3.63 (m, 4 H), 3.61 – 3.48 (m, 2 H) 3.09 (br s, 1 H), 
2.81 (ddt, J = 17.2, 7.2, 2.4 Hz, 1 H), 2.68 (ddt, J = 16.8, 6.8, 2.4 Hz, 1 H), 2.47 – 
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2.39 (m, 2H), 2.19 (br s, 1 H), 1.97 (ddd, J = 14.4, 9.6, 5.2 Hz, 1 H), 1.83 (ddd, J = 
14.0, 5.2, 2.8 Hz, 1 H), 1.21 (td, J = 7.2, 1.6 Hz, 6 H); 13C NMR (125 MHz, CDCl3) δ 
101.6, 79.8, 78.1, 69.2, 64.7, 62.5, 62.2, 61.3, 38.2, 25.3, 23.3, 15.4 (2 C); HRMS 
(FAB) calcd for C13H23ClO4 [M–H]+ 277.1207, found 277.1200. 
 
Vinylsilane 175.  (Procedure adapted from: Kawasaki, Y.; Ishikawa, Y.; 
Igawa, K.; Tomooka, K. J. Am. Chem. Soc. 2011, 133, 20712).  A solution of 
chlorodimethylvinylsilane (0.358 mL, 2.58 mmol, 1.20 equiv) in Et2O (4 mL) was 
added dropwise very slowly to a solution of 172 (0.600 g, 2.15 mmol, 1.00 equiv) and 
pyridine (0.87 mL, 10.8 mmol, 5.0 equiv) in Et2O (18 mL) at –78 °C.  After 30 min at 
–78 °C, the reaction mixture was quenched by the addition of MeOH (0.10 mL), 
diluted with pentane (22 mL), and allowed to warm to 25 °C.  Salts were removed by 
filtration and the resultant clear solution was concentrated to dryness, sealed under 
argon, dissolved in THF (22 mL), and heated to 40 °C.  TBSH (0.464 mL, 2.80 
mmol, 1.3 equiv) and a solution of Karstedt’s catalyst (0.10 M in xylenes, 0.430 mL, 
0.0430 mmol, 0.020 equiv) were added and the resultant yellow solution was 
maintained at 40 °C for 3 h.  The reaction mixture was then cooled to 0 °C and a 
solution of TBAF (3.23 mL, 1.0 M in THF, 3.2 mmol, 1.5 equiv) was added slowly. 
After an additional 10 min at 0 °C, the reaction mixture was quenched by the addition 
of 10% aqueous ammonium chloride (50 mL), then extracted with EtOAc (3 × 30 
mL).  The combined organic layers were washed with brine, dried (MgSO4), filtered, 
concentrated, flushed through a plug of silica gel with hexanes:EtOAc (1:1, 100mL) 
and dried for 1 h under vac (to effect complete removal of xylenes) to afford pure 175 
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(0.845 g, 99% yield) as a colorless viscous oil [Note: This material was prone to 
decomposition and was carried forward immediately].  175: Rf = 0.4 (silica gel, 
hexanes:EtOAc, 1:1); 1H NMR (400 MHz, CDCl3) δ 5.90 (t, J = 6.8 Hz, 1 H), 4.72 (t, 
J = 5.2 Hz, 1 H), 4.02 – 3.93 (m, 2 H), 3.75 – 3.49 (m, 6 H), 3.11 (br d, J = 3.6 Hz, 1 
H), 2.83 (ddd, J = 15.2, 10.8, 5.6 Hz, 1 H), 2.68 (m, 1 H), 2.58 – 2.43 (m, 2 H), 1.98 
(ddd, J = 14.0, 9.2, 5.2 Hz, 1 H), 1.86 (ddd, J = 14.0, 5.6, 2.4 Hz, 1 H), 1.26 (t, J = 7.2 
Hz, 3 H), 1.22 (t, J = 7.2 Hz, 3 H), 1.21 (t, J = 7.2 Hz, 3 H), 0.88 (s, 9 H), 0.08 (s, 3 
H), 0.07 (s, 3 H) [Note: the attached 1H NMR spectrum is of compound prior to 
completely drying under vacuum; no 1H NMR spectrum could be located for dry 
material]. 
 
Bromocyclized Tetrahydrofuran 180.  (Procedure adapted from: Denmark, 
S. E.; Burk, M. T. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 20655).  A solution of 
NBS (0.28 g, 0.71 mmol, 1.5 equiv) in CH2Cl2 (9 mL) and a solution of Ph3PS (0.042 
g, 0.14 mmol, 0.20 equiv) in CH2Cl2 (2 mL) were added slowly and sequentially to a 
solution of 175 (0.280 g, 0.709 mmol, 1.0 equiv) and AcOH (0.16 mL, 2.8 mmol, 4.0 
equiv) in CH2Cl2 (11 mL) at –55 °C in the dark.  The resultant bright yellow solution 
was stirred for 12 h at –55 °C, then quenched by the addition of EtOH (5 mL) and 2-
methoxypropene (2 mL).  The resultant solution was stirred at 25 °C for 15 min, then 
poured into and saturated aqueous sodium bicarbonate (50 mL) and extracted with 
CH2Cl2 (3 × 20 mL).  The combined organic layers were dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:1) to afford 180 (0.200 g, contaminated with a small amount 
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of an undesired byproduct, ~57% yield over 2 steps) as a colorless amorphous solid.  
180: Rf = 0.37 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 3443 (br), 2972, 2932, 
2861, 1253, 1059, 831 cm–1; 1H NMR (500 MHz, CDCl3) δ 4.63 (dd, J = 7.5, 4.0 Hz, 
1 H), 4.54 (dd, J = 10.0, 5.5 Hz, 1 H), 4.49 (t, J = 4.0 Hz, 1 H), 4.35 (ddd, J = 7.5, 
4.5, 2.5 Hz, 1 H), 4.08 (m, 1 H), 3.90 (m, 1 H), 3.78 – 3.50 (m, 5 H), 2.60 (ddd, J = 
13.5, 10.0, 4.5 Hz, 1 H), 2.42 – 2.34 (m, 2 H), 2.27 (ddd, J = 15.5, 8.0, 3.5 Hz, 1 H), 
2.08 (ddd, J = 14.0, 8.0, 4.0 Hz, 1 H), 1.95 (ddd, J = 14.0, 7.5, 4.5 Hz, 1 H), 1.57 (br 
s, 1 H), 1.23 (t, J = 7.5 Hz, 3 H), 1.21 (t, J = 7.0 Hz, 3 H), 1.00 (s, 9 H), 0.22 (s, 3 H), 
0.21 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 101.0, 82.3, 79.7, 68.9, 63.4, 63.2, 62.0, 
60.8, 43.6, 43.0, 36.7, 28.8 (3 C), 19.7, 15.5 (2 C), –3.8, –4.6; HRMS: No molecular 
ion peak could be observed. 
 
Reduced Tetrahydrofuran 181.  A solution of Et3B (0.100 mL, 1.0 M in 
hexanes, 0.10 mmol, 0.30 equiv) was added dropwise to a solution of 180 (0.158 g, 
0.333 mmol, 1.00 equiv) and Bu3SnH (0.132 mL, 0.500 mmol, 1.50 equiv) in toluene 
(10 mL) sealed tightly under argon at 25 °C.  Immediately thereafter, the argon inlet 
was replaced with a needle (16 gauge) to permit the slow diffusion of air into the 
reaction mixture.  After 30 min at 25 °C, the reaction mixture was concentrated by 
rotary evaporation and purified directly by flash column chromatography (silica gel, 
hexanes:EtOAc, 1:0 → 2:3) to afford 181 (0.110 g, 83% yield, colorless amorphous 
solid) as an inseparable mixture of diastereomers (2.4:1 dr) about the silylated carbon.  
181: Rf = 0.28 (silica gel, hexanes:EtOAc, 2:1); IR (film) νmax 3421 (br), 2955, 2929, 
2882, 2857, 1254, 1056, 827 cm–1; Major Diastereomer 1H NMR (selected peaks 
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only, 400 MHz, CDCl3) δ 4.69 (ddd, J = 11.2, 5.2, 5.2 Hz, 1 H), 3.36 (br s, 1 H), 1.21 
(t, J = 7.2 Hz, 3 H), 1.20 (t, J = 7.2 Hz, 3 H), 0.92 (s, 9 H), –0.02 (s, 3 H), –0.03 (s, 3 
H); 13C NMR (125 MHz, CDCl3) δ 101.0, 79.3, 78.5, 63.7, 63.3, 62.5, 61.5, 39.6, 
36.9, 28.2, 27.3 (3 C), 24.9, 17.5, 15.5, 15.4, –6.2, –6.3; Minor Diastereomer 1H 
NMR (selected peaks only, 400 MHz, CDCl3) δ 3.07 (br s, 1 H), 2.33 (ddd, J = 13.6, 
4.8, 0.8 Hz, 1 H), 1.21 (t, J = 7.2 Hz, 3 H), 1.20 (t, J = 7.2 Hz, 3 H), 0.92 (s, 9 H), 
0.02 (s, 6 H); 13C NMR (125 MHz, CDCl3) δ 101.0, 80.2, 77.4, 64.1, 63.8, 62.5, 61.4, 
43.8, 36.8, 31.9, 29.9, 27.6 (3 C), 18.0, 15.5, 13.7, –4.5, –4.7. 
 
Protected Ring-Expansion Precursor 182.  Synthesized according to the 
procedure used to synthesize 183 (see below), omitting the acid hydrolysis step, 
affording 182 (0.026 g, contaminated with two minor byproducts, ~70% yield over 2 
steps, colorless viscous oil) as an inseparable mixture of diastereomers about the 
silylated carbon.  182: Rf = 0.5 (silica gel, hexanes:EtOAc, 9:1); 1H NMR: No 1H 
NMR spectrum could be located for this material. 
 
Deprotected Ring-Expansion Precursor 183.  Oxalyl chloride (0.035 mL, 
0.42 mmol, 1.5 equiv) was added dropwise to a solution of DMSO (0.049 mL, 0.70 
mmol, 2.5 equiv) in CH2Cl2 (6 mL) at –78 °C.  After 5 min at –78 °C, a solution of 
181 (0.110 g, 0.278 mmol, 1.00 equiv) in CH2Cl2 (2 mL) was added slowly.  After an 
additional 5 min at –78 °C, Et3N (0.19 mL, 1.4 mmol, 5.0 equiv) was added.  The 
resultant colorless solution was allowed to warm slowly from –78 °C to –30 °C over 
the course of 1 h.  Upon completion, the reaction contents were quenched by the 
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addition of saturated aqueous sodium bicarbonate (5 mL) and water (5 mL), then 
extracted with CH2Cl2 (3 × 10 mL).  The combined organic layers were dried 
(MgSO4), filtered, and concentrated to afford the desired aldehyde, which was 
coevaporated with anhydrous toluene and used immediately without further 
purification in the following step.  Next, a solution of KOt-Bu (0.556 mL, 1.0 M in 
THF, 0.56 mmol, 2.0 equiv) was added dropwise to a suspension of 
propyltriphenylphosphonium bromide (0.24 g, 0.61 mmol, 2.2 equiv) in THF (6 mL) 
at 25 °C.  After stirring vigorously for 20 min at 25 °C, the resultant orange 
heterogeneous ylid solution was cooled to 0 °C and a solution of the aldehyde 
produced above (0.278 mmol assumed, 1.0 equiv) in THF (2 mL) was added.  After 1 
h at 0 °C, an aqueous solution of HCl (2.78 mL, 1.0 M, 2.8 mmol, 10 equiv) was 
slowly added and the resultant light yellow solution was heated to 50 °C for 2 h.  
Upon completion, the reaction mixture was allowed to cool to 25 °C, then carefully 
poured into saturated aqueous sodium bicarbonate (20 mL) and extracted with 
CH2Cl2 (3 × 15 mL).  The combined organic layers were dried (MgSO4), filtered, 
concentrated, and purified by flash column chromatography (silica gel, 
hexanes:CH2Cl2, 1:0 → 1:4) to afford 183 (0.055 g, 57% yield) as well as its 
undesired diastereomer (from the minor diastereomer of 181, 0.023 g, 24% yield), 
both as colorless viscous oils.  The connectivity and stereochemistry of 183  were 
validated by COSY and NOESY NMR experiments.  183:  Rf = 0.33 (silica gel, 
hexanes:CH2Cl2, 1:2); IR (film) νmax 2958, 2930, 2857, 1726, 1466, 1254, 1085, 827 
cm–1; 1H NMR (400 MHz, CDCl3) δ 9.80 (t, J = 1.2 Hz, 1 H), 5.42 – 5.24 (m, 2 H), 
4.63 (t, J = 3.6 Hz, 1 H), 4.55 (m, 1 H), 4.46 (td, J = 6.4, 3.2 Hz, 1 H), 2.86 
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(ABquartet, 2 H), 2.30 – 2.11 (m, 4 H), 2.09 – 1.98 (m, 2 H), 1.38 (q, J = 6.0 Hz, 1 
H), 0.96 (t, J = 7.6 Hz, 3 H), 0.91 (s, 9 H), 0.00 (s, 3 H), –0.01 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 200.2, 131.1, 130.5, 80.0, 76.5, 63.3, 46.5, 41.2, 29.5, 27.4 (3 
C), 24.5, 20.8, 17.4, 14.3, –5.3 (2 C); HRMS (FAB) calcd for C18H34ClO2Si [M+H]+ 
345.2017, found 345.2002. 
 
Ring-Expanded Aldehyde 184.  Afforded as the minor diastereomer during 
the BDSB cyclization of 183 (see synthesis of 152).  184:  Rf = 0.45 (silica gel, 
CH2Cl2); IR (film) νmax 3026, 2963, 2930, 2854, 2731, 1721, 1556, 1458, 1100 cm–1; 
1H NMR (500 MHz, C6D6) δ 9.32 (s, 1 H), 5.52 – 5.37 (m, 2 H), 4.43 (m, 1 H), 3.81 
(ddd, J = 11.5, 5.5, 2.5 Hz, 1 H), 3.78 (ddd, J = 9.0, 4.5, 1.5 Hz, 1 H), 3.49 (td, J = 
8.5, 5.0 Hz, 1 H), 2.83 (ddd, J = 18.5, 5.0, 1.0 Hz, 1 H), 2.57 (dd, J = 18.5, 7.0 Hz, 1 
H), 2.52 (m, 1 H), 2.20 (ddd, J = 14.0, 7.0, 4.0 Hz, 1 H), 2.11 (ddd, J = 16.5, 11.0, 6.5 
Hz, 1 H), 1.75 (ddd, J = 16.0, 6.0, 2.0 Hz, 1 H), 1.54 (m, 2 H), 0.85 (t, J = 7.5 Hz, 3 
H); 13C NMR (125 MHz, CDCl3) δ 200.5, 130.1, 127.4, 79.5, 69.0, 65.3, 61.3, 49.1, 
33.8, 31.3, 28.9, 12.3. 
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